0000055785-23-000054.txt : 20230725 0000055785-23-000054.hdr.sgml : 20230725 20230725095412 ACCESSION NUMBER: 0000055785-23-000054 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230725 DATE AS OF CHANGE: 20230725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KIMBERLY CLARK CORP CENTRAL INDEX KEY: 0000055785 STANDARD INDUSTRIAL CLASSIFICATION: CONVERTED PAPER & PAPERBOARD PRODS (NO CONTAINERS/BOXES) [2670] IRS NUMBER: 390394230 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-00225 FILM NUMBER: 231106809 BUSINESS ADDRESS: STREET 1: 351 PHELPS DRIVE CITY: IRVING STATE: TX ZIP: 75038 BUSINESS PHONE: 9722811200 MAIL ADDRESS: STREET 1: P O BOX 619100 STREET 2: DFW AIRPORT STATION CITY: DALLAS STATE: TX ZIP: 75261-9100 10-Q 1 kmb-20230630.htm 10-Q FORM kmb-20230630
000005578512/312023Q2FALSE00000557852023-01-012023-06-300000055785us-gaap:CommonStockMemberexch:XNYS2023-01-012023-06-300000055785kmb:A0.625NotesDue2024Memberexch:XNYS2023-01-012023-06-3000000557852023-07-18xbrli:shares00000557852023-04-012023-06-30iso4217:USD00000557852022-04-012022-06-3000000557852022-01-012022-06-30iso4217:USDxbrli:shares00000557852023-06-3000000557852022-12-310000055785us-gaap:CommonStockMember2023-03-310000055785us-gaap:AdditionalPaidInCapitalMember2023-03-310000055785us-gaap:TreasuryStockCommonMember2023-03-310000055785us-gaap:RetainedEarningsMember2023-03-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000055785us-gaap:NoncontrollingInterestMember2023-03-3100000557852023-03-310000055785us-gaap:RetainedEarningsMember2023-04-012023-06-300000055785us-gaap:NoncontrollingInterestMember2023-04-012023-06-300000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300000055785us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000055785us-gaap:TreasuryStockCommonMember2023-04-012023-06-300000055785us-gaap:CommonStockMember2023-06-300000055785us-gaap:TreasuryStockCommonMember2023-06-300000055785us-gaap:NoncontrollingInterestMember2023-06-300000055785us-gaap:CommonStockMember2022-12-310000055785us-gaap:AdditionalPaidInCapitalMember2022-12-310000055785us-gaap:TreasuryStockCommonMember2022-12-310000055785us-gaap:RetainedEarningsMember2022-12-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000055785us-gaap:NoncontrollingInterestMember2022-12-310000055785us-gaap:RetainedEarningsMember2023-01-012023-06-300000055785us-gaap:NoncontrollingInterestMember2023-01-012023-06-300000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300000055785us-gaap:AdditionalPaidInCapitalMember2023-01-012023-06-300000055785us-gaap:TreasuryStockCommonMember2023-01-012023-06-300000055785us-gaap:AdditionalPaidInCapitalMember2023-06-300000055785us-gaap:RetainedEarningsMember2023-06-300000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000055785us-gaap:CommonStockMember2022-03-310000055785us-gaap:AdditionalPaidInCapitalMember2022-03-310000055785us-gaap:TreasuryStockCommonMember2022-03-310000055785us-gaap:RetainedEarningsMember2022-03-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000055785us-gaap:NoncontrollingInterestMember2022-03-3100000557852022-03-310000055785us-gaap:RetainedEarningsMember2022-04-012022-06-300000055785us-gaap:NoncontrollingInterestMember2022-04-012022-06-300000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000055785us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300000055785us-gaap:TreasuryStockCommonMember2022-04-012022-06-300000055785us-gaap:CommonStockMember2022-06-300000055785us-gaap:AdditionalPaidInCapitalMember2022-06-300000055785us-gaap:TreasuryStockCommonMember2022-06-300000055785us-gaap:RetainedEarningsMember2022-06-300000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000055785us-gaap:NoncontrollingInterestMember2022-06-3000000557852022-06-300000055785us-gaap:CommonStockMember2021-12-310000055785us-gaap:AdditionalPaidInCapitalMember2021-12-310000055785us-gaap:TreasuryStockCommonMember2021-12-310000055785us-gaap:RetainedEarningsMember2021-12-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000055785us-gaap:NoncontrollingInterestMember2021-12-3100000557852021-12-310000055785us-gaap:RetainedEarningsMember2022-01-012022-06-300000055785us-gaap:NoncontrollingInterestMember2022-01-012022-06-300000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300000055785us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-300000055785us-gaap:TreasuryStockCommonMember2022-01-012022-06-300000055785us-gaap:GeographicConcentrationRiskMemberkmb:KCArgentinaMemberus-gaap:SalesMember2022-01-012022-06-30xbrli:pure0000055785us-gaap:GeographicConcentrationRiskMemberkmb:KCArgentinaMemberus-gaap:SalesMember2023-01-012023-06-300000055785us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesMembercountry:TR2023-01-012023-06-300000055785us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesMembercountry:TR2022-01-012022-06-300000055785kmb:ThinxIncMember2022-02-242022-02-240000055785kmb:ThinxIncMember2022-02-2400000557852023-01-012023-03-310000055785kmb:ThinxIncMember2023-03-310000055785kmb:ThinxIncMember2023-01-012023-03-310000055785kmb:PersonalCareMemberkmb:ThinxIncMember2023-06-300000055785kmb:ThinxIncMember2022-01-012022-03-310000055785kmb:BeforeTaxMemberkmb:ThinxIncMember2022-01-012022-03-310000055785kmb:AfterTaxMemberkmb:ThinxIncMember2022-01-012022-03-310000055785kmb:ThinxIncMember2023-04-012023-06-300000055785kmb:SaleOfBrazilTissueAssetsMember2023-04-012023-06-300000055785kmb:SaleOfBrazilTissueAssetsMemberkmb:BeforeTaxMember2023-04-012023-06-300000055785kmb:SaleOfBrazilTissueAssetsMemberkmb:AfterTaxMember2023-04-012023-06-300000055785us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300000055785us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310000055785us-gaap:FairValueInputsLevel3Member2023-06-300000055785us-gaap:FairValueInputsLevel3Member2022-12-310000055785kmb:NetAssetValueorItsEquivalentMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300000055785kmb:NetAssetValueorItsEquivalentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310000055785us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2023-06-300000055785us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000055785us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2022-12-310000055785us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000055785us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-06-300000055785us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000055785us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000055785us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000055785kmb:UnrealizedTranslationMember2021-12-310000055785us-gaap:PensionPlansDefinedBenefitMember2021-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-12-310000055785kmb:UnrealizedTranslationMember2022-01-012022-06-300000055785us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-06-300000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-06-300000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-01-012022-06-300000055785kmb:UnrealizedTranslationMember2022-06-300000055785us-gaap:PensionPlansDefinedBenefitMember2022-06-300000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-06-300000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-06-300000055785kmb:UnrealizedTranslationMember2022-12-310000055785us-gaap:PensionPlansDefinedBenefitMember2022-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-12-310000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-12-310000055785kmb:UnrealizedTranslationMember2023-01-012023-06-300000055785us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-06-300000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-06-300000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-01-012023-06-300000055785kmb:UnrealizedTranslationMember2023-06-300000055785us-gaap:PensionPlansDefinedBenefitMember2023-06-300000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-06-300000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-06-300000055785us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2023-06-300000055785us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2023-06-300000055785us-gaap:NetInvestmentHedgingMember2023-06-300000055785us-gaap:NondesignatedMember2023-04-012023-06-300000055785us-gaap:NondesignatedMember2022-04-012022-06-300000055785us-gaap:NondesignatedMember2023-01-012023-06-300000055785us-gaap:NondesignatedMember2022-01-012022-06-300000055785us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-06-300000055785kmb:PersonalCareMember2023-04-012023-06-300000055785kmb:PersonalCareMember2022-04-012022-06-300000055785kmb:PersonalCareMember2023-01-012023-06-300000055785kmb:PersonalCareMember2022-01-012022-06-300000055785kmb:ConsumerTissueMember2023-04-012023-06-300000055785kmb:ConsumerTissueMember2022-04-012022-06-300000055785kmb:ConsumerTissueMember2023-01-012023-06-300000055785kmb:ConsumerTissueMember2022-01-012022-06-300000055785kmb:KCProfessionalMember2023-04-012023-06-300000055785kmb:KCProfessionalMember2022-04-012022-06-300000055785kmb:KCProfessionalMember2023-01-012023-06-300000055785kmb:KCProfessionalMember2022-01-012022-06-300000055785us-gaap:CorporateAndOtherMember2023-04-012023-06-300000055785us-gaap:CorporateAndOtherMember2022-04-012022-06-300000055785us-gaap:CorporateAndOtherMember2023-01-012023-06-300000055785us-gaap:CorporateAndOtherMember2022-01-012022-06-300000055785kmb:OtherincomeandexpensenetMember2023-04-012023-06-300000055785kmb:OtherincomeandexpensenetMember2022-04-012022-06-300000055785kmb:OtherincomeandexpensenetMember2023-01-012023-06-300000055785kmb:OtherincomeandexpensenetMember2022-01-012022-06-300000055785kmb:BabyandchildcareproductsMember2023-04-012023-06-300000055785kmb:BabyandchildcareproductsMember2022-04-012022-06-300000055785kmb:BabyandchildcareproductsMember2023-01-012023-06-300000055785kmb:BabyandchildcareproductsMember2022-01-012022-06-300000055785kmb:ConsumerTissueMember2023-04-012023-06-300000055785kmb:ConsumerTissueMember2022-04-012022-06-300000055785kmb:ConsumerTissueMember2023-01-012023-06-300000055785kmb:ConsumerTissueMember2022-01-012022-06-300000055785kmb:KCProfessionalMember2023-04-012023-06-300000055785kmb:KCProfessionalMember2022-04-012022-06-300000055785kmb:KCProfessionalMember2023-01-012023-06-300000055785kmb:KCProfessionalMember2022-01-012022-06-300000055785kmb:AllOtherMember2023-04-012023-06-300000055785kmb:AllOtherMember2022-04-012022-06-300000055785kmb:AllOtherMember2023-01-012023-06-300000055785kmb:AllOtherMember2022-01-012022-06-300000055785kmb:LifoMember2023-06-300000055785kmb:NonLifoMember2023-06-300000055785kmb:LifoMember2022-12-310000055785kmb:NonLifoMember2022-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2023
OR
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________  
Commission file number 1-225
kclogoa24.jpg
KIMBERLY-CLARK CORPORATION
(Exact name of registrant as specified in its charter)

Delaware 39-0394230
(State or other jurisdiction of
incorporation)
 (I.R.S. Employer
Identification No.)
P.O. Box 619100
Dallas, TX
75261-9100
(Address of principal executive offices)
(Zip code)
(972) 281-1200
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common StockKMBNew York Stock Exchange
0.625% Notes due 2024KMB24New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x
  Accelerated filer
Non-accelerated filer  Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      No x
As of July 18, 2023, there were 338,185,161 shares of the Corporation's common stock outstanding.



Table of Contents




PART I – FINANCIAL INFORMATION
Item 1.    Financial Statements
KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED INCOME STATEMENTS
(Unaudited)
Three Months Ended
June 30
Six Months Ended
June 30
(Millions of dollars, except per share amounts)2023202220232022
Net Sales$5,134 $5,063 $10,329 $10,158 
Cost of products sold3,403 3,534 6,872 7,109 
Gross Profit1,731 1,529 3,457 3,049 
Marketing, research and general expenses1,015 906 1,939 1,792 
Impairment of intangible assets658  658  
Other (income) and expense, net(55)2 (40)(57)
Operating Profit113 621 900 1,314 
Nonoperating expense(42)(27)(58)(31)
Interest income9 1 16 3 
Interest expense(76)(68)(149)(133)
Income Before Income Taxes and Equity Interests4 527 709 1,153 
(Provision for) benefit from income taxes32 (115)(141)(229)
Income Before Equity Interests36 412 568 924 
Share of net income of equity companies50 29 93 52 
Net Income86 441 661 976 
Net (income) loss attributable to noncontrolling interests16 (4)7 (16)
Net Income Attributable to Kimberly-Clark Corporation$102 $437 $668 $960 
Per Share Basis
Net Income Attributable to Kimberly-Clark Corporation
Basic$0.30 $1.30 $1.98 $2.85 
Diluted$0.30 $1.29 $1.97 $2.84 
See notes to the unaudited interim consolidated financial statements.

1


KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
 Three Months Ended
June 30
Six Months Ended
June 30
(Millions of dollars)2023202220232022
Net Income$86 $441 $661 $976 
Other Comprehensive Income (Loss), Net of Tax
   Unrealized currency translation adjustments(52)(267)41 (214)
   Employee postretirement benefits24 5 16 16 
   Cash flow hedges and other47 43 (31)34 
Total Other Comprehensive Income (Loss), Net of Tax19 (219)26 (164)
Comprehensive Income105 222 687 812 
   Comprehensive (income) loss attributable to noncontrolling interests20 6 12 (2)
Comprehensive Income Attributable to Kimberly-Clark Corporation$125 $228 $699 $810 
See notes to the unaudited interim consolidated financial statements.

2


KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(2023 Data is Unaudited)
(Millions of dollars)June 30, 2023December 31, 2022
ASSETS
Current Assets
Cash and cash equivalents$580 $427 
Accounts receivable, net2,359 2,280 
Inventories2,128 2,269 
Other current assets677 753 
Total Current Assets5,744 5,729 
Property, Plant and Equipment, Net7,815 7,885 
Investments in Equity Companies299 238 
Goodwill2,086 2,074 
Other Intangible Assets, Net208 851 
Other Assets1,231 1,193 
TOTAL ASSETS$17,383 $17,970 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Debt payable within one year$188 $844 
Trade accounts payable3,713 3,813 
Accrued expenses and other current liabilities2,302 2,289 
Dividends payable395 388 
Total Current Liabilities6,598 7,334 
Long-Term Debt7,947 7,578 
Noncurrent Employee Benefits639 654 
Deferred Income Taxes490 647 
Other Liabilities848 799 
Redeemable Common and Preferred Securities of Subsidiaries210 258 
Stockholders' Equity
Kimberly-Clark Corporation
Preferred stock - no par value - authorized 20.0 million shares, none issued
  
Common stock - $1.25 par value - authorized 1.2 billion shares; issued 378.6 million shares at June 30, 2023 and December 31, 2022
473 473 
Additional paid-in capital697 679 
Common stock held in treasury, at cost - 40.4 and 41.1 million shares at June 30, 2023 and December 31, 2022, respectively
(5,071)(5,137)
Retained earnings8,040 8,201 
Accumulated other comprehensive income (loss)(3,639)(3,669)
Total Kimberly-Clark Corporation Stockholders' Equity500 547 
Noncontrolling Interests151 153 
Total Stockholders' Equity651 700 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $17,383 $17,970 
See notes to the unaudited interim consolidated financial statements.
3


KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)


Three Months Ended June 30, 2023
(Millions of dollars, shares in thousands, except per share amounts)Common Stock
Issued
Additional Paid-in CapitalTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)Non-controlling InterestsTotal Stockholders' Equity
SharesAmountSharesAmount
Balance at March 31, 2023378,597 $473 $694 41,231 $(5,153)$8,365 $(3,660)$142 $861 
Net income in stockholders' equity, excludes redeemable interests' share— — — — — 102 — 10 112 
Other comprehensive income, net of tax,
excludes redeemable interests' share
— — — — — — 23 (3)20 
Stock-based awards exercised or vested— — (47)(1,069)113 — — — 66 
Shares repurchased— — — 220 (31)— — — (31)
Recognition of stock-based compensation— — 45 —  — — — 45 
Dividends declared ($1.18 per share)
— — — — — (399)—  (399)
Other— — 5 — — (28)(2)2 (23)
Balance at June 30, 2023378,597 $473 $697 40,382 $(5,071)$8,040 $(3,639)$151 $651 


Six Months Ended June 30, 2023
(Millions of dollars, shares in thousands, except per share amounts)Common Stock
Issued
Additional Paid-in CapitalTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)Non-controlling InterestsTotal Stockholders' Equity
SharesAmountSharesAmount
Balance at December 31, 2022378,597 $473 $679 41,135 $(5,137)$8,201 $(3,669)$153 $700 
Net income in stockholders' equity, excludes redeemable interests' share     668  20 688 
Other comprehensive income, net of tax, excludes redeemable interests' share      31 (6)25 
Stock-based awards exercised or vested  (59)(1,238)131    72 
Shares repurchased   485 (65)   (65)
Recognition of stock-based compensation  68      68 
Dividends declared ($2.36 per share)
     (797) (16)(813)
Other  9   (32)(1) (24)
Balance at June 30, 2023378,597 $473 $697 40,382 $(5,071)$8,040 $(3,639)$151 $651 

4


KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)


Three Months Ended June 30, 2022
(Millions of dollars, shares in thousands, except per share amounts)Common Stock
Issued
Additional Paid-in CapitalTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)Non-controlling InterestsTotal Stockholders' Equity
SharesAmountSharesAmount
Balance at March 31, 2022378,597 $473 $599 41,630 $(5,175)$7,988 $(3,180)$149 $854 
Net income in stockholders' equity, excludes redeemable interests' share — — — — 437 — 9 446 
Other comprehensive income, net of tax, excludes redeemable interests' share — — — — — (209)(9)(218)
Stock-based awards exercised or vested — (53)(841)87 — — — 34 
Shares repurchased — — 173 (23)— — — (23)
Recognition of stock-based compensation — 51 — — — — — 51 
Dividends declared ($1.16 per share)
 — — — — (392)— 1 (391)
Other — 1 — — (11)— (1)(11)
Balance at June 30, 2022378,597 $473 $598 40,962 $(5,111)$8,022 $(3,389)$149 $742 


Six Months Ended June 30, 2022
(Millions of dollars, shares in thousands, except per share amounts)Common Stock
Issued
Additional Paid-in CapitalTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)Non-controlling InterestsTotal Stockholders' Equity
SharesAmountSharesAmount
Balance at December 31, 2021378,597 $473 $605 41,762 $(5,183)$7,858 $(3,239)$223 $737 
Net income in stockholders' equity, excludes redeemable interests' share— — — — — 960 — 21 981 
Other comprehensive income, net of tax, excludes redeemable interests' share— — — — — — (150)(13)(163)
Stock-based awards exercised or vested— — (79)(1,188)122 — — — 43 
Shares repurchased— — — 388 (50)— — — (50)
Recognition of stock-based compensation— — 67 — — — — — 67 
Dividends declared ($2.32 per share)
— — — — — (783)— (81)(864)
Other— — 5 — — (13)— (1)(9)
Balance at June 30, 2022378,597 $473 $598 40,962 $(5,111)$8,022 $(3,389)$149 $742 


See notes to the unaudited interim consolidated financial statements.

5


KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED CASH FLOW STATEMENTS
(Unaudited)
Six Months Ended
June 30
(Millions of dollars)20232022
Operating Activities
Net income$661 $976 
Depreciation and amortization377 380 
Asset impairments676  
Gain on previously held equity investment in Thinx (85)
Stock-based compensation71 68 
Deferred income taxes(238)(35)
Net (gains) losses on asset and business dispositions(71)13 
Equity companies' earnings (in excess of) less than dividends paid(60)(21)
Operating working capital(35)(348)
Postretirement benefits26 (1)
Other(7)(3)
Cash Provided by Operations1,400 944 
Investing Activities
Capital spending(389)(470)
Acquisition of business, net of cash acquired (46)
Proceeds from asset and business dispositions218 1 
Investments in time deposits(388)(300)
Maturities of time deposits470 545 
Other14 (7)
Cash Used for Investing(75)(277)
Financing Activities
Cash dividends paid(790)(775)
Change in short-term debt(307)553 
Debt proceeds357  
Debt repayments(350)(300)
Proceeds from exercise of stock options96 75 
Acquisitions of common stock for the treasury(63)(49)
Cash paid for redemption of common securities of Thinx(48) 
Cash dividends paid to noncontrolling interests(16)(82)
Other(31)(42)
Cash Used for Financing(1,152)(620)
Effect of Exchange Rate Changes on Cash and Cash Equivalents(20)(6)
Change in Cash and Cash Equivalents153 41 
Cash and Cash Equivalents - Beginning of Period427 270 
Cash and Cash Equivalents - End of Period$580 $311 
See notes to the unaudited interim consolidated financial statements.

6



KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1. Accounting Policies
Basis of Presentation
The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all material adjustments which are of a normal and recurring nature necessary for a fair presentation of the results for the periods presented have been reflected. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted.
For further information, refer to the consolidated financial statements and footnotes included in our Annual Report on Form 10-K for the year ended December 31, 2022. The terms "Corporation," "Kimberly-Clark," "K-C," "we," "our" and "us" refer to Kimberly-Clark Corporation and its consolidated subsidiaries.
Highly Inflationary Accounting
GAAP guidance requires the use of highly inflationary accounting for countries whose cumulative three-year inflation exceeds 100 percent. Under highly inflationary accounting, the countries’ functional currency becomes the U.S. dollar, and its income statement and balance sheet are measured in U.S. dollars using both current and historical rates of exchange. In the second quarter of 2018, published inflation indices indicated that the three-year cumulative inflation in Argentina exceeded 100 percent, and as of July 1, 2018, we elected to adopt highly inflationary accounting for our subsidiaries in Argentina (“K-C Argentina”). The effect of changes in exchange rates on peso-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material. As of June 30, 2023, K-C Argentina had a small net peso monetary position. Net sales of K-C Argentina were approximately 1 percent of our consolidated net sales for the six months ended June 30, 2023 and 2022.
In the first quarter of 2022, published inflation indices indicated that the three-year cumulative inflation in Turkey exceeded 100 percent, and as of April 1, 2022, we elected to adopt highly inflationary accounting for our subsidiary in Turkey (“K-C Turkey”). The effect of changes in exchange rates on lira-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material. As of June 30, 2023, K-C Turkey had a small net lira monetary position. Net sales of K-C Turkey were less than 1 percent of our consolidated net sales for the six months ended June 30, 2023 and 2022.
Recently Adopted Accounting Standard
In September 2022, the Financial Accounting Standards Board issued Accounting Standard Update (“ASU”) No. 2022-04, Liabilities – Supplier Finance Programs (Subtopic 405-50). The new guidance requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. This ASU was effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the provision on roll forward information, which is effective for fiscal years beginning after December 15, 2023. We adopted this ASU as of January 1, 2023, except for the amendment on roll forward information which will be adopted January 1, 2024. As the guidance requires only additional disclosure, there were no effects of this standard on our financial position, results of operations or cash flows. See disclosure contained in Note 9.
Note 2. Acquisition and Divestiture
Acquisition
On February 24, 2022, we completed our acquisition of a majority and controlling share of Thinx Inc. (“Thinx”), an industry leader in the reusable period and incontinence underwear category, for total consideration of $181 consisting of cash of $53, the fair value of our previously held equity investment of $127, and certain share-based award costs of $1.
We previously accounted for our ownership interest in Thinx as an equity method investment, but upon increasing our ownership to 58 percent, we began consolidating the operations of Thinx into our financial statements at the end of the first quarter of 2022. The consolidated results of operations for Thinx are reported in our Personal Care business segment on a one-month lag. The share of Thinx net income and equity attributable to the third-party minority owner of Thinx is classified in our consolidated income statement within Net income attributable to noncontrolling interests and in our consolidated balance sheet
7


within Redeemable Common and Preferred Securities of Subsidiaries. This noncontrolling equity interest is measured at the estimated redemption value, which approximates fair value.
During the first quarter of 2022, we substantially completed an initial purchase price allocation in which we utilized several generally accepted valuation methodologies to estimate the fair value of certain acquired assets. The primary valuation methods included two forms of the Income Approach (i.e., the multi-period excess earnings method [distributor method] and the relief-from-royalty method). The purchase price allocation was finalized in the first quarter of 2023 with immaterial measurement period adjustments recorded.
The total purchase price consideration was allocated to the net assets acquired based upon their respective final estimated fair values as follows:
Current Assets$28 
Property, Plant and Equipment, Net2 
Goodwill298 
Other Intangible Assets, Net123 
Other Assets4 
Current Liabilities(18)
Deferred Income Taxes(18)
Other Liabilities(4)
Fair value of net assets acquired415 
Less fair value of non-controlling interest(234)
Total purchase price consideration$181 
Other Intangible Assets, Net includes brands and customer relationships which have estimated useful lives of 4 to 15 years, primarily 15 years.
Goodwill of $298 was allocated to the Personal Care business segment. The goodwill is primarily attributable to future growth opportunities and any intangible assets that did not qualify for separate recognition. For tax purposes, the acquisition of additional Thinx shares was treated as a stock acquisition, and the goodwill acquired is not tax deductible.
As a result of this transaction during the quarter ended March 31, 2022, an $85 non-recurring, non-cash gain was recognized in Other (income) expense, net as a result of the remeasurement of the carrying value of our previously held equity investment to fair value, and related transaction and integration costs of $21 were recorded in Marketing, research and general expenses. This recognition resulted in a net benefit of $64 pre-tax ($68 after tax) being included in our consolidated income statement for the quarter ended March 31, 2022. In addition, we removed the non-cash gain impact from Operating Activities in our consolidated cash flow statements for the six months ended June 30, 2022.
In the first quarter of 2023, we delivered a redemption notice to the third-party minority owner with respect to a portion of the remaining common securities of Thinx and reclassified $48 to Accrued expenses and other current liabilities from Redeemable Common and Preferred Securities. This redemption closed in the second quarter of 2023, and we acquired additional ownership of Thinx for $48, increasing our controlling ownership to 70 percent. As the purchase of additional ownership in an already controlled subsidiary represents an equity transaction, no gain or loss was recognized in consolidated net income or comprehensive income, and the transaction was recorded through a reduction in Accrued expenses and other current liabilities.
Divestiture
On June 1, 2023, we completed the sale transaction, announced on October 24, 2022, of our Neve tissue brand and related consumer and K-C Professional tissue assets in Brazil for $212, including the base purchase price of $175 and preliminary working capital and other closing adjustments of $37. This transaction also included a licensing agreement to allow the acquirer to manufacture and market in Brazil the Kleenex, Scott and Wypall brands to consumers and away-from-home customers for a period of time. The assets included in the sale agreement were reclassified to Other current assets as of December 31, 2022, and upon closure of the transaction, a gain of $74 pre-tax was recognized in Other (income) and expense, net. We incurred divestiture-related costs of $30 pre-tax during the three months ended June 30, 2023, which were recorded in Cost of products sold and Marketing, research and general expenses, resulting in a net benefit of $44 pre-tax ($26 after tax).

8


Note 3. Impairment of Intangible Assets
In the second quarter of 2023, we conducted forecasting and strategic reviews and integration assessments of our Softex Indonesia business, acquired in the fourth quarter of 2020, and with performance below expectations since acquisition, we revised internal financial projections of the business to reflect updated expectations of future financial performance. These reviews and the subsequent revisions in the projections highlighted challenges for the Softex business arising from modified consumer shopping behavior in the post-COVID-19 period, inflationary pressures and other macroeconomic factors and increased competitive activity in the region. As a result of separate management reviews, we also have revised internal financial projections associated with our acquisition of a controlling interest in Thinx as a result of performance below expectations due to the impact of modified consumer shopping behavior in the post-COVID-19 period.
These revisions were considered triggering events requiring interim impairment assessments to be performed relative to the intangible assets that had been recorded as part of these acquisitions. These intangible assets were recorded as part of the Personal Care business segment and included indefinite-lived and finite-lived brands and finite-lived distributor and customer relationships. As a result of the interim impairment assessments, we recognized impairment charges, principally arising from the impairment charge of $593 related to the Softex business, totaling $658 pre-tax ($483 after tax) to write-down these intangible assets to their respective fair values aggregating to $188 as of June 30, 2023. The valuation methods used in the assessments included the relief from royalty and distributor and customer relationships methods. This noncash charge was included in Impairment of intangible assets in our consolidated income statement and in Asset impairments within Operating Activities in our consolidated cash flow statement.
We believe our estimates and assumptions used in the valuations are reasonable and comparable to those that would be used by other market participants; however, actual events and results could differ substantially from those used in the valuation, and to the extent such factors result in a failure to achieve the projected cash flows used to estimate fair value, additional noncash impairment charges could be required in the future.
Note 4. Fair Value Information
The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are:
Level 1 – Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities.
Level 2 – Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly.
Level 3 – Prices or valuations that require inputs that are significant to the valuation and are unobservable.
A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
During the six months ended June 30, 2023 and for the full year 2022, there were no significant transfers to or from level 3 fair value determinations.
Derivative assets and liabilities are measured on a recurring basis at fair value. At June 30, 2023 and December 31, 2022, derivative assets were $89 and $99, respectively, and derivative liabilities were $328 and $318, respectively. The fair values of derivatives used to manage interest rate risk are based on the Secured Overnight Financing Rate ("SOFR") as of June 30, 2023, and on LIBOR rates as of December 31, 2022, and interest rate swap curves. The fair values of derivatives used to manage commodity price risk are based on commodity price quotations. The fair values of hedging instruments used to manage foreign currency risk are based on published quotations of spot currency rates and forward points, which are converted into implied forward currency rates. Measurement of our derivative assets and liabilities is considered a level 2 measurement. Additional information on our classification and use of derivative instruments is contained in Note 7.
Redeemable common and preferred securities of subsidiaries are measured on a recurring basis at their estimated redemption values, which approximate fair value. As of June 30, 2023 and December 31, 2022, the securities were valued at $210 and $258, respectively. The securities are not traded in active markets, and their measurement is considered a level 3 measurement. In the first quarter of 2023, we delivered a redemption notice to the third-party minority owner with respect to a portion of the remaining common securities of Thinx, and the amount associated with the expected redemption was reclassified to Accrued expenses and other current liabilities, reducing our outstanding redeemable common securities by $48. In the second quarter of 2023, we closed on the redemption. Additional information on this transaction is contained in Note 2.
9


Company-owned life insurance ("COLI") assets are measured on a recurring basis at fair value. COLI assets were $65 and $63 at June 30, 2023 and December 31, 2022, respectively. The COLI policies are a source of funding primarily for our nonqualified employee benefits and are included in Other Assets. The COLI policies are measured at fair value using the net asset value per share practical expedient, and therefore, are not classified in the fair value hierarchy.
The following table includes the fair value of our financial instruments for which disclosure of fair value is required:
Fair Value Hierarchy LevelCarrying AmountEstimated Fair ValueCarrying AmountEstimated Fair Value
June 30, 2023December 31, 2022
Assets
Cash and cash equivalents(a)
1$580 $580 $427 $427 
Time deposits(b)
1182 182 268 268 
Liabilities
Short-term debt(c)
267 67 373 373 
Long-term debt(d)
28,068 7,530 8,049 7,403 
(a)Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.
(b)Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value.
(c)Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.
(d)Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.
Note 5. Earnings Per Share ("EPS")
There are no adjustments required to be made to net income for purposes of computing basic and diluted EPS. The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows:
Three Months Ended
June 30
Six Months Ended
June 30
(Millions of shares)2023202220232022
Basic338.0 337.4 337.7 337.2 
Dilutive effect of stock options and restricted share unit awards0.9 0.9 1.0 1.1 
Diluted338.9 338.3 338.7 338.3 
The impact of options outstanding that were not included in the computation of diluted EPS because their exercise price was greater than the average market price of the common shares was insignificant. The number of common shares outstanding as of June 30, 2023 and 2022 was 338.2 million and 337.6 million, respectively.
Note 6. Stockholders' Equity
Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in Accumulated Other Comprehensive Income ("AOCI"). For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation.
Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.
The change in net unrealized currency translation for the six months ended June 30, 2023 was primarily due to the strengthening of certain foreign currencies versus the U.S. dollar.
10


The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows:
Unrealized TranslationDefined Benefit Pension PlansOther Postretirement Benefit PlansCash Flow Hedges and Other
Balance as of December 31, 2021$(2,422)$(803)$(34)$20 
Other comprehensive income (loss) before reclassifications
(199)(11)(3)42 
(Income) loss reclassified from AOCI 30 (a) (a)(9)
Net current period other comprehensive income (loss)(199)19 (3)33 
Balance as of June 30, 2022$(2,621)$(784)$(37)$53 
Balance as of December 31, 2022$(2,769)$(789)$52 $(163)
Other comprehensive income (loss) before
    reclassifications
46 (18)(1)(103)
(Income) loss reclassified from AOCI 35 (a) (a)71 
Net current period other comprehensive income (loss)46 17 (1)(32)
Balance as of June 30, 2023$(2,723)$(772)$51 $(195)
(a)    Included in computation of net periodic benefit costs.
Note 7. Objectives and Strategies for Using Derivatives
As a multinational enterprise, we are exposed to financial risks, such as changes in foreign currency exchange rates, interest rates, and commodity prices. We employ a number of practices to manage these risks, including operating and financing activities and, where appropriate, the use of derivative instruments.
At June 30, 2023 and December 31, 2022, derivative assets were $89 and $99, respectively, and derivative liabilities were $328 and $318, respectively, primarily comprised of foreign currency exchange and commodity price contracts. Derivative assets are recorded in Other current assets or Other Assets, as appropriate, and derivative liabilities are recorded in Accrued expenses and other current liabilities or Other Liabilities, as appropriate.
Foreign Currency Exchange Rate Risk
Translation adjustments result from translating foreign entities' financial statements into U.S. dollars from their functional currencies. The risk to any particular entity's net assets is reduced to the extent that the entity is financed with local currency borrowings. A portion of our balance sheet translation exposure for certain affiliates, which results from changes in translation rates between the affiliates’ functional currencies and the U.S. dollar, is hedged with cross-currency swap contracts and certain foreign denominated debt which are designated as net investment hedges. The foreign currency exposure on certain non-functional currency denominated monetary assets and liabilities, primarily intercompany loans and accounts payable, is hedged with primarily undesignated derivative instruments.
Derivative instruments are entered into to hedge a portion of forecasted cash flows denominated in foreign currencies for non-U.S. operations' purchases of raw materials, which are priced in U.S. dollars, and imports of intercompany finished goods and work-in-process priced predominantly in U.S. dollars and euros. The derivative instruments used to manage these exposures are designated as cash flow hedges.
Interest Rate Risk
Interest rate risk is managed using a portfolio of variable and fixed-rate debt composed of short and long-term instruments. Interest rate swap contracts may be used to facilitate the maintenance of the desired ratio of variable and fixed-rate debt and are designated as fair value hedges. From time to time, we also hedge the anticipated issuance of fixed-rate debt, and these contracts are designated as cash flow hedges.
Commodity Price Risk
We use derivative instruments, such as forward contracts, to hedge a portion of our exposure to market risk arising from changes in prices of certain commodities. These derivatives are designated as cash flow hedges of specific quantities of the underlying commodity expected to be purchased in future months. In addition, we utilize negotiated contracts of varying durations along with strategic pricing mechanisms to manage volatility for a portion of our commodity costs.
11


Fair Value Hedges
Derivative instruments that are designated and qualify as fair value hedges are predominantly used to manage interest rate risk. The fair values of these interest rate derivative instruments are recorded as an asset or liability, as appropriate, with the offset recorded in Interest expense. The offset to the change in fair values of the related debt is also recorded in Interest expense. Any realized gain or loss on the derivatives that hedge interest rate risk is amortized to Interest expense over the life of the related debt. As of June 30, 2023, the aggregate notional values and carrying values of debt subject to outstanding interest rate contracts designated as fair value hedges were $525 and $471, respectively. For the six months ended June 30, 2023 and 2022, gains or losses recognized in Interest expense for interest rate swaps were not significant.
Cash Flow Hedges
For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same income statement line and period that the hedged exposure affects earnings. As of June 30, 2023, outstanding commodity forward contracts were in place to hedge a portion of our estimated requirements of the related underlying commodities in the remainder of 2023 and future periods. As of June 30, 2023, the aggregate notional value of outstanding foreign exchange derivative contracts designated as cash flow hedges was $2.8 billion. For the six months ended June 30, 2023 and 2022, no significant gains or losses were reclassified into Interest expense, Cost of products sold or Other (income) and expense, net as a result of the discontinuance of cash flow hedges due to the original forecasted transaction no longer being probable of occurring. At June 30, 2023, amounts to be reclassified from AOCI into Interest expense, Cost of products sold or Other (income) and expense, net during the next twelve months are not expected to be material. The maximum maturity of cash flow hedges in place at June 30, 2023 is June 2026.
Net Investment Hedges
For derivative instruments that are designated and qualify as net investment hedges, the aggregate notional value was $1.7 billion at June 30, 2023. We exclude the interest accruals on cross-currency swap contracts and the forward points on foreign exchange forward contracts from the assessment and measurement of hedge effectiveness.  We recognize the interest accruals on cross-currency swap contracts in earnings within Interest expense.  We amortize the forward points on foreign exchange contracts into earnings within Interest expense over the life of the hedging relationship.  Changes in fair value of net investment hedges are recorded in AOCI and offset the change in the value of the net investment being hedged.  For the six months ended June 30, 2023, unrealized losses of $15 related to net investment hedge fair value changes were recorded in AOCI and no significant amounts were reclassified from AOCI to Interest expense.
No significant amounts were excluded from the assessment of net investment, fair value or cash flow hedge effectiveness as of June 30, 2023.
Undesignated Hedging Instruments
Gains or losses on undesignated foreign exchange hedging instruments are immediately recognized in Other (income) and expense, net. Losses of $14 and $1 were recorded in the three months ended June 30, 2023 and 2022, respectively. Losses of $6 and $35 were recorded in the six months ended June 30, 2023 and 2022. The effect on earnings from the use of these non-designated derivatives is substantially neutralized by the transactional gains and losses recorded on the underlying assets and liabilities. At June 30, 2023, the notional value of these undesignated derivative instruments was approximately $2.6 billion.
Note 8. Business Segment Information
We are organized into operating segments based on product groupings. These operating segments have been aggregated into three reportable global business segments: Personal Care, Consumer Tissue and K-C Professional. The reportable segments were determined in accordance with how our chief operating decision maker and our executive managers develop and execute global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit.
12


Segment operating profit excludes Other (income) and expense, net and income and expense not associated with ongoing operations of the business segments.
The principal sources of revenue in each global business segment are described below:
Personal Care brands offer our consumers a trusted partner in caring for themselves and their families by delivering confidence, protection and discretion through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products.  Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex and other brand names.
Consumer Tissue offers a wide variety of innovative solutions and trusted brands that responsibly improve everyday living for families around the world.  Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Andrex, Viva, Scottex and other brand names.
K-C Professional partners with businesses to create Exceptional Workplaces, helping to make them healthier, safer and more productive through a range of solutions and supporting products such as wipers, tissue, towels, apparel, soaps and sanitizers. Our brands, including Kleenex, Scott, WypAll, Kimtech and KleenGuard are well known for quality and trusted to help people around the world work better.
Information concerning consolidated operations by business segment is presented in the following tables:
Three Months Ended June 30Six Months Ended June 30
20232022Change20232022Change
NET SALES
Personal Care$2,685 $2,710 -1 %$5,389 $5,439 -1 %
Consumer Tissue1,549 1,537 +1 %3,183 3,105 +3 %
K-C Professional887 802 +11 %1,734 1,582 +10 %
Corporate & Other13 14 N.M.23 32 N.M.
TOTAL NET SALES$5,134 $5,063 +1 %$10,329 $10,158 +2 %
OPERATING PROFIT
Personal Care$472 $466 +1 %$959 $941 +2 %
Consumer Tissue200 178 +12 %440 349 +26 %
K-C Professional187 85 +120 %346 175 +98 %
Corporate & Other(a)
(801)(106)N.M.(885)(208)N.M.
Other (income) and expense, net(a)
(55)2 N.M.(40)(57)-30 %
TOTAL OPERATING PROFIT$113 $621 -82 %$900 $1,314 -32 %
(a)    Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.
N.M. - Not Meaningful
Sales of Principal Products:
Three Months Ended June 30Six Months Ended June 30
(Billions of dollars)2023202220232022
Baby and child care products$1.8 $1.9 $3.5 $3.7 
Consumer tissue products1.5 1.5 3.2 3.1 
Away-from-home professional products0.9 0.8 1.7 1.6 
All other0.9 0.9 1.9 1.8 
Consolidated$5.1 $5.1 $10.3 $10.2 
13


Note 9. Supplemental Balance Sheet Data
The following schedule presents a summary of inventories by major class:
June 30, 2023December 31, 2022
LIFONon-LIFOTotalLIFONon-LIFOTotal
Raw materials$139 $363 $502 $147 $425 $572 
Work in process113 107 220 139 107 246 
Finished goods532 770 1,302 518 870 1,388 
Supplies and other 315 315  302 302 
784 1,555 2,339 804 1,704 2,508 
Excess of FIFO or weighted-average cost over
  LIFO cost
(211) (211)(239) (239)
Total$573 $1,555 $2,128 $565 $1,704 $2,269 
Inventories are valued at the lower of cost or net realizable value, determined on the FIFO or weighted-average cost methods, and at the lower of cost or market, determined on the LIFO cost method.
The following schedule presents a summary of property, plant and equipment, net:
June 30, 2023December 31, 2022
Land$159 $156 
Buildings3,046 3,062 
Machinery and equipment14,778 14,655 
Construction in progress741 676 
18,724 18,549 
Less accumulated depreciation(10,909)(10,664)
Total$7,815 $7,885 
Supplier Finance Program
We have a supplier finance program managed through two global financial institutions under which we agree to pay the financial institutions the stated amount of confirmed invoices from our participating suppliers on the invoice due date. We, or the global financial institutions, may terminate our agreements at any time upon 30 days written notice. The global financial institutions may terminate our agreements at any time upon three days written notice in the event there are insufficient funds available for disbursement. We do not provide any forms of guarantees under these agreements. Supplier participation in the program is solely up to the supplier, and the participating suppliers negotiate their arrangements directly with the global financial institutions. We have no economic interest in a supplier’s decision to participate in the program, and their participation has no bearing on our payment terms or amounts due. The payment terms that we have with our suppliers under this program generally range from 75 to 180 days and are considered commercially reasonable. The outstanding amount related to the suppliers participating in this program was $1.0 billion as of June 30, 2023 and December 31, 2022, and was recorded within Trade accounts payable.
14


Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations
Introduction
This management's discussion and analysis ("MD&A") of financial condition and results of operations is intended to provide investors with an understanding of our recent performance, financial condition and prospects.  Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted. The following will be discussed and analyzed:
Overview of Second Quarter 2023 Results
Results of Operations and Related Information
Liquidity and Capital Resources
Information Concerning Forward-Looking Statements
We describe our business outside North America in two groups – Developing and Emerging Markets ("D&E") and Developed Markets. D&E markets comprise Eastern Europe, the Middle East and Africa, Latin America and Asia-Pacific, excluding Australia and South Korea. Developed Markets consist of Western and Central Europe, Australia and South Korea. We have three reportable business segments: Personal Care, Consumer Tissue and K-C Professional. These business segments are described in greater detail in Note 8 to the unaudited interim consolidated financial statements.
On February 24, 2022, we completed our acquisition of a majority and controlling share of Thinx Inc. (“Thinx”), an industry leader in the reusable period and incontinence underwear category, for total consideration of $181 consisting of cash of $53, the fair value of our previously held equity investment of $127, and certain share-based award costs of $1. In the first quarter of 2023, we delivered a redemption notice to the third-party minority owner with respect to a portion of the remaining common securities of Thinx. This redemption closed in the second quarter of 2023, and we acquired additional ownership of Thinx for $48, increasing our ownership to 70 percent. As the purchase of additional ownership in an already controlled subsidiary represents an equity transaction, no gain or loss was recognized in consolidated net income or comprehensive income.

On June 1, 2023, we completed the sale transaction, announced on October 24, 2022, of our Neve tissue brand and related consumer and K-C Professional tissue assets in Brazil for $212, including the base purchase price of $175 and preliminary working capital and other closing adjustments of $37. This transaction also included a licensing agreement to allow the acquirer to manufacture and market in Brazil the Kleenex, Scott and Wypall brands to consumers and away-from-home customers for a period of time. The assets included in the sale agreement were reclassified to Other current assets as of December 31, 2022, and upon closure of the transaction, a gain of $74 pre-tax was recognized in Other (income) and expense, net. We incurred divestiture-related costs of $30 pre-tax during the three months ended June 30, 2023, which were recorded in Cost of products sold and Marketing, research and general expenses, resulting in a net benefit of $44 pre-tax ($26 after tax).
Beginning in March 2022, we have implemented significant adjustments to our business in Russia. We have substantially curtailed media, advertising and promotional activity and suspended capital investments in our sole manufacturing facility in Russia. Consistent with the humanitarian nature of our products, we manufacture and sell only essential items in Russia, such as baby diapers and feminine pads, which are critical to the health and hygiene of women, girls and babies. Our Russia business has represented approximately 1 to 3 percent of our net global sales, operating profit and total assets. Our ability to continue our operations in Russia may change as the situation evolves. Our business in Russia is experiencing increased input costs, supply chain complexities, reduced consumer demand and restricted access to financial institutions, as well as increased monetary, currency and payment controls. We are actively monitoring the situation, and as the business, geopolitical and regulatory environment concerning Russia evolves, we may not be able to sustain the limited manufacture and sale of our products, and our assets may be partially or fully impaired. We are also monitoring the increased risk of cyber-based attacks as a result of the war in Ukraine and have implemented additional cybersecurity measures designed to address the evolving threat landscape.
This section presents a discussion and analysis of our second quarter 2023 net sales, operating profit and other information relevant to an understanding of the results of operations. In addition, we provide commentary regarding organic sales growth, which describes the impact of changes in volume, net selling prices and product mix on net sales. Changes in foreign currency exchange rates and acquisitions also impact the year-over-year change in net sales. Revenue growth management is used to describe our capability that drives sustainable profit growth by maximizing our brands' revenue potential with consumer-centric insights. It focuses on strategic pricing decisions, price pack architecture, managing our product mix, trade promotion activity and trading terms. Our analysis compares the three and six months ended June 30, 2023 results to the same periods in 2022.
15


Throughout this MD&A, we refer to financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S., or GAAP, and are therefore referred to as non-GAAP financial measures. These measures include adjusted gross and operating profit, adjusted other (income) and expense, adjusted net income, adjusted earnings per share, and net and adjusted effective tax rate. We believe these measures provide our investors with additional information about our underlying results and trends, as well as insight into some of the financial measures used to evaluate management.
Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measures, and they should be read only in conjunction with our unaudited interim consolidated financial statements prepared in accordance with GAAP.  There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded.  We compensate for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures.
The non-GAAP financial measures exclude the following items for the relevant time periods as indicated in the reconciliations included later in this MD&A:
Sale of Brazil tissue and K-C Professional business - In the second quarter of 2023, we recognized a net benefit related to the sale of our Brazil tissue and K-C Professional business. See Item 1, Note 2 to the unaudited interim consolidated financial statements for details.
Impairment of intangible assets - In the second quarter of 2023, we recognized charges related to the impairment of certain intangible assets related to Softex Indonesia and Thinx. See Item 1, Note 3 to the unaudited interim consolidated financial statements for details.
Pension settlements - In the second quarter of 2023 and 2022, pension settlement charges were recognized related to lump-sum distributions from pension plan assets exceeding the total of annual service and interest costs resulting in a recognition of deferred actuarial losses.
Acquisition of controlling interest in Thinx – In the first quarter of 2022, we increased our investment in Thinx. As a result of this transaction, a net benefit was recognized primarily due to the non-recurring, non-cash gain recognized related to the remeasurement of the carrying value of our previously held equity investment to fair value partially offset by transaction and integration costs. See Item 1, Note 2 to the unaudited interim consolidated financial statements for details.
Overview of Second Quarter 2023 Results
Net sales of $5.1 billion increased 1 percent compared to the year-ago period, including organic sales growth of 5 percent.
Operating profit was $113 in 2023 and $621 in 2022. Net Income Attributable to Kimberly-Clark Corporation was $102 in 2023 compared to $437 in 2022, and diluted earnings per share were $0.30 in 2023 compared to $1.29 in 2022. Results in 2023 include the net benefit related to the sale of the Brazil tissue and K-C Professional business, charges related to the impairment of intangible assets and pension settlement charges, compared to 2022 results which include pension settlement charges.
Results of Operations and Related Information
This section presents a discussion and analysis of our second quarter 2023 net sales, operating profit and other information relevant to an understanding of the results of operations.
16


Consolidated
Selected Financial ResultsThree Months Ended June 30Six Months Ended June 30
20232022Percent Change20232022Percent Change
Net Sales:
North America$2,782 $2,657 +5 %$5,512 $5,271 +5 %
Outside North America2,424 2,479 -2 %4,946 5,025 -2 %
Intergeographic sales(72)(73)-1 %(129)(138)-7 %
Total Net Sales5,134 5,063 +1 %10,329 10,158 +2 %
Operating Profit:
North America615 497 +24 %1,189 956 +24 %
Outside North America244 232 +5 %556 509 +9 %
Corporate & Other(a)
(801)(106)N.M.(885)(208)N.M.
Other (income) and expense, net(a)
(55)N.M.(40)(57)-30 %
Total Operating Profit113 621 -82 %900 1,314 -32 %
Share of net income of equity companies50 29 +72 %93 52 +79 %
Net Income Attributable to Kimberly-Clark Corporation
102 437 -77 %668 960 -30 %
Diluted Earnings per Share0.30 1.29 -77 %1.97 2.84 -31 %
(a) Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including adjustments as indicated in the Non-GAAP Reconciliations.
N.M. - Not Meaningful
GAAP to Non-GAAP Reconciliations of Selected Financial Results
Three Months Ended June 30, 2023
As
Reported
Sale of Brazil Tissue and K-C Professional BusinessImpairment of Intangible AssetsPension SettlementsAs
Adjusted
Non-GAAP
Cost of products sold$3,403 $15 $ $ $3,388 
Gross Profit1,731 (15)  1,746 
Marketing, research and general expenses1,015 15   1,000 
Impairment of intangible assets658  658   
Other (income) and expense, net(55)(74)  19 
Operating Profit113 44 (658) 727 
Nonoperating expense(42)  (27)(15)
(Provision for) benefit from income taxes32 (18)175 7 (132)
Effective tax rateN.M.   20.5 %
Net (income) loss attributable to noncontrolling interests16  20  (4)
Net Income Attributable to Kimberly-Clark
  Corporation
102 26 (463)(20)559 
Diluted Earnings per Share(a)
0.30 0.08 (1.36)(0.06)1.65 
17


Three Months Ended June 30, 2022
As
Reported
Pension SettlementsAs
Adjusted
Non-GAAP
Nonoperating expense$(27)$(24)$(3)
Provision for income taxes(115)(121)
Effective tax rate21.8 %22.0 %
Net Income Attributable to Kimberly-Clark Corporation437 (18)455 
Diluted Earnings per Share(a)
1.29 (0.05)1.34 
Six Months Ended June 30, 2023
As
Reported
Sale of Brazil Tissue and K-C Professional BusinessImpairment of Intangible Assets Pension SettlementsAs
Adjusted
Non-GAAP
Cost of products sold$6,872 $15 $ $ $6,857 
Gross Profit3,457 (15)  3,472 
Marketing, research and general expenses1,939 15   1,924 
Impairment of intangible assets658  658   
Other (income) and expense, net(40)(74)  34 
Operating Profit900 44 (658) 1,514 
Nonoperating expense(58)  (27)(31)
Provision for income taxes(141)(18)175 7 (305)
Effective tax rate19.9 %   22.6 %
Net (income) loss attributable to noncontrolling interests7  20  (13)
Net Income Attributable to Kimberly-Clark
  Corporation
668 26 (463)(20)1,125 
Diluted Earnings per Share(a)
1.97 0.08 (1.36)(0.06)3.32 
Six Months Ended June 30, 2022
As
Reported
Acquisition of Controlling Interest in ThinxPension SettlementsAs
Adjusted
Non-GAAP
Marketing, research and general expenses$1,792 $21 $— $1,771 
Other (income) and expense, net(57)(85)— 28 
Operating Profit1,314 64 — 1,250 
Nonoperating expense(31)(24)(7)
Provision for income taxes(229)(239)
Effective tax rate19.9 %— 21.5 %
Net Income Attributable to Kimberly-Clark Corporation960 68 (18)910 
Diluted Earnings per Share(a)
2.84 0.20 (0.05)2.69 
(a) "As Adjusted Non-GAAP" may not equal "As Reported" plus "Adjustments" as a result of rounding.
N.M. - Not Meaningful
18


Analysis of Consolidated Results
Percent Change in Net Sales Three Months EndedVolumeNet PriceMix/Other
Exited Business(e)
Currency
Total(a)
Organic(b)
Consolidated(3)81(4)15
North America656
Developed & Emerging(5)101(1)(9)(4)6
Developed Markets(8)111(4)4
Percent Change in Net Sales Six Months EndedVolumeNet PriceMix/Other
Exited Business(e)
Currency
Total(a)
Organic(b)
Consolidated(4)91(4)25
North America(1)655
Developed & Emerging(7)112(1)(8)(4)5
Developed Markets(7)131(5)17
Percent Change in
Adjusted Operating Profit
VolumeNet PriceInput Costs
Cost Savings(c)
Currency Translation
Other(d)
Total
Three months ended(11)65(5)13(5)(40)17
Six months ended(10)72(15)15(5)(36)21
(a)    Total may not equal the sum of volume, net price, mix/other, acquisition and currency due to rounding and excludes intergeographic sales.
(b)    Combined impact of changes in volume, net price and mix/other.
(c)    Benefits of the FORCE (Focused On Reducing Costs Everywhere) program.
(d)    Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
(e)    Impact of the sale of Brazil tissue and K-C Professional business.
Net sales in the second quarter of $5.1 billion increased 1 percent. Organic sales increased 5 percent as changes in net selling prices and product mix increased sales by 8 percent and 1 percent, respectively, driven by ongoing revenue growth management programs, while volume decreased 3 percent. Changes in foreign currency exchange rates decreased sales by approximately 4 percent.
In North America, net sales increased 5 percent, with Personal Care consistent with the prior year and increases of 7 percent in Consumer Tissue and 16 percent in K-C Professional. Organic sales increased 6 percent, including increases of 1 percent in Personal Care, 7 percent in Consumer Tissue and 17 percent in K-C Professional. Outside North America, net sales decreased 4 percent in D&E Markets and Developed Markets were consistent with the prior year. Organic sales were up 6 percent in D&E Markets and 4 percent in Developed Markets.
Operating profit in the second quarter was $113 in 2023 and $621 in 2022. Results in 2023 include the net benefit related to the sale of the Brazil tissue and K-C Professional business and charges related to the impairment of intangible assets. Adjusted operating profit was $727 in 2023. Results benefited from higher net selling prices and $80 in FORCE cost savings, partially offset by higher marketing, research and general expenses, unfavorable currency effects, higher other manufacturing costs, lower volumes and $30 of higher input costs.
Interest expense in the second quarter was $76 in 2023 compared to $68 in 2022 primarily due to higher weighted average interest rate on outstanding debt.
The second quarter effective tax rate was driven by a net benefit from income taxes of $32, which primarily reflected the net income tax expense benefit associated with charges for the impairment of intangible assets. The second quarter adjusted effective tax rate was 20.5 percent in 2023 and 22.0 percent in 2022. The lower adjusted rate in 2023 benefited from certain tax planning initiatives.
Our share of net income of equity companies in the second quarter was $50 in 2023 and $29 in 2022. The increase was primarily driven by Kimberly-Clark de Mexico, S.A.B. de C.V. results which benefited from increases in net selling prices and favorable currency effects, partially offset by higher input costs.
Diluted net income per share for the second quarter was $0.30 in 2023 and $1.29 in 2022. Second quarter adjusted earnings per share were $1.65 in 2023, an increase of 23 percent compared to $1.34 in 2022.
19


Year-to-date net sales of $10.3 billion increased 2 percent compared to the year ago period. Organic sales increased 5 percent, as changes in net selling prices and product mix increased sales by 9 percent and 1 percent, respectively, driven by ongoing revenue growth management programs, while volumes decreased 4 percent. Changes in foreign currency exchange rates decreased sales by approximately 4 percent. Year-to-date operating profit was $900 in 2023 and $1,314 in 2022. Results in 2023 include the net benefit related to the sale of the Brazil tissue and K-C Professional business and charges related to the impairment of intangible assets, compared to 2022 results which include the net benefit of the acquisition of a controlling interest in Thinx. Year-to-date adjusted operating profit was $1,514 in 2023 and $1,250 in 2022. Results benefited from higher net selling prices and $185 in FORCE cost savings, partially offset by higher marketing, research and general expenses, $190 in higher input costs, higher other manufacturing costs, unfavorable foreign currency effects and lower volumes. Through six months, diluted net income per share was $1.97 in 2023 and $2.84 in 2022. Year-to-date adjusted earnings per share were $3.32 in 2023 and $2.69 in 2022.
Results by Business Segments
Personal Care
Three Months Ended June 30Six Months Ended June 30


Three Months Ended June 30Six Months Ended June 30
20232022202320222023202220232022
Net Sales$2,685 $2,710 $5,389 $5,439 Operating Profit$472 $466 $959 $941 
Percent Change in Net Sales Three Months EndedVolumeNet PriceMix/OtherAcquisitionCurrency
Total(a)
Organic(b)
Total Personal Care(3)61(5)(1)4
North America(3)3(1)1
D&E Markets(3)102(11)(2)9
Developed Markets(6)81(6)(2)4
Percent Change in Net Sales Six Months EndedVolumeNet PriceMix/Other
Acquisition(e)
Currency
Total(a)
Organic(b)
Total Personal Care(4)71(5)(1)3
North America(2)31(1)11
D&E Markets(7)102(9)(3)6
Developed Markets(5)81(6)(2)4
Percent Change in
Operating Profit
VolumeNet PriceInput Costs
Cost Savings(c)
Currency Translation
Other(d)
Total
Three months ended(8)37(5)8(6)(25)1
Six months ended(7)39(6)6(6)(24)2
(a)    Total may not equal the sum of volume, net price, mix/other, acquisition and currency due to rounding and excludes intergeographic sales.
(b)    Combined impact of changes in volume, net price and mix/other.
(c)    Benefits of the FORCE program.
(d)    Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
(e)    Impact of the acquisition of Thinx Inc.
Net sales in the second quarter of $2.7 billion decreased 1 percent, while organic sales increased 4 percent, driven by changes in net selling prices and product mix of 6 percent and 1 percent, respectively, partially offset by decreased volume of 3 percent. Successful revenue growth management and commercial execution contributed to favorable trends in net revenue realization. Changes in foreign currency exchange rates decreased sales by 5 percent.
Second quarter operating profit of $472 increased 1 percent. Results benefited from higher net selling prices and cost savings, partially offset by higher marketing, research and general expenses, unfavorable currency effects, lower volumes and higher input costs.
20


Consumer Tissue

Three Months Ended June 30Six Months Ended June 30


Three Months Ended June 30Six Months Ended June 30
20232022202320222023202220232022
Net Sales$1,549 $1,537 $3,183 $3,105 Operating Profit$200 $178 $440 $349 
Percent Change in Net Sales
Three Months Ended
VolumeNet PriceMix/Other
Exited Business(e)
Currency
Total(a)
Organic(b)
Total Consumer Tissue(4)8(1)(2)14
North America2677
D&E Markets(11)9(5)(4)(11)(1)
Developed Markets(9)10(3)(2)1
Percent Change in Net Sales
Six Months Ended
VolumeNet PriceMix/Other
Exited Business(e)
Currency
Total(a)
Organic(b)
Total Consumer Tissue(4)9(1)(2)35
North America(1)766
D&E Markets(10)11(3)(4)(5)2
Developed Markets(6)14(5)27
Percent Change in
Operating Profit
VolumeNet PriceInput Costs
Cost Savings(c)
Currency Translation
Other(d)
Total
Three months ended(7)67(12)71(44)12
Six months ended(9)84(34)22(1)(36)26
(a)    Total may not equal the sum of volume, net price, mix/other and currency due to rounding and excludes intergeographic sales.
(b)    Combined impact of changes in volume, net price and mix/other.
(c)    Benefits of the FORCE program.
(d)    Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
(e)    Impact of the sale of Brazil tissue and K-C Professional business.
Net sales in the second quarter of $1.5 billion increased 1 percent, including organic sales growth of 4 percent driven by changes in net selling prices that increased sales by 8 percent, partially offset by decreased volume of 4 percent. Organic sales growth of 7 percent in North America led the increase with changes in net selling prices and higher volumes increasing sales by 6 percent and 2 percent, respectively. Successful revenue growth management and improving service levels contributed to the growth in net sales. Changes in foreign currency exchange rates decreased sales by 2 percent, and exited business decreased sales by 1 percent.
Second quarter operating profit of $200 increased 12 percent. Results benefited from higher net selling prices and cost savings, partially offset by higher other manufacturing costs, input cost inflation and higher marketing, research and general expenses.
21


K-C Professional

Three Months Ended June 30Six Months Ended June 30


Three Months Ended June 30Six Months Ended June 30
20232022202320222023202220232022
Net Sales$887 $802 $1,734 $1,582 Operating Profit$187 $85 $346 $175 
Percent Change in Net Sales
Three Months Ended
VolumeNet PriceMix/OtherCurrency
Total(a)
Organic(b)
Total K-C Professional(3)142(2)1113
North America3141(1)1617
D&E Markets(7)102(7)(1)6
Developed Markets(14)184(3)69
Percent Change in Net Sales
Six Months Ended
VolumeNet PriceMix/OtherCurrency
Total(a)
Organic(b)
Total K-C Professional(5)151(3)1012
North America15(1)1415
D&E Markets(6)102(6)6
Developed Markets(15)224(5)611
Percent Change in
Operating Profit
VolumeNet PriceInput Costs
Cost Savings(c)
Currency Translation
Other(d)
Total
Three months ended(20)1311434(6)(33)120
Six months ended(14)139(9)29(5)(42)98
(a)    Total may not equal the sum of volume, net price, mix/other and currency due to rounding and excludes intergeographic sales.
(b)    Combined impact of changes in volume, net price and mix/other.
(c)    Benefits of the FORCE program.
(d)    Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
Second quarter net sales of $887 increased 11 percent, including organic sales growth of 13 percent, driven by changes in net selling prices and product mix of 14 percent and 2 percent, respectively, partially offset by decreased volume of 3 percent. The segment had organic sales growth across key categories and regions, led by North America which had increases in both net selling prices and volume. Changes in foreign currency exchange rates decreased sales by 2 percent.
Second quarter operating profit of $187 increased 120 percent. Results benefited from higher net selling prices and cost savings, partially offset by lower volumes, unfavorable currency effects and higher marketing, research and general expenses.
Liquidity and Capital Resources
Cash Provided by Operations
Cash provided by operations was $1,400 for the first six months of 2023 compared to $944 in the prior year. The increase was driven by the increase in operating profit, excluding the effect of non-cash charges, and improvements in working capital.
Investing
During the six months ended June 30, 2023, our capital spending was $389 compared to $470 in the prior year. We anticipate that full year capital spending will be $800 to $900. Proceeds from asset and business dispositions of $218 in the first six months of 2023 primarily reflected the sale of our Brazil tissue and K-C Professional business. Acquisition of business, net of cash acquired of $46 in the first six months of 2022 reflected the acquisition of a controlling interest of Thinx.
Financing
Our short-term debt, which consists of U.S. commercial paper with original maturities up to 90 days and/or other similar short-term debt issued by non-U.S. subsidiaries, was $67 as of June 30, 2023 (included in Debt payable within one year on the consolidated balance sheet). The average month-end balance of short-term debt for the second quarter of 2023 was $132. These short-term borrowings provide supplemental funding to support our operations. The level of short-term debt generally
22


fluctuates depending upon the amount of operating cash flows and the timing of customer receipts and payments for items such as dividends and income taxes.
At June 30, 2023 and December 31, 2022, total debt was $8.1 billion and $8.4 billion, respectively.
In February 2023, we issued $350 aggregate principal amount of 4.50 percent notes due February 16, 2033. Proceeds from the offering were used for general corporate purposes including the repayment of a portion of our commercial paper indebtedness.

Our consolidated subsidiary, Thinx, has issued common securities to its third-party minority owner, who has certain redemption rights to sell those securities to us. During the six months ended June 30, 2023, Cash paid for redemption of common securities of Thinx of $48 was to acquire additional ownership of Thinx. See Item 1, Note 2 to the unaudited interim consolidated financial statements for details. If the remaining redemption right is exercised, it would require us to pay approximately $98 to $197 during a second exercise period of January 1, 2024 through June 30, 2026.
We maintain a $2.0 billion revolving credit facility which expires in June 2028 and a $750 revolving credit facility which expires in May 2024.  These facilities, currently unused, support our commercial paper program and would provide liquidity in the event our access to the commercial paper markets is unavailable for any reason.
The United Kingdom’s Financial Conduct Authority, which regulated the London Interbank Offered Rate (“LIBOR”), has completed its phase out of LIBOR as of June 30, 2023. The effect of the elimination of LIBOR was not material.
We repurchase shares of Kimberly-Clark common stock from time to time pursuant to publicly announced share repurchase programs. During the first six months of 2023, we repurchased 485 thousand shares of our common stock at a total cost of $65 through a broker in the open market. We are targeting full-year 2023 share repurchases of approximately $100 to $150, subject to market conditions.
We believe that our ability to generate cash from operations and our capacity to issue short-term and long-term debt are adequate to fund working capital, capital spending, pension contributions, dividends and other needs for the foreseeable future. Further, we do not expect restrictions or taxes on repatriation of cash held outside of the U.S. to have a material effect on our overall business, liquidity, financial condition or results of operations for the foreseeable future.
Information Concerning Forward-Looking Statements
Certain matters contained in this report concerning the business outlook, including raw material, energy and other input costs, the anticipated cost savings from our FORCE program, cash flow and uses of cash, growth initiatives, innovations, marketing and other spending, net sales, anticipated currency rates and exchange risks, including the impact in Argentina and Turkey, effective tax rate, contingencies and anticipated transactions of Kimberly-Clark, including dividends, share repurchases and pension contributions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and are based upon management's expectations and beliefs concerning future events impacting Kimberly-Clark.  There can be no assurance that these future events will occur as anticipated or that our results will be as estimated.  Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them. 
The assumptions used as a basis for the forward-looking statements include many estimates that, among other things, depend on the achievement of future cost savings and projected volume increases. In addition, many factors outside our control, including the war in Ukraine (including the related responses of consumers, customers, and suppliers and sanctions issued by the U.S., the European Union, Russia or other countries), pandemics (including the ongoing COVID-19 outbreak and the related responses of governments, consumers, customers, suppliers and employees), epidemics, fluctuations in foreign currency exchange rates, the prices and availability of our raw materials, supply chain disruptions, disruptions in the capital and credit markets, counterparty defaults (including customers, suppliers and financial institutions with which we do business), failure to realize the expected benefits or synergies from our acquisition and disposition activity, impairment of goodwill and intangible assets and our projections of operating results and other factors that may affect our impairment testing, changes in customer preferences, severe weather conditions, government trade or similar regulatory actions, potential competitive pressures on selling prices for our products, energy costs, general economic and political conditions globally and in the markets in which we do business, as well as our ability to maintain key customer relationships, could affect the realization of these estimates.
The factors described under Item 1A, "Risk Factors" in our Form 10-K, or in our other SEC filings, among others, could cause our future results to differ from those expressed in any forward-looking statements made by us or on our behalf. Other factors not presently known to us or that we presently consider immaterial could also affect our business operations and financial results.
23


Item 4.    Controls and Procedures
As of June 30, 2023, an evaluation was performed under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on that evaluation, management, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective as of June 30, 2023. There were no changes in our internal control over financial reporting during the quarter covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
24


PART II – OTHER INFORMATION
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
We repurchase shares of Kimberly-Clark common stock from time to time pursuant to publicly announced share repurchase programs. All our share repurchases during the second quarter of 2023 were made through a broker in the open market.
The following table contains information for shares repurchased during the second quarter of 2023. None of the shares in this table were repurchased directly from any of our officers or directors.
Period (2023)
Total Number
of Shares
Purchased(a)
Average
Price Paid
Per Share
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
Maximum Number
of Shares That May
Yet Be Purchased
Under the Plans or
Programs(b)
April 1 to April 3084,700 $139.99 39,438,481 40,561,519 
May 1 to May 3158,700 142.23 39,497,181 40,502,819 
June 1 to June 3076,800 136.17 39,573,981 40,426,019 
Total220,200 
(a)Share repurchases were made pursuant to a share repurchase program authorized by our Board of Directors on November 13, 2014. This program allows for the repurchase of 40 million shares in an amount not to exceed $5 billion (the "2014 Program").
(b)Includes shares under the 2014 Program, as well as available shares under a share repurchase program authorized by our Board of Directors on January 22, 2021 that allows for the repurchase of 40 million shares in an amount not to exceed $5 billion.
Item 5.    Other Information
(a)The following disclosure is provided in this Part II, Item 5 in lieu of disclosure under Item 2.06 of Form 8-K.
To the extent required by Item 2.06 of Form 8-K, the information contained in Part I, Item 1, Note 3 to the unaudited interim consolidated financial statements (Impairment of Intangible Assets) is incorporated herein by reference.
(c)Our directors and officers may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). During the quarter ended June 30, 2023, no such plans or other arrangements were adopted or terminated.


25


Item 6.    Exhibits
(a)Exhibits
Exhibit No. (101).INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
Exhibit No. (101).SCH XBRL Taxonomy Extension Schema Document
Exhibit No. (101).CAL XBRL Taxonomy Extension Calculation Linkbase Document
Exhibit No. (101).DEF XBRL Taxonomy Extension Definition Linkbase Document
Exhibit No. (101).LAB XBRL Taxonomy Extension Label Linkbase Document
Exhibit No. (101).PRE XBRL Taxonomy Extension Presentation Linkbase Document
Exhibit No. 104 The cover page from this Current Report on Form 10-Q formatted as Inline XBRL



26


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
KIMBERLY-CLARK CORPORATION
(Registrant)
By: /s/ Andrew S. Drexler
 Andrew S. Drexler
 Vice President and Controller
 (principal accounting officer)
July 25, 2023
27
EX-10.Q 2 kimberly-clarkcorporationp.htm KMB PRSU AWARD AGREEMENT Document

Exhibit No. (10)q

KIMBERLY-CLARK CORPORATION
PERFORMANCE RESTRICTED STOCK UNIT
AWARD AGREEMENT
This Award, granted effective on __________ (the “Grant Date”), by Kimberly-Clark Corporation, a Delaware corporation (hereinafter called the “Corporation”), to ________________ (the “Participant”) is subject to the terms and conditions of the Kimberly-Clark Corporation 2021 Equity Participation Plan (the “Plan”) and the Award Agreement, including any country-specific terms and conditions contained in Appendix A to the Award Agreement.
W I T N E S S E T H:
WHEREAS, the Corporation has adopted the Plan to encourage those employees who materially contribute, by managerial, scientific or other innovative means, to the success of the Corporation or of an Affiliate, to acquire an ownership interest in the Corporation, thereby increasing their motivation for and interest in the Corporation’s and its Affiliates' long-term success;
NOW, THEREFORE, it is agreed as follows:
1.    Number of Share Units Granted. The Corporation hereby grants to the Participant Performance Restricted Stock Units (“PRSUs”) at the target level of ______ (the “Target Level”), subject to the terms, conditions and restrictions set forth herein and, in the Plan, and the Corporation's attainment of the Performance Goals established by the Committee. The actual number of PRSUs earned by the Participant at the end of the Restricted Period may range from 0 to 200% of the Target Level.
2.    Transferability Restrictions.
(a)    Restricted Period. During the Restricted Period, the Participant may not sell, assign, transfer, or otherwise dispose of, or mortgage, pledge or otherwise encumber the Award, and any such attempted sale, assignment, transfer, pledge or disposal shall be void. Except as provided under paragraph 2, the Award, including any accrued dividend equivalents, shall be subject to forfeiture until the end of the Restricted Period. The Participant becomes 100% vested in the number of PRSUs earned based on attainment of the Performance Goal at the end of the Restricted Period as approved and authorized by the Committee.
The Restricted Period shall begin on the date of the granting of this Award and shall end on [Insert]. During the Restricted Period, holders of Awards shall have none of the rights of a shareholder with respect to the shares of Common Stock that may be earned pursuant to the PRSUs, including, but not limited to, any right to receive dividends in cash or other property or other distribution or rights in respect of such shares except as otherwise provided in this Award Agreement, nor any right to vote such shares as the record owner thereof.
During each year in the Restricted Period, the Participant will not be paid dividend equivalents on the unvested PRSUs but the Participant will receive a credit equal to dividends declared on the Corporation’s Common Stock which will be reinvested in additional PRSUs at the then fair market value of the Corporation’s Common Stock on the date dividends are paid, and the additional PRSUs will be accumulated and paid if and when the PRSUs vest, based on the actual number of PRSUs that vest. In the case of dividends paid in property other than cash, the amount of the dividend shall be deemed to be the fair market value of the property at the time of the payment of the dividend, as determined in good faith by the Corporation. The Corporation shall not be required to segregate any cash or other property of the Corporation.
Notwithstanding any provision in this Award Agreement, this Award will be forfeited if the Participant does not agree to the terms of any restrictive covenant agreement(s) containing non-competition, non-solicitation, confidentiality, business ideas and similar restrictions that may be presented to the Participant at any time prior to the last day of the calendar year in which this Award is granted (whether before or after the Grant Date) and that the Participant will be required to accept pursuant to such acceptance



procedures (including electronic acceptance) as will be communicated to the Participant. Such restrictive covenant agreement must be accepted by the Participant within thirty (30) days and if not so accepted, this Award will be forfeited, unless otherwise determined by the Corporation in its discretion.
(b)    Termination of Employment. For purposes of this Award, the Participant's employment will be considered terminated as of the date the Participant is no longer actively providing services to the Corporation or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant's employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation, the Participant’s right to receive PRSUs and vest in the Award under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant's employment agreement, if any); the Committee shall have the exclusive discretion to determine when the Participant is no longer employed for purposes of the Award (including whether the Participant may still be considered employed while on a leave of absence).
The Participant shall forfeit any unvested Award, including any accrued dividend equivalents, upon termination of employment unless such termination is (i) due to a Qualified Termination of Employment, or (ii) if more than six months after the Grant Date, due to death, Retirement, Total and Permanent Disability, or the shutdown or divestiture of a business unit. A termination of employment shall not be deemed to have occurred while a Participant is on military leave or other bona fide leave of absence if the period of such leave does not exceed six months, or if longer, so long as the Participant retains a right to reemployment with the Corporation or an Affiliate under an applicable statute or by contract. For purposes of this subparagraph, a leave of absence constitutes a bona fide leave of absence only if there is a reasonable expectation that the Participant will return to perform services for the Corporation or an Affiliate. If the period of leave exceeds six months and the Participant does not retain a right to reemployment under an applicable statute or by contract, the employment relationship is deemed to terminate on the first date immediately following such six-month period. Notwithstanding the foregoing, where a leave of absence is due to any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than six months, where such impairment causes the Participant to be unable to perform the duties of his or her position of employment or any substantially similar position of employment, a 29-month period of absence is substituted for such six-month period in determining whether a termination of employment shall be deemed to have occurred. A termination of employment with the Corporation or an Affiliate to accept immediate reemployment with the Corporation or an Affiliate likewise shall not be deemed to be a termination of employment for the purposes of the Plan. A Participant who is classified as an intermittent employee shall be deemed to have a termination of employment for purposes of the Plan.
For purposes of this Award, a termination of employment includes a termination that is deemed an “unfair dismissal” or a “constructive dismissal.” Further, the Participant understands that the Award is a conditional right. Participant shall forfeit any unvested Award upon termination of employment except as provided above, for example, regardless of whether (1) the Participant is considered to be unfairly dismissed without good cause; (2) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal; (3) the Participant terminates his or her employment or service relationship due to a change of work location, duties or any other employment or contractual condition; or (4) the Participant terminates his or her employment or service relationship due to a unilateral breach of contract by the Corporation or an Affiliate. Consequently, upon termination of the Participant’s employment or service relationship for any of the above reasons, the Participant may automatically lose any rights to the Awards that were not vested on the date of termination of the Participant’s employment or service relationship, as described in the Plan and the Award Agreement.
(c)    Death, Retirement, or Total and Permanent Disability. In the event that more than six months after the Grant Date the Participant’s termination of employment is due to death or Total and Permanent Disability, it shall result in pro rata vesting in the number of PRSUs earned. This pro rata vesting shall be determined based on the Target Level of PRSUs (including any accrued dividend equivalents accumulated pursuant to Section 2(a)) (1) prorated for the number of full months of employment during



the Restricted Period prior to the Participant’s termination of employment, multiplied by (2) the Performance Goal percentage as approved and authorized by the Committee at the end of the Restricted Period. Any fractional share of the Corporation resulting from such a prorated award shall be rounded to the nearest whole share and shall be paid, along with any other shares earned under such prorated award, within 70 days following the end of the Restricted Period or within such later period as permitted by Section 409A of the U.S. Internal Revenue Code of 1986 and the regulations thereunder, as amended from time to time (the "Code"). In the event that more than six months after the Grant Date the Participant’s termination of employment is due to Retirement, then provided that, in the sole discretion of the Corporation, (i) no circumstances exist that could lead to a determination that the Participant should be, or could have been, terminated for Cause; and (ii) the Participant has not engaged in conduct that would trigger the Committee’s right of recoupment under the Corporation's Recoupment Policy (as defined in Section 21 of this Award Agreement), it shall result in 100% vesting in the number of PRSUs earned based on attainment of the Performance Goal at the end of the Restricted Period as approved and authorized by the Committee, and such Award shall be paid within 70 days following the end of the Restricted Period.
Notwithstanding this Section 2(c), if the Corporation receives an opinion of counsel that there has been a legal judgment and/or legal development in the Participant’s jurisdiction that would likely result in the favorable Retirement treatment that applies to the PRSUs under this Section 2(c) being deemed unlawful and/or discriminatory, then the Corporation will not apply the favorable Retirement treatment and PRSUs will be treated as they would under the rules that apply if the Participant’s employment with the Corporation or an Affiliate ends for any other reason, as applicable.
(d)    Shutdown or Divestiture. In the event that more than six months after the Grant Date the Participant’s termination of employment is due to the shutdown or divestiture of the Corporation’s or its Affiliate’s business it shall result in pro rata vesting in the number of PRSUs earned. This pro rata vesting shall be determined based on the Target Level of PRSUs (including any accrued dividend equivalents accumulated pursuant to Section 2(a)) (1) prorated for the number of full years of employment during the Restricted Period prior to the Participant’s termination of employment, multiplied by (2) the Performance Goal percentage as approved and authorized by the Committee at the end of the Restricted Period. Any fractional share of the Corporation resulting from such a prorated award shall be rounded to the nearest whole share and shall be paid, along with any other shares earned under such prorated award, within 70 days following the end of the Restricted Period. For the purposes of this Award, a shutdown or divestiture of the Corporation’s or its Affiliate’s business unit is defined as one for which the charges related to the shutdown or divestiture are accounted for, and reported externally, as an exit activity in the Corporation's applicable SEC filings. The Corporation has complete discretion to determine whether a shutdown or divestiture of a business unit has occurred under the terms of the Plan.
(e)    Qualified Termination of Employment. In the event of a Qualified Termination of Employment, the Award which would have otherwise been forfeited will be handled consistent with subsection 14(b) of the Plan and shall be paid within 10 days following the last day of employment of the Participant with the Corporation or an Affiliate. Notwithstanding anything in this Agreement to the contrary, to the extent that the Award may constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code, the payment of an Award to a Key Employee who has separated from service due to a Qualified Termination of Employment shall be made at the earlier of the first day of the seventh month following the date of separation from service or the end of the Restricted Period. A Key Employee is any Participant who meets the definition of a specified employee as defined in Section 409A(a)(2)(B)(i) of the Code and the regulations promulgated thereunder.
(f)    Payment of Awards. The payment of the Award, including any accrued dividend equivalents accumulated pursuant to Section 2(a), shall be made in shares of Common Stock. Except as may otherwise be provided in subparagraph 2(e), the payment of an Award shall be made within 70 days following the end of the Restricted Period.
(g)    Payment of Tax-Related Items. No shares of Common Stock, nor any cash payment, may be delivered under this Award, unless prior to or simultaneously with such issuance, the Participant or, in the event of his death, the person succeeding to his rights hereunder, shall pay to the Corporation or an Affiliate, as applicable, such amount as the Corporation advises is required under applicable federal, state or local



laws to withhold and pay over to governmental taxing authorities in relation to this Award. The Corporation may, in its discretion, withhold payment of required Tax-Related items (as defined in the Acknowledgment of Conditions section) with cash or shares of Common Stock which otherwise would be delivered following the date of vesting of the Award under this Section 2.
3.    Nontransferability. Neither the Award nor the Participant’s right to receive payment for vested Awards may be assigned or transferred except upon the death of the Participant (i) by will, or (ii) by the laws of descent and distribution.
4.    Compliance with Law. No payment may be made under this Award, unless prior to the issuance thereof, the Corporation shall have received an opinion of counsel to the effect that this Award by the Corporation to the Participant will not constitute a violation of the U.S. Securities Act of 1933, as amended. As a condition of this Award, the Participant shall, if requested by the Corporation, submit a written statement in form satisfactory to counsel for the Corporation, to the effect that any shares received under this Award shall be for investment and not with a view to the distribution thereof within the meaning of the U.S. Securities Act of 1933, as amended, and the Corporation shall have the right, in its discretion, to cause the certificates representing shares hereunder to be appropriately legended to refer to such undertaking or to any legal restrictions imposed upon the transferability thereof by reason of such undertaking.
The Award granted hereby is subject to the condition that if the listing, registration or qualification of the shares subject hereto on any securities exchange or under any state or federal law, or if the consent or approval of any regulatory body shall be necessary as a condition of, or in connection with, the granting of the Award or the delivery of shares thereunder, such shares may not be delivered unless and until such listing, registration, qualification, consent or approval shall have been effected or obtained. The Corporation agrees to use its best efforts to obtain any such requisite listing, registration, qualification, consent or approval.
The Participant is solely responsible for obtaining/providing whatever exchange control approvals, permits, licenses, or notices, which may be necessary for the Participant to hold the Award, or to receive any payment of cash or shares or to hold or sell the shares subject to the Award, if any. Neither the Corporation nor its Affiliates will be responsible for obtaining any such approvals, licenses or permits, or for making any such notices, nor will the Corporation or its Affiliates be liable for any fines or penalties the Participant may incur for failure to obtain any required approvals, permits or licenses or to make any required notices.
5.    No Right of Continued Employment. The granting of this Award does not confer upon the Participant any legal right to be continued in the employ of the Corporation or its Affiliates, and the Corporation and its Affiliates reserve the right to discharge the Participant whenever the interest of the Corporation or its Affiliates may so require without liability to the Corporation or its Affiliates, the Board of Directors of the Corporation or its Affiliates, or the Committee, except as to any rights which may be expressly conferred on the Participant under this Award.
6.    Discretion of the Corporation, Board of Directors and the Committee. Any decision made or action taken by the Corporation or by the Board of Directors of the Corporation or by the Committee arising out of or in connection with the construction, administration, interpretation and effect of this Award shall be within the absolute discretion of the Corporation, the Board of Directors of the Corporation or the Committee, as the case may be, and shall be conclusive and binding upon all persons.
7.    Inalienability of Benefits and Interest. This Award and the rights and privileges conferred hereby shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance or charge, and any such attempted action shall be void and no such benefit or interest shall be in any manner liable for or subject to debts, contracts, liabilities, engagements, or torts of the Participant.
8.    Governing Law. The Plan is governed by and subject to the laws of the United States of America. To the extent permitted by the laws of the jurisdiction where the Participant works, all questions pertaining to the construction, interpretation, regulation, validity and effect of the provisions of this Award and any rights under the Plan shall be determined in accordance with the laws of the State of Delaware and federal courts located in the District of Delaware shall be the exclusive forum for any dispute arising out of or related to the Award or the Award Agreement and the Participant consents to and waives any objection to the exercise of personal jurisdiction and venue by such courts.



9.    Purchase of Common Stock. The Corporation and its Affiliates may, but shall not be required to, purchase shares of Common Stock of the Corporation for purposes of satisfying the requirements of this Award. The Corporation and its Affiliates shall have no obligation to retain and shall have the unlimited right to sell or otherwise deal with for their own account, any shares of Common Stock of the Corporation purchased for satisfying the requirements of this Award.
10.    Notices. Any notice to be given to the Corporation under this Award, except as required under Sections 19 and 20 below, shall be addressed to the Corporation in care of its Director of Compensation located at the World Headquarters, and any notice to be given to the Participant under the terms of this Award may be addressed to him or her at the address as it appears on the Corporation's records, or at such other address as either party may hereafter designate in writing to the other. Any such notice shall be deemed to have been duly given if and when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered and deposited, postage and registry fee prepaid, in a post office or branch post office regularly maintained by the United States Government or any equivalent non-U.S. postal service.
11.    Changes in Capitalization. In the event there are any changes in the Common Stock or the capitalization of the Corporation through a corporate transaction, such as any merger, any acquisition through the issuance of capital stock of the Corporation, any consolidation, any separation of the Corporation (including a spin-off or other distribution of stock of the Corporation), any reorganization of the Corporation (whether or not such reorganization comes within the definition of such term in Section 368 of the Code), or any partial or complete liquidation by the Corporation, recapitalization, stock dividend, stock split or other change in the corporate structure, appropriate adjustments and changes shall be made by the Committee in (a) the number and type or class of shares subject to this Award, and (b) such other provisions of this Award as may be necessary and equitable to carry out the foregoing purposes.
12.    Effect on Other Plans. All benefits under this Award shall constitute special incentives and shall not affect the level of benefits provided to or received by the Participant (or the Participant's estate or beneficiaries) as part of any employee benefit plan of the Corporation or an Affiliate. This Award shall not be construed to affect in any way the Participant's rights and obligations under any other plan maintained by the Corporation or an Affiliate on behalf of employees.
13.    Discretionary Nature of Award. The grant of an Award is a one-time benefit and does not create any contractual or other right to receive a grant of Awards or benefits in lieu of Awards in the future. Future grants, if any, will be at the sole discretion of the Corporation, including, but not limited to, the timing of any grant, the number of PRSUs and vesting provisions. The value of the Award is an extraordinary item outside the scope of the Participant’s employment contract, if any. As such, the Award is not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, leave-related payments, holiday pay, pension, retirement or welfare benefits or similar payments.
14.    Data Privacy. The Participant hereby authorizes their actual employer (the “Employer”) to furnish the Corporation (and any agent of the Corporation administering the Plan or providing Plan recordkeeping services) with such information and data as it shall request in order to facilitate the grant of Awards and administration of the Plan and the Participant waives any data privacy rights such Participant might otherwise have with respect to such information. The Controller of personal data processing is Kimberly-Clark Corporation with registered offices at 351 Phelps Drive, Irving, Texas 75038, United States of America.
15.    Conflict with Plan or Other Documents. This Award is awarded pursuant to and subject to the Plan. This Agreement is intended to supplement and carry out the terms of the Plan. It is subject to all terms and provisions of the Plan, and, in the event of a conflict, the Plan shall prevail. In the event of any conflict between this Agreement and the terms of any notice, communication, plan summary, prospectus or other ancillary documentation relating to the Award, this Agreement will prevail.
16.    Successors. This Award Agreement, including but not limited to the restrictive covenants described in Sections 19 and 20 below, shall be binding upon and inure to the benefit of any successor or successors of the Corporation.
17.    Amendments. The Committee may at any time alter or amend this Award to the extent (1) permitted by law, (2) permitted by the rules of any stock exchange on which the Common Stock or any other security of the



Corporation is listed, and (3) permitted under applicable provisions of the U.S. Securities Act of 1933, as amended, the U.S. Securities Exchange Act of 1934, as amended (including rule 16b-3 thereof).
18.    Defined Terms. Terms which are capitalized are defined herein or in the Plan and have the same meaning set forth in the Plan, unless the context indicates otherwise.
19.    Restrictive Covenants For U.S. Participants.
(a)Application. The provisions of this Section 19 apply to Participants who are employed by the Corporation or an Affiliate located in the United States and are subject to the laws of the United States as of the date of termination of the Participant's employment; provided, however, that to the extent the Participant is asked to execute an employment or other agreement with the Corporation or any Affiliate containing non-competition, non-solicitation, confidentiality, business ideas or similar restrictions (a “stand-alone restrictive covenant agreement”) after execution of this Award Agreement, the stand-alone restrictive covenant agreement and related enforcement provisions shall govern and the provisions of this Section 19 shall not apply. Notwithstanding the foregoing, sub-section (j) below shall apply in any case. For the avoidance of doubt, the provisions of this Section 19 shall supersede any restrictive covenants the Participant has entered into with the Corporation or any Affiliate prior to execution of this Award Agreement.
(b)Non-Competition. As the Award is intended to encourage the Participant to continue employment with the Corporation or an Affiliate, during which time the Participant will have access to Confidential Information (as defined below), including Confidential Information first developed after the Grant Date, during the term of the Participant’s employment with the Corporation or any Affiliate and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, without the written consent of the General Counsel of the Corporation or their designee, in any country or countries for which the Participant had development, marketing, innovation/technology (R&D), distribution, sales, administrative, operational/supply chain or manufacturing oversight responsibilities during the last two (2) years of the Participant’s employment or was provided with regular and material access to Confidential Information regarding the Corporation’s or an Affiliate's business operations in that country or countries during the last two (2) years of the Participant’s employment, either directly or indirectly, perform duties or undertake responsibilities for a Competitor (as defined below) that are the same or substantially similar to those duties or responsibilities that the Participant performed or undertook for the Corporation or an Affiliate during the two (2) year period prior to the end of the Participant’s employment with the Corporation or an Affiliate. “Confidential Information,” for purposes of this Section 19, shall mean (i) statutory trade secrets; (ii) proprietary information developed or acquired by the Corporation that does not rise to the level of a statutorily protectable trade secret and is made the property of the Corporation through this mutual Agreement of the parties; and (iii) information that is otherwise legally protectable. Such Confidential Information includes, but is not limited to, information in whatever form (including, without limitation, in written, oral, visual or electronic form or on any magnetic or optical disk or memory storage medium, as well as other physical items wherever located, and abstracts or summaries of the foregoing) relating to the business, suppliers, customers, products, affairs and finances of the Corporation or any Affiliate for the time being confidential to the Corporation or any Affiliate, ideas, conceptions, compilations of data, and developments created by the Corporation, whether or not patentable and whether or not copyrightable, and trade secrets including, without limitation, technical data and know-how relating to the business of the Corporation or any Affiliate, or any of their suppliers, customers, agents, distributors, shareholders or management, including (but not limited to) business plans, pricing strategies, financial information, patent rights, patent applications, information concerning tenders and potential contracts, information concerning proposed product ranges, product development information, employee and salary information, research and development activities or manufacturing methods that the Participant creates, develops, receives, obtains or has knowledge of in connection with the Participant’s employment, and all other matters which relate to the business of the Corporation or any Affiliate and in respect of which information is not readily available in the ordinary course of such business to the Corporation's Competitors, whether or not such information (if in anything other than oral form) is marked confidential. “Competitor,” for purposes of this Section 19, means a person or entity who engages in a business that is the same or substantially the same as any aspect of the Business of the Corporation. “Business of the



Corporation,” for purposes of this Section 19, is the development, production, sales and/or marketing of (i) health and hygiene products and related apparel; (ii) washroom and workplace protective and safety products; and (iii) the materials, packaging and other components/subcomponents of such products including, without limitation, non-wood plants and products derived therefrom including any fibers, pulps or extracts. Notwithstanding the foregoing, if the Participant’s residence or principal place of employment on the date of acceptance of this Award Agreement is in the States of California, Massachusetts, Oklahoma, Washington or in any other jurisdiction where any provision of this Section 19(b) prohibiting post-employment competition is prohibited or otherwise restricted by applicable law, then the provisions of this Section 19(b) will not apply to the extent any such provision is prohibited or otherwise restricted by applicable law.
(c)Non-Solicitation of Employees. For a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant’s termination date, and with whom the Participant had material dealings during the last two (2) years preceding the Participant’s termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate, or (2) be otherwise involved in the recruitment of such person, to leave the employment of the Corporation or of any Affiliate. Furthermore, the Participant shall not for a period of two (2) years following the termination date regardless of the reason for or the manner of termination, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant’s termination date and with whom the Participant had material dealings during the last two (2) preceding the Participant’s termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor or (2) be otherwise involved in the recruitment of such person to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor. The Participant must inform the Corporation immediately on becoming aware of any such recruitment.
(d)Non-Solicitation of Business. During the term of the Participant’s employment and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, either directly or indirectly, on the Participant’s own behalf or on behalf of any other person, firm or company or other entity, solicit, interfere with, entice or endeavor to entice away from the Corporation or any Affiliate any Restricted Customer (as defined below), or seek to conduct Restricted Business (as defined below), or conduct Restricted Business, with any Restricted Customer and/or otherwise persuade, induce, solicit or encourage any person or entity to terminate its contractual relationship with the Corporation or any Affiliate. “Restricted Business,” for purposes of this Section 19, means any business activity carried out by the Participant either directly or indirectly for the Corporation or any Affiliate during the last two (2) years preceding the Participant’s termination date. “Restricted Customer,” for purposes of this Section 19, means any person, firm or company or other entity who was a customer or distributor of the Corporation or any Affiliate as at the Participant’s termination date, or during the last two (2) years preceding the Participant’s termination date, including any Prospective Customer. “Prospective Customer,” for purposes of this Section 19, means any person, firm or company or other entity with whom the Corporation or any Affiliate was involved in negotiations as at the Participant’s termination date or during the last two (2) years preceding the Participant’s termination date, with a view to dealing with it as a customer and/or to conclude a contractual relationship with such entity, and/or with whom the Participant had contact at the Participant’s termination date or during the last two (2) years preceding the Participant’s termination date with a view to dealing with it as a customer of the Corporation or any Affiliate and/or to conclude a contractual relationship with such entity.
(e)Confidentiality. The Participant acknowledges that the Corporation and its Affiliates continually develop Confidential Information, that the Participant may develop Confidential Information for the Corporation or its Affiliates and that the Participant may learn of Confidential Information during the course of the employment relationship. The Corporation has expended and will continue to expend substantial effort and monies in acquiring knowledge and expertise in developing goodwill in the Business of the Corporation. The Participant therefore agrees as follows:



i.The Participant will comply with the policies and procedures of the Corporation for protecting Confidential Information and shall not disclose to any person or use, other than as required by applicable law or for the proper performance of the Participant’s duties and responsibilities to the Corporation and its Affiliates, any Confidential Information.
ii.The Participant understands that the restrictions set forth in this Section 19(e) shall continue to apply after the employment relationship terminates, regardless of the reason for such termination. The Participant understands and acknowledges that the Participant's obligations under this Award Agreement with regard to any particular Confidential Information shall commence immediately upon the Participant first having access to such Confidential Information and shall continue during and after employment with the Corporation or an Affiliate until such time as such Confidential Information has become public knowledge other than as a result of the Participant's breach of this Award Agreement or breach by those acting in concert with the Participant or on the Participant's behalf, and shall be indefinite where permitted by state and local law, and shall not continue longer than two (2) years where indefinite confidentiality provisions are not permitted. Notwithstanding, the Participant’s confidentiality obligations under this Award Agreement with regard to any trade secrets shall continue during and after the Participant 's employment by the Corporation or an Affiliate until such trade secrets are no longer trade secrets under applicable law.
iii.Nothing in this Award Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order, including initiating, testifying, assisting, complying with a subpoena from, or participating in any manner with an investigation conducted by a local, state, or federal agency, filing or disclosing any facts necessary to receive unemployment insurance, Medicaid, or other public benefits. The Participant shall promptly provide written notice of any such order to an authorized officer of the Corporation. Nothing in this Award Agreement prohibits or restricts the Participant (or Participant's attorney) from initiating communications directly with, responding to an inquiry from, or providing testimony before the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other self-regulatory organization, or any other federal or state regulatory authority.
iv.The Participant agrees and understands that, pursuant to the Defend Trade Secrets Act of 2016, the Participant shall not be held criminally, or civilly, liable under any Federal or State trade secret law for the disclosure of a trade secret that is made in confidence either directly or indirectly to a Federal, State, or local government official, or an attorney, for the sole purpose of reporting, or investigating, a violation of law. Moreover, the Participant agrees and understands that individuals may disclose trade secrets in a complaint, or other document, filed in a lawsuit, or other proceeding, if such filing is made under seal. Finally, the Participant agrees and understands that an individual who files a lawsuit alleging retaliation by the Corporation for reporting a suspected violation of the law may disclose the trade secret to the attorney of the individual and use the trade secret in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.
(f)    Business Ideas. The Participant acknowledges that the Corporation owns all rights in all Business Ideas (as defined below). For the avoidance of doubt, in the event an assignment is needed during the term of the Participant's employment with the Corporation or any Affiliate and at any time following the termination of employment, the Participant hereby assigns without further action being required to the Corporation all Business Ideas. The Participant shall promptly execute all documents which the Corporation may reasonably require to perfect, maintain and protect its patent, copyright, trade secret, trademark and any and all other rights to such Business Ideas throughout the world, and shall provide other reasonable assistance and cooperation as may be necessary for the Corporation to investigate, perfect, maintain and protect those rights, including assistance and cooperation with litigation relating to any Business Ideas. Even after the Participant's employment with the Corporation or any Affiliate terminates, the Participant will continue to be reasonably available to assist the Corporation with its efforts to investigate, perfect, maintain and protect rights in any Business Ideas, including assistance with litigation relating to any Business Ideas. “Business Ideas” as used in this Award Agreement means all



ideas, concepts, innovations, inventions, strategy, data, developments, and works of authorship, whether or not patentable, both technical and business, which the Participant originates, conceives or develops, either alone or in conjunction with others, at any time during the Participant's employment with the Corporation or any Affiliate, except those which satisfy all three of the following criteria: i) unrelated to the Corporation's business; ii) not originated, conceived or developed during the Participant's working hours; and iii) not originated, conceived or developed by use of any Corporation property such as tools, supplies, equipment, materials, facilities or other Corporation employees. Any idea, concept, innovation, invention, strategy, data, development or work of authorship that the Participant originates, conceives or develops, through the use of Corporation Confidential Information, at any time within six (6) months after the Participant's employment with the Corporation or any Affiliate terminates (for any reason) will be presumed to be a Business Idea unless the Participant can prove otherwise by clear and convincing evidence.
(g)     Notification Requirement. During the term of the Participant's employment with the Corporation or any Affiliate and for the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, regardless of the reason for or the manner of termination, the Participant agrees to notify the Corporation in writing prior to accepting new employment, or engaging in any other activity which may violate this Award Agreement, and the Participant agrees to provide in such notice information concerning the anticipated new employment or activity, including, but not limited to: name of new employer; address of new employer; name of new team leader; job title; and scope and responsibilities of the new position. The Participant recognizes that such duty of notification is not affected by the Participant’s belief that such employment may perhaps not violate this Award Agreement or otherwise be unfairly competitive with the Corporation or an Affiliate. The Participant’s written notice should be addressed to the Corporation's General Counsel with subject line Non-Competition Agreement, via email to Noncompete.Notification@kcc.com.
(h)    Other Notification. During the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, the Participant shall provide a copy of Section 19 of this Award Agreement to each new employer before starting in any new employment. The Participant agrees that the Corporation may notify any third party about the Participant’s obligations under Section 19 of this Award Agreement until such obligations are fulfilled.
(i)    Remedies. In the event of an anticipated or actual breach by the Participant of any of the provisions of this Section 19, the Participant acknowledges and agrees that damages would not be an adequate remedy to compensate the Corporation or an Affiliate for the harm to the business of the Corporation or the Affiliate and, in such event, agrees that the Corporation or the Affiliate, as applicable, shall be entitled to a temporary restraining order and to temporary injunctive relief to prevent or terminate such anticipated or actual breach, provided, however, that nothing in this Award Agreement shall be construed to limit any permanent relief to which the Corporation or the Affiliate may be entitled or the damages otherwise recoverable by the Corporation or the Affiliate in any such event.
(j)    Forfeiture of Award. Notwithstanding the Corporation's or an Affiliate's ability to pursue injunctive relief pursuant to Section 19(i), in the event of an actual breach by the Participant of any of the provisions of this Section 19 or of any stand-alone restrictive covenant agreement, the Corporation also is entitled to forfeit any portion of the Award that has not vested or been settled yet at the time the Corporation becomes aware of the breach.
(k)    Reimbursement of Fees. If the Participant violates any of the provisions of this Section 19, or any duty of loyalty or confidentiality imposed by law, in addition to any damages that the Participant may be required to pay, the Participant understands and agrees that the Participant shall be required to reimburse the Corporation for all its costs incurred to enforce this Award Agreement, including but not limited to, all attorneys’ fees.
(l)    Beneficiaries. For purposes of this Section 19, the Corporation and each of its Affiliates shall be deemed to be third-party beneficiaries with the right to seek enforcement of any of the provisions of this Section 19. Further, for purposes of this Section 19, references to acting directly or indirectly include acting jointly with or through another person.



(m)    Severability. If any provision of this Section 19 is held to be invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such provision shall be deemed to be severed from the Award Agreement and such invalidity, illegality or unenforceability will not affect any other provision of the Award Agreement, all of which shall remain valid and enforceable. Notwithstanding the foregoing, if a court of competent jurisdiction determines that the covenants contained in this Section 19 are unenforceable because they are overbroad in some respect, to the full extent permitted by applicable law, the court should sever, revise or reform any aspect of this Section 19 so as to make the scope of such Section 19 as broad as reasonable under applicable law and enforce this Section 19 as so modified. Without limiting the foregoing, if a court, government agency or other body of competent jurisdiction establishes or the Corporation otherwise determines that the covenants contained in this Award Agreement are unenforceable and/or in violation of applicable rules, the Corporation reserves the right to unilaterally amend the Award Agreement so as to comply with applicable rules.
(n)    Jurisdiction-Specific Terms. If the Participant works for the Corporation or an Affiliate in the District of Columbia, the length of the non-competition covenant in Section 19(b) of this Award Agreement shall be one (1) year. If the Participant works for the Corporation or an Affiliate in the State of Oregon, the Corporation will provide a signed written copy of this Award Agreement within 30 days after the termination of the Participant's employment. If the Participant works for the Corporation or an Affiliate in the State of Utah, the length of the non-competition covenant in Section 19(b) of this Award Agreement shall be one (1) year.
(o)    Advice to Seek Independent Counsel. The Participant is hereby advised in writing to consult with an attorney before entering into the covenants outlined in this Section 19. The Participant acknowledges that prior to acceptance of this Award Agreement, the Participant has been advised by the Corporation of the Participant's right to seek independent advice from an attorney of the Participant's own selection regarding this Award Agreement, including the restraints imposed upon the Participant pursuant to this Section 19. The Participant acknowledges that the Participant has entered into this Award Agreement knowingly and voluntarily and with full knowledge and understanding of the provisions of this Award Agreement after being given the opportunity to consult with counsel. The Participant further represents that in entering into this Award Agreement, the Participant is not relying on any statements or representations made by any of the Corporations' directors, officers, employees or agents which are not expressly set forth herein, and that the Participant is relying only upon the Participant's own judgment and any advice provided by the Participant's attorney. The Participant acknowledges he or she has been provided at minimum 14 calendar days to review the provisions contained herein.
20.    Restrictive Covenants For Participants Outside the U.S.
(a)    Application. The provisions of this Section 20 apply to Participants who are employed by an Affiliate located outside the United States and are subject to the laws of a jurisdiction outside of the United States as of the date of termination of the Participant's employment, provided, however, that to the extent the Participant is party to an employment or other agreement with any Affiliate containing non-competition, non-solicitation, confidentiality, business ideas or similar restrictions (the “local restrictive covenants”), whether or not such local restrictive covenants have been agreed to before or after execution of this Award Agreement, those local restrictive covenants and related enforcement provisions shall govern and the following provisions of this Section 20 shall not apply, unless otherwise determined by the Corporation in its sole discretion. Notwithstanding the foregoing, sub-section (j) below shall apply in any case.
(b)    Confidentiality. During the Participant’s employment with the Corporation or any Affiliate and indefinitely thereafter, the Participant undertakes to maintain the confidentiality of, and not to divulge to any person (except as required by law) any of the Corporation's or any Affiliate's Confidential Information (as defined below), nor use the same for any other purpose, other than to carry out the Participant’s functions as an employee of the Corporation or any of its Affiliates. The Participant shall use all personal endeavors to prevent publication or disclosure of such Confidential Information. The Participant will comply with the policies and procedures of the Corporation for protecting Confidential Information and shall not disclose to any person or use, other than as required by applicable law or for the proper performance of the Participant’s duties and responsibilities to the Corporation and its Affiliates, any Confidential Information. Nothing in this Award Agreement shall be construed to prevent disclosure



of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order, including initiating, testifying, assisting, complying with a subpoena from, or participating in any manner with an investigation conducted by a local agency, filing or disclosing any facts necessary to receive social insurance or other public benefits. The Participant shall promptly provide written notice of any such order to an authorized officer of the Corporation. Nothing in this Award Agreement prohibits or restricts the Participant (or Participant's attorney) from initiating communications directly with, responding to an inquiry from, or providing testimony before any regulatory authority. “Confidential Information,” for purposes of this Section 20, shall mean (i) statutory trade secrets; (ii) proprietary information developed or acquired by the Corporation that does not rise to the level of a statutorily protectable trade secret and is made the property of the Corporation through this mutual Agreement of the parties; and (iii) information that is otherwise legally protectable. Such Confidential Information includes, but is not limited to, information in whatever form (including, without limitation, in written, oral, visual or electronic form or on any magnetic or optical disk or memory storage medium, as well as other physical items wherever located, and abstracts or summaries of the foregoing) relating to the business, suppliers, customers, products, affairs and finances of the Corporation or any Affiliate for the time being confidential to the Corporation or any Affiliate, ideas, conceptions, compilations of data, and developments created by the Corporation, whether or not patentable and whether or not copyrightable, and trade secrets including, without limitation, technical data and know-how relating to the business of the Corporation or any Affiliate, or any of their suppliers, customers, agents, distributors, shareholders or management, including (but not limited to) business plans, pricing strategies, financial information, patent rights, patent applications, information concerning tenders and potential contracts, information concerning proposed product ranges, product development information, employee and salary information, research and development activities or manufacturing methods that the Participant creates, develops, receives, obtains or has knowledge of in connection with the Participant's employment, and all other matters which relate to the business of the Corporation or any Affiliate and in respect of which information is not readily available in the ordinary course of such business to the Corporation's Competitors, whether or not such information (if in anything other than oral form) is marked confidential. “Competitor,” for purposes of this Section 20, means a person or entity who engages in a business that is the same or substantially the same as any aspect of the Business of the Corporation. “Business of the Corporation,” for purposes of this Section 20, is the development, production, sales and/or marketing of (i) health and hygiene products and related apparel; (ii) washroom and workplace protective and safety products; and (iii) the materials, packaging and other components/subcomponents of such products including, without limitation, non-wood plants and products derived therefrom including any fibers, pulps or extracts.
(c)    Non-Competition. During the Participant’s employment with the Corporation or any Affiliate, it is acknowledged that the Participant will acquire Confidential Information, and should the Participant’s employment cease, it may be difficult to police sub-section (b) above, prohibiting the disclosure of such Confidential Information. It is further acknowledged that it may be difficult to police the non-solicitation and dealing sub-sections set out below. For these reasons, during the term of the Participant’s employment and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, without the written consent of General Counsel of the Corporation or their designee, in any country or countries for which Participant had development, marketing, innovation/technology (R&D), distribution, sales, administrative, operational/supply chain or manufacturing oversight responsibilities during the last two (2) years of Participant’s employment or was provided with regular and material access to Confidential Information regarding the Corporation’s or an Affiliate's business operations in that country or countries during the last two (2) years of Participant’s employment, either directly or indirectly, perform duties or undertake responsibilities for a Competitor that are the same or substantially similar to those duties or responsibilities that the Participant performed or undertook for the Corporation or an Affiliate during the two (2) year period prior to the end of the Participant’s employment with the Corporation or an Affiliate.
(d)     Business Ideas. The Participant acknowledges that the Corporation owns all rights in all Business Ideas (as defined below). For the avoidance of doubt, in the event an assignment is needed during the term of the Participant's employment with the Corporation or any Affiliate and at any time following the



termination of employment, the Participant hereby assigns without further action being required to the Employer all Business Ideas. The Participant shall promptly execute all documents which the Corporation may reasonably require to perfect, maintain and protect its patent, copyright, trade secret, trademark and any and all other rights to such Business Ideas throughout the world, and shall provide other reasonable assistance and cooperation as may be necessary for the Corporation or the Employer to investigate, perfect, maintain and protect those rights, including assistance and cooperation with litigation relating to any Business Ideas. Even after the Participant's employment with the Corporation or any Affiliate terminates, the Participant will continue to be reasonably available to assist the Corporation or the Employer with its efforts to investigate, perfect, maintain and protect rights in any Business Ideas, including assistance with litigation relating to any Business Ideas. “Business Ideas” as used in this Award Agreement means all ideas, concepts, innovations, inventions, strategy, data, developments, and works of authorship, whether or not patentable, both technical and business, which the Participant originates, conceives or develops, either alone or in conjunction with others, at any time during the Participant's employment with the Corporation or any Affiliate, except those which satisfy all three of the following criteria: i) unrelated to the Corporation's business; ii) not originated, conceived or developed during the Participant's working hours; and iii) not originated, conceived or developed by use of any Corporation property such as tools, supplies, equipment, materials, facilities or other Corporation employees. Any idea, concept, innovation, invention, strategy, data, development or work of authorship that the Participant originates, conceives or develops, through the use of Corporation Confidential Information, at any time within six (6) months after the Participant's employment with the Corporation or any Affiliate terminates (for any reason) will be presumed to be a Business Idea unless the Participant can prove otherwise by clear and convincing evidence.
(e)     Notification Requirement. During the term of the Participant's employment with the Corporation or any Affiliate and for the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, the Participant agrees to notify the Corporation in writing prior to accepting new employment, or engaging in any other activity which may violate this Award Agreement, and the Participant agrees to provide in such notice information concerning the anticipated new employment or activity, including, but not limited to: name of new employer; address of new employer; name of new team leader; job title; and scope and responsibilities of the new position. The Participant recognizes that such duty of notification is not affected by the Participant’s belief that such employment may perhaps not violate this Award Agreement or otherwise be unfairly competitive with the Corporation or an Affiliate. The Participant’s written notice should be addressed to the Corporation's General Counsel with subject line Non-Competition Agreement, via email to Noncompete.Notification@kcc.com.
(f)    Other Notification. During the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, the Participant shall provide a copy of Section 20 of this Award Agreement to each new employer before starting in any new employment. The Participant agrees that the Corporation may notify any third party about the Participant’s obligations under Section 20 of this Award Agreement until such obligations are fulfilled.
(g)    Non-Solicitation of Business. During the term of the Participant’s employment and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, either directly or indirectly, on the Participant’s own behalf or on behalf of any other person, firm or company or other entity, solicit, interfere with, entice or endeavor to entice away from the Corporation or any Affiliate any Restricted Customer (as defined below), or seek to conduct Restricted Business (as defined below), or conduct Restricted Business, with any Restricted Customer and/or otherwise persuade, induce, solicit or encourage any person or entity to terminate its contractual relationship with the Corporation or any Affiliate. “Restricted Business,” for purposes of this Section 20, means any business activity carried out by the Participant either directly or indirectly for the Corporation or any Affiliate during the last two (2) years preceding the Participant’s termination date. “Restricted Customer,” for purposes of this Section 20, means any person, firm or company or other entity who was a customer or distributor of the Corporation or any Affiliate as at the Participant’s termination date, or during the last two (2) years preceding the Participant’s termination date, including any Prospective Customer. “Prospective Customer,” for purposes of this Section 20, means any person, firm or company or other entity with whom the Corporation or any Affiliate was involved in negotiations as at the Participant’s termination date or during the last two (2) years preceding the Participant’s



termination date, with a view to dealing with it as a customer and/or to conclude a contractual relationship with such entity, and/or with whom the Participant had contact at the Participant’s termination date or during the last two (2) years preceding the Participant’s termination date with a view to dealing with it as a customer of the Corporation or any Affiliate and/or to conclude a contractual relationship with such entity.
(h)    Non-Solicitation of Employees. For a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant’s termination date and with whom the Participant had material dealings during the last two (2) years preceding the Participant’s termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate, or (2) be otherwise involved in the recruitment of such person, to leave the employment of the Corporation or of any Affiliate. Furthermore, the Participant shall not for a period of two (2) years following the termination date regardless of the reason for or the manner of termination, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant’s termination date and with whom the Participant had material dealings during the last two (2) preceding the Participant’s termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor or (2) be otherwise involved in the recruitment of such person to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor. The Participant must inform the Corporation immediately on becoming aware of any such recruitment.
(i)     Remedies. In the event of an anticipated or actual breach by the Participant of any of the provisions of this Section 20, the Participant acknowledges and agrees that damages would not be an adequate remedy to compensate the Corporation or an Affiliate for the harm to the business of the Corporation or the Affiliate and, in such event, agrees that the Corporation or the Affiliate, as applicable, shall be entitled to a temporary restraining order and to temporary injunctive relief to prevent or terminate such anticipated or actual breach, provided, however, that nothing in this Award Agreement shall be construed to limit any permanent relief to which the Corporation or the Affiliate may be entitled or the damages otherwise recoverable by the Corporation or the Affiliate in any such event.
(j)    Forfeiture of Award. Notwithstanding the Corporation's or an Affiliate's ability to pursue injunctive relief pursuant to Section 20(i), in the event of an actual breach by the Participant of any of the provisions of this Section 20 or of any local restrictive covenant agreement, the Corporation also is entitled to forfeit any portion of the Award that has not vested or been settled yet at the time the Corporation becomes aware of the breach.
(k)    Reimbursement of Fees. If the Participant violates any of the provisions of this Section 20, or any duty of loyalty or confidentiality imposed by law, in addition to any damages that the Participant may be required to pay, the Participant understands and agrees that the Participant shall be required to reimburse the Corporation for all its costs incurred to enforce this Award Agreement, including but not limited to, all attorneys’ fees.
(l)    Beneficiaries. For purposes of this Section 20, the Corporation and each of its Affiliates shall be deemed to be third party beneficiaries with the right to seek enforcement of any of the provisions of this Section 20. Further, for purposes of this Section 20, references to acting directly or indirectly include acting jointly with or through another person.
(m)    Severability. If any provision of this Section 20 is held to be invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such provision shall be deemed to be severed from the Award Agreement and such invalidity, illegality or unenforceability will not affect any other provision of the Award Agreement, all of which shall remain valid and enforceable. Notwithstanding the foregoing, if a court of competent jurisdiction determines that the covenants contained in this Section 20 are unenforceable because they are overbroad in some respect, to the full extent permitted by applicable law, the court should sever, revise or reform any aspect of this Section 20 so as to make the scope of such Section 20 as broad as reasonable under applicable law and enforce this Section 20 as so modified. Without limiting the foregoing, if a court, government agency or other body of competent jurisdiction



establishes or the Corporation otherwise determines that the covenants contained in this Award Agreement are unenforceable and/or in violation of applicable rules, the Corporation reserves the right to unilaterally amend the Award Agreement so as to comply with applicable rules.
21.    Forfeiture and Recoupment.
(a)    The PRSUs are subject to the compensation recovery provisions of the Plan. In addition, the PRSUs are subject to the Kimberly-Clark Corporation Compensation Recoupment Policy (such policy, as it may be amended from time to time, the “Recoupment Policy”) if the Participant is a Leader (as defined in the Recoupment Policy). A recovery under this section may be made by (a) cancelling any PRSUs which have not yet vested or been settled; (b) recovering shares of Common Stock or cash equal to the value of the shares of Common Stock issued on settlement of the PRSUs, including shares resulting from dividend equivalents; (c) recovering proceeds realized by the Participant on the sale of such Common Stock; (d) withholding compensation otherwise due to the Participant; (e) payment by the Participant; and/or (e) by such other means determined appropriate under the terms of the Recoupment Policy. If the Participant is required to repay the Corporation, the Corporation is entitled to offset the payment in a way that is intended to avoid the application of penalties under Section 409A of the Code, if applicable.
Without limiting the foregoing, if, following a Participant’s termination of employment for a reason other than the Participant’s termination for Cause, the Corporation discovers facts that such Participant’s termination of employment could have been for Cause, such Participant’s termination of employment will be deemed to have been for Cause for all purposes, and as a result, (a) the Corporation will not issue shares of Common Stock or any other benefit otherwise payable to the Participant under the Plan and (b) the Participant will be required to repay to the Corporation all proceeds received under the Plan that would not have been payable to such Participant had such termination of employment been for Cause.
The Corporation shall have the right to suspend any and all rights or benefits awarded to the Participant hereunder, including vesting and settlement of the PRSUs, pending its investigation and final determination with regard to whether the Participant has engaged in conduct constituting Cause or that would warrant application of the Recoupment Policy.
(b)    By accepting the Award Grant and the terms of this Award Agreement, the Participant understands, acknowledges and accepts that the grant, shares of Common Stock issued under the Plan and proceeds realized by the Participant pursuant to the Plan are subject to the terms of the Recoupment Policy and the Corporation may seek recovery by any of the methods described in Section 21(a) or other such means determined appropriate under the terms of the Recoupment Policy.
22.    Whistleblower Statutes. Notwithstanding anything to the contrary in this Award Agreement, nothing in Sections 19, 20 or 21 of this Award Agreement is intended to or shall limit, prevent, impede or interfere with the Participant's non-waivable right, without prior notice to the Corporation, to provide information to the government, participate in investigations, testify in proceedings regarding the Corporation, Employer or any Affiliate's past or future conduct, engage in any activities protected under whistleblower statutes, or to receive and fully retain a monetary award from a government-administered whistleblower award program for providing information directly to a government agency. The Participant does not need prior authorization from the Corporation to make any such reports or disclosures and is not required to notify the Corporation that the Participant has made such reports or disclosures.
23.    Section 409A. It is the intent of this Award Agreement that it and all payments and benefits hereunder be exempt from, or comply with, the requirements of Section 409A of the Code so that none of the PRSUs provided under this Award Agreement or shares of Common Stock issuable thereunder will be subject to the additional tax imposed under Section 409A of the Code, and any ambiguities herein will be interpreted to be so exempt or so comply.
24.    Acceptance of Award Terms and Conditions. A Participant has until the end of the ninety (90) day period beginning from the Grant Date of this Award to accept this Award Agreement. If the Participant does not accept this Award Agreement on or before the end of such ninety (90) day period then the grant of the Award, as set forth in Section 1, shall not be binding on and shall be voidable by the Corporation, in which case it shall have no further force or effect. Further, as set forth in the fourth paragraph of Section 2(a), the Award



will be forfeited if the Participant does not accept any restrictive covenant agreement presented to the Participant by the end of the period noted in Section 2(a).
Acknowledgment of Conditions
The Participant understands, acknowledges and agrees to the following conditions with respect to the Award granted under the Plan:
The Plan is established voluntarily by the Corporation, is discretionary in nature and may be modified, amended, suspended, cancelled or terminated at any time, to the extent permitted by the Plan. The grant of an Award is an exceptional, voluntary and occasional benefit and does not create any contractual or other right to receive an Award or benefits in lieu of an Award in the future, even if Awards have been granted in the past. Future grants, if any, will be at the sole discretion of the Corporation, including, but not limited to, the timing of any grant, the number of Awards and vesting provisions.
Participation in the Plan is voluntary and does not create a right to employment with the Participant’s Employer, shall not be interpreted as forming an employment or service contract with the Corporation, and shall not interfere with the ability of the Employer to terminate the Participant’s employment relationship at any time. The Participant understands that the Corporation has unilaterally, gratuitously and discretionally decided to grant Awards under the Plan to individuals who are employees of the Corporation or its Affiliates throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Corporation or any of its Affiliates on an ongoing basis. Consequently, the Participant understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Corporation or any of its Affiliates) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. Further, the Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from any gratuitous and discretionary grant since the future value of the Award and the underlying shares is unknown and unpredictable. In addition, the Participant understands that this grant would not be made but for the assumptions and conditions referred to above; thus, the Participant understands, acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then the Award shall be null and void.
The Award and the shares of Common Stock subject to the Award, and the income from and value of same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Corporation or, if different, the Employer, and which are outside the scope of the Participant's employment contract, if any, and are not intended to replace any pension rights or compensation. As such, the Award, and the income from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, leave-related payments, holiday pay, pension, retirement or welfare benefits or similar payments and in no event shall be considered as compensation for, or relating in any way to, past services for the Corporation, the Employer or any other Affiliate.
Unless otherwise agreed with the Corporation, the Award and shares of Common Stock subject to the Award, and the income from and value of same, are not granted as consideration for, or in connection with, any service the Participant may provide as a director of any Affiliate.
The future value of the underlying shares of Common Stock is unknown, indeterminable, and cannot be predicted with certainty.
The Award will be subject to any policy adopted by the Corporation relating to the recovery of such Award to the extent it is determined that the Performance Goals were not actually achieved.
No claim or entitlement to compensation or damages shall arise from forfeiture of the Award or recoupment of any shares of Common Stock acquired under the Plan resulting from (a) the termination of the Participant's employment by the Corporation or the Employer (regardless of the reason for such termination and whether or not the termination is later found to be invalid or in breach of employment laws); and/or (b) the application of the Corporation’s Recoupment Policy or any recovery or clawback policy required by law.
The Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan, or the acquisition or sale of the underlying shares of



Common Stock. Further, the Participant understands that he or she should consult with his or her own advisors regarding participation in the Plan before taking any action related to the Plan.
Neither the Corporation, the Employer nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the PRSUs or of any amounts due to the Participant pursuant to the settlement of the PRSUs or the subsequent sale of any shares of Common Stock acquired upon settlement.
Regardless of any action the Corporation or the Employer takes with respect to any or all income tax (including federal, state and local taxes), social insurance, fringe benefit tax, payroll tax, payment on account or other tax-related items related to the Participant’s participation in the Plan and legally applicable to the Participant (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant’s responsibility and may exceed the amount, if any, actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant of the PRSUs, the vesting of PRSUs, the conversion of the PRSUs into shares or the receipt of an equivalent cash payment, the subsequent sale of any shares acquired at vesting and the receipt of any dividends or dividend equivalents; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Corporation and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
In connection with the relevant taxable or tax withholding event, as applicable, the Participant shall pay or make adequate arrangements satisfactory to the Corporation and/or the Employer to satisfy or account for all applicable withholding obligations for Tax-Related Items. In this regard, the Participant authorizes the Corporation or the Employer, or their respective agents, at their discretion, to satisfy their withholding obligations, if any, with regard to all Tax-Related Items by one or a combination of the following:
(1)    withholding from the Participant’s wages or other cash compensation paid to the Participant by the Corporation and/or the Employer; or
(2)    withholding from the proceeds of the sale of shares acquired upon vesting of the Award either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant’s behalf, pursuant to this authorization); or
(3)    withholding shares to be issued upon vesting of the Award;
provided, however, that if the Participant is subject to Section 16 of the U.S. Securities Exchange Act of 1934, as amended, then the Corporation will withhold in shares upon the relevant taxable or tax withholding event, as applicable, unless the use of such withholding method is not feasible under applicable tax or law or has materially adverse accounting consequences, in which case, the obligation for Tax-Related Items may be satisfied by one or a combination of methods (1), (2) and (3) above.
The Corporation may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates, including minimum rates or maximum applicable rates in applicable jurisdictions. In the event of over-withholding, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the common stock equivalent), or if not refunded, the Participant may seek a refund from the applicable tax authorities. In the event of under-withholding, the Participant may be required to pay additional Tax-Related Items directly to the applicable tax authorities or to the Corporation or the Employer. If the obligation for Tax-Related Items is satisfied by withholding in shares, for tax purposes, the Participant is deemed to have been issued the full number of shares subject to the Award, notwithstanding that a number of shares is held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Plan.
The Participant shall pay to the Corporation or to the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to deliver shares or the proceeds of the sale of shares to the Participant if he or she fails to comply with his or her obligations in connection with the Tax-Related Items.



The Corporation is located at 351 Phelps Drive Irving, TX 75038, USA and grants employees of the Corporation and its Affiliates the opportunity to participate in the Plan, at the Corporation’s sole discretion. If the Participant would like to participate in the Plan and is an employee in a country outside the European Economic Area, the Participant understands that he or she should review the following information about the Corporation’s data processing practices and declare his or her consent. If the Participant is an employee in a country that is a member of the European Economic Area, the Participant should review the information about the Corporation’s data processing practices set forth in Appendix A attached hereto.
(1)Data Collection and Usage. The Corporation collects, processes and uses the Participant’s personal data, including, name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, citizenship, nationality, job title, any shares of stock or directorships held in the Corporation, and details of all awards, canceled, vested, or outstanding in the Participant’s favor, which the Corporation receives from the Participant or the Participant’s Employer. If the Corporation offers the Participant the opportunity to participate in the Plan, then the Corporation will collect the Participant’s personal data for purposes of allocating stock and implementing, administering and managing the Plan. The Corporation’s legal basis for the processing of the Participant's personal data would be the Participant’s consent.
(2)Stock Plan Administration Service Providers. The Corporation transfers participant data to Merrill Lynch, an independent service provider based in the United States, which assists the Corporation with the implementation, administration and management of the Plan. In the future, the Corporation may select a different service provider and share the Participant’s data with another company that serves in a similar manner. The Corporation’s service provider will open an account for the Participant. The Participant will be asked to agree on separate terms and data processing practices with the service provider, which is a condition for participation in the Plan.
(3)International Data Transfers. The Corporation and its service providers are based in the United States. If the Participant is outside of the United States, the Participant should note that his or her country may have enacted data privacy laws that are different from the United States. The Corporation’s legal basis for the transfer of the Participant’s personal data is the Participant’s consent.
(4)Data Retention. The Corporation will use the Participant’s personal data only as long as is necessary to implement, administer and manage his or her participation in the Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. This period may extend until the Participant’s employment or service with the Corporation is terminated, plus any additional time periods necessary for compliance with law, exercise or defense of legal rights, and archiving, back-up and deletion processes.
(5)Voluntariness and Consequences of Consent Denial or Withdrawal. The Participant’s participation in the Plan and the Participant’s grant of consent is purely voluntary. The Participant may deny or withdraw his or her consent at any time. If the Participant does not consent, or if he or she withdraws their consent, the Participant cannot participate in the Plan. This would not affect the Participant’s salary as an employee; the Participant would merely forfeit the opportunities associated with the Plan.
(6)Data Subject Rights. The Participant has a number of rights under data privacy laws in his or her country. Depending on where the Participant is based, the Participant’s rights may include the right to (i) request access or copies of personal data the Corporation processes, (ii) rectification of incorrect data, (iii) deletion of data, (iv) restrictions on processing, (v) portability of data, (vi) to lodge complaints with competent authorities in the Participant’s country, and/or (vii) a list with the names and addresses of any potential recipients of the Participant’s personal data. To receive clarification regarding the Participant’s rights or to exercise the rights please contact the Corporation at Attn: Long-term Incentive Plan Administration at Kimberly Clark, 351 Phelps Drive Irving, TX 75038, USA.
The Participant also understands that the Corporation may rely on a different legal basis for the processing or transfer of data in the future and/or request that the Participant provides another data privacy consent.  If applicable and upon request of the Corporation, the Participant agrees to provide an executed acknowledgment or data privacy consent form to the Corporation or the Employer (or any other acknowledgments, agreements or consents) that the Corporation and/or the Employer may deem necessary to obtain under the data privacy laws in the Participant’s country, either now or in the future.  The Participant understands that he or she will not be able to



participate in the Plan if the Participant fails to execute any such acknowledgment, agreement or consent requested by the Corporation and/or the Employer.
If the Participant agrees with the data processing practices described in this notice, the Participant will declare his or her consent by clicking the "Accept" icon on the Merrill Lynch website.
The Participant understands that he or she is solely responsible for obtaining/providing whatever exchange control approvals, permits, licenses or notices, which may be necessary for the Award, to acquire the shares or to hold or sell the shares subject to the Award. Neither the Corporation nor its Affiliates will be responsible for obtaining such approvals, licenses or permits, or for making any such notices, nor will the Corporation or its Affiliates be liable for any fines or penalties the Participant may incur for failure to obtain any required approvals, permits or licenses or to make any required notices.
In accepting the grant of this Award, the Participant acknowledges that he or she has received a copy of the Plan and the Award Agreement and has reviewed the Plan and the Award Agreement, including Appendix A, in their entirety and fully understands and accepts all provisions of the Plan and the Award Agreement, including Appendix A.
The Participant acknowledges that he or she has read and specifically and expressly approves the following sections of the Award Agreement: Section 2(g) on Payment of Tax-Related Items; Section 5 on No Right of Continued Employment; Section 8 on Governing Law; the section on Acknowledgment of Conditions; and the Data Privacy Notice sections of both the Award Agreement and Appendix A for the Participant's country.
The provisions of this Award Agreement are severable and if one or more of the provisions of this Award Agreement shall be held invalid, illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nonetheless be binding and enforceable. To the extent that any provisions of this Award Agreement are held to be invalid or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and the invalid, illegal or unenforceable provisions shall be deemed null and void; however, to the extent permissible by law, any provisions which could be deemed null and void shall first be construed, interpreted or revised retroactively to permit this Award Agreement to be construed so as to foster the intent of this Award Agreement and the Plan.
The Participant acknowledges that he or she is sufficiently proficient in English or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the terms and conditions of this Award Agreement. Furthermore, if the Participant has received this Award Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.
Notwithstanding any provisions in this Award Agreement, the Award shall be subject to any additional terms and conditions set forth in Appendix A to this Award Agreement for the Participant's country. Moreover, if the Participant relocates to any of the countries included in Appendix A, the additional terms and conditions for such country will apply to the Participant, to the extent the Corporation determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. Appendix A constitutes part of this Award Agreement.
The Participant acknowledges that the grant of an Award is expressly conditioned on the non-competition provisions set forth in Sections 19 and 20.
The Corporation reserves the right to impose other requirements on the Participant's participation in the Plan, on the Award and on any shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by on-line delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third-party designated by the Corporation.
A waiver by the Corporation of breach of any provision of this Award Agreement shall not operate or be construed as a waiver of any other provision of this Award Agreement, or of any subsequent breach by the Participant or any other participant.



The Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, which may affect the Participant's ability to, directly or indirectly, accept, acquire, sell, or attempt to sell or otherwise dispose of shares of Common Stock or rights to shares of Common Stock (e.g., PRSUs), or rights linked to the value of shares of Common Stock during such times as the Participant is considered to have “inside information” regarding the Corporation (as defined by the laws in the applicable jurisdictions or the Participant's country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant placed before possessing inside information. Furthermore, the Participant may be prohibited from (i) disclosing the inside information to any third party, including fellow employees (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them to otherwise buy or sell Corporation securities. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Corporation insider trading policy. The Participant is responsible for ensuring his or her compliance with any applicable restrictions and is advised to speak with his or her personal legal advisor on this matter.
The Participant's country may have certain foreign asset and/or foreign account reporting requirements, tax and/or exchange controls which may affect the Participant's ability to acquire or hold shares of Common Stock acquired under the Plan or cash received from participating in the Plan (including from any dividends paid on shares acquired under the Plan) in a brokerage or bank account outside the Participant's country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in the Participant's country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of participation in the Plan to his or her country through a designated bank or broker within a certain time after receipt. In addition, the Participant agrees to take any and all actions, and consent to any and all actions taken by the Corporation, or the Employer as may be required to allow the Corporation or the Employer to comply with local laws, rules and regulations in the Participant's country of residence (and country of employment, if different). Finally, the Participant agrees to take any and all actions as may be required to comply with their personal legal and tax obligations under local laws, rules and regulations in their country of residence (and country of employment, if different). The Participant should consult his or her personal legal advisor for any details.
The Participant acknowledges that he or she has reviewed the Corporation’s Code of Conduct. The Participant further acknowledges that he or she understands and will comply with the terms and standards contained in that Code of Conduct, including but not limited to the prohibition against retaliation, and specifically acknowledges that he or she has an obligation to report suspected violations of the Code of Conduct pursuant to the Corporation’s Escalation Policy.
Conclusion and Acceptance
The Participant accepts this grant via electronic signature by clicking the "Accept" icon and certifies that he or she has read, understands and agrees to the terms and conditions of the 2021 Equity Participation Plan (the "Plan"), the provisions of the applicable Award Agreement and all other applicable documents (including any country-specific terms applicable to the Participant's grant). The Participant hereby authorizes the Employer to furnish the Corporation (and any agent administering the Plan or providing recordkeeping services) with such information and data as it shall request in order to facilitate the grant of Awards and enable administration of the Plan and the Participant understands that such information shall be used only as long and to the extent necessary to administer the Participant's participation in the Plan. The Participant agrees that his or her participation in the Plan and the Awards granted to the Participant under the Plan will be governed solely by provisions of U.S. law.




KIMBERLY-CLARK CORPORATION
PERFORMANCE RESTRICTED STOCK UNIT
AWARD AGREEMENT
APPENDIX A
Certain capitalized terms used but not defined in this Appendix A have the meanings set forth in the Plan and/or the Award Agreement.
This Appendix A includes additional terms and conditions that govern the Award granted to the Participant under the Plan if the Participant resides and/or works in any of the countries listed below.
This Appendix A also includes information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of April 2023. Such laws are often complex and change frequently. As a result, the Participant should not rely on the information noted herein as the only source of information relating to the consequences of the Participant’s participation in the Plan because the information may be out of date at vesting of the Award or the subsequent sale of the shares or receipt of any dividends or dividend equivalents.
In addition, the information is general in nature and may not apply to the Participant’s particular situation, and the Corporation is not in a position to assure the Participant of any particular result. Accordingly, the Participant is advised to seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.
Finally, if the Participant is a citizen or resident of a country other than the one in which the Participant is currently residing and/or working, transferred or transfers employment and or residency after the Award is granted or is considered a resident of another country for local law purposes, the information contained herein may not be applicable to the Participant. The Corporation shall, in its sole discretion, determine to what extent the terms and conditions included herein will apply to the Participant in such circumstances.
EUROPEAN ECONOMIC AREA (INCLUDING THE UNITED KINGDOM) AND SWITZERLAND
Data Protection
For Participants resident in a country in the European Economic Area, Switzerland or the United Kingdom, the following language replaces in its entirety the data privacy section in the Acknowledgment of Conditions section of the Award Agreement:
(1)The Participant is hereby notified of the collection, use and transfer outside of the European Economic Area, as described in the Award Agreement, in electronic or other form, of his or her Personal Data (defined below) by and among, as applicable, the Corporation and certain of its Affiliates for the exclusive and legitimate purpose of implementing, administering and managing the Participant’s participation in the Plan.
(2)The Participant understands that the Corporation and the Employer hold certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares of Common Stock or directorships held in the Corporation, details of all entitlement to shares of Common Stock awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Personal Data”), for the purpose of implementing, administering and managing the Plan.
(3)The Participant understands that providing the Corporation with this Personal Data is necessary for the performance of the Award Agreement and that the Participant's refusal to provide the Personal Data would make it impossible for the Corporation to perform its contractual obligations and may affect the Participant's ability to participate in the Plan. The Participant's Personal Data shall be accessible within the Corporation only by the persons specifically charged with Personal



Data processing operations and by the persons that need to access the Personal Data because of their duties and position in relation to the performance of the Award Agreement.
(4)The Personal Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. This period may extend until the Participant’s employment or service with the Corporation is terminated, plus any additional time periods necessary for compliance with law, exercise or defense of legal rights, and archiving, back-up and deletion processes. The Participant may, at any time and without cost, contact Long-term Incentive Plan Administration at Kimberly Clark, 351 Phelps Drive Irving, TX 75038, USA to enforce his or her rights under the data protection laws in the Participant's country, which may include the right to (i) request access or copies of Personal Data subject to processing; (ii) request rectification of incorrect Personal Data; (iii) request deletion of Personal Data; (iv) request restriction on processing of Personal Data; (v) request portability of Personal Data; (vi) lodge complaints with competent authorities in the Participant's country; and/or (vii) request a list with the names and addresses of any potential recipients of Personal Data.
(5)The Corporation provides appropriate safeguards for protecting Personal Data that it receives in the U.S. through its adherence to data transfer agreements entered into between the Corporation and its Affiliates within the European Union.
(6)Further, the Participant understands that the Corporation will transfer Personal Data to Merrill Lynch and/or such other third parties as may be selected by the Corporation, which are assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Personal Data with such other provider(s) serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.
(7)Merrill Lynch is based in the United States. The Participant's country or jurisdiction may have different data privacy laws and protections than the United States. Notwithstanding, by participating in the Plan, the Participant agrees to the transfer of his or her Personal Data to Merrill Lynch for the exclusive purpose of administering the Participant's participation in the Plan. The Corporation's legal basis, where required, for the transfer of Data to Merrill Lynch is the Participant's consent.
(8)Finally, the Participant may choose to opt out of allowing the Corporation to share his or her Personal Data with Merrill Lynch and others as described above, although execution of such choice may mean the Corporation cannot grant awards under the Plan to the Participant. For questions about this choice or to make this choice, the Participant should contact Long-term Incentive Plan Administration at Kimberly Clark, 351 Phelps Drive Irving, TX 75038, USA.
ARGENTINA
Securities Law Information
Neither the PRSUs nor the underlying shares of Common Stock are publicly offered or listed on any stock exchange in Argentina.
Foreign Asset/Account Reporting Information
Argentine residents must report any shares of Common Stock acquired under the Plan and held on December 31st of each year on their annual tax return for the year.
Exchange Control Information
Please note that exchange control regulations in Argentina are subject to frequent change. The Participant should consult with his or her personal legal advisor regarding any exchange control obligations the Participant may have in connection with the Participant’s participation in the Plan. The Participant must comply with any and all Argentine currency exchange restrictions, approvals and reporting requirements in connection with the vesting of



the PRSUs, the subsequent sale of any shares acquired at vesting and the receipt of any dividends paid on such shares.
AUSTRALIA
Securities Law Information
This offer is being made under Division 1A, Part 7.12 of the Australia Corporations Act 2001 (Cth). Please note that if the Participant offers shares of Common Stock for sale to a person or entity resident in Australia, the offer may be subject to disclosure requirements under Australian law. The Participant should obtain legal advice regarding the relevant disclosure obligations prior to making any such offer.
Tax Information
The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the “Act”) applies (subject to conditions in the Act).
Compliance with Laws
Notwithstanding anything else in the Plan or the Award Agreement, the Participant will not be entitled to and shall not claim any benefit under the Plan if the provision of such benefit would give rise to a breach of Part 2D.2 of the Corporations Act 2001 (Cth.) (the “Act”), any other provision of the Act, or any other applicable statute, rule or regulation which limits or restricts the giving of such benefits. Further, the Employer is under no obligation to seek or obtain the approval of its shareholders in a general meeting for the purpose of overcoming any such limitation or restriction.
Exchange Control Information
Exchange control reporting is required for cash transactions exceeding AUD10,000 and for international fund transfers. If an Australian bank is assisting with the transaction, the bank will file the report on the Participant’s behalf. If there is no Australian bank involved in the transaction, the Participant will be required to file the report him or herself.
BAHRAIN
Securities Law Information
The Award Agreement, Plan and all other materials the Participant may receive regarding participation in the Plan do not constitute advertising or the offering of securities in Bahrain, nor do they constitute an allotment of securities in Bahrain. Any shares of Common Stock issued upon settlement of the PRSUs will be deposited into a Corporation-designated brokerage account outside Bahrain. In no event will shares of Common Stock be issued or delivered in Bahrain. The issuance of shares of Common Stock pursuant to the PRSUs described herein has not and will not be registered in Bahrain and, hence, the shares of Common Stock described herein may not be admitted or used for offering, placement or public circulation in Bahrain. Accordingly, the Participant may not make any public advertising or announcements regarding the PRSUs or shares of Common Stock in Bahrain, promote these shares of Common Stock to legal entities or individuals in Bahrain, or sell shares of Common Stock directly to other legal entities or individuals in Bahrain. Any disposition or sale of such shares of Common Stock must take place outside Bahrain.
BELGIUM
Foreign Asset/Account Reporting Information
Belgian residents are required to report any securities (e.g., shares acquired under the Plan), or bank accounts opened and maintained outside Belgium (e.g., any brokerage account opened in connection with the Plan) on their annual tax returns. Belgian residents are also required to complete a separate report providing the National Bank of Belgium with details regarding any such account, including the account number, the name of the bank in which such account is held and the country in which such account is located. The forms to complete this report are available on the website of the National Bank of Belgium. Belgian residents should consult with their personal tax advisors to determine their personal reporting obligations.



Stock Exchange Tax
A stock exchange tax applies to transactions executed by a Belgian resident through a non-Belgian financial intermediary, such as a U.S. broker. The Stock Exchange Tax likely will apply when the Participant sells shares of Common Stock. The Participant should consult with his or her personal tax advisor for additional details regarding the Participant’s obligations with respect to the Stock Exchange Tax.
Annual Securities Accounts Tax
An annual securities accounts tax may be payable if the total value of securities held in a Belgian or foreign securities account (e.g., shares of Common Stock acquired under the Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such cases, the tax will be due on the value of the qualifying securities held in such account. The Participant should consult with his or her personal tax advisor regarding the application of this tax.
BOLIVIA
There are no country-specific provisions.
BRAZIL
Compliance with Law
By accepting the Award, the Participant acknowledges that he or she agrees to comply with applicable Brazilian laws and pay any and all applicable Tax-Related Items associated with the vesting of the PRSUs, the conversion of the PRSUs into shares or the receipt of an equivalent cash payment, the receipt of any dividends, and the sale of shares of Common Stock acquired under the Plan.
Labor Law Acknowledgment
By accepting the Award, the Participant agrees that (i) the Participant is making an investment decision; (ii) the shares of Common Stock will be issued to Participant only if the vesting and/or performance conditions are met, and (iii) the value of the underlying shares of Common Stock is not fixed and may increase or decrease in value over the Restricted Period without compensation to the Participant.
Exchange Control Information
If the Participant is resident or domiciled in Brazil, he or she will be required to submit annually a declaration of assets and rights held outside of Brazil to the Central Bank of Brazil if the aggregate value of such assets and rights is equal to or greater than US$1,000,000. Assets and rights that must be reported include shares of Common Stock and may include PRSUs.
Tax on Financial Transaction (IOF).
Payments to foreign countries and repatriation of funds into Brazil (including proceeds from the sale) and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions. It is the Participant’s responsibility to comply with any applicable Tax on Financial Transactions arising from the Participant’s participation in the Plan. The Participant should consult with his or her personal tax advisor for additional details.
CANADA
Securities Law Information
The Participant is permitted to sell shares acquired through the Plan through the designated broker appointed under the Plan, if any, provided the resale of shares acquired under the Plan takes place outside of Canada through the facilities of a stock exchange on which the shares are listed. The Corporation’s shares are currently listed on New York Stock Exchange.
Acknowledgment of Conditions
The following provision supplements the Acknowledgment of Conditions section of the Award Agreement:
Except as may otherwise be explicitly provided in the Plan or this Award Agreement, for the purposes of this Award Agreement, the Participant's termination of employment will be measured effective as of the date that is the



earlier of: (1) the date the Participant's employment is terminated, no matter how the termination arises; and (2) the date the Participant receives notice of termination of employment from the Employer. In either case, the date shall exclude any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under local law. For greater certainty, the Participant will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which the Participant's right to vest terminates, nor will the Participant be entitled to any compensation for lost vesting. Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued vesting during a statutory notice period, the Participant's right to vest in the PRSUs, if any, will terminate effective as of the last day of the Participant's minimum statutory notice period, but the Participant will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of the Participant's statutory notice period, nor will the Participant be entitled to any compensation for lost vesting.
The Participant acknowledges and agrees that the vesting schedule may change prospectively in the event the Participant’s service status changes between full- and part-time and/or in the event the Participant is on a leave of absence, in accordance with Corporation’s policies relating to work schedules and vesting of PRSUs or as determined by the Committee. In case of any dispute as to whether and when a termination of the Participant’s employment has occurred, the Committee will have sole discretion to determine whether such termination of the Participant’s employment has occurred and the effective date of such termination (including whether the Participant may still be considered to be actively providing services while on a leave of absence).
Language
A French translation of the Plan and the Award Agreement can be made available to the Participant as soon as reasonably practicable upon the Participant’s request. The Participant understands that, from time to time, additional information related to the offering of the Plan might be provided in English and such information may not be immediately available in French. However, upon request, the Corporation will translate into French documents related to the offering of the Plan as soon as reasonably practicable.
Une traduction française du Plan et de l'Accord d'Attribution êtremise à la disposition de Participant dès que raisonnablement possible à la demande de l'Participant. Le Participant comprend que, de temps à autre, des informations supplémentaires liées à l'offre du Plan peuvent être fournies en anglais et que ces informations peuvent ne pas être immédiatement disponibles en français. Cependant, sur demande, la Société traduira en français les documents relatifs à l'offre du Plan dès que raisonnablement possible.
Authorization to Release and Transfer Necessary Personal Information
The Participant hereby authorizes the Corporation and the Corporation’s representatives, including the broker(s) designated by the Corporation, to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. The Participant further authorizes the Corporation, any Affiliate and the plan administrators to disclose and discuss the Plan with their advisors. The Participant further authorizes the Corporation and any Affiliate to record such information and to keep such information in the Participant’s employee file. The Participant acknowledges that the Participant’s personal information, including any sensitive personal information, may be transferred or disclosed outside the Province of Quebec, including to the United States. Finally, the Participant acknowledges that the Corporation, the Employer or any other Affiliate or other parties involved in the administration of the Plan use technology for profiling purposes and to make automated decisions that may have an impact on the Participant or the administration of the Plan.
Foreign Asset/Account Reporting Information
Foreign specified property (including shares of Common Stock) held by Canadian residents must be reported annually on Form T1135 (Foreign Income Verification Statement) if the total cost of such foreign specified property exceeds C$100,000 at any time during the year. Foreign specified property includes shares of Common Stock acquired under the Plan and may include the PRSUs. The PRSUs must be reported - generally at a nil cost - if the $100,000 cost threshold is exceeded because of other foreign property the Participant holds. If shares of Common Stock are acquired, their cost generally is the adjusted cost base (“ACB”) of the shares. The ACB would normally equal the Fair Market Value of the shares at vesting, but if the Participant owns other shares, this ACB may have to be averaged with the ACB of the other shares owned by the Participant. If due, the Form must be



filed by April 30 of the following year. The Participant should speak with a personal tax advisor to determine the scope of foreign property that must be considered for purposes of this requirement.
CHILE
Securities Law Information
The PRSUs are granted and are made subject to general ruling n° 336 of the Chilean Commission for the Financial Market (“CMF”). This offer refers to securities not registered at the securities registry or at the foreign securities registry of the CMF, and therefore such securities are not subject to its oversight. Given that these securities are not registered in Chile, there is no obligation from the issuer to provide public information on them in Chile. These securities cannot be subject to public offering in Chile while they are not registered at the corresponding securities registry in Chile.
La oferta privada de estos PRSUs se inicia y se acoge a las disposiciones de la norma de carácter general nº 336 de la Comisón para el Mercado Financiero (“CMF”). Esta oferta versa sobre valores no inscritos en el registro de valores o en el registro de valores extranjeros que lleva la CMF, por lo que tales valores no están sujetos a la fiscalización de ésta. Por tratarse de valores no inscritos en Chile, no existe la obligación por parte del emisor de entregar en Chile información pública respecto de los mismos. Estos valores no podrán ser objeto de oferta pública en Chile mientras no sean inscritos en el registro de valores correspondiente.
Exchange Control Information
The Participant is not required to repatriate funds obtained from the sale of shares or the receipt of any dividends. However, if the Participant decides to repatriate such funds, the Participant must do so through the Formal Exchange Market if the amount of the funds exceeds US$10,000. In such case, the Participant must report the payment to a commercial bank or registered foreign exchange office receiving the funds.
Foreign Asset/Account Reporting Information
The Chilean Internal Revenue Service (the “CIRS”) requires all taxpayers to provide information annually regarding (i) the results of investments held abroad and (ii) any taxes paid abroad which the taxpayers will use as a credit against Chilean income tax. The sworn statements disclosing this information (or Formularios) must be submitted electronically through the CIRS website, www.sii.cl, using Form 1929, which is due on July 1 each year.
CHINA
The following provisions apply only to Participants who are subject to exchange control restrictions imposed by the State Administration of Foreign Exchange ("SAFE"), as determined by the Corporation in its sole discretion:
Vesting of Awards
The Participant's Employer, Corporation any other Affiliate to which the Participant provides service must be registered with SAFE prior to settlement of the PRSUs. If the Corporation is unable to obtain registration approval or is required to obtain further approvals on behalf of the Employer, Corporation or any other Affiliate, the vesting or settlement of the PRSUs may be suspended or delayed. Further, the Corporation is under no obligation to vest the PRSUs and/or issue shares of Common Stock if the Corporation’s SAFE approval becomes invalid or ceases to be in effect by the time the Participant vests in the PRSUs.
Shutdown or Divestiture
The following provision replaces Section 2(d) of the Award Agreement.
In the event that, more than six months after the Grant Date, the Participant’s termination of employment is due to the shutdown or divestiture of the Corporation’s or its Affiliate’s business, it shall result in pro-rata vesting, as determined by the Committee, and the number of shares that are considered to vest shall be determined based on the Target Level of Awards (including any accrued dividend equivalents accumulated pursuant to Section 2(a)) and by prorating the number of full years of employment during the Restricted Period prior to the Participant's termination of employment, and shall be paid within 70 days following the Participant's termination of employment. Any fractional share of the Corporation resulting from such a prorated Award shall be rounded to the nearest whole share. For the purposes of this Award, a shutdown or divestiture of the Corporation’s or its Affiliate’s business unit is defined as one for which the charges related to the shutdown or divestiture are



accounted for, and reported externally, as an exit activity in the Corporation's applicable SEC filings. The Corporation has complete discretion to determine whether a shutdown or divestiture of a business unit has occurred under the terms of the Plan.
Termination of Employment
Except for a termination of employment due to Retirement or the shutdown or divestiture of a business unit, as described above, and notwithstanding any other provision in the Award Agreement, the Participant shall forfeit any unvested Award, including any accrued dividend equivalents, upon any termination of employment including, but not limited to, any termination that is due to a Qualified Termination of Employment, death, or Total and Permanent Disability.
In the event that, more than six months after the Grant Date, the Participant’s termination of employment is due to Retirement, then provided that, in the sole discretion of the Corporation, (i) no circumstances exist that could lead to a determination that the Participant should be, or could have been, terminated for Cause; and (ii) the Participant has not engaged in conduct that would trigger the Committee’s right of recoupment under the Corporation's Recoupment Policy (as defined in Section 21 of this Award Agreement), it shall result in 100% vesting and the number of shares that are considered to vest shall be determined based on the Target Level of Awards (including any accrued dividend equivalents accumulated pursuant to Section 2(a)). Any PRSUs vested pursuant to this paragraph shall be paid within 70 days following the Participant's termination of employment. 
The Participant acknowledges and agrees that he or she must sell any shares of Common Stock issued to him or her upon vesting of the Awards as soon as practicable following the Participant's termination of employment for any reason and in no event later than three months following the Participant's termination of employment. The Participant agrees that if he or she continues to hold any of such shares of Common Stock after this time, the shares of Common Stock may be sold by the Corporation’s designated broker on the Participant's behalf at the instruction of the Corporation. Therefore, by accepting the Awards, the Participant understands and agrees that the Corporation is authorized to, and may in its sole discretion, instruct its designated broker to assist with the mandatory sale of shares of Common Stock (on the Participant’s behalf pursuant to this authorization) and that the Participant expressly authorizes the Corporation’s designated broker to complete the sale of such shares of Common Stock. The Participant acknowledges that the Corporation’s designated broker is under no obligation to arrange for the sale of the shares of Common Stock at any particular price. Upon the sale of the shares of Common Stock, the proceeds, less any Tax-Related Items and brokerage fees or commissions will be remitted to the Participant pursuant to the procedures described in the “Exchange Control Information” section below.
Exchange Control Information
Shares of Common Stock issued to the Participant under the Plan must be maintained in an account with Merrill Lynch or such other broker as may be designated by the Corporation until the shares of Common Stock are sold through that broker. If the Corporation changes its broker, the Participant acknowledges and agrees that the Corporation may transfer any shares of Common Stock issued under the Plan to the new designated broker if necessary for legal or administrative reasons. The Participant agrees to sign any documentation necessary to facilitate the transfer. In addition, the Participant may be required to sell any shares of Common Stock obtained under the Plan if the Corporation determines that the application of such condition is necessary or advisable for China SAFE exchange control, legal or other administrative reasons.
The Participant understands and agrees that, to facilitate compliance with exchange control requirements, the Participant will be required to immediately repatriate to China the cash proceeds from the sale of shares of Common Stock acquired upon vesting of the Awards or from any dividends or dividend equivalents paid on the shares of Common Stock. The Participant further understands that, under local law, such repatriation of the cash proceeds will be effectuated through a special exchange control account established by the Corporation or one of its Affiliates in China, and the Participant hereby consents and agrees that the cash proceeds related to the Participant's participation in the Plan may be transferred to such special account prior to being delivered to the Participant. The Corporation may deliver the proceeds to the Participant in U.S. dollars or local currency at the Corporation's discretion. If the proceeds are paid in U.S. dollars, the Participant understands that he or she will be required to set up a U.S. dollar bank account in China so that the proceeds may be deposited into this account. If the proceeds are converted to local currency, there may be delays in delivering the proceeds to the Participant. The Participant agrees to bear the risk of any currency fluctuation between the time the shares of Common Stock are sold, either through voluntary sale or through a mandatory sale arranged by the Corporation, or proceeds are



otherwise realized under the Plan and the time such proceeds are distributed to the Participant through the special exchange control account.
The Participant further agrees to comply with any other requirements that may be imposed by the Corporation in the future to facilitate compliance with exchange control requirements in China.
COLOMBIA
Securities Law Information
The shares of Common Stock are not and will not be registered in the Colombian registry of publicly traded securities (Registro Nacional de Valores y Emisores) and therefore the shares of Common Stock may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia. An offer of shares of Common Stock to employees will not be considered a public offer provided that it meets the conditions set forth in Article 6.1.1.1.1 in Decree 2555,2010. In the event that the Corporation, in its sole discretion, determines that the offer of the Awards in Colombia may constitute a “public offer of securities”, the Participant understands and agrees that the Corporation may, in its sole discretion, cease to offer participation in the Plan in Colombia. In the event that the Corporation exercises its discretion to cease offering the Plan in Colombia, the Participant will no longer be permitted to participate in the Plan as of the date established by the Corporation.
Exchange Control Information
Colombian residents must register shares of Common Stock acquired under the Plan, regardless of value, with the Central Bank of Colombia (Banco de la República) as foreign investment held abroad. In addition, the liquidation of such investments must be transferred through the Colombian foreign exchange market (e.g., local banks), which includes the obligation of correctly completing and filing the appropriate foreign exchange form (declaración de cambio). The Participant is responsible for complying with applicable exchange control requirements in Colombia.
Foreign Asset/Account Reporting Information
The Participant must file an informative return with the Colombian Tax Office detailing any assets held abroad. If the individual value of any of these assets exceeds a certain threshold, the Participant must describe each asset and indicate the jurisdiction in which it is located, its nature and its value.
Acknowledgment of Conditions
The following provision supplements the Acknowledgment of Conditions section of the Award Agreement:
The Participant acknowledges that pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component of the Participant's “salary” for any legal purpose. To this extent, they will not be included for purposes of calculating any labor benefits, such as legal/fringe benefits, vacation, indemnities, payroll taxes, social insurance contributions and/or any other labor-related amount which may be payable.
COSTA RICA
There are no country-specific provisions.
CZECH REPUBLIC
Exchange Control Information
The Czech National Bank may require the Participant to fulfill certain notification duties in relation to the acquisition of shares of Common Stock and the opening and maintenance of a foreign account (e.g., may be required to report foreign direct investment, financial credits from abroad, investment in foreign securities, and associated collections and payments). However, because exchange control regulations change frequently and without notice, the Participant should consult with his or her personal legal advisor prior to the vesting of the PRSUs and the sale of Common Stock to ensure compliance with current regulations. It is the Participant’s responsibility to comply with any applicable Czech exchange control laws.
DOMINICAN REPUBLIC
There are no country-specific provisions.



ECUADOR
There are no country-specific provisions.
EL SALVADOR
There are no country-specific provisions.
FRANCE
PRSUs Not Tax-Qualified
The Participant understands that this Award is not intended to be French tax-qualified.
Consent to Receive Information in English
By accepting the Award Agreement providing for the terms and conditions of the Participant’s grant, the Participant confirms having read and understood the documents relating to this grant (the Plan and this Award Agreement) which were provided in English language. The Participant accepts the terms of those documents accordingly.
En acceptant le Contrat d'Attribution décrivant les termes et conditions de l’attribution, le participant confirme ainsi avoir lu et compris les documents relatifs à cette attribution (le Plan U.S. et ce Contrat d'Attribution) qui ont été communiqués en langue anglaise. Le participant accepte les termes en connaissance de cause.
Foreign Asset/Account Reporting Information
French residents holding shares of Common Stock outside of France or maintaining a foreign bank account are required to report such to the French tax authorities when filing their annual tax returns, including any accounts that were closed during the year. Further, failure to comply could trigger significant penalties.
GERMANY
Exchange Control Information
Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank. No report is required for payments less than €12,500. In case of payments in connection with securities (including proceeds realized upon the sale of shares of Common Stock), the report must be made by the 5th day of the month following the month in which the payment was received. Effective from September 2013, the report must be filed electronically. The form of report (“Allgemeine Meldeportal Statistik”) can be accessed via the Bundesbank’s website (www.bundesbank.de) and is available in both German and English. The Participant is responsible for satisfying the reporting obligation.
Foreign Asset/Account Reporting Information
If the Participant’s acquisition of shares of Common Stock leads to a so-called qualified participation at any point during the calendar year, the Participant will need to report the acquisition when he or she files a tax return for the relevant year. A qualified participation occurs only if (i) the Participant owns 1% or more of the Corporation and the value of the shares of Common Stock exceeds €150,000 or (ii) the Participant holds shares of Common Stock exceeding 10% of the Corporation’s total Common Stock.
GUATEMALA
Language Waiver
By participating in the Plan, the Participant acknowledges that he or she is proficient in reading and understanding English and fully understands the terms of the Plan, or, alternatively, that the Participant will seek appropriate assistance to understand the terms and conditions in the Award Agreement and this Appendix A.
HONDURAS
There are no country-specific provisions.
HONG KONG
Securities Law Warning



The offer of this Award and the shares of Common Stock subject to this Award do not constitute a public offering of securities under Hong Kong law and are available only to employees of the Corporation or its Affiliates participating in the Plan. The Participant should be aware that the Plan, the Plan prospectus and the contents of this Award Agreement (i) have not been prepared in accordance with and are not intended to constitute a “prospectus” for a public offering of securities under the applicable securities legislation in Hong Kong, (ii) have not been reviewed by any regulatory authority in Hong Kong, and (iii) are intended only for the personal use of each Participant and may not be distributed to any other person. The Participant is advised to exercise caution in relation to the offer. If the Participant is in any doubt about any of the contents of the Award Agreement, including this Appendix A, or the Plan, the Participant should obtain independent professional advice.
Award Payable Only in Shares
Awards granted to Participants in Hong Kong shall be paid in shares of Common Stock only and do not provide any right for the Participant to receive a cash payment.
Sale of Shares
In the event the Award vests within six months of the Grant Date, the Participant agrees that he or she will not offer to the public or otherwise dispose of the shares acquired prior to the six-month anniversary of the Grant Date. Any shares of Common Stock acquired under the Plan are accepted as a personal investment.
INDIA
Awards Payable in Cash Only
Notwithstanding anything in the Award Agreement, Awards granted to Participants in India do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.
ISRAEL
Securities Law Information
The offer of this Award does not constitute a public offering under Securities Law, 1968.
Broker Designation
Shares of Common Stock issued to the Participant under the Plan must be maintained in an account with Merrill Lynch or such other broker as may be designated by the Corporation until the shares of Common Stock are sold through that broker.
Restricted from Online Brokerage Transactions
The Participant acknowledges and agrees that he or she will be restricted from online brokerage account transactions the Corporation’s designated broker. Therefore, by accepting the Awards, the Participant understands and agrees that the Participant will call the Corporation’s designated broker to initiate any sale or transfer of any shares of Common Stock issued to him or her upon vesting of the Awards. The Participant acknowledges that the Corporation’s designated broker is under no obligation to arrange for the sale of the shares of Common Stock at any particular price.
ITALY
Plan Document Acknowledgment
In accepting the grant of this Award, the Participant acknowledges that he or she has received a copy of the Plan and the Award Agreement and has reviewed the Plan and the Award Agreement, including this Appendix A, in their entirety and fully understands and accepts all provisions of the Plan and the Award Agreement, including this Appendix A.
The Participant acknowledges that he or she has read and specifically and expressly approves the following sections of the Award Agreement: Section 2(g) on Payment of Withholding Taxes; Section 5 on No Right of



Continued Employment; Section 8 on Delaware Law to Govern; the section on Acknowledgment of Conditions; and the Data Privacy Notice section included in this Appendix A.
Foreign Asset/Account Reporting Information
Italian residents who, at any time during the fiscal year, hold foreign financial assets (including cash and shares of Common Stock) which may generate income taxable in Italy are required to report these assets on their annual tax returns (UNICO Form, RW Schedule) for the year during which the assets are held, or on a special form if no tax return is due. These reporting obligations will also apply to Italian residents who are the beneficial owners of foreign financial assets under Italian money laundering provisions.
Foreign Asset Tax Information
The value of financial assets held outside of Italy (including shares of Common Stock) by Italian residents is subject to a foreign asset tax. The taxable amount will be the fair market value of the financial assets (e.g., shares of Common Stock acquired under the Plan) assessed at the end of the calendar year.
KAZAKHSTAN
Securities Law Notification
This offer is addressed only to certain eligible employees in the form of the shares of Common Stock to be issued by the Corporation. Neither the Plan nor the Award Agreement has been approved, nor do they need to be approved, by the National Bank of Kazakhstan. This offer is intended only for the original recipient and is not for general circulation in the Republic of Kazakhstan.
Exchange Control Information
Residents of Kazakhstan may be required to notify the National Bank of Kazakhstan when they acquire shares of Common Stock under the Plan if the value of such shares of Common Stock exceeds US$100,000.
Please note that the exchange control regulations in Kazakhstan are subject to change. The Participant should consult with his or her personal legal advisor regarding any exchange control obligations that the Participant may have prior to vesting or receiving proceeds from the sale of shares of Common Stock acquired under the Plan. The Participant is responsible for ensuring compliance with all exchange control laws in Kazakhstan.
KENYA
Tax Registration Notification
Under Tax Procedure Act, 2015, the Participant is required to complete and submit a tax registration application to the Commissioner of Income Tax with 30 days of first vesting of the PRSUs. The registration should be completed through the online portal “I TAX” and is a one-time only registration. The Participant is solely responsible for ensuring compliance with all registration requirements in Kenya.
KOREA
Awards Payable in Cash Only
Notwithstanding anything in the Award Agreement, Awards granted to Participants in Korea do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.
MALAYSIA
Data Privacy Notice
This provision replaces in its entirety the data privacy section in the Acknowledgment of Conditions section of the Award Agreement:
The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant's personal data as described in this Award Agreement by and among, as



applicable, the Participant's Employer, the Corporation, and its other Affiliates for the exclusive purpose of implementing, administering and managing the Participant's participation in the Plan.
The Participant understands that the Corporation and the Participant's Employer may hold certain personal information about the Participant, including, but not limited to, the Participant's name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of Common Stock or directorships held in the Corporation, details of all Awards or any other entitlement to shares awarded, canceled, vested, unvested or outstanding in the Participant's favor (“Data”), for the purpose of implementing, administering and managing the Plan.
The Participant understands that Data will be transferred to Merrill Lynch, or such other stock plan service provider as may be selected by the Corporation in the future, which is assisting the Corporation with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant's country. The Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative LiLin.Ng@kcc.com at telephone number 603 78068288. The Participant authorizes the Corporation, Merrill Lynch and any other possible recipients which may assist the Corporation (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Participant's participation in the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant's participation in the Plan. The Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative. Further, the Participant understands that he or she is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or later seeks to revoke his or her consent, the Participant's employment status or service and career with the Employer will not be affected; the only consequence of refusing or withdrawing consent is that the Corporation would not be able to grant the Participant PRSUs or other equity awards or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing consent may affect the Participant's ability to participate in the Plan. For more information on the consequences of the Participant's refusal to consent or withdrawal of consent, the Participant understands that he or she may contact his or her local human resources representative.
Malaysian Translation:
Peserta dengan ini secara eksplisit dan tanpa sebarang keraguan mengizinkan pengumpulan, penggunaan dan pemindahan, dalam bentuk elektronik atau lain-lain, data peribadi Peserta seperti yang diterangkan dalam Perjanjian Penganugerahan dan apa-apa bahan geran opsyen lain oleh dan di antara, seperti mana yang terpakai, Majikan, Syarikat dan Anak-Anak Syarikat Sekutunya untuk tujuan ekslusif bagi melaksanakan, mentadbir dan menguruskan penyertaan peserta dalam Pelan.
Peserta memahami bahawa Syarikat dan Majikan mungkin memegang maklumat peribadi tertentu tentang Peserta , termasuk, tetapi tidak terhad kepada, nama Peserta , alamat rumah dan nombor telefon, tarikh lahir, nombor insurans sosial atau nombor pengenalan lain, gaji, kewarganegaraan, jawatan, apa-apa syer dalam saham atau jawatan pengarah yang dipegang di Syarikat, butir-butir semua opsyen atau apa-apa hak lain atas syer dalam saham biasa yang dianugerahkan, dibatalkan, dilaksanakan, terletak hak, tidak diletak hak ataupun yang belum dijelaskan bagi faedah Peserta ("Data"), untuk tujuan eksklusif bagi melaksanakan, mentadbir dan menguruskan Pelan.
Peserta memahami bahawa Data akan dipindahkan kepada Merrill Lynch, atau pembekal perkhidmatan pelan saham yang mungkin ditetapkan oleh Syarikat pada masa depan yang membantu Syarikat dengan pelaksanaan, pentadbiran dan pengurusan Pelan. Peserta memahami bahawa penerim a-penerima Data mungkin berada di Amerika Syarikat atau mana-mana tempat lain dan bahawa negara penerima-penerima (contohnya di Amerika Syarikat) mungkin mempunyai undang-undang privasi data dan perlindungan yang berbeza daripada negara Peserta. Peserta memahami bahawa Peserta boleh meminta satu senarai yang mengandungi nama dan alamat penerima-penerima Data yang berpotensi dengan menghubungi wakil sumber manusia tempatan Peserta LiLin.Ng@kcc.com, T: 603 78068288. Peserta memberi kuasa kepada Syarikat,



Merrill Lynch dan mana-mana penerima-penerima lain yang mungkin membantu Syarikat (pada masa sekarang atau pada masa depan) dengan melaksanakan, mentadbir dan menguruskan Pelan untuk menerima, memiliki, menggunakan, mengekalkan dan memindahkan Data, dalam bentuk elektronik atau lain-lain, semata-mata dengan tujuan untuk melaksanakan, mentadbir dan menguruskan penyertaan Peserta dalam Pelan. Peserta memahami bahawa Data hanya akan disimpan untuk tempoh yang perlu bagi melaksanakan, mentadbir, dan menguruskan penyertaan Peserta dalam Pelan. Peserta memahami bahawa Peserta boleh, pada bila-bila masa, melihat Data, meminta maklumat tambahan mengenai penyimpanan dan pemprosesan Data, meminta bahawa pindaan-pindaan dilaksanakan ke atas Data atau menolak atau menarik balik persetujuan dalam ini, dalam mana-mana kes, tanpa kos, dengan menghubungi secara bertulis wakil sumber manusia tempatan Peserta. Peserta selanjutnya memahami bahawa Peserta memberi persetujuan ini secara sukarela. Sekiranya Peserta tidak bersetuju, atau kemudian membatalkan persetujuan Peserta, status pekerjaan atau perkhidmatan dan kerjaya Peserta dengan Majikan tidak akan terjejas; satunya akibat jika Peserta tidak bersetuju atau menarik balik persetujuan Peserta adalah bahawa Syarikat tidak akan dapat menganugerahkan kepada PRSUs atau anugerah ekuiti lain atau mentadbir atau mengekalkan anugerah tersebut. Oleh itu, Peserta memahami bahawa keengganan atau penarikan balik persetujuan Peserta boleh menjejaskan keupayaan Peserta untuk mengambil bahagian dalam Pelan. Untuk maklumat lanjut mengenai akibat keengganan Peserta untuk memberikan keizinan atau penarikan balik keizinan, Peserta boleh menghubungi wakil sumber manusia tempatan.
Director Notification Obligation
If the Participant is a director of the Corporation’s Malaysian Affiliate, the Participant is subject to certain notification requirements under the Malaysian Companies Act. Among these requirements is an obligation to notify the Malaysian Affiliate in writing when the Participant receives or disposes of an interest (e.g., an Award or shares) in the Corporation or any related company. Such notifications must be made within 14 days of receiving or disposing of any interest in the Corporation or any related company.
MEXICO
Modification
By accepting the Award, the Participant understands and agrees that any modification of the Plan or the Award Agreement or its termination shall not constitute a change or impairment of the terms and conditions of employment.
Acknowledgment of the Grant
In accepting the Award, the Participant acknowledges that the Participant has received a copy of the Plan and the Award Agreement, including this Appendix A, has reviewed the Plan and the Award Agreement, including this Appendix A, in their entirety and fully understands and accepts all provisions of the Plan and the Award Agreement, including this Appendix A. The Participant further acknowledges that the Participant has read and specifically and expressly approves the Acknowledgment of Conditions section of the Award Agreement, in which the following is clearly described and established:
(1)    The Participant’s participation in the Plan does not constitute an acquired right.
(2)    The Plan and the Participant’s participation in the Plan are offered by the Corporation on a wholly discretionary basis.
(3)    The Participant’s participation in the Plan is voluntary.
(4)    Neither the Corporation nor any Affiliates are responsible for any decrease in the value of the Award granted and/or shares of Common Stock issued under the Plan.
Labor Acknowledgment and Policy Statement
In accepting the grant of this Award, the Participant expressly recognizes that Kimberly-Clark Corporation, with registered offices at 351 Phelps Drive, Irving, Texas 75038, U.S.A., is solely responsible for the administration of the Plan and that the Participant’s participation in the Plan and acquisition of shares of Common Stock do not constitute an employment relationship between the Participant and the Corporation since the Participant is participating in the Plan on a wholly commercial basis and his or her sole Employer is K-C AFC Manufacturing S. de R.L. de C.V. (“KCC-Mexico”). Based on the foregoing, the Participant expressly recognizes that the Plan and the benefits that he or she may derive from participating in the Plan do not establish any rights between the



Participant and the Employer, KCC-Mexico and do not form part of the employment conditions and/or benefits provided by KCC-Mexico, and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of the Participant’s employment.
The Participant further understands that his or her participation in the Plan is as a result of a unilateral and discretionary decision of the Corporation; therefore, Kimberly-Clark Corporation reserves the absolute right to amend and/or discontinue the Participant’s participation at any time without any liability to the Participant.
Finally, the Participant hereby declares that he or she does not reserve to him- or herself any action or right to bring any claim against Kimberly-Clark Corporation for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and the Participant therefore grants a full and broad release to the Corporation, its Affiliates, branches, representation offices, its shareholders, officers, agents, or legal representatives with respect to any claim that may arise.
Spanish Translation
Modificación
Al aceptar el Premio, el Participante entiende y acuerda que cualquier modificación al Plan o al Acuerdo o su terminación, no cambiará o disminuirá los términos y condiciones de empleo.
Reconocimiento del Otorgamiento
Al aceptar el Premio, el Participante está de acuerdo en haber recibido una copia del Plan, del Acuerdo incluyendo el presente Anexo “A” y ha revisado el Plan y el Acuerdo, incluyendo este Anexo “A” en su totalidad y comprende y acepta todas las disposiciones previstas en el Plan, en el Acuerdo, incluyendo el presente Anexo “A”. Asimismo, el Participante reconoce que ha leído y manifiesta su específica y expresa conformidad con los términos y condiciones establecidos del Acuerdo, en el cual claramente se describe y establece lo siguiente:
(1)    La participación del Participants en el Plan no constituye un derecho adquirido.
(2)     El Plan y la participación del Participante en el Plan se ofrecen por la Compañía de forma completamente discrecional.
(3)     La participación del Participante en el Plan es voluntaria.
(4)    Ni la Compañía ni sus Afiliadas son responsables por la reducción del valor del Premio y/o Acciones Ordinarias emitidas bajo el Plan.
Reconocimiento de la Legislación Laboral y Declaración de la Política
Al aceptar el otorgamiento de este Premio, el Participante expresamente reconoce que Kimberly-Clark Corporation con oficinas registradas en 351 Phelps Drive, Irving, Texas 75038, U.S.A., es la única responsable por la administración del Plan y que la participación del Participante en el Plan y en su caso la adquisición de las Opciones de Compra de Acciones o Acciones no constituyen ni podrán interpretarse como una relación de trabajo entre el Participante y Kimberly-Clark Corporation, ya que el Participante participa en el Plan en un marco totalmente comercial y su único Patrón lo es K-C AFC Manufacturing S. de R.L. de C.V. (“KCC-Mexico”). Derivado de lo anterior, el Participante expresamente reconoce que el Plan y los beneficios que pudieran derivar de la participación en el Plan no establecen derecho alguno entre el Participante y el Patrón, KCC-Mexico y no forma parte de las condiciones de trabajo y/o las prestaciones otorgadas por KCC-Mexico y que cualquier modificación al Plan o su terminación no constituye un cambio o impedimento de los términos y condiciones de la relación de trabajo del Participante.
Asimismo, el Participante reconoce que su participación en el Plan es resultado de una decisión unilateral y discrecional de Kimberly-Clark Corporation por lo tanto, Kimberly-Clark Corporation se reserva el absoluto derecho de modificar y/o terminar la participación del Participante en cualquier momento y sin responsabilidad alguna frente el Participante.
Finalmente, el Participante por este medio declara que no se reserva derecho o acción alguna que ejercitar en contra de Kimberly-Clark Corporation por cualquier compensación o daño en relación con las disposiciones del Plan o de los beneficios derivados del Plan y por lo tanto, el Participante otorga el más amplio finiquito que en derecho proceda a Kimberly-Clark Corporation , sus afiliadas, subsidiarias, oficinas de representación, sus accionistas, funcionarios, agentes o representantes legales en relación con cualquier demanda que pudiera surgir.
Securities Law Notification



The PRSUs and the shares of Common Stock offered under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the Plan, the Award Agreement and any other document relating to the PRSUs may not be publicly distributed in Mexico. These materials are addressed to the Participant only because of their existing relationship with the Corporation and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Mexican subsidiary of the Corporation made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.
NETHERLANDS
There are no country-specific provisions.
NEW ZEALAND
Securities Law Information
The Participant is being offered PRSUs which, if vested, will entitle the Participant to acquire shares of Common Stock in accordance with the terms of the Award Agreement and the Plan. The shares of Common Stock, if issued, will give the Participant a stake in the ownership of the Corporation. The Participant may receive a return if dividends are paid.
If the Corporation runs into financial difficulties and is wound up, the Participant will be paid only after all creditors and holders of preferred shares (if any) have been paid. The Participant may lose some or all of the Participant’s investment, if any.
New Zealand law normally requires people who offer financial products to give information to investors before they invest. This information is designed to help investors to make an informed decision. The usual rules do not apply to this offer because it is made under an employee share scheme. As a result, the Participant may not be given all the information usually required. The Participant will also have fewer other legal protections for this investment. The Participant is advised to ask questions, read all documents carefully, and seek independent financial advice before committing.
The shares of Common Stock are quoted on the New York Stock Exchange (“NYSE”). This means that if the Participant acquires shares of Common Stock under the Plan, the Participant may be able to sell the shares of Common Stock on the NYSE if there are interested buyers. The Participant may get less than the Participant invested. The price will depend on the demand for the shares of Common Stock.
For a copy of the Corporation’s most recent financial statements (and, where applicable, a copy of the auditor’s report on those financial statements), as well as information on risk factors impacting the Corporation’s business that may affect the value of the shares pf Common Stock, the Participant should refer to the risk factors discussion on the Corporation’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available online at www.sec.gov, as well as on the Corporation’s “Investor Relations” website at http://investor.kimberly-clark.com/index.cfm.
NIGERIA
There are no country-specific provisions.
PANAMA
Securities Law Information
Neither this Award nor any shares of Common Stock that the Participant may acquire at vesting of this Award constitute a public offering of securities, as they are available only to eligible employees of the Corporation and its Affiliates.
PARAGUAY
There are no country-specific provisions.
PERU



Securities Law Information
The offer of this Award is considered a private offering in Peru; therefore, it is not subject to registration in Peru. For more information concerning the offer, please refer to the Plan, the Award Agreement and any other materials or documentation made available by the Corporation. For more information regarding the Corporation, please refer to the Corporation’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available at www.sec.gov, as well as the Corporation’s “Investor Relations” website at: http://investor.kimberly-clark.com/
Labor Law Acknowledgment
By accepting the Award, the Participant acknowledges that the PRSUs are being granted ex gratia to the Participant.
PHILIPPINES
Awards Payable in Cash Only
Notwithstanding anything in the Award Agreement, Awards granted to Participants in the Philippines do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash in an amount equal to the value of the shares of Common Stock at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.
Fringe Benefit Tax Obligation
By accepting the Award, the Participant consents and agrees to assume any and all liability for fringe benefit tax that may be payable by the Corporation and/or the Employer (as determined by the Corporation or the Employer in their discretion) in connection with the Award and any awards previously granted by the Corporation. Further, by accepting the Award, the Participant agrees that the Corporation and/or the Employer may collect the fringe benefit tax from the Participant by any of the means set forth in the Acknowledgment of Conditions section of the Award Agreement, or any other reasonable method established by the Corporation. The Participant agrees to execute other consents or elections to accomplish the foregoing, promptly upon request by the Corporation or the Employer.




POLAND
Foreign Asset/Account Reporting Information
Polish residents holding foreign securities (e.g., shares of Common Stock) and/or maintaining accounts abroad must report information to the National Bank of Poland on transactions and balances regarding such securities and cash deposited in such accounts if the value of such securities and cash (when combined with all other assets possessed abroad) exceeds certain thresholds. If required, the reports must be filed on a quarterly basis on special forms that are available on the website of the National Bank of Poland. Polish residents should consult with their personal tax advisor to determine their personal reporting obligations.
Exchange Control Information
Transfers of funds into and out of Poland in excess of €15,000 (or PLN 15,000 if such transfer of funds is connected with business activity of an entrepreneur) must be made via a bank account held at a bank in Poland. Additionally, Polish residents are required to store all documents connected with any foreign exchange transactions that Polish residents are engaged in for a period of five years, as measured from the end of the year in which such transaction occurred.
PUERTO RICO
There are no country-specific provisions.
RUSSIA
Settlement of PRSUs 
Depending on applicable restrictions then in effect, the Corporation has the sole discretion to postpone the vesting and/or settlement of any PRSUs, to determine whether to settle any vested PRSUs in shares of Common Stock or in cash, or to cancel such PRSUs for no consideration. 
Securities Law Information
This Award Agreement, the Plan and all other materials the Participant may receive regarding participation in the Plan do not constitute advertising or an offering of securities in Russia. Absent any requirement under local law, the issuance of shares of Common Stock under the Plan has not and will not be registered in Russia and hence the shares described in any Plan-related documents may not be offered or placed in public circulation in Russia.
US Transaction
The Participant understands that the PRSUs and any shares of Common Stock under the Plan are to be issued and sold solely in the United States. Any shares of Common Stock issued to the Participant upon vesting of the PRSUs shall be delivered to the Participant’s brokerage account in the United States, where such shares of Common Stock must be held until the time of sale. In no event will shares of Common Stock be delivered to the Participant in Russia.
Exchange Control Information
All restrictions on the payment of funds by non-residents into a Russian resident’s declared foreign brokerage account, including dividends and proceeds from the sale of shares of Common Stock have been abolished. Russian residents may now receive, hold and remit dividends and proceeds from the sale of shares (including shares of Common Stock acquired under the Plan) into and out of a brokerage account without any requirement to first repatriate such funds to an authorized bank in Russia. The Participant should be aware that the rules related to foreign bank accounts are different and that certain restrictions with respect to payments by non-residents into a Russian currency resident’s foreign bank account may continue to apply where the foreign bank account is located in the U.S. The Participant should contact his or her personal advisor to confirm the application of the exchange control restrictions prior to vesting in the PRSUs and selling shares of Common Stock, as significant penalties may apply in the case of non-compliance with the exchange control restrictions and because such exchange control restrictions are subject to change.
Foreign Asset/Account Reporting Information
Russian residents are required to report the opening, closing or change in account details of any foreign bank account to the Russian tax authorities within one month of the opening, closing or change of such account. Russian



residents are also required to report to the Russian tax authorities on or before June 1 of the following year (i) the beginning and ending balances in a foreign bank account each year and (ii) transactions related to such foreign account during the year. Foreign brokerage accounts and foreign accounts with other financial institutions (financial market organizations) must also be reported. Certain specific exemptions from reporting requirements may apply. Non-compliance with the reporting obligations could impact the Participant's ability to vest, receive shares of Common Stock pursuant to the PRSUs, maintain the account outside of Russia and participate in the Plan. The Participant should consult with his or her personal legal advisor to determine how these reporting requirements may apply to any account opened in connection with the Participant’s participation in the Plan.
Data Privacy Notice
This provision supplements the Data Privacy section in the Acknowledgment and Conditions section of the Award Agreement:
The Participant understands and agrees that he or she must complete and return a Consent to Processing of Personal Data (the “Consent”) form to the Corporation if requested. Further, the Participant understands and agrees that if the Participant does not complete and return a Consent form to the Corporation if requested, the Corporation will not be able to grant PRSUs to the Participant or other awards or administer or maintain such awards. Therefore, the Participant understands that refusing to complete a Consent form or withdrawing his or her consent may affect the Participant’s ability to participate in the Plan.
Anti-Corruption Information
Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (e.g., shares of foreign companies such as the Corporation). Accordingly, the Participant should inform the Corporation if he or she is covered by these laws because the Participant should not hold shares of common stock acquired under the Plan.
Labor Law Information
If the Participant continues to hold shares of Common Stock acquired at vesting of the PRSUs after an involuntary termination of employment, he or she may not be eligible to receive unemployment benefits in Russia.
SAUDI ARABIA
Securities Law Information.
This document may not be distributed in the Kingdom except to such persons as are permitted under the Rules on the Offer of Securities and Continuing Obligations issued by the Capital Market Authority.
The Capital Market Authority does not make any representation as to the accuracy or completeness of this document, and expressly disclaims any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this document. Prospective purchasers of the securities offered hereby should conduct their own due diligence on the accuracy of the information relating to the securities. If the Participant does not understand the contents of this document, the Participant should consult an authorized financial adviser.
SINGAPORE
Sale Restriction
The Participant agrees that any shares of Common Stock acquired pursuant to the PRSUs will not be offered for sale in Singapore prior to the six-month anniversary of the Grant Date, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”), or pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA.
Securities Law Information
The grant of the PRSUs is being made pursuant to the “Qualifying Person” exemption” under section 273(1)(f) of the SFA under which it is exempt from the prospectus and registration requirements and is not made with a view to the underlying shares of Common Stock being subsequently offered for sale to any other party. The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore.
Director Notification Obligation



If the Participant is a director, associate director or shadow director of the Corporation’s Singapore Affiliate, the Participant is subject to certain notification requirements under the Singapore Companies Act (Cap. 50, Rev Ed 2006). Among these requirements is an obligation to notify the Corporation’s Singapore Affiliate in writing when the Participant receives an interest (e.g., an Award or shares) in the Corporation or any Affiliate. In addition, the Participant must notify the Corporation’s Singapore Affiliate when he or she sells shares of the Corporation or of any Affiliate (including when the Participant sells shares issued upon vesting and settlement of the Award). These notifications must be made within two business days of (i) acquiring or disposing of any interest in the Corporation or any Affiliate, or (ii) any change in a previously-disclosed interest (e.g., upon vesting of the Award or when shares of Common Stock acquired under the Plan are subsequently sold). In addition, a notification of the Participant’s interests in the Corporation or any Affiliate must be made within two business days of becoming a director, associate director or shadow director.
SLOVAK REPUBLIC
Foreign Asset/Account Reporting Information
If the Participant permanently resides in the Slovak Republic and, apart from being employed, carries on business activities as an independent entrepreneur (in Slovakian, podnikatel), the Participant will be obligated to report his or her foreign assets (including any foreign securities) to the National Bank of Slovakia (provided that the value of the foreign assets exceeds an amount of €2,000,000). These reports must be submitted on a monthly basis by the 15th day of the respective calendar month, as well as on a quarterly basis by the 15th day of the calendar month following the respective calendar quarter, using notification form DEV (NBS) 1-12, which may be found at the National Bank of Slovakia’s website at www.nbs.sk.
SOUTH AFRICA
Tax Acknowledgment
By accepting the Award, the Participant agrees to notify the Employer of the amount of any gain realized upon vesting of the Award. If the Participant fails to advise the Employer of the gain realized upon vesting, the Participant may be liable for a fine. The Participant will be responsible for paying any difference between the actual tax liability and the amount withheld.
Exchange Control Information
To participate in the Plan, the Participant must comply with exchange control regulations and rulings (the “Exchange Control Regulations”) in South Africa.
Because the Exchange Control Regulations change frequently and without notice, the Participant understands that he or she should consult a legal advisor prior to the acquisition or sale of shares under the Plan to ensure compliance with current regulations. The Participant understands that it is his or her responsibility to comply with South African exchange control laws, and neither the Corporation nor the Employer will be liable for any fines or penalties resulting from failure to comply with applicable laws.
Securities Law Information
In compliance with South African securities law, the Participant acknowledges that the documents listed below are available for review at the addresses listed below:
1)The Corporation's most recent annual financial statements: http://investor.kimberly-clark.com/sec.cfm?DocType=Annual&Year=
2)The Corporation's most recent Plan prospectus may be accessed online through Merrill Lynch, or such other stock plan service provider as may be selected by the Corporation in the future, at www.mybenefits.ml.com in the Document Library.
A copy of the above documents will be sent free of charge upon written request to Stock Plan Administrator, P.O. Box 619100, Dallas, Texas 75261-9100. In addition, the Participant should contact his or her tax advisor for specific information concerning his or her personal tax situation with regard to Plan participation.



SPAIN
Securities Law Information
No “offer of securities to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of this Award. The Award Agreement (including this Appendix A) has not been, nor will it be, registered with the Comisión Nacional del Mercado de Valores, and does not constitute a public offering prospectus.
Labor Law Acknowledgment
By accepting the Award, the Participant acknowledges that he or she understands and agrees to participation in the Plan and that he or she has received a copy of the Plan.
The Participant understands that the Corporation has unilaterally, gratuitously and discretionally decided to grant Awards under the Plan to individuals who may be employees of the Corporation or its Affiliates throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Corporation or any of its Affiliates on an ongoing basis. Consequently, the Participant understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Corporation or any of its Affiliates) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. Further, the Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from any gratuitous and discretionary grant since the future value of the Award and the underlying shares is unknown and unpredictable. In addition, the Participant understands that this grant would not be made but for the assumptions and conditions referred to above; thus, the Participant understands, acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then the Award shall be null and void.
Further, the Participant understands that the Award is a conditional right. Participant shall forfeit any unvested Award upon termination of employment unless such termination is (i) due to a Qualified Termination of Employment, or (ii) if more than six months after the Grant Date, due to death, Total and Permanent Disability, or the shutdown or divestiture of a business unit. Vesting will cease, for example, regardless of whether (1) the Participant is considered to be unfairly dismissed without good cause (i.e., subject to a “despido improcedente”); (2) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal; (3) the Participant terminates his or her employment or service relationship due to a change of work location, duties or any other employment or contractual condition; and (4) the Participant terminates his or her employment or service relationship due to a unilateral breach of contract by the Corporation or an Affiliate. Consequently, upon termination of the Participant’s employment or service relationship for any of the above reasons, the Participant may automatically lose any rights to the PRSUs that were not vested on the date of termination of the Participant’s employment or service relationship, as described in the Plan and the Award Agreement.
Exchange Control Information
If the Participant holds 10% or more of the Corporation’s share capital, the Participant must declare the acquisition, ownership and disposition of shares of Common Stock to the Spanish Dirección General de Comercio e Inversiones (the “DGCI”) of the Ministry of Economy and Competitiveness.
In addition, the Participant may be required to declare electronically to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), any foreign instruments (including any shares of Common Stock acquired under the Plan) and any transactions with non-Spanish residents (including any payments of shares of Common Stock made to the Participant by the Corporation) depending on the value of such accounts and instruments and the amount of the transactions during the relevant year as of December 31 of the relevant year.
Foreign Asset/Account Reporting Information
If the Participant holds rights or assets (e.g., shares of Common Stock or cash held in a bank or brokerage account) outside of Spain with a value in excess of €50,000 per type of right or asset (e.g., shares of Common Stock, cash, etc.) as of December 31 each year, the Participant is required to report certain information regarding such rights and assets on tax form 720.  After such rights and/or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than €20,000



or if the ownership of the assets is transferred or relinquished during the year. The reporting must be completed by the following March 31.
SWITZERLAND
Securities Law Information
Neither this document nor any other materials relating to the Awards (i) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (“FinSA”) (ii) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than a participant or (iii) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (“FINMA”).
TAIWAN
Data Privacy
The following provision supplements the data privacy section in the Acknowledgment of Conditions section of the Award Agreement:
The Participant acknowledges that he or she has read and understands the terms regarding collection, processing and transfer of data contained in the Acknowledgment of Conditions section of the Award Agreement and, by participating in the Plan the Participant agrees to such terms. In this regard, upon request of the Corporation or the Employer, the Participant agrees to provide any executed data privacy consent form to the Employer or the Corporation (or any other agreements or consents that may be required by the Employer or the Corporation) that the Corporation and/or the Employer may deem necessary to obtain under the data privacy laws now or in the future. The Participant understands that he or she will not be able to participate in the Plan if the Participant fails to execute any such consent or agreement.
Securities Law Information
The offer of participation in the Plan is available only for employees of the Corporation and its Affiliates. The offer of participation in the Plan is not a public offer of securities by a Taiwanese company.
Exchange Control Information
Taiwanese residents may acquire and remit foreign currency (including proceeds from the sale of shares of Common Stock or the receipt of dividends) into and out of Taiwan up to US$5,000,000 per year. If the transaction amount is TWD500,000 or more in a single transaction, the Participant must submit a foreign exchange transaction form and also provide supporting documentation to the satisfaction of the remitting bank.
THAILAND
Exchange Control Information
If the proceeds from the sale of shares of Common Stock or the receipt of dividends paid on such shares are equal to or greater than US$1,000,000 in a single transaction, Thai residents must repatriate all cash proceeds to Thailand immediately following the receipt of the cash proceeds and then either convert such proceeds to Thai Baht or deposit the proceeds into a foreign currency account opened with a commercial bank in Thailand within 360 days of repatriation. In addition, Thai residents must specifically report the inward remittance to the Bank of Thailand on a foreign exchange transaction form.
Failure to comply with the above obligations may lead to penalties being assessed by the Bank of Thailand. Because exchange control regulations change frequently and without notice, the Participant should consult with his or her legal advisor before selling any shares of Common Stock (or receiving any other funds in connection with the Plan) to ensure compliance with current regulations. It is the Participant’s responsibility to comply with exchange control laws in Thailand and neither the Corporation nor the Employer will be liable for any fines or penalties resulting from failure to comply with applicable laws.
TURKEY
Securities Law Information



Turkish residents are not permitted to sell shares of Common Stock acquired under the Plan in Turkey. Turkish residents must sell the shares of Common Stock acquired under the Plan outside of Turkey. The Shares are currently traded on the New York Stock Exchange in the U.S. under the ticker symbol “KMB”, and shares of Common Stock may be sold on this exchange.
Exchange Control Information
Under Turkish law, Turkish residents are permitted to purchase and sell securities or derivatives traded on exchanges abroad only through a financial intermediary licensed in Turkey. Therefore, the Participant may be required to appoint a Turkish broker to assist him or her with the sale of the shares of Common Stock acquired under the Plan. The Participant should consult his or her personal legal advisor before selling any shares of Common Stock acquired under the Plan to confirm the applicability of this requirement to the Participant.
UKRAINE
Awards Payable in Cash Only1
Notwithstanding anything in the Award Agreement, Awards granted to Participants in Ukraine do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to Participant through local payroll. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.
UNITED ARAB EMIRATES
Securities Law Information
The offer of the Award is available only for select employees of the Corporation and its Affiliates and is in the nature of providing employee incentives in the United Arab Emirates. The Plan and the Award Agreement are intended for distribution only to such employees and must not be delivered to, or relied on, by any other person. Prospective purchasers of securities should conduct their own due diligence.
The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the Plan and the Award Agreement, or any other incidental communication materials distributed in connection with the Award. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the Plan and the Award Agreement should obtain independent professional advice.
UNITED KINGDOM
Tax Acknowledgment
The following information supplements the information regarding Tax-Related Items in the Acknowledgment of Conditions section of the Award Agreement:
Without limitation to the information regarding Tax-Related Items in the Award Agreement, the Participant agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Corporation or, if different, the Employer or by HM Revenue & Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant agrees to indemnify and keep indemnified the Corporation and/or the Employer for all Tax-Related Items that they are required to pay, or withhold or have paid or will pay to HMRC on the Participant’s behalf (or any other tax authority or any other relevant authority) and authorizes the Corporation and/or the Employer to recover such amounts by any of the means referred to in the Acknowledgment of Conditions section of the Award Agreement.
Notwithstanding the foregoing, if the Participant is an executive officer or director (as within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), the Participant understands that he or she may not be able to indemnify the Corporation for the amount of any Tax-Related Items not collected from or
1 KCC discussing tax considerations with E&Y and will determine whether to share-settle. Please let Baker know so we can update if needed.



paid by the Participant, if the indemnification could be considered to be a loan. In this case, the Tax-Related Items not collected or paid may constitute a benefit to the Participant on which additional income tax and National Insurance contributions (“NICs”) may be payable.
The Participant acknowledges that the Participant ultimately will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Corporation or the Employer (as appropriate) the amount of any NICs due on this additional benefit which the Corporation and/or the Employer may also recover from the Participant at any time thereafter by any of the means referred to in the Acknowledgment of Conditions section of the Award Agreement.
URUGUAY
There are no country-specific provisions.
VIETNAM
Awards Payable in Cash Only
Notwithstanding anything in the Award Agreement, Awards granted to Participants in Vietnam do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant through local payroll. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.


EX-10.R 3 kimberly-clarkcorporationo.htm KMB OFF-CYCLE TIME-VESTED RSU AWARD AGREEMENT Document

Exhibit No. (10)r

KIMBERLY-CLARK CORPORATION
OFF-CYCLE TIME-VESTED RESTRICTED STOCK UNIT
AWARD AGREEMENT


This Award, granted effective on __________ (the “Grant Date”), by Kimberly-Clark Corporation, a Delaware corporation (hereinafter called the “Corporation”), to ________________ (the “Participant”) is subject to the terms and conditions of the Kimberly-Clark Corporation 2021 Equity Participation Plan (the “Plan”) and the Award Agreement, including any country-specific terms and conditions contained in Appendix A to the Award Agreement.

W I T N E S S E T H:

WHEREAS, the Corporation has adopted the Plan to encourage those employees who materially contribute, by managerial, scientific or other innovative means, to the success of the Corporation or of an Affiliate, to acquire an ownership interest in the Corporation, thereby increasing their motivation for and interest in the Corporation's and its Affiliates' long-term success;

NOW, THEREFORE, it is agreed as follows:

1.    Number of Share Units Granted. The Corporation hereby grants to the Participant the right to receive all or any part of ________ Off-Cycle Time-Vested Restricted Stock Units (“RSUs”) of the $1.25 par value Common Stock of the Corporation, subject to the terms, conditions and restrictions set forth herein and in the Plan.

2.    Transferability Restrictions.

(a)    Restricted Period. During the Restricted Period, the Participant may not sell, assign, transfer, or otherwise dispose of, or mortgage, pledge or otherwise encumber the Award, and any such attempted sale, assignment, transfer, pledge or disposal shall be void. Except as provided in this Section 2, the RSUs, including any accrued dividend equivalents, shall be subject to forfeiture until the Participant becomes vested in such Awards on the date that was approved on the Grant Date and as reflected on the Merrill Lynch Benefits On-line site, or any successor system, via the Grant Summary screen as the Future Vesting table.

The Restricted Period shall begin on the date of the granting of this Award, and shall end on [insert]. During the Restricted Period, holders of Awards shall have none of the rights of a shareholder with respect to the shares of Common Stock that may be earned pursuant to the RSUs, including, but not limited to, any right to receive dividends in cash or other property or other distribution or rights in respect of such shares except as otherwise provided in this Award Agreement, nor any right to vote such shares as the record owner thereof.

During each year in the Restricted Period, the Participant will not be paid dividend equivalents on the unvested RSUs but the Participant will receive a credit equal to dividends declared on the Corporation’s Common Stock which will be reinvested in additional RSUs at the then fair market value of the Corporation’s Common Stock on the date dividends are paid, and the additional RSUs will be accumulated and paid if and when the RSUs vest, based on the actual number of RSUs that vest. In the case of dividends paid in property other than cash, the amount of the dividend shall be deemed to be the fair market value of the property at the time of the payment of the dividend, as determined in good faith by the Corporation. The Corporation shall not be required to segregate any cash or other property of the Corporation.




Notwithstanding any provision in this Award Agreement, this Award will be forfeited if the Participant does not agree to the terms of any restrictive covenant agreement(s) containing non-competition, non-solicitation, confidentiality, business ideas and similar restrictions that may be presented to the Participant at any time prior to the last day of the calendar year in which this Award is granted (whether before or after the Grant Date) and that the Participant will be required to accept pursuant to such acceptance procedures (including electronic acceptance) as will be communicated to the Participant. Such restrictive covenant agreement must be accepted by the Participant within thirty (30) days and if not so accepted, this Award will be forfeited, unless otherwise determined by the Corporation in its discretion.

(b)    Termination of Employment. For purposes of this Award, the Participant's employment will be considered terminated as of the date the Participant is no longer actively providing services to the Corporation or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant's employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation, the Participant’s right to receive RSUs and vest in the Award under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant's employment agreement, if any); the Committee shall have the exclusive discretion to determine when the Participant is no longer employed for purposes of the Award (including whether the Participant may still be considered employed while on a leave of absence).

The Participant shall forfeit any unvested Award, including any accrued dividend equivalents, upon termination of employment unless such termination is (i) due to a Qualified Termination of Employment, or (ii) due to death, Total and Permanent Disability, or the shutdown or divestiture of a business unit. A termination of employment shall not be deemed to have occurred while a Participant is on a military leave or other bona fide leave of absence if the period of such leave does not exceed six months, or if longer, so long as the Participant retains a right to reemployment with the Corporation or an Affiliate under an applicable statute or by contract. For purposes of this subparagraph, a leave of absence constitutes a bona fide leave of absence only if there is a reasonable expectation that the Participant will return to perform services for the Corporation or an Affiliate. If the period of leave exceeds six months and the Participant does not retain a right to reemployment under an applicable statute or by contract, the employment relationship is deemed to terminate on the first date immediately following such six-month period. Notwithstanding the foregoing, where a leave of absence is due to any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than six months, where such impairment causes the Participant to be unable to perform the duties of his or her position of employment or any substantially similar position of employment, a 29-month period of absence is substituted for such six-month period in determining whether a termination of employment shall be deemed to have occurred. A termination of employment with the Corporation or an Affiliate to accept immediate reemployment with the Corporation or an Affiliate likewise shall not be deemed to be a termination of employment for the purposes of the Plan. A Participant who is classified as an intermittent employee shall be deemed to have a termination of employment for purposes of the Plan if the level of bona fide services the Participant would perform after such date would permanently decrease to less than 50 percent of the average level of bona fide services performed over the immediately preceding 36-month period (or the full period of services to the Corporation or an Affiliate if the Participant has been providing such services less than 36 months).

For purposes of this Award, a termination of employment includes a termination that is deemed an “unfair dismissal” or a “constructive dismissal.” Further, the Participant understands that the Award is a conditional right. Participant shall forfeit any unvested Award upon termination of employment except as provided above, for example, regardless of whether (1) the Participant is considered to be unfairly dismissed without good cause; (2) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal; (3) the Participant terminates his or her employment or service relationship due to a change of work location, duties or any other employment or contractual condition; or (4) the




Participant terminates his or her employment or service relationship due to a unilateral breach of contract by the Corporation or an Affiliate. Consequently, upon termination of the Participant’s employment or service relationship for any of the above reasons, the Participant may automatically lose any rights to the RSUs that were not vested on the date of termination of the Participant’s employment or service relationship, as described in the Plan and the Award Agreement.

(c)    Death or Total and Permanent Disability. If the Participant’s termination of employment is due to death or Total and Permanent Disability, it shall result in pro rata vesting, as determined by the Committee, and the number of shares that are considered to vest shall be prorated for the number of full months of employment during the Restricted Period prior to the Participant’s termination of employment, and shall be paid 70 days following the Participant’s termination of employment or within such later period as permitted by Section 409A of the U.S. Internal Revenue Code of 1986 and the regulations thereunder, as amended from time to time (the “Code”), subject to Section 20(l) of the Plan, if applicable. Any fractional share of the Corporation resulting from such a prorated Award shall be rounded to the nearest whole share.

(d)    Shutdown or Divestiture. In the event that after the Grant Date the Participant’s termination of employment is due to the shutdown or divestiture of the Corporation’s or its Affiliate’s business, it shall result in pro rata vesting, as determined by the Committee, and the number of shares that are considered to vest shall be determined at the end of the Restricted Period, prorated for the number of full years of employment during the Restricted Period prior to the Participant’s termination of employment, and shall be paid within 70 days following the end of the Restricted Period. Any fractional share of the Corporation resulting from such a prorated Award shall be rounded to the nearest whole share. For the purposes of this Award, a shutdown or divestiture of the Corporation’s or its Affiliate’s business unit is defined as one for which the charges related to the shutdown or divestiture are accounted for, and reported externally, as an exit activity in the Corporation's applicable SEC filings. The Corporation has complete discretion to determine whether a shutdown or divestiture of a business unit has occurred under the terms of the Plan.

(e)    Qualified Termination of Employment. In the event of a Qualified Termination of Employment, all restrictions will lapse and the shares will become fully vested and shall be paid within 10 days following the last day of employment of the Participant with the Corporation or an Affiliate, subject to Section 20(l) of the Plan, if applicable.

(f)    Payment of Awards. The payment of the Award shall be made in shares of Common Stock. Unless otherwise set forth herein, the payment of an Award shall be made within 70 days following the end of the Restricted Period.

(g)    Payment of Tax-Related Items. No shares of Common Stock, nor any cash payment, may be delivered under this Award, unless prior to or simultaneously with such issuance, the Participant or, in the event of his death, the person succeeding to his rights hereunder, shall pay to the Corporation or an Affiliate, as applicable, such amount as the Corporation advises is required under applicable federal, state or local laws to withhold and pay over to governmental taxing authorities in relation to this Award. The Corporation may, in its discretion, withhold payment of required Tax-Related items (as defined in the Acknowledgment of Conditions section) with cash or shares of Common Stock which otherwise would be delivered following the date of vesting of the Award under this Section 2.

3.    Nontransferability. Neither the Award nor the Participant’s right to receive payment for vested Awards may be assigned or transferred except upon the death of the Participant (i) by will or (ii) by the laws of descent and distribution.

4.    Compliance with Law. No payment may be made under this Award, unless prior to the issuance thereof, the Corporation shall have received an opinion of counsel to the effect that this Award by the Corporation to the Participant will not constitute a violation of the U.S. Securities Act of 1933, as amended. As a condition of




this Award, the Participant shall, if requested by the Corporation, submit a written statement in form satisfactory to counsel for the Corporation, to the effect that any shares received under this Award shall be for investment and not with a view to the distribution thereof within the meaning of the U.S. Securities Act of 1933, as amended, and the Corporation shall have the right, in its discretion, to cause the certificates representing shares hereunder to be appropriately legended to refer to such undertaking or to any legal restrictions imposed upon the transferability thereof by reason of such undertaking.

The Award granted hereby is subject to the condition that if the listing, registration or qualification of the shares subject hereto on any securities exchange or under any state or federal law, or if the consent or approval of any regulatory body shall be necessary as a condition of, or in connection with, the granting of the Award or the delivery of shares thereunder, such shares may not be delivered unless and until such listing, registration, qualification, consent or approval shall have been effected or obtained. The Corporation agrees to use its best efforts to obtain any such requisite listing, registration, qualification, consent or approval.

The Participant is solely responsible for obtaining/providing whatever exchange control approvals, permits, licenses, or notices, which may be necessary for the Participant to hold the Award, or to receive any payment of cash or shares or to hold or sell the shares subject to the Award, if any. Neither the Corporation nor its Affiliates will be responsible for obtaining any such approvals, licenses or permits, or for making any such notices, nor will the Corporation or its Affiliates be liable for any fines or penalties the Participant may incur for failure to obtain any required approvals, permits or licenses or to make any required notices.

5.    No Right of Continued Employment. The granting of this Award does not confer upon the Participant any legal right to be continued in the employ of the Corporation or its Affiliates, and the Corporation and its Affiliates reserve the right to discharge the Participant whenever the interest of the Corporation or its Affiliates may so require without liability to the Corporation or its Affiliates, the Board of Directors of the Corporation or its Affiliates, or the Committee, except as to any rights which may be expressly conferred on the Participant under this Award.

6.    Discretion of the Corporation, Board of Directors and the Committee. Any decision made or action taken by the Corporation or by the Board of Directors of the Corporation or by the Committee arising out of or in connection with the construction, administration, interpretation and effect of this Award shall be within the absolute discretion of the Corporation, the Board of Directors of the Corporation or the Committee, as the case may be, and shall be conclusive and binding upon all persons.

7.    Inalienability of Benefits and Interest. This Award and the rights and privileges conferred hereby shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance or charge, and any such attempted action shall be void and no such benefit or interest shall be in any manner liable for or subject to debts, contracts, liabilities, engagements, or torts of the Participant.

8.    Governing Law. The Plan is governed by and subject to the laws of the United States of America. To the extent permitted by the laws of the jurisdiction where the Participant works, all questions pertaining to the construction, interpretation, regulation, validity and effect of the provisions of this Award and any rights under the Plan shall be determined in accordance with the laws of the State of Delaware and federal courts located in the District of Delaware shall be the exclusive forum for any dispute arising out of or related to the Award or the Award Agreement and the Participant consents to and waives any objection to the exercise of personal jurisdiction and venue by such courts.

9.    Purchase of Common Stock. The Corporation and its Affiliates may, but shall not be required to, purchase shares of Common Stock of the Corporation for purposes of satisfying the requirements of this Award. The Corporation and its Affiliates shall have no obligation to retain and shall have the unlimited right to sell or otherwise deal with for their own account, any shares of Common Stock of the Corporation purchased for satisfying the requirements of this Award.





10.    Notices. Any notice to be given to the Corporation under this Award, except as required under Sections 19 and 20 below, shall be addressed to the Corporation in care of its Director of Compensation located at the World Headquarters, and any notice to be given to the Participant under the terms of this Award may be addressed to him or her at the address as it appears on the Corporation's records, or at such other address as either party may hereafter designate in writing to the other. Any such notice shall be deemed to have been duly given if and when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered and deposited, postage and registry fee prepaid, in a post office or branch post office regularly maintained by the United States Government or any equivalent non-U.S. postal service.

11.    Changes in Capitalization. In the event there are any changes in the Common Stock or the capitalization of the Corporation through a corporate transaction, such as any merger, any acquisition through the issuance of capital stock of the Corporation, any consolidation, any separation of the Corporation (including a spin-off or other distribution of stock of the Corporation), any reorganization of the Corporation (whether or not such reorganization comes within the definition of such term in Section 368 of the Code), or any partial or complete liquidation by the Corporation, recapitalization, stock dividend, stock split or other change in the corporate structure, appropriate adjustments and changes shall be made by the Committee in (a) the number and type or class of shares subject to this Award, and (b) such other provisions of this Award as may be necessary and equitable to carry out the foregoing purposes.

12.    Effect on Other Plans. All benefits under this Award shall constitute special incentives and shall not affect the level of benefits provided to or received by the Participant (or the Participant's estate or beneficiaries) as part of any employee benefit plan of the Corporation or an Affiliate. This Award shall not be construed to affect in any way the Participant's rights and obligations under any other plan maintained by the Corporation or an Affiliate on behalf of employees.

13.    Discretionary Nature of Award. The grant of an Award is a one-time benefit and does not create any contractual or other right to receive a grant of Awards or benefits in lieu of Awards in the future. Future grants, if any, will be at the sole discretion of the Corporation, including, but not limited to, the timing of any grant, the number of RSUs and vesting provisions. The value of the Award is an extraordinary item outside the scope of the Participant’s employment contract, if any. As such, the Award is not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, leave-related payments, holiday pay, pension, retirement or welfare benefits or similar payments.

14.    Data Privacy. The Participant hereby authorizes their actual employer (the “Employer”) to furnish the Corporation (and any agent of the Corporation administering the Plan or providing Plan recordkeeping services) with such information and data as it shall request in order to facilitate the grant of Awards and administration of the Plan and the Participant waives any data privacy rights such Participant might otherwise have with respect to such information. The Controller of personal data processing is Kimberly-Clark Corporation with registered offices at 351 Phelps Drive, Irving, Texas 75038, United States of America.

15.    Conflict with Plan or Other Documents. This Award is awarded pursuant to and subject to the Plan. This Agreement is intended to supplement and carry out the terms of the Plan. It is subject to all terms and provisions of the Plan and, in the event of a conflict, the Plan shall prevail. In the event of any conflict between this Agreement and the terms of any notice, communication, plan summary, prospectus or other ancillary documentation relating to the Award, this Agreement will prevail.

16.    Successors. This Award Agreement, including but not limited to the restrictive covenants described in Sections 19 and 20 below, shall be binding upon and inure to the benefit of any successor or successors of the Corporation.

17.    Amendments. The Committee may at any time alter or amend this Award to the extent (1) permitted by law, (2) permitted by the rules of any stock exchange on which the Common Stock or any other security of the




Corporation is listed, and (3) permitted under applicable provisions of the U.S. Securities Act of 1933, as amended, the U.S. Securities Exchange Act of 1934, as amended (including rule 16b-3 thereof).

18.    Defined Terms. Terms which are capitalized are defined herein or in the Plan and have the same meaning set forth in the Plan, unless the context indicates otherwise.

19.    Restrictive Covenants For U.S. Participants.

(a)Application. The provisions of this Section 19 apply to Participants who are employed by the Corporation or an Affiliate located in the United States and are subject to the laws of the United States as of the date of termination of the Participant's employment; provided, however, that to the extent the Participant is asked to execute an employment or other agreement with the Corporation or any Affiliate containing non-competition, non-solicitation, confidentiality, business ideas or similar restrictions (a “stand-alone restrictive covenant agreement”) after execution of this Award Agreement, the stand-alone restrictive covenant agreement and related enforcement provisions shall govern and the provisions of this Section 19 shall not apply. Notwithstanding the foregoing, sub-section (j) below shall apply in any case. For the avoidance of doubt, the provisions of this Section 19 shall supersede any restrictive covenants the Participant has entered into with the Corporation or any Affiliate prior to execution of this Award Agreement.

(b)Non-Competition. As the Award is intended to encourage the Participant to continue employment with the Corporation or an Affiliate, during which time the Participant will have access to Confidential Information (as defined below), including Confidential Information first developed after the Grant Date, during the term of the Participant’s employment with the Corporation or any Affiliate and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, without the written consent of the General Counsel of the Corporation or their designee, in any country or countries for which the Participant had development, marketing, innovation/technology (R&D), distribution, sales, administrative, operational/supply chain or manufacturing oversight responsibilities during the last two (2) years of the Participant’s employment or was provided with regular and material access to Confidential Information regarding the Corporation’s or an Affiliate's business operations in that country or countries during the last two (2) years of the Participant’s employment, either directly or indirectly, perform duties or undertake responsibilities for a Competitor (as defined below) that are the same or substantially similar to those duties or responsibilities that the Participant performed or undertook for the Corporation or an Affiliate during the two (2) year period prior to the end of the Participant’s employment with the Corporation or an Affiliate. “Confidential Information,” for purposes of this Section 19, shall mean (i) statutory trade secrets; (ii) proprietary information developed or acquired by the Corporation that does not rise to the level of a statutorily protectable trade secret and is made the property of the Corporation through this mutual Agreement of the parties; and (iii) information that is otherwise legally protectable. Such Confidential Information includes, but is not limited to, information in whatever form (including, without limitation, in written, oral, visual or electronic form or on any magnetic or optical disk or memory storage medium, as well as other physical items wherever located, and abstracts or summaries of the foregoing) relating to the business, suppliers, customers, products, affairs and finances of the Corporation or any Affiliate for the time being confidential to the Corporation or any Affiliate, ideas, conceptions, compilations of data, and developments created by the Corporation, whether or not patentable and whether or not copyrightable, and trade secrets including, without limitation, technical data and know-how relating to the business of the Corporation or any Affiliate, or any of their suppliers, customers, agents, distributors, shareholders or management, including (but not limited to) business plans, pricing strategies, financial information, patent rights, patent applications, information concerning tenders and potential contracts, information concerning proposed product ranges, product development information, employee and salary information, research and development activities or manufacturing methods that the Participant creates, develops, receives, obtains or has knowledge of in connection with the Participant’s employment, and all other matters which relate to the business of the Corporation or any Affiliate and in respect of which information is not readily available in the ordinary course of such business to the Corporation's




Competitors, whether or not such information (if in anything other than oral form) is marked confidential. “Competitor,” for purposes of this Section 19, means a person or entity who engages in a business that is the same or substantially the same as any aspect of the Business of the Corporation. “Business of the Corporation,” for purposes of this Section 19, is the development, production, sales and/or marketing of (i) health and hygiene products and related apparel; (ii) washroom and workplace protective and safety products; and (iii) the materials, packaging and other components/subcomponents of such products including, without limitation, non-wood plants and products derived therefrom including any fibers, pulps or extracts. Notwithstanding the foregoing, if the Participant’s residence or principal place of employment on the date of acceptance of this Award Agreement is in the States of California, Massachusetts, Oklahoma, Washington or in any other jurisdiction where any provision of this Section 19(b) prohibiting post-employment competition is prohibited or otherwise restricted by applicable law, then the provisions of this Section 19(b) will not apply to the extent any such provision is prohibited or otherwise restricted by applicable law.

(c)Non-Solicitation of Employees. For a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant’s termination date, and with whom the Participant had material dealings during the last two (2) years preceding the Participant’s termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate, or (2) be otherwise involved in the recruitment of such person, to leave the employment of the Corporation or of any Affiliate. Furthermore, the Participant shall not for a period of two (2) years following the termination date regardless of the reason for or the manner of termination, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant’s termination date and with whom the Participant had material dealings during the last two (2) preceding the Participant’s termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor or (2) be otherwise involved in the recruitment of such person to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor. The Participant must inform the Corporation immediately on becoming aware of any such recruitment.

(d)Non-Solicitation of Business. During the term of the Participant’s employment and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, either directly or indirectly, on the Participant’s own behalf or on behalf of any other person, firm or company or other entity, solicit, interfere with, entice or endeavor to entice away from the Corporation or any Affiliate any Restricted Customer (as defined below), or seek to conduct Restricted Business (as defined below), or conduct Restricted Business, with any Restricted Customer and/or otherwise persuade, induce, solicit or encourage any person or entity to terminate its contractual relationship with the Corporation or any Affiliate. “Restricted Business,” for purposes of this Section 19, means any business activity carried out by the Participant either directly or indirectly for the Corporation or any Affiliate during the last two (2) years preceding the Participant’s termination date. “Restricted Customer,” for purposes of this Section 19, means any person, firm or company or other entity who was a customer or distributor of the Corporation or any Affiliate as at the Participant’s termination date, or during the last two (2) years preceding the termination date, including any Prospective Customer. “Prospective Customer,” for purposes of this Section 19, means any person, firm or company or other entity with whom the Corporation or any Affiliate was involved in negotiations as at the Participant’s termination date or during the last two (2) years preceding the Participant’s termination date, with a view to dealing with it as a customer and/or to conclude a contractual relationship with such entity, and/or with whom the Participant had contact at the Participant’s termination date or during the last two (2) years preceding the Participant’s termination date with a view to dealing with it as a customer of the Corporation or any Affiliate and/or to conclude a contractual relationship with such entity.

(e)Confidentiality. The Participant acknowledges that the Corporation and its Affiliates continually develop Confidential Information, that the Participant may develop Confidential Information for the Corporation




or its Affiliates and that the Participant may learn of Confidential Information during the course of the employment relationship. The Corporation has expended and will continue to expend substantial effort and monies in acquiring knowledge and expertise in developing goodwill in the Business of the Corporation. The Participant therefore agrees as follows:

i.The Participant will comply with the policies and procedures of the Corporation for protecting Confidential Information and shall not disclose to any person or use, other than as required by applicable law or for the proper performance of the Participant’s duties and responsibilities to the Corporation and its Affiliates, any Confidential Information.

ii.The Participant understands that the restrictions set forth in this Section 19(e) shall continue to apply after the employment relationship terminates, regardless of the reason for such termination. The Participant understands and acknowledges that the Participant's obligations under this Award Agreement with regard to any particular Confidential Information shall commence immediately upon the Participant first having access to such Confidential Information and shall continue during and after employment with the Corporation or an Affiliate until such time as such Confidential Information has become public knowledge other than as a result of the Participant's breach of this Award Agreement or breach by those acting in concert with the Participant or on the Participant's behalf, and shall be indefinite where permitted by state and local law, and shall not continue longer than two (2) years where indefinite confidentiality provisions are not permitted. Notwithstanding, the Participant’s confidentiality obligations under this Award Agreement with regard to any trade secrets shall continue during and after the Participant 's employment by the Corporation or an Affiliate until such trade secrets are no longer trade secrets under applicable law.

iii.Nothing in this Award Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order, including initiating, testifying, assisting, complying with a subpoena from, or participating in any manner with an investigation conducted by a local, state, or federal agency, filing or disclosing any facts necessary to receive unemployment insurance, Medicaid, or other public benefits. The Participant shall promptly provide written notice of any such order to an authorized officer of the Corporation. Nothing in this Award Agreement prohibits or restricts the Participant (or Participant's attorney) from initiating communications directly with, responding to an inquiry from, or providing testimony before the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other self-regulatory organization, or any other federal or state regulatory authority.

iv.The Participant agrees and understands that, pursuant to the Defend Trade Secrets Act of 2016, the Participant shall not be held criminally, or civilly, liable under any Federal or State trade secret law for the disclosure of a trade secret that is made in confidence either directly or indirectly to a Federal, State, or local government official, or an attorney, for the sole purpose of reporting, or investigating, a violation of law. Moreover, the Participant agrees and understands that individuals may disclose trade secrets in a complaint, or other document, filed in a lawsuit, or other proceeding, if such filing is made under seal. Finally, the Participant agrees and understands that an individual who files a lawsuit alleging retaliation by the Corporation for reporting a suspected violation of the law may disclose the trade secret to the attorney of the individual and use the trade secret in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.

(f)Business Ideas. The Participant acknowledges that the Corporation owns all rights in all Business Ideas (as defined below). For the avoidance of doubt, in the event an assignment is needed during the term of the Participant's employment with the Corporation or any Affiliate and at any time following the termination of employment, the Participant hereby assigns without further action being required to the Corporation all Business Ideas. The Participant shall promptly execute all documents which the




Corporation may reasonably require to perfect, maintain and protect its patent, copyright, trade secret, trademark and any and all other rights to such Business Ideas throughout the world, and shall provide other reasonable assistance and cooperation as may be necessary for the Corporation to investigate, perfect, maintain and protect those rights, including assistance and cooperation with litigation relating to any Business Ideas. Even after the Participant's employment with the Corporation or any Affiliate terminates, the Participant will continue to be reasonably available to assist the Corporation with its efforts to investigate, perfect, maintain and protect rights in any Business Ideas, including assistance with litigation relating to any Business Ideas. “Business Ideas” as used in this Award Agreement means all ideas, concepts, innovations, inventions, strategy, data, developments, and works of authorship, whether or not patentable, both technical and business, which the Participant originates, conceives or develops, either alone or in conjunction with others, at any time during the Participant's employment with the Corporation or any Affiliate, except those which satisfy all three of the following criteria: i) unrelated to the Corporation's business; ii) not originated, conceived or developed during the Participant's working hours; and iii) not originated, conceived or developed by use of any Corporation property such as tools, supplies, equipment, materials, facilities or other Corporation employees. Any idea, concept, innovation, invention, strategy, data, development or work of authorship that the Participant originates, conceives or develops, through the use of Corporation Confidential Information, at any time within six (6) months after the Participant's employment with the Corporation or any Affiliate terminates (for any reason) will be presumed to be a Business Idea unless the Participant can prove otherwise by clear and convincing evidence.

(g)Notification Requirement. During the term of the Participant's employment with the Corporation or any Affiliate and for the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, regardless of the reason for or the manner of termination, the Participant agrees to notify the Corporation in writing prior to accepting new employment, or engaging in any other activity which may violate this Award Agreement, and the Participant agrees to provide in such notice information concerning the anticipated new employment or activity, including, but not limited to: name of new employer; address of new employer; name of new team leader; job title; and scope and responsibilities of the new position. The Participant recognizes that such duty of notification is not affected by the Participant’s belief that such employment may perhaps not violate this Award Agreement or otherwise be unfairly competitive with the Corporation or an Affiliate. The Participant’s written notice should be addressed to the Corporation's General Counsel with subject line Non-Competition Agreement, via email to Noncompete.Notification@kcc.com.

(h)Other Notification. During the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, the Participant shall provide a copy of Section 19 of this Award Agreement to each new employer before starting in any new employment. The Participant agrees that the Corporation may notify any third party about the Participant’s obligations under Section 19 of this Award Agreement until such obligations are fulfilled.

(i)Remedies. In the event of an anticipated or actual breach by the Participant of any of the provisions of this Section 19, the Participant acknowledges and agrees that damages would not be an adequate remedy to compensate the Corporation or an Affiliate for the harm to the business of the Corporation or the Affiliate and, in such event, agrees that the Corporation or the Affiliate, as applicable, shall be entitled to a temporary restraining order and to temporary injunctive relief to prevent or terminate such anticipated or actual breach, provided, however, that nothing in this Award Agreement shall be construed to limit any permanent relief to which the Corporation or the Affiliate may be entitled or the damages otherwise recoverable by the Corporation or the Affiliate in any such event.

(j)Forfeiture of Award. Notwithstanding the Corporation's or an Affiliate's ability to pursue injunctive relief pursuant to Section 19(i), in the event of an actual breach by the Participant of any of the provisions of this Section 19 or of any stand-alone restrictive covenant agreement, the Corporation also is entitled to forfeit any portion of the Award that has not vested or been settled yet at the time the Corporation becomes aware of the breach.





(k)Reimbursement of Fees. If the Participant violates any of the provisions of this Section 19, or any duty of loyalty or confidentiality imposed by law, in addition to any damages that the Participant may be required to pay, the Participant understands and agrees that the Participant shall be required to reimburse the Corporation for all its costs incurred to enforce this Award Agreement, including but not limited to, all attorneys’ fees.

(l)Beneficiaries. For purposes of this Section 19, the Corporation and each of its Affiliates shall be deemed to be third-party beneficiaries with the right to seek enforcement of any of the provisions of this Section 19. Further, for purposes of this Section 19, references to acting directly or indirectly include acting jointly with or through another person.

(m)Severability. If any provision of this Section 19 is held to be invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such provision shall be deemed to be severed from the Award Agreement and such invalidity, illegality or unenforceability will not affect any other provision of the Award Agreement, all of which shall remain valid and enforceable. Notwithstanding the foregoing, if a court of competent jurisdiction determines that the covenants contained in this Section 19 are unenforceable because they are overbroad in some respect, to the full extent permitted by applicable law, the court should sever, revise or reform any aspect of this Section 19 so as to make the scope of such Section 19 as broad as reasonable under applicable law and enforce this Section 19 as so modified. Without limiting the foregoing, if a court, government agency or other body of competent jurisdiction establishes or the Corporation otherwise determines that the covenants contained in this Award Agreement are unenforceable and/or in violation of applicable rules, the Corporation reserves the right to unilaterally amend the Award Agreement so as to comply with applicable rules.

(n)Jurisdiction-Specific Terms. If the Participant works for the Corporation or an Affiliate in the District of Columbia, the length of the non-competition covenant in Section 19(b) of this Award Agreement shall be one (1) year. If the Participant works for the Corporation or an Affiliate in the State of Oregon, the Corporation will provide a signed written copy of this Award Agreement within 30 days after the termination of the Participant's employment. If the Participant works for the Corporation or an Affiliate in the State of Utah, the length of the non-competition covenant in Section 19(b) of this Award Agreement shall be one (1) year.

(o)Advice to Seek Independent Counsel. The Participant is hereby advised in writing to consult with an attorney before entering into the covenants outlined in this Section 19. The Participant acknowledges that prior to acceptance of this Award Agreement, the Participant has been advised by the Corporation of the Participant's right to seek independent advice from an attorney of the Participant's own selection regarding this Award Agreement, including the restraints imposed upon the Participant pursuant to this Section 19. The Participant acknowledges that the Participant has entered into this Award Agreement knowingly and voluntarily and with full knowledge and understanding of the provisions of this Award Agreement after being given the opportunity to consult with counsel. The Participant further represents that in entering into this Award Agreement, the Participant is not relying on any statements or representations made by any of the Corporations' directors, officers, employees or agents which are not expressly set forth herein, and that the Participant is relying only upon the Participant's own judgment and any advice provided by the Participant's attorney. The Participant acknowledges he or she has been provided at minimum 14 calendar days to review the provisions contained herein.

20.    Restrictive Covenants For Participants Outside the U.S.

(a)    Application. The provisions of this Section 20 apply to Participants who are employed by an Affiliate located outside the United States and are subject to the laws of a jurisdiction outside of the United States as of the date of termination of the Participant's employment, provided, however, that to the extent the Participant is party to an employment or other agreement with any Affiliate containing non-competition, non-solicitation, confidentiality, business ideas or similar restrictions (the “local restrictive covenants”),




whether or not such local restrictive covenants have been agreed to before or after execution of this Award Agreement, those local restrictive covenants and related enforcement provisions shall govern and the following provisions of this Section 20 shall not apply, unless otherwise determined by the Corporation in its sole discretion. Notwithstanding the foregoing, sub-section (j) below shall apply in any case.
(b)    Confidentiality. During the Participant’s employment with the Corporation or any Affiliate and indefinitely thereafter, the Participant undertakes to maintain the confidentiality of, and not to divulge to any person (except as required by law) any of the Corporation's or any Affiliate's Confidential Information (as defined below), nor use the same for any other purpose, other than to carry out the Participant’s functions as an employee of the Corporation or any of its Affiliates. The Participant shall use all personal endeavors to prevent publication or disclosure of such Confidential Information. The Participant will comply with the policies and procedures of the Corporation for protecting Confidential Information and shall not disclose to any person or use, other than as required by applicable law or for the proper performance of the Participant’s duties and responsibilities to the Corporation and its Affiliates, any Confidential Information. Nothing in this Award Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order, including initiating, testifying, assisting, complying with a subpoena from, or participating in any manner with an investigation conducted by a local agency, filing or disclosing any facts necessary to receive social insurance or other public benefits. The Participant shall promptly provide written notice of any such order to an authorized officer of the Corporation. Nothing in this Award Agreement prohibits or restricts the Participant (or Participant's attorney) from initiating communications directly with, responding to an inquiry from, or providing testimony before any regulatory authority. “Confidential Information,” for purposes of this Section 20, shall mean (i) statutory trade secrets; (ii) proprietary information developed or acquired by the Corporation that does not rise to the level of a statutorily protectable trade secret and is made the property of the Corporation through this mutual Agreement of the parties; and (iii) information that is otherwise legally protectable. Such Confidential Information includes, but is not limited to, information in whatever form (including, without limitation, in written, oral, visual or electronic form or on any magnetic or optical disk or memory storage medium, as well as other physical items wherever located, and abstracts or summaries of the foregoing) relating to the business, suppliers, customers, products, affairs and finances of the Corporation or any Affiliate for the time being confidential to the Corporation or any Affiliate, ideas, conceptions, compilations of data, and developments created by the Corporation, whether or not patentable and whether or not copyrightable, and trade secrets including, without limitation, technical data and know-how relating to the business of the Corporation or any Affiliate, or any of their suppliers, customers, agents, distributors, shareholders or management, including (but not limited to) business plans, pricing strategies, financial information, patent rights, patent applications, information concerning tenders and potential contracts, information concerning proposed product ranges, product development information, employee and salary information, research and development activities or manufacturing methods that the Participant creates, develops, receives, obtains or has knowledge of in connection with the Participant's employment, and all other matters which relate to the business of the Corporation or any Affiliate and in respect of which information is not readily available in the ordinary course of such business to the Corporation's Competitors, whether or not such information (if in anything other than oral form) is marked confidential. “Competitor,” for purposes of this Section 20, means a person or entity who engages in a business that is the same or substantially the same as any aspect of the Business of the Corporation. “Business of the Corporation,” for purposes of this Section 20, is the development, production, sales and/or marketing of (i) health and hygiene products and related apparel; (ii) washroom and workplace protective and safety products; and (iii) the materials, packaging and other components/subcomponents of such products including, without limitation, non-wood plants and products derived therefrom including any fibers, pulps or extracts.
(c)    Non-Competition. During the Participant’s employment with the Corporation or any Affiliate, it is acknowledged that the Participant will acquire Confidential Information, and should the Participant’s employment cease, it may be difficult to police sub-section (b) above, prohibiting the disclosure of such




Confidential Information. It is further acknowledged that it may be difficult to police the non-solicitation and dealing sub-sections set out below. For these reasons, during the term of the Participant’s employment and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, without the written consent of General Counsel of the Corporation or their designee, in any country or countries for which Participant had development, marketing, innovation/technology (R&D), distribution, sales, administrative, operational/supply chain or manufacturing oversight responsibilities during the last two (2) years of Participant’s employment or was provided with regular and material access to Confidential Information regarding the Corporation’s or an Affiliate's business operations in that country or countries during the last two (2) years of Participant’s employment, either directly or indirectly, perform duties or undertake responsibilities for a Competitor that are the same or substantially similar to those duties or responsibilities that the Participant performed or undertook for the Corporation or an Affiliate during the two (2) year period prior to the end of the Participant’s employment with the Corporation or an Affiliate.
(d)     Business Ideas. The Participant acknowledges that the Corporation owns all rights in all Business Ideas (as defined below). For the avoidance of doubt, in the event an assignment is needed during the term of the Participant's employment with the Corporation or any Affiliate and at any time following the termination of employment, the Participant hereby assigns without further action being required to the Employer all Business Ideas. The Participant shall promptly execute all documents which the Corporation may reasonably require to perfect, maintain and protect its patent, copyright, trade secret, trademark and any and all other rights to such Business Ideas throughout the world, and shall provide other reasonable assistance and cooperation as may be necessary for the Corporation or the Employer to investigate, perfect, maintain and protect those rights, including assistance and cooperation with litigation relating to any Business Ideas. Even after the Participant's employment with the Corporation or any Affiliate terminates, the Participant will continue to be reasonably available to assist the Corporation or the Employer with its efforts to investigate, perfect, maintain and protect rights in any Business Ideas, including assistance with litigation relating to any Business Ideas. “Business Ideas” as used in this Award Agreement means all ideas, concepts, innovations, inventions, strategy, data, developments, and works of authorship, whether or not patentable, both technical and business, which the Participant originates, conceives or develops, either alone or in conjunction with others, at any time during the Participant's employment with the Corporation or any Affiliate, except those which satisfy all three of the following criteria: i) unrelated to the Corporation's business; ii) not originated, conceived or developed during the Participant's working hours; and iii) not originated, conceived or developed by use of any Corporation property such as tools, supplies, equipment, materials, facilities or other Corporation employees. Any idea, concept, innovation, invention, strategy, data, development or work of authorship that the Participant originates, conceives or develops, through the use of Corporation Confidential Information, at any time within six (6) months after the Participant's employment with the Corporation or any Affiliate terminates (for any reason) will be presumed to be a Business Idea unless the Participant can prove otherwise by clear and convincing evidence.

(e)    Notification Requirement. During the term of the Participant's employment with the Corporation or any Affiliate and for the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, the Participant agrees to notify the Corporation in writing prior to accepting new employment, or engaging in any other activity which may violate this Award Agreement, and the Participant agrees to provide in such notice information concerning the anticipated new employment or activity, including, but not limited to: name of new employer; address of new employer; name of new team leader; job title; and scope and responsibilities of the new position. The Participant recognizes that such duty of notification is not affected by the Participant’s belief that such employment may perhaps not violate this Award Agreement or otherwise be unfairly competitive with the Corporation or an Affiliate. The Participant’s written notice should be addressed to the Corporation's General Counsel with subject line Non-Competition Agreement, via email to Noncompete.Notification@kcc.com.

(f)     Other Notification. During the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, the Participant shall provide a copy of Section 20 of this




Award Agreement to each new employer before starting in any new employment. The Participant agrees that the Corporation may notify any third party about the Participant’s obligations under Section 20 of this Award Agreement until such obligations are fulfilled.

(g)    Non-Solicitation of Business. During the term of the Participant’s employment and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, either directly or indirectly, on the Participant’s own behalf or on behalf of any other person, firm or company or other entity, solicit, interfere with, entice or endeavor to entice away from the Corporation or any Affiliate any Restricted Customer (as defined below), or seek to conduct Restricted Business(as defined below) or conduct Restricted Business, with any Restricted Customer and/or otherwise persuade, induce, solicit or encourage any person or entity to terminate its contractual relationship with the Corporation or any Affiliate. “Restricted Business,” for purposes of this Section 20, means any business activity carried out by the Participant either directly or indirectly for the Corporation or any Affiliate during the last two (2) years preceding the Participant’s termination date. “Restricted Customer,” for purposes of this Section 20, means any person, firm or company or other entity who was a customer or distributor of the Corporation or any Affiliate as at the Participant’s termination date, or during the last two (2) years preceding the termination date, including any Prospective Customer. “Prospective Customer,” for purposes of this Section 20, means any person, firm or company or other entity with whom the Corporation or any Affiliate was involved in negotiations as at the Participant’s termination date or during the last two (2) years preceding the Participant’s termination date, with a view to dealing with it as a customer and/or to conclude a contractual relationship with such entity, and/or with whom the Participant had contact at the Participant’s termination date or during the last two (2) years preceding the Participant’s termination date with a view to dealing with it as a customer of the Corporation or any Affiliate and/or to conclude a contractual relationship with such entity.
(h)    Non-Solicitation of Employees. For a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant’s termination date and with whom the Participant had material dealings during the last two (2) years preceding the Participant’s termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate, or (2) be otherwise involved in the recruitment of such person, to leave the employment of the Corporation or of any Affiliate. Furthermore, the Participant shall not for a period of two (2) years following the termination date regardless of the reason for or the manner of termination, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant’s termination date and with whom the Participant had material dealings during the last two (2) preceding the Participant’s termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor or (2) be otherwise involved in the recruitment of such person to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor. The Participant must inform the Corporation immediately on becoming aware of any such recruitment.

(i)    Remedies. In the event of an anticipated or actual breach by the Participant of any of the provisions of this Section 20, the Participant acknowledges and agrees that damages would not be an adequate remedy to compensate the Corporation or an Affiliate for the harm to the business of the Corporation or the Affiliate and, in such event, agrees that the Corporation or the Affiliate, as applicable, shall be entitled to a temporary restraining order and to temporary injunctive relief to prevent or terminate such anticipated or actual breach, provided, however, that nothing in this Award Agreement shall be construed to limit any permanent relief to which the Corporation or the Affiliate may be entitled or the damages otherwise recoverable by the Corporation or the Affiliate in any such event.

(j)    Forfeiture of Award. Notwithstanding the Corporation's or an Affiliate's ability to pursue injunctive relief pursuant to Section 20(i), in the event of an actual breach by the Participant of any of the provisions of this Section 20 or of any local restrictive covenant agreement, the Corporation also is entitled to forfeit




any portion of the Award that has not vested or been settled yet at the time the Corporation becomes aware of the breach.

(k)    Reimbursement of Fees. If the Participant violates any of the provisions of this Section 20, or any duty of loyalty or confidentiality imposed by law, in addition to any damages that the Participant may be required to pay, the Participant understands and agrees that the Participant shall be required to reimburse the Corporation for all its costs incurred to enforce this Award Agreement, including but not limited to, all attorneys’ fees.

(l)    Beneficiaries. For purposes of this Section 20, the Corporation and each of its Affiliates shall be deemed to be third party beneficiaries with the right to seek enforcement of any of the provisions of this Section 20. Further, for purposes of this Section 20, references to acting directly or indirectly include acting jointly with or through another person.

(m)    Severability. If any provision of this Section 20 is held to be invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such provision shall be deemed to be severed from the Award Agreement and such invalidity, illegality or unenforceability will not affect any other provision of the Award Agreement, all of which shall remain valid and enforceable. Notwithstanding the foregoing, if a court of competent jurisdiction determines that the covenants contained in this Section 20 are unenforceable because they are overbroad in some respect, to the full extent permitted by applicable law, the court should sever, revise or reform any aspect of this Section 20 so as to make the scope of such Section 20 as broad as reasonable under applicable law and enforce this Section 20 as so modified. Without limiting the foregoing, if a court, government agency or other body of competent jurisdiction establishes or the Corporation otherwise determines that the covenants contained in this Award Agreement are unenforceable and/or in violation of applicable rules, the Corporation reserves the right to unilaterally amend the Award Agreement so as to comply with applicable rules.

21.    Forfeiture and Recoupment.
(a)    The RSUs are subject to the compensation recovery provisions of the Plan. In addition, the RSUs are subject to the Kimberly-Clark Corporation Compensation Recoupment Policy (such policy, as it may be amended from time to time, the “Recoupment Policy”) if the Participant is a Leader (as defined in the Recoupment Policy). A recovery under this section may be made by (a) cancelling any RSUs which have not yet vested or been settled; (b) recovering shares of Common Stock or cash equal to the value of the shares of Common Stock issued on settlement of the RSUs, including shares resulting from dividend equivalents; (c) recovering proceeds realized by the Participant on the sale of such Common Stock; (d) withholding compensation otherwise due to the Participant; (e) payment by the Participant; and/or (e) by such other means determined appropriate under the terms of the Recoupment Policy. If the Participant is required to repay the Corporation, the Corporation is entitled to offset the payment in a way that is intended to avoid the application of penalties under Section 409A of the Code, if applicable.
Without limiting the foregoing, if, following a Participant’s termination of employment for a reason other than the Participant’s termination for Cause, the Corporation discovers facts that such Participant’s termination of employment could have been for Cause, such Participant’s termination of employment will be deemed to have been for Cause for all purposes, and as a result, (a) the Corporation will not issue shares of Common Stock or any other benefit otherwise payable to the Participant under the Plan and (b) the Participant will be required to repay to the Corporation all proceeds received under the Plan that would not have been payable to such Participant had such termination of employment been for Cause.
The Corporation shall have the right to suspend any and all rights or benefits awarded to the Participant hereunder, including vesting and settlement of the RSUs, pending its investigation and final determination with regard to whether the Participant has engaged in conduct constituting Cause or that would warrant application of the Recoupment Policy.




(b)    By accepting the Award Grant and the terms of this Award Agreement, the Participant understands, acknowledges and accepts that the grant, shares of Common Stock issued under the Plan and proceeds realized by the Participant pursuant to the Plan are subject to the terms of the Recoupment Policy and the Corporation may seek recovery by any of the methods described in Section 21(a) or other such means determined appropriate under the terms of the Recoupment Policy.

22.    Whistleblower Statutes. Notwithstanding anything to the contrary in this Award Agreement, nothing in Sections 19 , 20 or 21 of this Award Agreement is intended to or shall limit, prevent, impede or interfere with the Participant's non-waivable right, without prior notice to the Corporation, to provide information to the government, participate in investigations, testify in proceedings regarding the Corporation, Employer or any Affiliate's past or future conduct, engage in any activities protected under whistleblower statutes, or to receive and fully retain a monetary award from a government-administered whistleblower award program for providing information directly to a government agency. The Participant does not need prior authorization from the Corporation to make any such reports or disclosures and is not required to notify the Corporation that the Participant has made such reports or disclosures.

23.    Section 409A. It is the intent of this Award Agreement that it and all payments and benefits hereunder be exempt from, or comply with, the requirements of Section 409A of the Code so that none of the RSUs provided under this Award Agreement or shares of Common Stock issuable thereunder will be subject to the additional tax imposed under Section 409A of the Code, and any ambiguities herein will be interpreted to be so exempt or so comply.
24.    Acceptance of Award Terms and Conditions. A Participant has until the end of the ninety (90) day period beginning from the Grant Date of this Award to accept this Award Agreement. If the Participant does not accept this Award Agreement on or before the end of such ninety (90) day period, then the grant of the Award, as set forth in Section 1, shall not be binding on and shall be voidable by the Corporation, in which case it shall have no further force or effect. Further, as set forth in the fourth paragraph of Section 2(a), the Award will be forfeited if the Participant does not accept any restrictive covenant agreement presented to the Participant by the end of the period noted in Section 2(a).

Acknowledgment of Conditions

The Participant understands, acknowledges and agrees to the following conditions with respect to the Award granted under the Plan:

The Plan is established voluntarily by the Corporation, is discretionary in nature and may be modified, amended, suspended, cancelled or terminated at any time, to the extent permitted by the Plan. The grant of an Award is an exceptional, voluntary and occasional benefit and does not create any contractual or other right to receive an Award or benefits in lieu of an Award in the future, even if Awards have been granted in the past. Future grants, if any, will be at the sole discretion of the Corporation, including, but not limited to, the timing of any grant, the number of Awards and vesting provisions.

Participation in the Plan is voluntary and does not create a right to employment with the Participant’s Employer, shall not be interpreted as forming an employment or service contract with the Corporation, and shall not interfere with the ability of the Employer to terminate the Participant’s employment relationship at any time. The Participant understands that the Corporation has unilaterally, gratuitously and discretionally decided to grant Awards under the Plan to individuals who are employees of the Corporation or its Affiliates throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Corporation or any of its Affiliates on an ongoing basis. Consequently, the Participant understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Corporation or any of its Affiliates) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. Further, the Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from any gratuitous and discretionary grant since the future value of the Award and the




underlying shares is unknown and unpredictable. In addition, the Participant understands that this grant would not be made but for the assumptions and conditions referred to above; thus, the Participant understands, acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then the Award shall be null and void.

The Award and the shares of Common Stock subject to the Award, and the income from and value of same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Corporation or, if different, the Employer, and which are outside the scope of the Participant’s employment contract, if any, and are not intended to replace any pension rights or compensation. As such, the Award, and the income from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, leave-related payments, holiday pay, pension, retirement or welfare benefits or similar payments and in no event shall be considered as compensation for, or relating in any way to, past services for the Corporation, the Employer or any other Affiliate.

Unless otherwise agreed with the Corporation, the Award and shares of Common Stock subject to the Award, and the income from and value of same, are not granted as consideration for, or in connection with, any service the Participant may provide as a director of any Affiliate.

The future value of the underlying shares of Common Stock is unknown, indeterminable, and cannot be predicted with certainty.
No claim or entitlement to compensation or damages shall arise from forfeiture of the Award or the recoupment of any shares of Common Stock acquired under the Plan resulting from (a) the termination of the Participant’s employment by the Corporation or the Employer (regardless of the reason for such termination and whether or not the termination is later found to be invalid or in breach of employment laws); and/or (b) the application of the Corporation’s Recoupment Policy or any recovery or clawback policy required by law.
The Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan, or the acquisition or sale of the underlying shares of Common Stock. Further, the Participant understands that he or she should consult with his or her own advisors regarding participation in the Plan before taking any action related to the Plan.
Neither the Corporation, the Employer nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the settlement of the RSUs or the subsequent sale of any shares of Common Stock acquired upon settlement.
Regardless of any action the Corporation or the Employer takes with respect to any or all income tax (including federal, state and local taxes), social insurance, fringe benefit tax, payroll tax, payment on account or other tax-related items related to the Participant’s participation in the Plan and legally applicable to the Participant (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant’s responsibility and may exceed the amount, if any, actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant of the RSUs, the vesting of RSUs, the conversion of the RSUs into shares or the receipt of an equivalent cash payment, the subsequent sale of any shares acquired at vesting and the receipt of any dividends or dividend equivalents; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Corporation and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.




In connection with the relevant taxable or tax withholding event, as applicable, the Participant shall pay or make adequate arrangements satisfactory to the Corporation and/or the Employer to satisfy or account for all applicable withholding obligations for Tax-Related Items. In this regard, the Participant authorizes the Corporation or the Employer, or their respective agents, at their discretion, to satisfy their withholding obligations, if any, with regard to all Tax-Related Items by one or a combination of the following:
(1)    withholding from the Participant’s wages or other cash compensation paid to the Participant by the Corporation and/or the Employer; or
(2)    withholding from the proceeds of the sale of shares acquired upon vesting of the Award either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant’s behalf, pursuant to this authorization); or
(3)    withholding shares to be issued upon vesting of the Award;
provided, however, that if the Participant is subject to Section 16 of the U.S. Securities Exchange Act of 1934, as amended, then the Corporation will withhold in shares upon the relevant taxable or tax withholding event, as applicable, unless the use of such withholding method is not feasible under applicable tax or law or has materially adverse accounting consequences, in which case, the obligation for Tax-Related Items may be satisfied by one or a combination of methods (1), (2) and (3) above.
The Corporation may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates, including minimum rates or maximum applicable rates in applicable jurisdictions. In the event of over-withholding, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the common stock equivalent), or if not refunded, the Participant may seek a refund from the applicable tax authorities. In the event of under-withholding, the Participant may be required to pay additional Tax-Related Items directly to the applicable tax authorities or to the Corporation or the Employer. If the obligation for Tax-Related Items is satisfied by withholding in shares, for tax purposes, the Participant is deemed to have been issued the full number of shares subject to the Award, notwithstanding that a number of shares is held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Plan.
The Participant shall pay to the Corporation or to the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to deliver shares or the proceeds of the sale of shares to the Participant if he or she fails to comply with his or her obligations in connection with the Tax-Related Items.
The Corporation is located at 351 Phelps Drive Irving, TX 75038, USA and grants employees of the Corporation and its Affiliates the opportunity to participate in the Plan, at the Corporation’s sole discretion. If the Participant would like to participate in the Plan and is an employee in a country outside the European Economic Area, the Participant understands that he or she should review the following information about the Corporation’s data processing practices and declare his or her consent. If the Participant is an employee in a country that is a member of the European Economic Area, the Participant should review the information about the Corporation's data processing practices set forth in Appendix A attached hereto.
(1)Data Collection and Usage. The Corporation collects, processes and uses the Participant’s personal data, including, name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, citizenship, nationality, job title, any shares of stock or directorships held in the Corporation, and details of all awards, canceled, vested, or outstanding in the Participant’s favor, which the Corporation receives from the Participant or the Participant’s Employer. If the Corporation offers the Participant the opportunity to participate in the Plan, then the Corporation will collect the Participant’s personal data for purposes of allocating stock




and implementing, administering and managing the Plan. The Corporation’s legal basis for the processing of the Participant’s personal data would be the Participant’s consent.
(2)Stock Plan Administration Service Providers. The Corporation transfers participant data to Merrill Lynch, an independent service provider based in the United States, which assists the Corporation with the implementation, administration and management of the Plan. In the future, the Corporation may select a different service provider and share the Participant’s data with another company that serves in a similar manner. The Corporation’s service provider will open an account for the Participant. The Participant will be asked to agree on separate terms and data processing practices with the service provider, which is a condition for participation in the Plan.
(3)International Data Transfers. The Corporation and its service providers are based in the United States. If the Participant is outside of the United States, the Participant should note that his or her country may have enacted data privacy laws that are different from the United States. The Corporation’s legal basis for the transfer of the Participant's personal data is the Participant’s consent.
(4)Data Retention. The Corporation will use the Participant’s personal data only as long as is necessary to implement, administer and manage his or her participation in the Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. This period may extend until the Participant’s employment or service with the Corporation is terminated, plus any additional time periods necessary for compliance with law, exercise or defense of legal rights, and archiving, back-up and deletion processes.
(5)Voluntariness and Consequences of Consent Denial or Withdrawal. The Participant’s participation in the Plan and the Participant’s grant of consent is purely voluntary. The Participant may deny or withdraw his or her consent at any time. If the Participant does not consent, or if he or she withdraws their consent, the Participant cannot participate in the Plan. This would not affect the Participant’s salary as an employee; the Participant would merely forfeit the opportunities associated with the Plan.
(6)Data Subject Rights. The Participant has a number of rights under data privacy laws in his or her country. Depending on where the Participant is based, the Participant’s rights may include the right to (i) request access or copies of personal data the Corporation processes, (ii) rectification of incorrect data, (iii) deletion of data, (iv) restrictions on processing, (v) portability of data, (vi) to lodge complaints with competent authorities in the Participant’s country, and/or (vii) a list with the names and addresses of any potential recipients of the Participant’s personal data. To receive clarification regarding the Participant’s rights or to exercise the rights please contact the Corporation at Attn: Long-term Incentive Plan Administration at Kimberly Clark, 351 Phelps Drive Irving, TX 75038, USA.
The Participant also understands that the Corporation may rely on a different legal basis for the processing or transfer of data in the future and/or request that the Participant provides another data privacy consent.  If applicable and upon request of the Corporation, the Participant agrees to provide an executed acknowledgment or data privacy consent form to the Corporation or the Employer (or any other acknowledgments, agreements or consents) that the Corporation and/or the Employer may deem necessary to obtain under the data privacy laws in the Participant’s country, either now or in the future.  The Participant understands that he or she will not be able to participate in the Plan if the Participant fails to execute any such acknowledgment, agreement or consent requested by the Corporation and/or the Employer.

If the Participant agrees with the data processing practices described in this notice, the Participant will declare his or her consent by clicking the "Accept" icon on the Merrill Lynch website.
The Participant understands that he or she is solely responsible for obtaining/providing whatever exchange control approvals, permits, licenses or notices, which may be necessary for the Award, to acquire the shares or to hold or sell the shares subject to the Award. Neither the Corporation nor its Affiliates will be responsible for obtaining such approvals, licenses or permits, or for making any such notices, nor will the Corporation or its Affiliates be




liable for any fines or penalties the Participant may incur for failure to obtain any required approvals, permits or licenses or to make any required notices.

In accepting the grant of this Award, the Participant acknowledges that he or she has received a copy of the Plan and the Award Agreement and has reviewed the Plan and the Award Agreement, including Appendix A, in their entirety and fully understands and accepts all provisions of the Plan and the Award Agreement, including Appendix A.

The Participant acknowledges that he or she has read and specifically and expressly approves the following sections of the Award Agreement: Section 2(g) on Payment of Tax-Related Items; Section 5 on No Right of Continued Employment; Section 8 on Governing Law; the section on Acknowledgment of Conditions; and the Data Privacy Notice sections of both the Award Agreement and Appendix A for the Participant’s country.
The provisions of this Award Agreement are severable and if one or more of the provisions of this Award Agreement shall be held invalid, illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nonetheless be binding and enforceable. To the extent that any provisions of this Award Agreement are held to be invalid or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and the invalid, illegal or unenforceable provisions shall be deemed null and void; however, to the extent permissible by law, any provisions which could be deemed null and void shall first be construed, interpreted or revised retroactively to permit this Award Agreement to be construed so as to foster the intent of this Award Agreement and the Plan.
The Participant acknowledges that he or she is sufficiently proficient in English, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the terms and conditions of this Award Agreement. Furthermore, if the Participant has received this Award Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.
Notwithstanding any provisions in this Award Agreement, the Award shall be subject to any additional terms and conditions set forth in Appendix A to this Award Agreement for the Participant’s country. Moreover, if the Participant relocates to any of the countries included in Appendix A, the additional terms and conditions for such country will apply to the Participant, to the extent the Corporation determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. Appendix A constitutes part of this Award Agreement.
The Participant acknowledges that the grant of an Award is expressly conditioned on the non-competition provisions set forth in Sections 19 and 20.
The Corporation reserves the right to impose other requirements on the Participant’s participation in the Plan, on the Award and on any shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by on-line delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third-party designated by the Corporation.
A waiver by the Corporation of breach of any provision of this Award Agreement shall not operate or be construed as a waiver of any other provision of this Award Agreement, or of any subsequent breach by the Participant or any other participant.
The Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, which may affect the Participant’s ability to, directly or indirectly, accept, acquire, sell, or attempt to sell or




otherwise dispose of shares of Common Stock or rights to shares of Common Stock (e.g., RSUs) or rights linked to the value of shares of Common Stock during such times as the Participant is considered to have “inside information” regarding the Corporation (as defined by the laws in the applicable jurisdictions or the Participant’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant placed before possessing inside information. Furthermore, the Participant may be prohibited from (i) disclosing the inside information to any third party, including fellow employees (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them to otherwise buy or sell Corporation securities.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Corporation insider trading policy.  The Participant is responsible for ensuring his or her compliance with any applicable restrictions and is advised to speak with his or her personal legal advisor on this matter.
The Participant’s country may have certain foreign asset and/or foreign account reporting requirements, tax and/or exchange controls which may affect the Participant’s ability to acquire or hold shares of Common Stock acquired under the Plan or cash received from participating in the Plan (including from any dividends paid on shares acquired under the Plan) in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in the Participant’s country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of his or her participation in the Plan to the Participant’s country through a designated bank or broker within a certain time after receipt. In addition, the Participant agrees to take any and all actions, and consent to any and all actions taken by the Corporation or the Employer as may be required to allow the Corporation or the Employer to comply with local laws, rules and regulations in the Participant's country of residence (and country of employment, if different). Finally, the Participant agrees to take any and all actions as may be required to comply with their personal legal and tax obligations under local laws, rules and regulations in their country of residence (and country of employment, if different). The Participant should consult his or her personal legal advisor for any details.
The Participant acknowledges that he or she has reviewed the Corporation’s Code of Conduct. The Participant further acknowledges that he or she understands and will comply with the terms and standards contained in that Code of Conduct, including but not limited to the prohibition against retaliation, and specifically acknowledges that he or she has an obligation to report suspected violations of the Code of Conduct pursuant to the Corporation’s Escalation Policy.

Conclusion and Acceptance

The Participant accepts this grant via electronic signature by clicking the "Accept" icon and certifies that he or she has read, understands and agrees to the terms and conditions of the 2021 Equity Participation Plan (the "Plan"), the provisions of the applicable Award Agreement and all other applicable documents (including any country-specific terms applicable to the Participant’s grant). The Participant hereby authorizes the Employer to furnish the Corporation (and any agent administering the Plan or providing recordkeeping services) with such information and data as it shall request in order to facilitate the grant of Awards and enable administration of the Plan and the Participant understands that such information shall be used only as long and to the extent necessary to administer the Participant’s participation in the Plan. The Participant agrees that his or her participation in the Plan and the Awards granted to the Participant under the Plan will be governed solely by provisions of U.S. law.





KIMBERLY-CLARK CORPORATION
OFF-CYCLE TIME-VESTED RESTRICTED STOCK UNIT
AWARD AGREEMENT

APPENDIX A

Certain capitalized terms used but not defined in this Appendix A have the meanings set forth in the Plan and/or the Award Agreement.

This Appendix A includes additional terms and conditions that govern the Award granted to the Participant under the Plan if the Participant resides and/or works in any of the countries listed below.

This Appendix A also includes information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of April 2023. Such laws are often complex and change frequently. As a result, the Participant should not rely on the information noted herein as the only source of information relating to the consequences of the Participant’s participation in the Plan because the information may be out of date at vesting of the Award or the subsequent sale of the shares or receipt of any dividends or dividend equivalents.

In addition, the information is general in nature and may not apply to the Participant’s particular situation, and the Corporation is not in a position to assure the Participant of any particular result. Accordingly, the Participant is advised to seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident of a country other than the one in which the Participant is currently residing and/or working, transferred or transfers employment and or residency after the Award is granted or is considered a resident of another country for local law purposes, the information contained herein may not be applicable to the Participant. The Corporation shall, in its sole discretion, determine to what extent the terms and conditions included herein will apply to the Participant in such circumstances.

EUROPEAN ECONOMIC AREA (INCLUDING THE UNITED KINGDOM) AND SWITZERLAND

Data Protection
For Participants resident in a country in the European Economic Area, Switzerland or the United Kingdom, the following language replaces in its entirety the data privacy section in the Acknowledgment of Conditions section of the Award Agreement:
1.The Participant is hereby notified of the collection, use and transfer outside of the European Economic Area, as described in the Award Agreement, in electronic or other form, of his or her Personal Data (defined below) by and among, as applicable, the Corporation and certain of its Affiliates for the exclusive and legitimate purpose of implementing, administering and managing the Participant’s participation in the Plan.
i.The Participant understands that the Corporation and the Employer hold certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares of Common Stock or directorships held in the Corporation, details of all entitlement to shares of Common Stock awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Personal Data”), for the purpose of implementing, administering and managing the Plan.




ii.The Participant understands that providing the Corporation with this Personal Data is necessary for the performance of the Award Agreement and that the Participant's refusal to provide the Personal Data would make it impossible for the Corporation to perform its contractual obligations and may affect the Participant's ability to participate in the Plan. The Participant's Personal Data shall be accessible within the Corporation only by the persons specifically charged with Personal Data processing operations and by the persons that need to access the Personal Data because of their duties and position in relation to the performance of the Award Agreement.
iii.The Personal Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. This period may extend until the Participant’s employment or service with the Corporation is terminated, plus any additional time periods necessary for compliance with law, exercise or defense of legal rights, and archiving, back-up and deletion processes. The Participant may, at any time and without cost, contact Long-term Incentive Plan Administration at Kimberly Clark, 351 Phelps Drive Irving, TX 75038, USA to enforce his or her rights under the data protection laws in the Participant's country, which may include the right to (i) request access or copies of Personal Data subject to processing; (ii) request rectification of incorrect Personal Data; (iii) request deletion of Personal Data; (iv) request restriction on processing of Personal Data; (v) request portability of Personal Data; (vi) lodge complaints with competent authorities in the Participant's country; and/or (vii) request a list with the names and addresses of any potential recipients of Personal Data.
iv.The Corporation provides appropriate safeguards for protecting Personal Data that it receives in the U.S. through its adherence to data transfer agreements entered into between the Corporation and its Affiliates within the European Union.
v.Further, the Participant understands that the Corporation will transfer Personal Data to Merrill Lynch and/or such other third parties as may be selected by the Corporation, which are assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Personal Data with such other provider(s) serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.
vi.Merrill Lynch is based in the United States. The Participant's country or jurisdiction may have different data privacy laws and protections than the United States. Notwithstanding, by participating in the Plan, the Participant agrees to the transfer of his or her Personal Data to Merrill Lynch for the exclusive purpose of administering the Participant's participation in the Plan. The Corporation's legal basis, where required, for the transfer of Data to Merrill Lynch is the Participant's consent.
vii.Finally, the Participant may choose to opt out of allowing the Corporation to share his or her Personal Data with Merrill Lynch and others as described above, although execution of such choice may mean the Corporation cannot grant awards under the Plan to the Participant. For questions about this choice or to make this choice, the Participant should contact Long-term Incentive Plan Administration at Kimberly Clark, 351 Phelps Drive Irving, TX 75038, USA.
ARGENTINA

Securities Law Information
Neither the RSUs nor the underlying shares of Common Stock are publicly offered or listed on any stock exchange in Argentina.




Foreign Asset/Account Reporting Information
Argentine residents must report any shares of Common Stock acquired under the Plan and held on December 31st of each year on their annual tax return for the year.
Exchange Control Information
Please note that exchange control regulations in Argentina are subject to frequent change. The Participant should consult with his or her personal legal advisor regarding any exchange control obligations the Participant may have in connection with the Participant’s participation in the Plan. The Participant must comply with any and all Argentine currency exchange restrictions, approvals and reporting requirements in connection with the vesting of the RSUs, the subsequent sale of any shares acquired at vesting and the receipt of any dividends paid on such shares.
AUSTRALIA
Securities Law Information

This offer is being made under Division 1A, Part 7.12 of the Australia Corporations Act 2001 (Cth). Please note that if the Participant offers shares of Common Stock for sale to a person or entity resident in Australia, the offer may be subject to disclosure requirements under Australian law. The Participant should obtain legal advice regarding the relevant disclosure obligations prior to making any such offer.
Tax Information

The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the “Act”) applies (subject to conditions in the Act).

Compliance with Laws

Notwithstanding anything else in the Plan or the Award Agreement, the Participant will not be entitled to and shall not claim any benefit under the Plan if the provision of such benefit would give rise to a breach of Part 2D.2 of the Corporations Act 2001 (Cth.) (the “Act”), any other provision of the Act, or any other applicable statute, rule or regulation which limits or restricts the giving of such benefits. Further, the Employer is under no obligation to seek or obtain the approval of its shareholders in a general meeting for the purpose of overcoming any such limitation or restriction.

Exchange Control Information

Exchange control reporting is required for cash transactions exceeding AUD 10,000 and for international fund transfers. If an Australian bank is assisting with the transaction, the bank will file the report on the Participant’s behalf. If there is no Australian bank involved in the transaction, the Participant will be required to file the report him or herself.

BAHRAIN

Securities Law Information

The Award Agreement, Plan and all other materials the Participant may receive regarding participation in the Plan do not constitute advertising or the offering of securities in Bahrain, nor do they constitute an allotment of securities in Bahrain. Any shares of Common Stock issued upon settlement of the RSUs will be deposited into a Corporation-designated brokerage account outside Bahrain. In no event will shares of Common Stock be issued or delivered in Bahrain. The issuance of shares of Common Stock pursuant to the RSUs described herein has not and will not be registered in Bahrain and, hence, the shares of Common Stock described herein may not be admitted or used for offering, placement or public circulation in Bahrain. Accordingly, the Participant may not make any




public advertising or announcements regarding the RSUs or shares of Common Stock in Bahrain, promote these shares of Common Stock to legal entities or individuals in Bahrain, or sell shares of Common Stock directly to other legal entities or individuals in Bahrain. Any disposition or sale of such shares of Common Stock must take place outside Bahrain.

BELGIUM

Foreign Asset/Account Reporting Information
Belgian residents are required to report any securities (e.g., shares acquired under the Plan) or bank accounts opened and maintained outside Belgium (e.g., any brokerage account opened in connection with the Plan) on their annual tax returns. Belgian residents are also required to complete a separate report providing the National Bank of Belgium with details regarding any such account, including the account number, the name of the bank in which such account is held and the country in which such account is located. The forms to complete this report are available on the website of the National Bank of Belgium. Belgian residents should consult with their personal tax advisors to determine their personal reporting obligations.
Stock Exchange Tax
A stock exchange tax applies to transactions executed by a Belgian resident through a non-Belgian financial intermediary, such as a U.S. broker. The Stock Exchange Tax likely will apply when the Participant sells shares of Common Stock. The Participant should consult with his or her personal tax advisor for additional details regarding the Participant’s obligations with respect to the Stock Exchange Tax.
Annual Securities Accounts Tax
An annual securities accounts tax may be payable if the total value of securities held in a Belgian or foreign securities account (e.g., shares of Common Stock acquired under the Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such cases, the tax will be due on the value of the qualifying securities held in such account. The Participant should consult with his or her personal tax advisor regarding the application of this tax.
BOLIVIA

There are no country-specific provisions.

BRAZIL

Compliance with Law

By accepting the Award, the Participant acknowledges that he or she agrees to comply with applicable Brazilian laws and pay any and all applicable Tax-Related Items associated with the vesting of the RSUs, the conversion of the RSUs into shares or the receipt of an equivalent cash payment, the receipt of any dividends, and the sale of shares of Common Stock acquired under the Plan.

Labor Law Acknowledgment

By accepting the Award, the Participant agrees that (i) the Participant is making an investment decision; (ii) the shares of Common Stock will be issued to Participant only if the vesting and/or performance conditions are met, and (iii) the value of the underlying shares of Common Stock is not fixed and may increase or decrease in value over the vesting period without compensation to the Participant.





Exchange Control Information

If the Participant is resident or domiciled in Brazil, he or she will be required to submit annually a declaration of assets and rights held outside of Brazil to the Central Bank of Brazil if the aggregate value of such assets and rights is equal to or greater than US$1,000,000. Assets and rights that must be reported include shares of Common Stock, and may include RSUs.

Tax on Financial Transaction (IOF).

Payments to foreign countries and repatriation of funds into Brazil (including proceeds from the sale) and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions. It is the Participant’s responsibility to comply with any applicable Tax on Financial Transactions arising from the Participant’s participation in the Plan. The Participant should consult with his or her personal tax advisor for additional details.

CANADA

Securities Law Information

The Participant is permitted to sell shares acquired through the Plan through the designated broker appointed under the Plan, if any, provided the resale of shares acquired under the Plan takes place outside of Canada through the facilities of a stock exchange on which the shares are listed. The Corporation’s shares are currently listed on New York Stock Exchange.

Acknowledgment of Conditions

The following provision supplements the Acknowledgment of Conditions section of the Award Agreement:

Except as may otherwise be explicitly provided in the Plan or this Award Agreement, for the purposes of this Award Agreement, the Participant's termination of employment will be measured effective as of the date that is the earlier of: (1) the date the Participant's employment is terminated, no matter how the termination arises; and (2) the date the Participant receives notice of termination of employment from the Employer. In either case, the date shall exclude any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under local law. For greater certainty, the Participant will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which the Participant's right to vest terminates, nor will the Participant be entitled to any compensation for lost vesting. Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued vesting during a statutory notice period, the Participant's right to vest in the RSUs, if any, will terminate effective as of the last day of the Participant's minimum statutory notice period, but the Participant will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of the Participant's statutory notice period, nor will the Participant be entitled to any compensation for lost vesting.

The Participant acknowledges and agrees that the vesting schedule may change prospectively in the event the Participant’s service status changes between full- and part-time and/or in the event the Participant is on a leave of absence, in accordance with Corporation’s policies relating to work schedules and vesting of RSUs or as determined by the Committee. In case of any dispute as to whether and when a termination of the Participant’s employment has occurred, the Committee will have sole discretion to determine whether such termination of the Participant’s employment has occurred and the effective date of such termination (including whether the Participant may still be considered to be actively providing services while on a leave of absence).
Language
A French translation of the Plan and the Award Agreement can be made available to the Participant as soon as reasonably practicable upon the Participant’s request. The Participant understands that, from time to time,




additional information related to the offering of the Plan might be provided in English and such information may not be immediately available in French. However, upon request, the Corporation will translate into French documents related to the offering of the Plan as soon as reasonably practicable.
Une traduction française du Plan et de l'Accord d'Attribution êtremise à la disposition de Participant dès que raisonnablement possible à la demande de l'Participant. Le Participant comprend que, de temps à autre, des informations supplémentaires liées à l'offre du Plan peuvent être fournies en anglais et que ces informations peuvent ne pas être immédiatement disponibles en français. Cependant, sur demande, la Société traduira en français les documents relatifs à l'offre du Plan dès que raisonnablement possible.
Authorization to Release and Transfer Necessary Personal Information

The Participant hereby authorizes the Corporation and the Corporation’s representatives, including the broker(s) designated by the Corporation, to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. The Participant further authorizes the Corporation, any Affiliate and the plan administrators to disclose and discuss the Plan with their advisors. The Participant further authorizes the Corporation and any Affiliate to record such information and to keep such information in the Participant’s employee file. The Participant acknowledges that the Participant’s personal information, including any sensitive personal information, may be transferred or disclosed outside the Province of Quebec, including to the United States. Finally, the Participant acknowledges that the Corporation, the Employer or any other Affiliate or other parties involved in the administration of the Plan use technology for profiling purposes and to make automated decisions that may have an impact on the Participant or the administration of the Plan.
Foreign Asset/Account Reporting Information

Foreign specified property (including shares of Common Stock) held by Canadian residents must be reported annually on Form T1135 (Foreign Income Verification Statement) if the total cost of such foreign specified property exceeds C$100,000 at any time during the year. Foreign specified property includes shares of Common Stock acquired under the Plan and may include the RSUs. The RSUs must be reported - generally at a nil cost - if the $100,000 cost threshold is exceeded because of other foreign property the Participant holds. If shares of Common Stock are acquired, their cost generally is the adjusted cost base (“ACB”) of the shares. The ACB would normally equal the Fair Market Value of the shares at vesting, but if the Participant owns other shares, this ACB may have to be averaged with the ACB of the other shares owned by the Participant. If due, the Form must be filed by April 30 of the following year. The Participant should speak with a personal tax advisor to determine the scope of foreign property that must be considered for purposes of this requirement.

CHILE

Securities Law Information

The RSUs are granted and are made subject to general ruling n° 336 of the Chilean Commission for the Financial Market (“CMF”). This offer refers to securities not registered at the securities registry or at the foreign securities registry of the CMF, and therefore such securities are not subject to its oversight. Given that these securities are not registered in Chile, there is no obligation from the issuer to provide public information on them in Chile. These securities cannot be subject to public offering in Chile while they are not registered at the corresponding securities registry in Chile.

La oferta privada de estos RSUs se inicia y se acoge a las disposiciones de la norma de carácter general nº 336 de la Comisón para el Mercado Financiero (“CMF”). Esta oferta versa sobre valores no inscritos en el registro de valores o en el registro de valores extranjeros que lleva la CMF, por lo que tales valores no están sujetos a la fiscalización de ésta. Por tratarse de valores no inscritos en Chile, no existe la obligación por parte del emisor de entregar en Chile información pública respecto de los mismos. Estos valores no podrán ser objeto de oferta pública en Chile mientras no sean inscritos en el registro de valores correspondiente.





Exchange Control Information

The Participant is not required to repatriate funds obtained from the sale of shares or the receipt of any dividends. However, if the Participant decides to repatriate such funds, the Participant must do so through the Formal Exchange Market if the amount of the funds exceeds US$10,000. In such case, the Participant must report the payment to a commercial bank or registered foreign exchange office receiving the funds.

Foreign Asset/Account Reporting Information

The Chilean Internal Revenue Service (the “CIRS”) requires all taxpayers to provide
information annually regarding (i) the results of investments held abroad and (ii) any taxes paid
abroad which the taxpayers will use as a credit against Chilean income tax. The sworn
statements disclosing this information (or Formularios) must be submitted electronically
through the CIRS website,
www.sii.cl, using Form 1929, which is due on July 1 each year.

CHINA

The following provisions apply only to Participants who are subject to exchange control restrictions imposed by the State Administration of Foreign Exchange ("SAFE"), as determined by the Corporation in its sole discretion:

Vesting of RSUs

The Participant's Employer, Corporation any other Affiliate to which the Participant provides service must be registered with SAFE prior to settlement of the RSUs. If the Corporation is unable to obtain registration approval or is required to obtain further approvals on behalf of the Employer, Corporation or any other Affiliate, the vesting or settlement of the RSUs may be suspended or delayed. Further, the Corporation is under no obligation to vest the RSUs and/or issues shares of Common Stock if the Corporation’s SAFE approval becomes invalid or ceases to be in effect by the time the Participant vests in the RSUs.
Shutdown or Divestiture

The following provision replaces Section 2(d) of the Award Agreement.

In the event that, more than six months after the Grant Date, the Participant’s termination of employment is due to the shutdown or divestiture of the Corporation’s or its Affiliate’s business, it shall result in pro-rata vesting, as determined by the Committee, and the number of shares that are considered to vest shall be determined based on the Target Level of Awards (including any accrued dividend equivalents accumulated pursuant to Section 2(a)) and by prorating the number of full years of employment during the Restricted Period prior to the Participant's termination of employment, and shall be paid within 70 days following the Participant's termination of employment. Any fractional share of the Corporation resulting from such a prorated Award shall be rounded to the nearest whole share. For the purposes of this Award, a shutdown or divestiture of the Corporation’s or its Affiliate’s business unit is defined as one for which the charges related to the shutdown or divestiture are accounted for, and reported externally, as an exit activity in the Corporation's applicable SEC filings. The Corporation has complete discretion to determine whether a shutdown or divestiture of a business unit has occurred under the terms of the Plan.

Termination of Employment

Except for a termination of employment due to the shutdown or divestiture of a business unit, as described above, and notwithstanding any other provision in the Award Agreement, the Participant shall forfeit any unvested Award, including any accrued dividend equivalents, upon any termination of employment including, but not limited to, any termination that is due to a Qualified Termination of Employment, death or Total and Permanent Disability.





The Participant acknowledges and agrees that he or she must sell any shares of Common Stock issued to him or her upon vesting of the RSUs as soon as practicable following the Participant's termination of employment for any reason and in no event later than three months following the Participant's termination of employment. The Participant agrees that if he or she continues to hold any of such shares of Common Stock after this time, the shares of Common Stock may be sold by the Corporation’s designated broker on the Participant's behalf at the instruction of the Corporation. Therefore, by accepting the RSUs, the Participant understands and agrees that the Corporation is authorized to, and may in its sole discretion, instruct its designated broker to assist with the mandatory sale of shares of Common Stock (on the Participant’s behalf pursuant to this authorization) and that the Participant expressly authorizes the Corporation’s designated broker to complete the sale of such shares of Common Stock. The Participant acknowledges that the Corporation’s designated broker is under no obligation to arrange for the sale of the shares of Common Stock at any particular price. Upon the sale of the shares of Common Stock, the proceeds, less any Tax-Related Items and brokerage fees or commissions will be remitted to the Participant pursuant to the procedures described in the “Exchange Control Information” section below.

Exchange Control Information

Shares of Common Stock issued to the Participant under the Plan must be maintained in an account with Merrill Lynch or such other broker as may be designated by the Corporation until the shares of Common Stock are sold through that broker. If the Corporation changes its broker, the Participant acknowledges and agrees that the Corporation may transfer any shares of Common Stock issued under the Plan to the new designated broker if necessary for legal or administrative reasons. The Participant agrees to sign any documentation necessary to facilitate the transfer. In addition, the Participant may be required to sell any shares of Common Stock obtained under the Plan if the Corporation determines that the application of such condition is necessary or advisable for China SAFE exchange control, legal or other administrative reasons.
The Participant understands and agrees that, to facilitate compliance with exchange control requirements, the Participant will be required to immediately repatriate to China the cash proceeds from the sale of shares of Common Stock acquired upon vesting of the RSUs or from any dividends or dividend equivalents paid on the shares of Common Stock. The Participant further understands that, under local law, such repatriation of the cash proceeds will be effectuated through a special exchange control account established by the Corporation or one of its Affiliates in China, and the Participant hereby consents and agrees that the cash proceeds related to the Participant's participation in the Plan may be transferred to such special account prior to being delivered to the Participant. The Corporation may deliver the proceeds to the Participant in U.S. dollars or local currency at the Corporation's discretion. If the proceeds are paid in U.S. dollars, the Participant understands that he or she will be required to set up a U.S. dollar bank account in China so that the proceeds may be deposited into this account. If the proceeds are converted to local currency, there may be delays in delivering the proceeds to the Participant. The Participant agrees to bear the risk of any currency fluctuation between the time the shares of Common Stock are sold, either through voluntary sale or through a mandatory sale arranged by the Corporation, or proceeds are otherwise realized under the Plan and the time such proceeds are distributed to the Participant through the special exchange control account.
The Participant further agrees to comply with any other requirements that may be imposed by the Corporation in the future to facilitate compliance with exchange control requirements in China.
COLOMBIA
Securities Law Information
The shares of Common Stock are not and will not be registered in the Colombian registry of publicly traded securities (Registro Nacional de Valores y Emisores) and therefore the shares of Common Stock may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia. An offer of shares of Common Stock to employees will not be considered a public offer provided that it meets the conditions set forth in Article 6.1.1.1.1 in Decree 2555,2010. In the event that the




Corporation, in its sole discretion, determines that the offer of the Awards in Colombia may constitute a “public offer of securities”, the Participant understands and agrees that the Corporation may, in its sole discretion, cease to offer participation in the Plan in Colombia. In the event that the Corporation exercises its discretion to cease offering the Plan in Colombia, the Participant will no longer be permitted to participate in the Plan as of the date established by the Corporation.
Exchange Control Information
Colombian residents must register shares of Common Stock acquired under the Plan, regardless of value, with the Central Bank of Colombia (Banco de la República) as foreign investment held abroad. In addition, the liquidation of such investments must be transferred through the Colombian foreign exchange market (e.g. local banks), which includes the obligation of correctly completing and filing the appropriate foreign exchange form (declaración de cambio). The Participant is responsible for complying with applicable exchange control requirements in Colombia.
Foreign Asset/Account Reporting Information
The Participant must file an informative return with the Colombian Tax Office detailing any assets held abroad. If the individual value of any of these assets exceeds a certain threshold, the Participant must describe each asset and indicate the jurisdiction in which it is located, its nature and its value.
Acknowledgment of Conditions
The following provision supplements the Acknowledgment of Conditions section of the Award Agreement:
The Participant acknowledges that pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component of the Participant's “salary” for any legal purpose. To this extent, they will not be included for purposes of calculating any labor benefits, such as legal/fringe benefits, vacation, indemnities, payroll taxes, social insurance contributions and/or any other labor-related amount which may be payable.

COSTA RICA

There are no country-specific provisions.

CZECH REPUBLIC

Exchange Control Information

The Czech National Bank may require the Participant to fulfill certain notification duties in relation to the acquisition of shares of Common Stock and the opening and maintenance of a foreign account (e.g., may be required to report foreign direct investment, financial credits from abroad, investment in foreign securities, and associated collections and payments). However, because exchange control regulations change frequently and without notice, the Participant should consult with his or her personal legal advisor prior to the vesting of the RSUs and the sale of Common Stock to ensure compliance with current regulations. It is the Participant’s responsibility to comply with any applicable Czech exchange control laws.

DOMINICAN REPUBLIC

There are no country-specific provisions.

ECUADOR

There are no country-specific provisions.





EL SALVADOR

There are no country-specific provisions.

FRANCE

RSUs Not Tax-Qualified

The Participant understands that this Award is not intended to be French tax-qualified.

Consent to Receive Information in English

By accepting the Award Agreement providing for the terms and conditions of the Participant’s grant, the Participant confirms having read and understood the documents relating to this grant (the Plan and this Award Agreement) which were provided in English language. The Participant accepts the terms of those documents accordingly.

En acceptant le Contrat d'Attribution décrivant les termes et conditions de l’attribution, le participant confirme ainsi avoir lu et compris les documents relatifs à cette attribution (le Plan U.S. et ce Contrat d'Attribution) qui ont été communiqués en langue anglaise. Le participant accepte les termes en connaissance de cause.

Foreign Asset/Account Reporting Information

French residents holding shares of Common Stock outside of France or maintaining a foreign bank account are required to report such to the French tax authorities when filing their annual tax returns, including any accounts that were closed during the year. Further, failure to comply could trigger significant penalties.

GERMANY

Exchange Control Information

Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank. No report is required for payments less than €12,500. In case of payments in connection with securities (including proceeds realized upon the sale of shares of Common Stock), the report must be made by the 5th day of the month following the month in which the payment was received. Effective from September 2013, the report must be filed electronically. The form of report (“Allgemeine Meldeportal Statistik”) can be accessed via the Bundesbank’s website (www.bundesbank.de) and is available in both German and English. The Participant is responsible for satisfying the reporting obligation.

Foreign Asset/Account Reporting Information

If the Participant’s acquisition of shares of Common Stock leads to a so-called qualified participation at any point during the calendar year, the Participant will need to report the acquisition when he or she files a tax return for the relevant year. A qualified participation occurs only if (i) the Participant owns 1% or more of the Corporation and the value of the shares of Common Stock exceeds €150,000 or (ii) the Participant holds shares of Common Stock exceeding 10% of the Corporation’s total Common Stock.





GUATEMALA

Language Waiver

By participating in the Plan, the Participant acknowledges that he or she is proficient in reading and understanding English and fully understands the terms of the Plan, or, alternatively, that the Participant will seek appropriate assistance to understand the terms and conditions in the Award Agreement and this Appendix A.

HONDURAS

There are no country-specific provisions.

HONG KONG

Securities Law Warning

The offer of this Award and the shares of Common Stock subject to this Award do not constitute a public offering of securities under Hong Kong law and are available only to employees of the Corporation or its Affiliates participating in the Plan. The Participant should be aware that the Plan, the Plan prospectus and the contents of this Award Agreement (i) have not been prepared in accordance with and are not intended to constitute a “prospectus” for a public offering of securities under the applicable securities legislation in Hong Kong, (ii) have not been reviewed by any regulatory authority in Hong Kong, and (iii) are intended only for the personal use of each Participant and may not be distributed to any other person. The Participant is advised to exercise caution in relation to the offer. If the Participant is in any doubt about any of the contents of the Award Agreement, including this Appendix A, or the Plan, the Participant should obtain independent professional advice.

Award Payable Only in Shares

Awards granted to Participants in Hong Kong shall be paid in shares of Common Stock only and do not provide any right for the Participant to receive a cash payment.
Sale of Shares

In the event the Award vests within six months of the Grant Date, the Participant agrees that he or she will not offer to the public or otherwise dispose of the shares acquired prior to the six-month anniversary of the Grant Date. Any shares of Common Stock acquired under the Plan are accepted as a personal investment.

INDIA

Awards Payable in Cash Only

Notwithstanding anything in the Award Agreement, Awards granted to Participants in India do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.

ISRAEL

Securities Law Information

The offer of this Award does not constitute a public offering under Securities Law, 1968.





Broker Designation

Shares of Common Stock issued to the Participant under the Plan must be maintained in an account with Merrill Lynch or such other broker as may be designated by the Corporation until the shares of Common Stock are sold through that broker.

Restricted from Online Brokerage Transactions

The Participant acknowledges and agrees that he or she will be restricted from online brokerage account transactions the Corporation’s designated broker. Therefore, by accepting the Awards, the Participant understands and agrees that the Participant will call the Corporation’s designated broker to initiate any sale or transfer of any shares of Common Stock issued to him or her upon vesting of the Awards. The Participant acknowledges that the Corporation’s designated broker is under no obligation to arrange for the sale of the shares of Common Stock at any particular price.

ITALY

Plan Document Acknowledgment

In accepting the grant of this Award, the Participant acknowledges that he or she has received a copy of the Plan and the Award Agreement and has reviewed the Plan and the Award Agreement, including this Appendix A, in their entirety and fully understands and accepts all provisions of the Plan and the Award Agreement, including this Appendix A.

The Participant acknowledges that he or she has read and specifically and expressly approves the following sections of the Award Agreement: Section 2(g) on Payment of Withholding Taxes; Section 5 on No Right of Continued Employment; Section 8 on Delaware Law to Govern; the section on Acknowledgment of Conditions; and the Data Privacy Notice section included in this Appendix A.

Foreign Asset/Account Reporting Information

Italian residents who, at any time during the fiscal year, hold foreign financial assets (including cash and shares of Common Stock) which may generate income taxable in Italy are required to report these assets on their annual tax returns (UNICO Form, RW Schedule) for the year during which the assets are held, or on a special form if no tax return is due. These reporting obligations will also apply to Italian residents who are the beneficial owners of foreign financial assets under Italian money laundering provisions.

Foreign Asset Tax Information

The value of financial assets held outside of Italy (including shares of Common Stock) by Italian residents is subject to a foreign asset tax. The taxable amount will be the fair market value of the financial assets (e.g., shares of Common Stock acquired under the Plan) assessed at the end of the calendar year.

KAZAKHSTAN

Securities Law Notification

This offer is addressed only to certain eligible employees in the form of the shares of Common Stock to be issued by the Corporation. Neither the Plan nor the Award Agreement has been approved, nor do they need to be approved, by the National Bank of Kazakhstan. This offer is intended only for the original recipient and is not for general circulation in the Republic of Kazakhstan.





Exchange Control Information

Residents of Kazakhstan may be required to notify the National Bank of Kazakhstan when they acquire shares of Common Stock under the Plan if the value of such shares of Common Stock exceeds US$100,000.

Please note that the exchange control regulations in Kazakhstan are subject to change. The Participant should consult with his or her personal legal advisor regarding any exchange control obligations that the Participant may have prior to vesting or receiving proceeds from the sale of shares of Common Stock acquired under the Plan. The Participant is responsible for ensuring compliance with all exchange control laws in Kazakhstan.

KENYA

Tax Registration Notification

Under Tax Procedure Act, 2015, the Participant is required to complete and submit a tax registration application to the Commissioner of Income Tax with 30 days of first vesting of the RSUs. The registration should be completed through the online portal “I TAX” and is a one-time only registration. The Participant is solely responsible for ensuring compliance with all registration requirements in Kenya.

KOREA

Awards Payable in Cash Only

Notwithstanding anything in the Award Agreement, Awards granted to Participants in Korea do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.

MALAYSIA

Data Privacy Notice
This provision replaces in its entirety the data privacy section in the Acknowledgment of Conditions section of the Award Agreement:
The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant's personal data as described in this Award Agreement by and among, as applicable, the Participant's Employer, the Corporation, and its other Affiliates for the exclusive purpose of implementing, administering and managing the Participant's participation in the Plan.
The Participant understands that the Corporation and the Participant's Employer may hold certain personal information about the Participant, including, but not limited to, the Participant's name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of Common Stock or directorships held in the Corporation, details of all Awards or any other entitlement to shares awarded, canceled, vested, unvested or outstanding in the Participant's favor (“Data”), for the purpose of implementing, administering and managing the Plan.
The Participant understands that Data will be transferred to Merrill Lynch, or such other stock plan service provider as may be selected by the Corporation in the future, which is assisting the Corporation with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant's country. The Participant




understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative LiLin.Ng@kcc.com at telephone number 603 78068288. The Participant authorizes the Corporation, Merrill Lynch and any other possible recipients which may assist the Corporation (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Participant's participation in the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant's participation in the Plan. The Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative. Further, the Participant understands that he or she is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or later seeks to revoke his or her consent, the Participant's employment status or service and career with the Employer will not be affected; the only consequence of refusing or withdrawing consent is that the Corporation would not be able to grant the Participant RSUs or other equity awards or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing consent may affect the Participant's ability to participate in the Plan. For more information on the consequences of the Participant's refusal to consent or withdrawal of consent, the Participant understands that he or she may contact his or her local human resources representative.
Malaysian Translation:
Peserta dengan ini secara eksplisit dan tanpa sebarang keraguan mengizinkan pengumpulan, penggunaan dan pemindahan, dalam bentuk elektronik atau lain-lain, data peribadi Peserta seperti yang diterangkan dalam Perjanjian Penganugerahan dan apa-apa bahan geran opsyen lain oleh dan di antara, seperti mana yang terpakai, Majikan, Syarikat dan Anak-Anak Syarikat Sekutunya untuk tujuan ekslusif bagi melaksanakan, mentadbir dan menguruskan penyertaan peserta dalam Pelan.
Peserta memahami bahawa Syarikat dan Majikan mungkin memegang maklumat peribadi tertentu tentang Peserta , termasuk, tetapi tidak terhad kepada, nama Peserta , alamat rumah dan nombor telefon, tarikh lahir, nombor insurans sosial atau nombor pengenalan lain, gaji, kewarganegaraan, jawatan, apa-apa syer dalam saham atau jawatan pengarah yang dipegang di Syarikat, butir-butir semua opsyen atau apa-apa hak lain atas syer dalam saham biasa yang dianugerahkan, dibatalkan, dilaksanakan, terletak hak, tidak diletak hak ataupun yang belum dijelaskan bagi faedah Peserta ("Data"), untuk tujuan eksklusif bagi melaksanakan, mentadbir dan menguruskan Pelan.
Peserta memahami bahawa Data akan dipindahkan kepada Merrill Lynch, atau pembekal perkhidmatan pelan saham yang mungkin ditetapkan oleh Syarikat pada masa depan yang membantu Syarikat dengan pelaksanaan, pentadbiran dan pengurusan Pelan. Peserta memahami bahawa penerim a-penerima Data mungkin berada di Amerika Syarikat atau mana-mana tempat lain dan bahawa negara penerima-penerima (contohnya di Amerika Syarikat) mungkin mempunyai undang-undang privasi data dan perlindungan yang berbeza daripada negara Peserta. Peserta memahami bahawa Peserta boleh meminta satu senarai yang mengandungi nama dan alamat penerima-penerima Data yang berpotensi dengan menghubungi wakil sumber manusia tempatan Peserta LiLin.Ng@kcc.com, T: 603 78068288. Peserta memberi kuasa kepada Syarikat, Merrill Lynch dan mana-mana penerima-penerima lain yang mungkin membantu Syarikat (pada masa sekarang atau pada masa depan) dengan melaksanakan, mentadbir dan menguruskan Pelan untuk menerima, memiliki, menggunakan, mengekalkan dan memindahkan Data, dalam bentuk elektronik atau lain-lain, semata-mata dengan tujuan untuk melaksanakan, mentadbir dan menguruskan penyertaan Peserta dalam Pelan. Peserta memahami bahawa Data hanya akan disimpan untuk tempoh yang perlu bagi melaksanakan, mentadbir, dan menguruskan penyertaan Peserta dalam Pelan. Peserta memahami bahawa Peserta boleh, pada bila-bila masa, melihat Data, meminta maklumat tambahan mengenai penyimpanan dan pemprosesan Data, meminta bahawa pindaan-pindaan dilaksanakan ke atas Data atau menolak atau menarik balik persetujuan dalam ini, dalam mana-mana kes, tanpa kos, dengan menghubungi secara bertulis wakil sumber manusia tempatan Peserta . Peserta selanjutnya memahami bahawa Peserta memberi persetujuan ini secara sukarela. Sekiranya Peserta tidak bersetuju, atau kemudian membatalkan persetujuan Peserta , status




pekerjaan atau perkhidmatan dan kerjaya Peserta dengan Majikan tidak akan terjejas; satunya akibat jika Peserta tidak bersetuju atau menarik balik persetujuan Peserta adalah bahawa Syarikat tidak akan dapat menganugerahkan kepada RSUs atau anugerah ekuiti lain atau mentadbir atau mengekalkan anugerah tersebut. Oleh itu, Peserta memahami bahawa keengganan atau penarikan balik persetujuan Peserta boleh menjejaskan keupayaan Peserta untuk mengambil bahagian dalam Pelan. Untuk maklumat lanjut mengenai akibat keengganan Peserta untuk memberikan keizinan atau penarikan balik keizinan, Peserta boleh menghubungi wakil sumber manusia tempatan.
Director Notification Obligation
If the Participant is a director of the Corporation’s Malaysian Affiliate, the Participant is subject to certain notification requirements under the Malaysian Companies Act. Among these requirements is an obligation to notify the Malaysian Affiliate in writing when the Participant receives or disposes of an interest (e.g., an Award or shares) in the Corporation or any related company. Such notifications must be made within 14 days of receiving or disposing of any interest in the Corporation or any related company.
MEXICO

Modification

By accepting the Award, the Participant understands and agrees that any modification of the Plan or the Award Agreement or its termination shall not constitute a change or impairment of the terms and conditions of employment.

Acknowledgment of the Grant

In accepting the Award, the Participant acknowledges that the Participant has received a copy of the Plan and the Award Agreement, including this Appendix A, has reviewed the Plan and the Award Agreement, including this Appendix A, in their entirety and fully understands and accepts all provisions of the Plan and the Award Agreement, including this Appendix A. The Participant further acknowledges that the Participant has read and specifically and expressly approves the Acknowledgment of Conditions section of the Award Agreement, in which the following is clearly described and established:

(1)    The Participant’s participation in the Plan does not constitute an acquired right.
(2)    The Plan and the Participant’s participation in the Plan are offered by the Corporation on a wholly discretionary basis.
(3)    The Participant’s participation in the Plan is voluntary.
(4)    Neither the Corporation nor any Affiliates are responsible for any decrease in the value of the Award granted and/or shares of Common Stock issued under the Plan.

Labor Acknowledgment and Policy Statement

In accepting the grant of this Award, the Participant expressly recognizes that the Corporation, with registered offices at 351 Phelps Drive, Irving, Texas 75038, U.S.A., is solely responsible for the administration of the Plan and that the Participant’s participation in the Plan and acquisition of shares of Common Stock do not constitute an employment relationship between the Participant and the Corporation since the Participant is participating in the Plan on a wholly commercial basis and his or her sole Employer is K-C AFC Manufacturing S. de R.L. de C.V. (“KCC-Mexico”). Based on the foregoing, the Participant expressly recognizes that the Plan and the benefits that he or she may derive from participating in the Plan do not establish any rights between the Participant and the Employer, KCC-Mexico and do not form part of the employment conditions and/or benefits provided by KCC-Mexico, and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of the Participant’s employment.





The Participant further understands that his or her participation in the Plan is as a result of a unilateral and discretionary decision of the Corporation; therefore, the Corporation reserves the absolute right to amend and/or discontinue the Participant’s participation at any time without any liability to the Participant.

Finally, the Participant hereby declares that he or she does not reserve to him- or herself any action or right to bring any claim against the Corporation for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and the Participant therefore grants a full and broad release to the Corporation, its Affiliates, branches, representation offices, its shareholders, officers, agents, or legal representatives with respect to any claim that may arise.

Spanish Translation

Modificación

Al aceptar el Premio, el Participante entiende y acuerda que cualquier modificación al Plan o al Acuerdo o su terminación, no cambiará o disminuirá los términos y condiciones de empleo.

Reconocimiento del Otorgamiento

Al aceptar el Premio, el Participante está de acuerdo en haber recibido una copia del Plan, del Acuerdo incluyendo el presente Anexo “A” y ha revisado el Plan y el Acuerdo, incluyendo este Anexo “A” en su totalidad y comprende y acepta todas las disposiciones previstas en el Plan, en el Acuerdo, incluyendo el presente Anexo “A”. Asimismo, el Participante reconoce que ha leído y manifiesta su específica y expresa conformidad con los términos y condiciones establecidos del Acuerdo, en el cual claramente se describe y establece lo siguiente:

(1)    La participación del Participante en el Plan no constituye un derecho adquirido.
(2)    El Plan y la participación del Participante en el Plan se ofrecen por la Compañía de forma completamente discrecional.
(3)    La participación del Participante en el Plan es voluntaria.
(4)    Ni la Compañía ni sus Afiliadas son responsables por la reducción del valor del Premio y/o Acciones Ordinarias emitidas bajo el Plan.

Reconocimiento de la Legislación Laboral y Declaración de la Política

Al aceptar el otorgamiento de este Premio, el Participante expresamente reconoce que Kimberly-Clark Corporación con oficinas registradas en 351 Phelps Drive, Irving, Texas 75038, EE.UU., es la única responsable por la administración del Plan y que la participación del Participante en el Plan y en su caso la adquisición de las Opciones de Compra de Acciones o Acciones no constituyen ni podrán interpretarse como una relación de trabajo entre el Participante y Kimberly-Clark Corporación, ya que el Participante participa en el Plan en un marco totalmente comercial y su único Patrón lo es K-C AFC Manufacturing S. de R.L. de C.V. (“KCC-Mexico”). Derivado de lo anterior, el Participante expresamente reconoce que el Plan y los beneficios que pudieran derivar de la participación en el Plan no establecen derecho alguno entre el Participante y el Patrón, KCC-Mexico y no forma parte de las condiciones de trabajo y/o las prestaciones otorgadas por KCC-Mexico y que cualquier modificación al Plan o su terminación no constituye un cambio o impedimento de los términos y condiciones de la relación de trabajo del Participante.

Asimismo, el Participante reconoce que su participación en el Plan es resultado de una decisión unilateral y discrecional de Kimberly-Clark Corporación por lo tanto, Kimberly-Clark Corporación se reserva el absoluto derecho de modificar y/o terminar la participación del Participante en cualquier momento y sin responsabilidad alguna frente el Participante.

Finalmente, el Participante por este medio declara que no se reserva derecho o acción alguna que ejercitar en contra de Kimberly-Clark Corporación por cualquier compensación o daño en relación con las disposiciones del Plan o de los beneficios derivados del Plan y por lo tanto, el Participante otorga el más amplio finiquito que en




derecho proceda a Kimberly-Clark Corporación, sus afiliadas, subsidiarias, oficinas de representación, sus accionistas, funcionarios, agentes o representantes legales en relación con cualquier demanda que pudiera surgir.

Securities Law Notification
The RSUs and the shares of Common Stock offered under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the Plan, the Award Agreement and any other document relating to the RSUs may not be publicly distributed in Mexico. These materials are addressed to the Participant only because of their existing relationship with the Corporation and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Mexican subsidiary of the Corporation made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.

NETHERLANDS

There are no country-specific provisions

NEW ZEALAND

Securities Law Information

The Participant is being offered RSUs which, if vested, will entitle the Participant to acquire shares of Common Stock in accordance with the terms of the Award Agreement and the Plan. The shares of Common Stock, if issued, will give the Participant a stake in the ownership of the Corporation. The Participant may receive a return if dividends are paid.

If the Corporation runs into financial difficulties and is wound up, the Participant will be paid only after all creditors and holders of preferred shares (if any) have been paid. The Participant may lose some or all of the Participant’s investment, if any.

New Zealand law normally requires people who offer financial products to give information to investors before they invest. This information is designed to help investors to make an informed decision. The usual rules do not apply to this offer because it is made under an employee share scheme. As a result, the Participant may not be given all the information usually required. The Participant will also have fewer other legal protections for this investment. The Participant is advised to ask questions, read all documents carefully, and seek independent financial advice before committing.

The shares of Common Stock are quoted on the New York Stock Exchange (“NYSE”). This means that if the Participant acquires shares of Common Stock under the Plan, the Participant may be able to sell the shares of Common Stock on the NYSE if there are interested buyers. The Participant may get less than the Participant invested. The price will depend on the demand for the shares of Common Stock.

For a copy of the Corporation’s most recent financial statements (and, where applicable, a copy of the auditor’s report on those financial statements), as well as information on risk factors impacting the Corporation’s business that may affect the value of the shares pf Common Stock, the Participant should refer to the risk factors discussion on the Corporation’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available online at www.sec.gov, as well as on the Corporation’s “Investor Relations” website at http://investor.kimberly-clark.com/index.cfm.

NIGERIA

There are no country-specific provisions.





PANAMA

Securities Law Information

Neither this Award nor any shares of Common Stock that the Participant may acquire at vesting of this Award constitute a public offering of securities, as they are available only to eligible employees of the Corporation and its Affiliates.

PARAGUAY

There are no country-specific provisions.

PERU

Securities Law Information

The offer of this Award is considered a private offering in Peru; therefore, it is not subject to registration in Peru. For more information concerning the offer, please refer to the Plan, the Award Agreement and any other materials or documentation made available by the Corporation. For more information regarding the Corporation, please refer to the Corporation’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available at www.sec.gov, as well as the Corporation’s “Investor Relations” website at: http://investor.kimberly-clark.com/

Labor Law Acknowledgment

By accepting the Award, the Participant acknowledges that the RSUs are being granted ex gratia to the Participant.

PHILIPPINES

Awards Payable in Cash Only

Notwithstanding anything in the Award Agreement, Awards granted to Participants in the Philippines do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash in an amount equal to the value of the shares of Common Stock at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.

Fringe Benefit Tax Obligation

By accepting the Award, the Participant consents and agrees to assume any and all liability for fringe benefit tax that may be payable by the Corporation and/or the Employer (as determined by the Corporation or the Employer in their discretion) in connection with the Award and any awards previously granted by the Corporation. Further, by accepting the Award, the Participant agrees that the Corporation and/or the Employer may collect the fringe benefit tax from the Participant by any of the means set forth in the Acknowledgment of Conditions section of the Award Agreement, or any other reasonable method established by the Corporation. The Participant agrees to execute other consents or elections to accomplish the foregoing, promptly upon request by the Corporation or the Employer.





POLAND

Foreign Asset/Account Reporting Information
Polish residents holding foreign securities (e.g., shares of Common Stock) and/or maintaining accounts abroad must report information to the National Bank of Poland on transactions and balances regarding such securities and cash deposited in such accounts if the value of such securities and cash (when combined with all other assets possessed abroad) exceeds certain thresholds. If required, the reports must be filed on a quarterly basis on special forms that are available on the website of the National Bank of Poland. Polish residents should consult with their personal tax advisor to determine their personal reporting obligations.

Exchange Control Information
Transfers of funds into and out of Poland in excess of €15,000 (or PLN 15,000 if such transfer of funds is connected with business activity of an entrepreneur) must be made via a bank account held at a bank in Poland. Additionally, Polish residents are required to store all documents connected with any foreign exchange transactions that Polish residents are engaged in for a period of five years, as measured from the end of the year in which such transaction occurred.
PUERTO RICO

There are no country specific provisions.

RUSSIA
Settlement of RSUs 
Depending on applicable restrictions then in effect, the Corporation has the sole discretion to postpone the vesting and/or settlement of any RSUs, to determine whether to settle any vested RSUs in shares of Common Stock or in cash, or to cancel such RSUs for no consideration. 
Securities Law Information
This Award Agreement, the Plan and all other materials the Participant may receive regarding participation in the Plan do not constitute advertising or an offering of securities in Russia. Absent any requirement under local law, the issuance of shares of Common Stock under the Plan has not and will not be registered in Russia and hence the shares described in any Plan-related documents may not be offered or placed in public circulation in Russia.
US Transaction
The Participant understands that the RSUs and any shares of Common Stock under the Plan are to be issued and sold solely in the United States. Any shares of Common Stock issued to the Participant upon vesting of the RSUs shall be delivered to the Participant’s brokerage account in the United States, where such shares of Common Stock must be held until the time of sale. In no event will shares of Common Stock be delivered to the Participant in Russia.
Exchange Control Information
All restrictions on the payment of funds by non-residents into a Russian resident’s declared foreign brokerage account, including dividends and proceeds from the sale of shares of Common Stock have been abolished. Russian residents may now receive, hold and remit dividends and proceeds from the sale of shares (including shares of Common Stock acquired under the Plan) into and out of a brokerage account without any requirement to first repatriate such funds to an authorized bank in Russia. The Participant should be aware that the rules related to foreign bank accounts are different and that certain restrictions with respect to payments by non-residents into a




Russian currency resident’s foreign bank account may continue to apply where the foreign bank account is located in the U.S. The Participant should contact his or her personal advisor to confirm the application of the exchange control restrictions prior to vesting in the RSUs and selling shares of Common Stock, as significant penalties may apply in the case of non-compliance with the exchange control restrictions and because such exchange control restrictions are subject to change.
Foreign Asset/Account Reporting Information
Russian residents are required to report the opening, closing or change in account details of any foreign bank account to the Russian tax authorities within one month of the opening, closing or change of such account. Russian residents are also required to report to the Russian tax authorities on or before June 1 of the following year (i) the beginning and ending balances in a foreign bank account each year and (ii) transactions related to such foreign account during the year. Foreign brokerage accounts and foreign accounts with other financial institutions (financial market organizations) must also be reported. Certain specific exemptions from reporting requirements may apply. Non-compliance with the reporting obligations could impact the Participant's ability to vest, receive shares of Common Stock pursuant to the RSUs, maintain the account outside of Russia and participate in the Plan. The Participant should consult with his or her personal legal advisor to determine how these reporting requirements may apply to any account opened in connection with the Participant’s participation in the Plan.
Data Privacy Notice
This provision supplements the Data Privacy section in the Acknowledgment and Conditions section of the Award Agreement:
The Participant understands and agrees that he or she must complete and return a Consent to Processing of Personal Data (the “Consent”) form to the Corporation if requested. Further, the Participant understands and agrees that if the Participant does not complete and return a Consent form to the Corporation if requested, the Corporation will not be able to grant RSUs to the Participant or other awards or administer or maintain such awards. Therefore, the Participant understands that refusing to complete a Consent form or withdrawing his or her consent may affect the Participant’s ability to participate in the Plan.
Anti-Corruption Information
Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (e.g., shares of foreign companies such as the Corporation). Accordingly, the Participant should inform the Corporation if he or she is covered by these laws because the Participant should not hold shares of common stock acquired under the Plan.
Labor Law Information
If the Participant continues to hold shares of Common Stock acquired at vesting of the RSUs after an involuntary termination of employment, he or she may not be eligible to receive unemployment benefits in Russia.
SAUDI ARABIA

Securities Law Information.
This document may not be distributed in the Kingdom except to such persons as are permitted under the Rules on the Offer of Securities and Continuing Obligations issued by the Capital Market Authority.
The Capital Market Authority does not make any representation as to the accuracy or completeness of this document, and expressly disclaims any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this document. Prospective purchasers of the securities offered hereby should conduct their own due




diligence on the accuracy of the information relating to the securities. If the Participant does not understand the contents of this document, the Participant should consult an authorized financial adviser.
SINGAPORE
Sale Restriction
The Participant agrees that any shares of Common Stock acquired pursuant to the RSUs will not be offered for sale in Singapore prior to the six-month anniversary of the Grant Date, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”), or pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA.
Securities Law Information
The grant of the RSUs is being made pursuant to the “Qualifying Person” exemption” under section 273(1)(f) of the SFA under which it is exempt from the prospectus and registration requirements and is not made with a view to the underlying shares of Common Stock being subsequently offered for sale to any other party. The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore.
Director Notification Obligation
If the Participant is a director, associate director or shadow director of the Corporation’s Singapore Affiliate, the Participant is subject to certain notification requirements under the Singapore Companies Act (Cap. 50, Rev Ed 2006). Among these requirements is an obligation to notify the Corporation’s Singapore Affiliate in writing when the Participant receives an interest (e.g., an Award or shares) in the Corporation or any Affiliate. In addition, the Participant must notify the Corporation’s Singapore Affiliate when he or she sells shares of the Corporation or of any Affiliate (including when the Participant sells shares issued upon vesting and settlement of the Award). These notifications must be made within two business days of (i) acquiring or disposing of any interest in the Corporation or any Affiliate, or (ii) any change in a previously-disclosed interest (e.g., upon vesting of the Award or when shares of Common Stock acquired under the Plan are subsequently sold). In addition, a notification of the Participant’s interests in the Corporation or any Affiliate must be made within two business days of becoming a director, associate director or shadow director.
SLOVAK REPUBLIC
Foreign Asset/Account Reporting Information

If the Participant permanently resides in the Slovak Republic and, apart from being employed, carries on business activities as an independent entrepreneur (in Slovakian, podnikatel), the Participant will be obligated to report his or her foreign assets (including any foreign securities) to the National Bank of Slovakia (provided that the value of the foreign assets exceeds an amount of €2,000,000). These reports must be submitted on a monthly basis by the 15th day of the respective calendar month, as well as on a quarterly basis by the 15th day of the calendar month following the respective calendar quarter, using notification form DEV (NBS) 1-12, which may be found at the National Bank of Slovakia’s website at www.nbs.sk.
SOUTH AFRICA

Tax Acknowledgment

By accepting the Award, the Participant agrees to notify the Employer of the amount of any gain realized upon vesting of the Award. If the Participant fails to advise the Employer of the gain realized upon vesting, the Participant may be liable for a fine. The Participant will be responsible for paying any difference between the actual tax liability and the amount withheld.





Exchange Control Information

To participate in the Plan, the Participant must comply with exchange control regulations and rulings (the “Exchange Control Regulations”) in South Africa.

Because the Exchange Control Regulations change frequently and without notice, the Participant understands that he or she should consult a legal advisor prior to the acquisition or sale of shares under the Plan to ensure compliance with current regulations. The Participant understands that it is his or her responsibility to comply with South African exchange control laws, and neither the Corporation nor the Employer will be liable for any fines or penalties resulting from failure to comply with applicable laws.

Securities Law Information

In compliance with South African securities law, the Participant acknowledges that the documents listed below are available for review at the addresses listed below:

1)The Corporation's most recent annual financial statements: http://investor.kimberly-clark.com/sec.cfm?DocType=Annual&Year=

2)The Corporation's most recent Plan prospectus may be accessed online through Merrill Lynch, or such other stock plan service provider as may be selected by the Corporation in the future, at www.mybenefits.ml.com in the Document Library.

A copy of the above documents will be sent free of charge upon written request to Stock Plan Administrator, P.O. Box 619100, Dallas, Texas 75261-9100. In addition, the Participant should contact his or her tax advisor for specific information concerning his or her personal tax situation with regard to Plan participation.

SPAIN

Securities Law Information
No “offer of securities to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of the Award. The Award Agreement (including this Appendix A) has not been, nor will it be, registered with the Comisión Nacional del Mercado de Valores, and does not constitute a public offering prospectus.

Labor Law Acknowledgment

By accepting the Award, the Participant acknowledges that he or she understands and agrees to participation in the Plan and that he or she has received a copy of the Plan.

The Participant understands that the Corporation has unilaterally, gratuitously and discretionally decided to grant Awards under the Plan to individuals who may be employees of the Corporation or its Affiliates throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Corporation or any of its Affiliates on an ongoing basis. Consequently, the Participant understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Corporation or any of its Affiliates) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. Further, the Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from any gratuitous and discretionary grant since the future value of the Award and the underlying shares is unknown and unpredictable. In addition, the Participant understands that this grant would not be made but for the assumptions and conditions referred to above; thus, the Participant understands, acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then the Award shall be null and void.




Further, the Participant understands that the Award is a conditional right. Participant shall forfeit any unvested Award upon termination of employment unless such termination is (i) due to a Qualified Termination of Employment, or (ii) due to death, Total and Permanent Disability, or the shutdown or divestiture of a business unit. Vesting will cease, for example, regardless of whether (1) the Participant is considered to be unfairly dismissed without good cause (i.e., subject to a “despido improcedente”); (2) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal; (3) the Participant terminates his or her employment or service relationship due to a change of work location, duties or any other employment or contractual condition; and (4) the Participant terminates his or her employment or service relationship due to a unilateral breach of contract by the Corporation or an Affiliate. Consequently, upon termination of the Participant’s employment or service relationship for any of the above reasons, the Participant may automatically lose any rights to the RSUs that were not vested on the date of termination of the Participant’s employment or service relationship, as described in the Plan and the Award Agreement.
Exchange Control Information
If the Participant holds 10% or more of the Corporation’s share capital, the Participant must declare the acquisition, ownership and disposition of shares of Common Stock to the Spanish Dirección General de Comercio e Inversiones (the “DGCI”) of the Ministry of Economy and Competitiveness.
In addition, the Participant may be required to declare electronically to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), any foreign instruments (including any shares of Common Stock acquired under the Plan) and any transactions with non-Spanish residents (including any payments of shares of Common Stock made to the Participant by the Corporation) depending on the value of such accounts and instruments and the amount of the transactions during the relevant year as of December 31 of the relevant year.
Foreign Asset/Account Reporting Information
If the Participant holds rights or assets (e.g., shares of Common Stock or cash held in a bank or brokerage account) outside of Spain with a value in excess of €50,000 per type of right or asset (e.g., shares of Common Stock, cash, etc.) as of December 31 each year, the Participant is required to report certain information regarding such rights and assets on tax form 720.  After such rights and/or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than €20,000 or if the ownership of the assets is transferred or relinquished during the year.  The reporting must be completed by the following March 31. 
SWITZERLAND

Securities Law Information

Neither this document nor any other materials relating to the Awards (i) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (“FinSA”) (ii) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than a participant or (iii) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (“FINMA”).

TAIWAN

Data Privacy

The following provision supplements the data privacy section in the Acknowledgment of Conditions section of the Award Agreement:

The Participant acknowledges that he or she has read and understands the terms regarding collection, processing and transfer of data contained in the Acknowledgment of Conditions section of the Award Agreement and, by




participating in the Plan the Participant agrees to such terms. In this regard, upon request of the Corporation or the Employer, the Participant agrees to provide any executed data privacy consent form to the Employer or the Corporation (or any other agreements or consents that may be required by the Employer or the Corporation) that the Corporation and/or the Employer may deem necessary to obtain under the data privacy laws now or in the future. The Participant understands that he or she will not be able to participate in the Plan if the Participant fails to execute any such consent or agreement.

Securities Law Information

The offer of participation in the Plan is available only for employees of the Corporation and its Affiliates. The offer of participation in the Plan is not a public offer of securities by a Taiwanese company.

Exchange Control Information

Taiwanese residents may acquire and remit foreign currency (including proceeds from the sale of shares of Common Stock or the receipt of dividends) into and out of Taiwan up to US$5,000,000 per year. If the transaction amount is TWD500,000 or more in a single transaction, the Participant must submit a foreign exchange transaction form and also provide supporting documentation to the satisfaction of the remitting bank.

THAILAND
Exchange Control Information
If the proceeds from the sale of shares of Common Stock or the receipt of dividends paid on such shares are equal to or greater than US$1,000,000 in a single transaction, Thai residents must repatriate all cash proceeds to Thailand immediately following the receipt of the cash proceeds and then either convert such proceeds to Thai Baht or deposit the proceeds into a foreign currency account opened with a commercial bank in Thailand within 360 days of repatriation. In addition, Thai residents must specifically report the inward remittance to the Bank of Thailand on a foreign exchange transaction form.
Failure to comply with the above obligations may lead to penalties being assessed by the Bank of Thailand. Because exchange control regulations change frequently and without notice, the Participant should consult with his or her legal advisor before selling any shares of Common Stock (or receiving any other funds in connection with the Plan) to ensure compliance with current regulations. It is the Participant’s responsibility to comply with exchange control laws in Thailand and neither the Corporation nor the Employer will be liable for any fines or penalties resulting from failure to comply with applicable laws.

TURKEY

Securities Law Information

Turkish residents are not permitted to sell shares of Common Stock acquired under the Plan in Turkey. Turkish residents must sell the shares of Common Stock acquired under the Plan outside of Turkey. The Shares are currently traded on the New York Stock Exchange in the U.S. under the ticker symbol “KMB” and shares of Common Stock may be sold on this exchange.

Exchange Control Information

Under Turkish law, Turkish residents are permitted to purchase and sell securities or derivatives traded on exchanges abroad only through a financial intermediary licensed in Turkey.  Therefore, the Participant may be required to appoint a Turkish broker to assist him or her with the sale of the shares of Common Stock acquired under the Plan.  The Participant should consult his or her personal legal advisor before selling any shares of Common Stock acquired under the Plan to confirm the applicability of this requirement to the Participant.





UKRAINE

Awards Payable in Cash Only1

Notwithstanding anything in the Award Agreement, Awards granted to Participants in Ukraine do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to Participant through local payroll. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.

UNITED ARAB EMIRATES

Securities Law Information
The offer of the Award is available only for select employees of the Corporation and its Affiliates and is in the nature of providing employee incentives in the United Arab Emirates. The Plan and the Award Agreement are intended for distribution only to such employees and must not be delivered to, or relied on, by any other person. Prospective purchasers of securities should conduct their own due diligence.
The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the Plan and the Award Agreement, or any other incidental communication materials distributed in connection with the Award. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the Plan and the Award Agreement should obtain independent professional advice.

UNITED KINGDOM

Tax Acknowledgment

The following information supplements the information regarding Tax-Related Items in the Acknowledgment of Conditions section of the Award Agreement:

Without limitation to the information regarding Tax-Related Items in the Award Agreement, the Participant agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Corporation or, if different, the Employer or by HM Revenue & Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant agrees to indemnify and keep indemnified the Corporation and/or the Employer for all Tax-Related Items that they are required to pay, or withhold or have paid or will pay to HMRC on the Participant’s behalf (or any other tax authority or any other relevant authority) and authorizes the Corporation and/or the Employer to recover such amounts by any of the means referred to in the Acknowledgment of Conditions section of the Award Agreement.

Notwithstanding the foregoing, if the Participant is an executive officer or director (as within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), the Participant understands that he or she may not be able to indemnify the Corporation for the amount of any Tax-Related Items not collected from or paid by the Participant, if the indemnification could be considered a loan. In this case, the Tax-Related Items not collected or paid may constitute a benefit to the Participant on which additional income tax and National Insurance contributions (“NICs”) may be payable.

1 KCC discussing tax considerations with E&Y and will determine whether to share-settle. Please let Baker know so we can update if needed.




The Participant acknowledges that the Participant ultimately will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Corporation or the Employer (as appropriate) the amount of any NICs due on this additional benefit, which the Corporation and/or the Employer may also recover from the Participant at any time thereafter by any of the means referred to in the Acknowledgment of Conditions section of the Award Agreement.

URUGUAY

There are no country-specific provisions.

VIETNAM

Awards Payable in Cash Only

Notwithstanding anything in the Award Agreement, Awards granted to Participants in Vietnam do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant through local payroll. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.



EX-10.T 4 kimberly-clarkcorporationa.htm KMB ANNUAL TIME-VESTED RSU AWARD AGREEMENT (GRADED SCHEDULE) Document

Exhibit No. (10)t
KIMBERLY-CLARK CORPORATION
ANNUAL TIME-VESTED RESTRICTED STOCK UNIT
AWARD AGREEMENT
(Graded Schedule)


This Award, granted effective on __________ (the “Grant Date”), by Kimberly-Clark Corporation, a Delaware corporation (hereinafter called the “Corporation”), to ________________ (the “Participant”) is subject to the terms and conditions of the Kimberly-Clark Corporation 2021 Equity Participation Plan (the “Plan”) and the Award Agreement, including any country-specific terms and conditions contained in Appendix A to the Award Agreement.

W I T N E S S E T H:

WHEREAS, the Corporation has adopted the Plan to encourage those employees who materially contribute, by managerial, scientific or other innovative means, to the success of the Corporation or of an Affiliate, to acquire an ownership interest in the Corporation, thereby increasing their motivation for and interest in the Corporation's and its Affiliates' long-term success;

NOW, THEREFORE, it is agreed as follows:

1.    Number of Share Units Granted. The Corporation hereby grants to the Participant the right to receive all or any part of ________ Annual Time-Vested Restricted Stock Units (“RSUs”) of the $1.25 par value Common Stock of the Corporation, subject to the terms, conditions and restrictions set forth herein and in the Plan.

2.    Transferability Restrictions.

(a)    Restricted Period. During the Restricted Period, the Participant may not sell, assign, transfer, or otherwise dispose of, or mortgage, pledge or otherwise encumber the Award, and any such attempted sale, assignment, transfer, pledge or disposal shall be void. Except as provided in this Section 2, the RSUs, including any accrued dividend equivalents, shall be subject to forfeiture until the Participant becomes vested in such Awards on the date that was approved on the Grant Date and as reflected on the Merrill Lynch Benefits On-line site, or any successor system, via the Grant Summary screen as the Future Vesting table.

The Restricted Period shall begin on the date of the granting of this Award. Thirty percent (30%) of the RSUs will vest on the first anniversary of the Grant Date; thirty percent (30%) of the RSUs will vest on the second anniversary of the Grant Date; and forty percent (40%) of the RSUs will vest on the third anniversary of the Grant Date. During the Restricted Period, holders of Awards shall have none of the rights of a shareholder with respect to the shares of Common Stock that may be earned pursuant to the RSUs, including, but not limited to, any right to receive dividends in cash or other property or other distribution or rights in respect of such shares except as otherwise provided in this Award Agreement, nor any right to vote such shares as the record owner thereof.

During each year in the Restricted Period, the Participant will not be paid dividend equivalents on the unvested RSUs but the Participant will receive a credit equal to dividends declared on the Corporation’s Common Stock which will be reinvested in additional RSUs at the then fair market value of the Corporation’s Common Stock on the date dividends are paid, and the additional RSUs will be accumulated and paid if and when the RSUs vest, based on the actual number of RSUs that vest. In the case of dividends paid in property other than cash, the amount of the dividend shall be deemed to be the fair market value of the property at the time of the payment of the dividend, as determined in good faith by the Corporation. The Corporation shall not be required to segregate any cash or other property of the Corporation.




Notwithstanding any provision in this Award Agreement, this Award will be forfeited if the Participant does not agree to the terms of any restrictive covenant agreement(s) containing non-competition, non-solicitation, confidentiality, business ideas and similar restrictions that may be presented to the Participant at any time prior to the last day of the calendar year in which this Award is granted (whether before or after the Grant Date) and that the Participant will be required to accept pursuant to such acceptance procedures (including electronic acceptance) as will be communicated to the Participant. Such restrictive covenant agreement must be accepted by the Participant within thirty (30) days and if not so accepted, this Award will be forfeited, unless otherwise determined by the Corporation in its discretion.

(b)    Termination of Employment. For purposes of this Award, the Participant's employment will be considered terminated as of the date the Participant is no longer actively providing services to the Corporation or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant's employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation, the Participant’s right to receive RSUs and vest in the Award under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant's employment agreement, if any); the Committee shall have the exclusive discretion to determine when the Participant is no longer employed for purposes of the Award (including whether the Participant may still be considered employed while on a leave of absence).

The Participant shall forfeit any unvested Award, including any accrued dividend equivalents, upon termination of employment unless such termination is (i) due to a Qualified Termination of Employment, or (ii) if more than six months from the Grant Date due to death, Retirement, Total and Permanent Disability, or the shutdown or divestiture of a business unit. A termination of employment shall not be deemed to have occurred while a Participant is on a military leave or other bona fide leave of absence if the period of such leave does not exceed six months, or if longer, so long as the Participant retains a right to reemployment with the Corporation or an Affiliate under an applicable statute or by contract. For purposes of this subparagraph, a leave of absence constitutes a bona fide leave of absence only if there is a reasonable expectation that the Participant will return to perform services for the Corporation or an Affiliate. If the period of leave exceeds six months and the Participant does not retain a right to reemployment under an applicable statute or by contract, the employment relationship is deemed to terminate on the first date immediately following such six-month period. Notwithstanding the foregoing, where a leave of absence is due to any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than six months, where such impairment causes the Participant to be unable to perform the duties of his or her position of employment or any substantially similar position of employment, a 29-month period of absence is substituted for such six-month period in determining whether a termination of employment shall be deemed to have occurred. A termination of employment with the Corporation or an Affiliate to accept immediate reemployment with the Corporation or an Affiliate likewise shall not be deemed to be a termination of employment for the purposes of the Plan. A Participant who is classified as an intermittent employee shall be deemed to have a termination of employment for purposes of the Plan if the level of bona fide services the Participant would perform after such date would permanently decrease to less than 50 percent of the average level of bona fide services performed over the immediately preceding 36-month period (or the full period of services to the Corporation or an Affiliate if the Participant has been providing such services less than 36 months).

For purposes of this Award, a termination of employment includes a termination that is deemed an “unfair dismissal” or a “constructive dismissal.” Further, the Participant understands that the Award is a conditional right. Participant shall forfeit any unvested Award upon termination of employment except as provided above, for example, regardless of whether (1) the Participant is considered to be unfairly dismissed without good cause; (2) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal; (3) the Participant terminates his or her employment or service relationship due



to a change of work location, duties or any other employment or contractual condition; or (4) the Participant terminates his or her employment or service relationship due to a unilateral breach of contract by the Corporation or an Affiliate. Consequently, upon termination of the Participant’s employment or service relationship for any of the above reasons, the Participant may automatically lose any rights to the RSUs that were not vested on the date of termination of the Participant’s employment or service relationship, as described in the Plan and the Award Agreement.

(c)    Death, Retirement or Total and Permanent Disability. In the event that more than six months after the Grant Date the Participant’s termination of employment is due to death or Total and Permanent Disability, it shall result in full vesting, as determined by the Committee, and shall be paid, within 70 days following the Participant’s termination of employment or within such later period as permitted by Section 409A of the U.S. Internal Revenue Code of 1986 and the regulations thereunder, as amended from time to time (the “Code”), subject to Section 20(l) of the Plan, if applicable. In the event that the Participant’s termination of employment is due to Retirement, then provided that, in the sole discretion of the Corporation, (i) no circumstances exist that could lead to a determination that the Participant should be, or could have been, terminated for Cause; and (ii) the Participant has not engaged in conduct that would trigger the Committee’s right of recoupment under the Corporation's Recoupment Policy (as defined in Section 21 of this Award Agreement), it shall result in 100% vesting of any RSUs that are outstanding and unvested under this Award grant and such Award shall be paid 70 days following the Participant’s termination of employment or within such later period as permitted by Section 409A of the Code, subject to Section 20(l) of the Plan, if applicable.

(d)    Shutdown or Divestiture. In the event that after the Grant Date the Participant’s termination of employment is due to the shutdown or divestiture of the Corporation’s or its Affiliate’s business, it shall result in pro rata vesting, as determined by the Committee, and the number of shares that are considered to vest shall be calculated as (1) the total number of RSUs granted under the Award minus the number of RSUs already vested under the Award multiplied by (2) the number of full months of employment during the Restricted Period divided by 36. Any fractional share of the Corporation resulting from such a prorated award shall be rounded to the nearest whole share and shall be paid, along with any other shares earned under such prorated award, within 70 days following the end of the Restricted Period. For the purposes of this Award, a shutdown or divestiture of the Corporation’s or its Affiliate’s business unit is defined as one for which the charges related to the shutdown or divestiture are accounted for, and reported externally, as an exit activity in the Corporation's applicable SEC filings. The Corporation has complete discretion to determine whether a shutdown or divestiture of a business unit has occurred under the terms of the Plan.

(e)    Qualified Termination of Employment. In the event of a Qualified Termination of Employment, all restrictions will lapse and the shares will become fully vested and shall be paid within 10 days following the last day of employment of the Participant with the Corporation or an Affiliate, subject to Section 20(l) of the Plan, if applicable.

(f)    Payment of Awards. The payment of the Award shall be made in shares of Common Stock. Unless otherwise set forth herein, the payment of an Award shall be made within 70 days following the end of the Restricted Period.

(g)    Payment of Tax-Related Items. No shares of Common Stock, nor any cash payment, may be delivered under this Award, unless prior to or simultaneously with such issuance, the Participant or, in the event of his death, the person succeeding to his rights hereunder, shall pay to the Corporation or an Affiliate, as applicable, such amount as the Corporation advises is required under applicable federal, state or local laws to withhold and pay over to governmental taxing authorities in relation to this Award. The Corporation may, in its discretion, withhold payment of required Tax-Related items (as defined in the Acknowledgment of Conditions section) with cash or shares of Common Stock which otherwise would be delivered following the date of vesting of the Award under this Section 2.




3.    Nontransferability. Neither the Award nor the Participant’s right to receive payment for vested Awards may be assigned or transferred except upon the death of the Participant (i) by will or (ii) by the laws of descent and distribution.

4.    Compliance with Law. No payment may be made under this Award, unless prior to the issuance thereof, the Corporation shall have received an opinion of counsel to the effect that this Award by the Corporation to the Participant will not constitute a violation of the U.S. Securities Act of 1933, as amended. As a condition of this Award, the Participant shall, if requested by the Corporation, submit a written statement in form satisfactory to counsel for the Corporation, to the effect that any shares received under this Award shall be for investment and not with a view to the distribution thereof within the meaning of the U.S. Securities Act of 1933, as amended, and the Corporation shall have the right, in its discretion, to cause the certificates representing shares hereunder to be appropriately legended to refer to such undertaking or to any legal restrictions imposed upon the transferability thereof by reason of such undertaking.

The Award granted hereby is subject to the condition that if the listing, registration or qualification of the shares subject hereto on any securities exchange or under any state or federal law, or if the consent or approval of any regulatory body shall be necessary as a condition of, or in connection with, the granting of the Award or the delivery of shares thereunder, such shares may not be delivered unless and until such listing, registration, qualification, consent or approval shall have been effected or obtained. The Corporation agrees to use its best efforts to obtain any such requisite listing, registration, qualification, consent or approval.

The Participant is solely responsible for obtaining/providing whatever exchange control approvals, permits, licenses, or notices, which may be necessary for the Participant to hold the Award, or to receive any payment of cash or shares or to hold or sell the shares subject to the Award, if any. Neither the Corporation nor its Affiliates will be responsible for obtaining any such approvals, licenses or permits, or for making any such notices, nor will the Corporation or its Affiliates be liable for any fines or penalties the Participant may incur for failure to obtain any required approvals, permits or licenses or to make any required notices.

5.    No Right of Continued Employment. The granting of this Award does not confer upon the Participant any legal right to be continued in the employ of the Corporation or its Affiliates, and the Corporation and its Affiliates reserve the right to discharge the Participant whenever the interest of the Corporation or its Affiliates may so require without liability to the Corporation or its Affiliates, the Board of Directors of the Corporation or its Affiliates, or the Committee, except as to any rights which may be expressly conferred on the Participant under this Award.

6.    Discretion of the Corporation, Board of Directors and the Committee. Any decision made or action taken by the Corporation or by the Board of Directors of the Corporation or by the Committee arising out of or in connection with the construction, administration, interpretation and effect of this Award shall be within the absolute discretion of the Corporation, the Board of Directors of the Corporation or the Committee, as the case may be, and shall be conclusive and binding upon all persons.

7.    Inalienability of Benefits and Interest. This Award and the rights and privileges conferred hereby shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance or charge, and any such attempted action shall be void and no such benefit or interest shall be in any manner liable for or subject to debts, contracts, liabilities, engagements, or torts of the Participant.

8.    Governing Law. The Plan is governed by and subject to the laws of the United States of America. To the extent permitted by the laws of the jurisdiction where the Participant works, all questions pertaining to the construction, interpretation, regulation, validity and effect of the provisions of this Award and any rights under the Plan shall be determined in accordance with the laws of the State of Delaware and federal courts located in the District of Delaware shall be the exclusive forum for any dispute arising out of or related to the Award or the Award Agreement and the Participant consents to and waives any objection to the exercise of personal jurisdiction and venue by such courts.




9.    Purchase of Common Stock. The Corporation and its Affiliates may, but shall not be required to, purchase shares of Common Stock of the Corporation for purposes of satisfying the requirements of this Award. The Corporation and its Affiliates shall have no obligation to retain and shall have the unlimited right to sell or otherwise deal with for their own account, any shares of Common Stock of the Corporation purchased for satisfying the requirements of this Award.

10.    Notices. Any notice to be given to the Corporation under this Award, except as required under Sections 19 and 20 below, shall be addressed to the Corporation in care of its Director of Compensation located at the World Headquarters, and any notice to be given to the Participant under the terms of this Award may be addressed to him or her at the address as it appears on the Corporation's records, or at such other address as either party may hereafter designate in writing to the other. Any such notice shall be deemed to have been duly given if and when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered and deposited, postage and registry fee prepaid, in a post office or branch post office regularly maintained by the United States Government or any equivalent non-U.S. postal service.

11.    Changes in Capitalization. In the event there are any changes in the Common Stock or the capitalization of the Corporation through a corporate transaction, such as any merger, any acquisition through the issuance of capital stock of the Corporation, any consolidation, any separation of the Corporation (including a spin-off or other distribution of stock of the Corporation), any reorganization of the Corporation (whether or not such reorganization comes within the definition of such term in Section 368 of the Code), or any partial or complete liquidation by the Corporation, recapitalization, stock dividend, stock split or other change in the corporate structure, appropriate adjustments and changes shall be made by the Committee in (a) the number and type or class of shares subject to this Award, and (b) such other provisions of this Award as may be necessary and equitable to carry out the foregoing purposes.

12.    Effect on Other Plans. All benefits under this Award shall constitute special incentives and shall not affect the level of benefits provided to or received by the Participant (or the Participant's estate or beneficiaries) as part of any employee benefit plan of the Corporation or an Affiliate. This Award shall not be construed to affect in any way the Participant's rights and obligations under any other plan maintained by the Corporation or an Affiliate on behalf of employees.

13.    Discretionary Nature of Award. The grant of an Award is a one-time benefit and does not create any contractual or other right to receive a grant of Awards or benefits in lieu of Awards in the future. Future grants, if any, will be at the sole discretion of the Corporation, including, but not limited to, the timing of any grant, the number of RSUs and vesting provisions. The value of the Award is an extraordinary item outside the scope of the Participant’s employment contract, if any. As such, the Award is not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, leave-related payments, holiday pay, pension, retirement or welfare benefits or similar payments.

14.    Data Privacy. The Participant hereby authorizes their actual employer (the “Employer”) to furnish the Corporation (and any agent of the Corporation administering the Plan or providing Plan recordkeeping services) with such information and data as it shall request in order to facilitate the grant of Awards and administration of the Plan and the Participant waives any data privacy rights such Participant might otherwise have with respect to such information. The Controller of personal data processing is Kimberly-Clark Corporation with registered offices at 351 Phelps Drive, Irving, Texas 75038, United States of America.

15.    Conflict with Plan or Other Documents. This Award is awarded pursuant to and subject to the Plan. This Agreement is intended to supplement and carry out the terms of the Plan. It is subject to all terms and provisions of the Plan and, in the event of a conflict, the Plan shall prevail. In the event of any conflict between this Agreement and the terms of any notice, communication, plan summary, prospectus or other ancillary documentation relating to the Award, this Agreement will prevail.




16.    Successors. This Award Agreement, including but not limited to the restrictive covenants described in Sections 19 and 20 below, shall be binding upon and inure to the benefit of any successor or successors of the Corporation.

17.    Amendments. The Committee may at any time alter or amend this Award to the extent (1) permitted by law, (2) permitted by the rules of any stock exchange on which the Common Stock or any other security of the Corporation is listed, and (3) permitted under applicable provisions of the U.S. Securities Act of 1933, as amended, the U.S. Securities Exchange Act of 1934, as amended (including rule 16b-3 thereof).

18.    Defined Terms. Terms which are capitalized are defined herein or in the Plan and have the same meaning set forth in the Plan, unless the context indicates otherwise.

19.    Restrictive Covenants For U.S. Participants.

(a)Application. The provisions of this Section 19 apply to Participants who are employed by the Corporation or an Affiliate located in the United States and are subject to the laws of the United States as of the date of termination of the Participant's employment; provided, however, that to the extent the Participant is asked to execute an employment or other agreement with the Corporation or any Affiliate containing non-competition, non-solicitation, confidentiality, business ideas or similar restrictions (a “stand-alone restrictive covenant agreement”) after execution of this Award Agreement, the stand-alone restrictive covenant agreement and related enforcement provisions shall govern and the provisions of this Section 19 shall not apply. Notwithstanding the foregoing, sub-section (j) below shall apply in any case. For the avoidance of doubt, the provisions of this Section 19 shall supersede any restrictive covenants the Participant has entered into with the Corporation or any Affiliate prior to execution of this Award Agreement.

(b)Non-Competition. As the Award is intended to encourage the Participant to continue employment with the Corporation or an Affiliate, during which time the Participant will have access to Confidential Information (as defined below), including Confidential Information first developed after the Grant Date, during the term of the Participant’s employment with the Corporation or any Affiliate and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, without the written consent of the General Counsel of the Corporation or their designee, in any country or countries for which the Participant had development, marketing, innovation/technology (R&D), distribution, sales, administrative, operational/supply chain or manufacturing oversight responsibilities during the last two (2) years of the Participant’s employment or was provided with regular and material access to Confidential Information regarding the Corporation’s or an Affiliate's business operations in that country or countries during the last two (2) years of the Participant’s employment, either directly or indirectly, perform duties or undertake responsibilities for a Competitor (as defined below) that are the same or substantially similar to those duties or responsibilities that the Participant performed or undertook for the Corporation or an Affiliate during the two (2) year period prior to the end of the Participant’s employment with the Corporation or an Affiliate. “Confidential Information,” for purposes of this Section 19, shall mean (i) statutory trade secrets; (ii) proprietary information developed or acquired by the Corporation that does not rise to the level of a statutorily protectable trade secret and is made the property of the Corporation through this mutual Agreement of the parties; and (iii) information that is otherwise legally protectable. Such Confidential Information includes, but is not limited to, information in whatever form (including, without limitation, in written, oral, visual or electronic form or on any magnetic or optical disk or memory storage medium, as well as other physical items wherever located, and abstracts or summaries of the foregoing) relating to the business, suppliers, customers, products, affairs and finances of the Corporation or any Affiliate for the time being confidential to the Corporation or any Affiliate, ideas, conceptions, compilations of data, and developments created by the Corporation, whether or not patentable and whether or not copyrightable, and trade secrets including, without limitation, technical data and know-how relating to the business of the Corporation or any Affiliate, or any of their suppliers, customers, agents, distributors, shareholders or management, including (but not limited to) business plans, pricing strategies, financial information, patent



rights, patent applications, information concerning tenders and potential contracts, information concerning proposed product ranges, product development information, employee and salary information, research and development activities or manufacturing methods that the Participant creates, develops, receives, obtains or has knowledge of in connection with the Participant’s employment, and all other matters which relate to the business of the Corporation or any Affiliate and in respect of which information is not readily available in the ordinary course of such business to the Corporation's Competitors, whether or not such information (if in anything other than oral form) is marked confidential. “Competitor,” for purposes of this Section 19, means a person or entity who engages in a business that is the same or substantially the same as any aspect of the Business of the Corporation. “Business of the Corporation,” for purposes of this Section 19, is the development, production, sales and/or marketing of (i) health and hygiene products and related apparel; (ii) washroom and workplace protective and safety products; and (iii) the materials, packaging and other components/subcomponents of such products including, without limitation, non-wood plants and products derived therefrom including any fibers, pulps or extracts. Notwithstanding the foregoing, if the Participant’s residence or principal place of employment on the date of acceptance of this Award Agreement is in the States of California, Massachusetts, Oklahoma, Washington or in any other jurisdiction where any provision of this Section 19(b) prohibiting post-employment competition is prohibited or otherwise restricted by applicable law, then the provisions of this Section 19(b) will not apply to the extent any such provision is prohibited or otherwise restricted by applicable law.

(c)Non-Solicitation of Employees. For a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant's termination date, and with whom the Participant had material dealings during the last two (2) years preceding the Participant's termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate, or (2) be otherwise involved in the recruitment of such person, to leave the employment of the Corporation or of any Affiliate. Furthermore, the Participant shall not for a period of two (2) years following the termination date regardless of the reason for or the manner of termination, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant’s termination date and with whom the Participant had material dealings during the last two (2) preceding the Participant’s termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor or (2) be otherwise involved in the recruitment of such person to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor. The Participant must inform the Corporation immediately on becoming aware of any such recruitment.

(d)Non-Solicitation of Business. During the term of the Participant’s employment and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, either directly or indirectly, on the Participant’s own behalf or on behalf of any other person, firm or company or other entity, solicit, interfere with, entice or endeavor to entice away from the Corporation or any Affiliate any Restricted Customer (as defined below), or seek to conduct Restricted Business (as defined below), or conduct Restricted Business, with any Restricted Customer and/or otherwise persuade, induce, solicit or encourage any person or entity to terminate its contractual relationship with the Corporation or any Affiliate. “Restricted Business,” for purposes of this Section 19, means any business activity carried out by the Participant either directly or indirectly for the Corporation or any Affiliate during the last two (2) years preceding the Participant's termination date. “Restricted Customer,” for purposes of this Section 19, means any person, firm or company or other entity who was a customer or distributor of the Corporation or any Affiliate as at the Participant's termination date, or during the last two (2) years preceding the Participant's termination date, including any Prospective Customer. “Prospective Customer,” for purposes of this Section 19, means any person, firm or company or other entity with whom the Corporation or any Affiliate was involved in negotiations as at the Participant's termination date or during the last two (2) years preceding the Participant's termination date, with a view to dealing with it as a customer and/or to conclude a contractual relationship with such entity,



and/or with whom the Participant had contact at the Participant's termination date or during the last two (2) years preceding the Participant's termination date with a view to dealing with it as a customer of the Corporation or any Affiliate and/or to conclude a contractual relationship with such entity.

(e)Confidentiality. The Participant acknowledges that the Corporation and its Affiliates continually develop Confidential Information, that the Participant may develop Confidential Information for the Corporation or its Affiliates and that the Participant may learn of Confidential Information during the course of the employment relationship. The Corporation has expended and will continue to expend substantial effort and monies in acquiring knowledge and expertise in developing goodwill in the Business of the Corporation. The Participant therefore agrees as follows:

i.The Participant will comply with the policies and procedures of the Corporation for protecting Confidential Information and shall not disclose to any person or use, other than as required by applicable law or for the proper performance of the Participant's duties and responsibilities to the Corporation and its Affiliates, any Confidential Information.

ii.The Participant understands that the restrictions set forth in this Section 19(e) shall continue to apply after the employment relationship terminates, regardless of the reason for such termination. The Participant understands and acknowledges that the Participant's obligations under this Award Agreement with regard to any particular Confidential Information shall commence immediately upon the Participant first having access to such Confidential Information and shall continue during and after employment with the Corporation or an Affiliate until such time as such Confidential Information has become public knowledge other than as a result of the Participant's breach of this Award Agreement or breach by those acting in concert with the Participant or on the Participant's behalf, and shall be indefinite where permitted by state and local law, and shall not continue longer than two (2) years where indefinite confidentiality provisions are not permitted. Notwithstanding, the Participant's confidentiality obligations under this Award Agreement with regard to any trade secrets shall continue during and after the Participant 's employment by the Corporation or an Affiliate until such trade secrets are no longer trade secrets under applicable law.

iii.Nothing in this Award Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order, including initiating, testifying, assisting, complying with a subpoena from, or participating in any manner with an investigation conducted by a local, state, or federal agency, filing or disclosing any facts necessary to receive unemployment insurance, Medicaid, or other public benefits. The Participant shall promptly provide written notice of any such order to an authorized officer of the Corporation. Nothing in this Award Agreement prohibits or restricts the Participant (or Participant's attorney) from initiating communications directly with, responding to an inquiry from, or providing testimony before the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other self-regulatory organization, or any other federal or state regulatory authority.

iv.The Participant agrees and understands that, pursuant to the Defend Trade Secrets Act of 2016, the Participant shall not be held criminally, or civilly, liable under any Federal or State trade secret law for the disclosure of a trade secret that is made in confidence either directly or indirectly to a Federal, State, or local government official, or an attorney, for the sole purpose of reporting, or investigating, a violation of law. Moreover, the Participant agrees and understands that individuals may disclose trade secrets in a complaint, or other document, filed in a lawsuit, or other proceeding, if such filing is made under seal. Finally, the Participant agrees and understands that an individual who files a lawsuit alleging retaliation by the Corporation for reporting a suspected violation of the law may disclose the trade secret to the attorney of the individual and use the trade secret in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.




(f)Business Ideas. The Participant acknowledges that the Corporation owns all rights in all Business Ideas (as defined below). For the avoidance of doubt, in the event an assignment is needed during the term of the Participant's employment with the Corporation or any Affiliate and at any time following the termination of employment, the Participant hereby assigns without further action being required to the Corporation all Business Ideas. The Participant shall promptly execute all documents which the Corporation may reasonably require to perfect, maintain and protect its patent, copyright, trade secret, trademark and any and all other rights to such Business Ideas throughout the world, and shall provide other reasonable assistance and cooperation as may be necessary for the Corporation to investigate, perfect, maintain and protect those rights, including assistance and cooperation with litigation relating to any Business Ideas. Even after the Participant's employment with the Corporation or any Affiliate terminates, the Participant will continue to be reasonably available to assist the Corporation with its efforts to investigate, perfect, maintain and protect rights in any Business Ideas, including assistance with litigation relating to any Business Ideas. “Business Ideas” as used in this Award Agreement means all ideas, concepts, innovations, inventions, strategy, data, developments, and works of authorship, whether or not patentable, both technical and business, which the Participant originates, conceives or develops, either alone or in conjunction with others, at any time during the Participant's employment with the Corporation or any Affiliate, except those which satisfy all three of the following criteria: i) unrelated to the Corporation's business; ii) not originated, conceived or developed during the Participant's working hours; and iii) not originated, conceived or developed by use of any Corporation property such as tools, supplies, equipment, materials, facilities or other Corporation employees. Any idea, concept, innovation, invention, strategy, data, development or work of authorship that the Participant originates, conceives or develops, through the use of Corporation Confidential Information, at any time within six (6) months after the Participant's employment with the Corporation or any Affiliate terminates (for any reason) will be presumed to be a Business Idea unless the Participant can prove otherwise by clear and convincing evidence.

(g)Notification Requirement. During the term of the Participant's employment with the Corporation or any Affiliate and for the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, regardless of the reason for or the manner of termination, the Participant agrees to notify the Corporation in writing prior to accepting new employment, or engaging in any other activity which may violate this Award Agreement, and the Participant agrees to provide in such notice information concerning the anticipated new employment or activity, including, but not limited to: name of new employer; address of new employer; name of new team leader; job title; and scope and responsibilities of the new position. The Participant recognizes that such duty of notification is not affected by the Participant’s belief that such employment may perhaps not violate this Award Agreement or otherwise be unfairly competitive with the Corporation or an Affiliate. The Participant’s written notice should be addressed to the Corporation's General Counsel with subject line Non-Competition Agreement, via email to Noncompete.Notification@kcc.com.

(h)Other Notification. During the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, the Participant shall provide a copy of Section 19 of this Award Agreement to each new employer before starting in any new employment. The Participant agrees that the Corporation may notify any third party about the Participant’s obligations under Section 19 of this Award Agreement until such obligations are fulfilled.

(i)Remedies. In the event of an anticipated or actual breach by the Participant of any of the provisions of this Section 19, the Participant acknowledges and agrees that damages would not be an adequate remedy to compensate the Corporation or an Affiliate for the harm to the business of the Corporation or the Affiliate and, in such event, agrees that the Corporation or the Affiliate, as applicable, shall be entitled to a temporary restraining order and to temporary injunctive relief to prevent or terminate such anticipated or actual breach, provided, however, that nothing in this Award Agreement shall be construed to limit any permanent relief to which the Corporation or the Affiliate may be entitled or the damages otherwise recoverable by the Corporation or the Affiliate in any such event.




(j)Forfeiture of Award. Notwithstanding the Corporation's or an Affiliate's ability to pursue injunctive relief pursuant to Section 19(i), in the event of an actual breach by the Participant of any of the provisions of this Section 19 or of any stand-alone restrictive covenant agreement, the Corporation also is entitled to forfeit any portion of the Award that has not vested or been settled yet at the time the Corporation becomes aware of the breach.

(k)Reimbursement of Fees. If the Participant violates any of the provisions of this Section 19, or any duty of loyalty or confidentiality imposed by law, in addition to any damages that the Participant may be required to pay, the Participant understands and agrees that the Participant shall be required to reimburse the Corporation for all its costs incurred to enforce this Award Agreement, including but not limited to, all attorneys’ fees.

(l)Beneficiaries. For purposes of this Section 19, the Corporation and each of its Affiliates shall be deemed to be third-party beneficiaries with the right to seek enforcement of any of the provisions of this Section 19. Further, for purposes of this Section 19, references to acting directly or indirectly include acting jointly with or through another person.
(m)Severability. If any provision of this Section 19 is held to be invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such provision shall be deemed to be severed from the Award Agreement and such invalidity, illegality or unenforceability will not affect any other provision of the Award Agreement, all of which shall remain valid and enforceable. Notwithstanding the foregoing, if a court of competent jurisdiction determines that the covenants contained in this Section 19 are unenforceable because they are overbroad in some respect, to the full extent permitted by applicable law, the court should sever, revise or reform any aspect of this Section 19 so as to make the scope of such Section 19 as broad as reasonable under applicable law and enforce this Section 19 as so modified. Without limiting the foregoing, if a court, government agency or other body of competent jurisdiction establishes or the Corporation otherwise determines that the covenants contained in this Award Agreement are unenforceable and/or in violation of applicable rules, the Corporation reserves the right to unilaterally amend the Award Agreement so as to comply with applicable rules.

(n)Jurisdiction-Specific Terms. If the Participant works for the Corporation or an Affiliate in the District of Columbia, the length of the non-competition covenant in Section 19(b) of this Award Agreement shall be one (1) year. If the Participant works for the Corporation or an Affiliate in the State of Oregon, the Corporation will provide a signed written copy of this Award Agreement within 30 days after the termination of the Participant's employment. If the Participant works for the Corporation or an Affiliate in the State of Utah, the length of the non-competition covenant in Section 19(b) of this Award Agreement shall be one (1) year.

(o)Advice to Seek Independent Counsel. The Participant is hereby advised in writing to consult with an attorney before entering into the covenants outlined in this Section 19. The Participant acknowledges that prior to acceptance of this Award Agreement, the Participant has been advised by the Corporation of the Participant's right to seek independent advice from an attorney of the Participant's own selection regarding this Award Agreement, including the restraints imposed upon the Participant pursuant to this Section 19. The Participant acknowledges that the Participant has entered into this Award Agreement knowingly and voluntarily and with full knowledge and understanding of the provisions of this Award Agreement after being given the opportunity to consult with counsel. The Participant further represents that in entering into this Award Agreement, the Participant is not relying on any statements or representations made by any of the Corporations' directors, officers, employees or agents which are not expressly set forth herein, and that the Participant is relying only upon the Participant's own judgment and any advice provided by the Participant's attorney. The Participant acknowledges he or she has been provided at minimum 14 calendar days to review the provisions contained herein.




20.    Restrictive Covenants For Participants Outside the U.S.

(a)    Application. The provisions of this Section 20 apply to Participants who are employed by an Affiliate located outside the United States and are subject to the laws of a jurisdiction outside of the United States as of the date of termination of the Participant's employment, provided, however, that to the extent the Participant is party to an employment or other agreement with any Affiliate containing non-competition, non-solicitation, confidentiality, business ideas or similar restrictions (the “local restrictive covenants”), whether or not such local restrictive covenants have been agreed to before or after execution of this Award Agreement, those local restrictive covenants and related enforcement provisions shall govern and the following provisions of this Section 20 shall not apply, unless otherwise determined by the Corporation in its sole discretion. Notwithstanding the foregoing, sub-section (j) below shall apply in any case.
(b)    Confidentiality. During the Participant’s employment with the Corporation or any Affiliate and indefinitely thereafter, the Participant undertakes to maintain the confidentiality of, and not to divulge to any person (except as required by law) any of the Corporation's or any Affiliate's Confidential Information (as defined below), nor use the same for any other purpose, other than to carry out the Participant’s functions as an employee of the Corporation or any of its Affiliates. The Participant shall use all personal endeavors to prevent publication or disclosure of such Confidential Information. The Participant will comply with the policies and procedures of the Corporation for protecting Confidential Information and shall not disclose to any person or use, other than as required by applicable law or for the proper performance of the Participant’s duties and responsibilities to the Corporation and its Affiliates, any Confidential Information. Nothing in this Award Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order, including initiating, testifying, assisting, complying with a subpoena from, or participating in any manner with an investigation conducted by a local agency, filing or disclosing any facts necessary to receive social insurance or other public benefits. The Participant shall promptly provide written notice of any such order to an authorized officer of the Corporation. Nothing in this Award Agreement prohibits or restricts the Participant (or Participant's attorney) from initiating communications directly with, responding to an inquiry from, or providing testimony before any regulatory authority. “Confidential Information,” for purposes of this Section 20, shall mean (i) statutory trade secrets; (ii) proprietary information developed or acquired by the Corporation that does not rise to the level of a statutorily protectable trade secret and is made the property of the Corporation through this mutual Agreement of the parties; and (iii) information that is otherwise legally protectable. Such Confidential Information includes, but is not limited to, information in whatever form (including, without limitation, in written, oral, visual or electronic form or on any magnetic or optical disk or memory storage medium, as well as other physical items wherever located, and abstracts or summaries of the foregoing) relating to the business, suppliers, customers, products, affairs and finances of the Corporation or any Affiliate for the time being confidential to the Corporation or any Affiliate, ideas, conceptions, compilations of data, and developments created by the Corporation, whether or not patentable and whether or not copyrightable, and trade secrets including, without limitation, technical data and know-how relating to the business of the Corporation or any Affiliate, or any of their suppliers, customers, agents, distributors, shareholders or management, including (but not limited to) business plans, pricing strategies, financial information, patent rights, patent applications, information concerning tenders and potential contracts, information concerning proposed product ranges, product development information, employee and salary information, research and development activities or manufacturing methods that the Participant creates, develops, receives, obtains or has knowledge of in connection with the Participant's employment, and all other matters which relate to the business of the Corporation or any Affiliate and in respect of which information is not readily available in the ordinary course of such business to the Corporation's Competitors, whether or not such information (if in anything other than oral form) is marked confidential. “Competitor,” for purposes of this Section 20, means a person or entity who engages in a business that is the same or substantially the same as any aspect of the Business of the Corporation. “Business of the Corporation,” for purposes of



this Section 20, is the development, production, sales and/or marketing of (i) health and hygiene products and related apparel; (ii) washroom and workplace protective and safety products; and (iii) the materials, packaging and other components/subcomponents of such products including, without limitation, non-wood plants and products derived therefrom including any fibers, pulps or extracts.
(c)    Non-Competition. During the Participant’s employment with the Corporation or any Affiliate, it is acknowledged that the Participant will acquire Confidential Information, and should the Participant’s employment cease, it may be difficult to police sub-section (b) above, prohibiting the disclosure of such Confidential Information. It is further acknowledged that it may be difficult to police the non-solicitation and dealing sub-sections set out below. For these reasons, during the term of the Participant’s employment and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, without the written consent of General Counsel of the Corporation or their designee, in any country or countries for which Participant had development, marketing, innovation/technology (R&D), distribution, sales, administrative, operational/supply chain or manufacturing oversight responsibilities during the last two (2) years of Participant’s employment or was provided with regular and material access to Confidential Information regarding the Corporation’s or an Affiliate's business operations in that country or countries during the last two (2) years of Participant’s employment, either directly or indirectly, perform duties or undertake responsibilities for a Competitor that are the same or substantially similar to those duties or responsibilities that the Participant performed or undertook for the Corporation or an Affiliate during the two (2) year period prior to the end of the Participant’s employment with the Corporation or an Affiliate.
(d)     Business Ideas. The Participant acknowledges that the Corporation owns all rights in all Business Ideas (as defined below). For the avoidance of doubt, in the event an assignment is needed during the term of the Participant's employment with the Corporation or any Affiliate and at any time following the termination of employment, the Participant hereby assigns without further action being required to the Employer all Business Ideas. The Participant shall promptly execute all documents which the Corporation may reasonably require to perfect, maintain and protect its patent, copyright, trade secret, trademark and any and all other rights to such Business Ideas throughout the world, and shall provide other reasonable assistance and cooperation as may be necessary for the Corporation or the Employer to investigate, perfect, maintain and protect those rights, including assistance and cooperation with litigation relating to any Business Ideas. Even after the Participant's employment with the Corporation or any Affiliate terminates, the Participant will continue to be reasonably available to assist the Corporation or the Employer with its efforts to investigate, perfect, maintain and protect rights in any Business Ideas, including assistance with litigation relating to any Business Ideas. “Business Ideas” as used in this Award Agreement means all ideas, concepts, innovations, inventions, strategy, data, developments, and works of authorship, whether or not patentable, both technical and business, which the Participant originates, conceives or develops, either alone or in conjunction with others, at any time during the Participant's employment with the Corporation or any Affiliate, except those which satisfy all three of the following criteria: i) unrelated to the Corporation's business; ii) not originated, conceived or developed during the Participant's working hours; and iii) not originated, conceived or developed by use of any Corporation property such as tools, supplies, equipment, materials, facilities or other Corporation employees. Any idea, concept, innovation, invention, strategy, data, development or work of authorship that the Participant originates, conceives or develops, through the use of Corporation Confidential Information, at any time within six (6) months after the Participant's employment with the Corporation or any Affiliate terminates (for any reason) will be presumed to be a Business Idea unless the Participant can prove otherwise by clear and convincing evidence.

(e)    Notification Requirement. During the term of the Participant's employment with the Corporation or any Affiliate and for the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, the Participant agrees to notify the Corporation in writing prior to accepting new employment, or engaging in any other activity which may violate this Award Agreement, and the Participant agrees to provide in such notice information concerning the anticipated new employment or activity, including, but not limited to: name of new employer; address of new employer; name of new team leader; job title; and scope and responsibilities of the new position. The Participant



recognizes that such duty of notification is not affected by the Participant’s belief that such employment may perhaps not violate this Award Agreement or otherwise be unfairly competitive with the Corporation or an Affiliate. The Participant’s written notice should be addressed to the Corporation's General Counsel with subject line Non-Competition Agreement, via email to Noncompete.Notification@kcc.com.

(f)    Other Notification. During the period of two (2) years following termination of the Participant’s employment with the Corporation or an Affiliate, the Participant shall provide a copy of Section 20 of this Award Agreement to each new employer before starting in any new employment. The Participant agrees that the Corporation may notify any third party about the Participant’s obligations under Section 20 of this Award Agreement until such obligations are fulfilled.

(g)    Non-Solicitation of Business. During the term of the Participant’s employment and for a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, either directly or indirectly, on the Participant’s own behalf or on behalf of any other person, firm or company or other entity, solicit, interfere with, entice or endeavor to entice away from the Corporation or any Affiliate any Restricted Customer (as defined below), or seek to conduct Restricted Business (as defined below), or conduct Restricted Business, with any Restricted Customer and/or otherwise persuade, induce, solicit or encourage any person or entity to terminate its contractual relationship with the Corporation or any Affiliate. “Restricted Business,” for purposes of this Section 20, means any business activity carried out by the Participant either directly or indirectly for the Corporation or any Affiliate during the last two (2) years preceding the Participant's termination date. “Restricted Customer,” for purposes of this Section 20, means any person, firm or company or other entity who was a customer or distributor of the Corporation or any Affiliate as at the Participant's termination date, or during the last two (2) years preceding the Participant's termination date, including any Prospective Customer. “Prospective Customer,” for purposes of this Section 20, means any person, firm or company or other entity with whom the Corporation or any Affiliate was involved in negotiations as at the Participant's termination date or during the last two (2) years preceding the Participant's termination date, with a view to dealing with it as a customer and/or to conclude a contractual relationship with such entity, and/or with whom the Participant had contact at the Participant's termination date or during the last two (2) years preceding the Participant's termination date with a view to dealing with it as a customer of the Corporation or any Affiliate and/or to conclude a contractual relationship with such entity.
(h)    Non-Solicitation of Employees. For a period of two (2) years following the termination of employment, regardless of the reason for or the manner of termination, the Participant shall not, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant's termination date and with whom the Participant had material dealings during the last two (2) years preceding the Participant's termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate, or (2) be otherwise involved in the recruitment of such person, to leave the employment of the Corporation or of any Affiliate. Furthermore, the Participant shall not for a period of two (2) years following the termination date regardless of the reason for or the manner of termination, with respect to any person who was an employee of the Corporation or any Affiliate at the Participant’s termination date and with whom the Participant had material dealings during the last two (2) preceding the Participant’s termination date, (1) directly or indirectly induce such person to leave the employment of the Corporation or of any Affiliate to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor or (2) be otherwise involved in the recruitment of such person to become employed by, associated with and/or form part of any business or concern, in any capacity whatsoever, of any Competitor. The Participant must inform the Corporation immediately on becoming aware of any such recruitment.

(i)    Remedies. In the event of an anticipated or actual breach by the Participant of any of the provisions of this Section 20, the Participant acknowledges and agrees that damages would not be an adequate remedy to compensate the Corporation or an Affiliate for the harm to the business of the Corporation or the Affiliate and, in such event, agrees that the Corporation or the Affiliate, as applicable, shall be entitled to



a temporary restraining order and to temporary injunctive relief to prevent or terminate such anticipated or actual breach, provided, however, that nothing in this Award Agreement shall be construed to limit any permanent relief to which the Corporation or the Affiliate may be entitled or the damages otherwise recoverable by the Corporation or the Affiliate in any such event.

(j)    Forfeiture of Award. Notwithstanding the Corporation's or an Affiliate's ability to pursue injunctive relief pursuant to Section 20(i), in the event of an actual breach by the Participant of any of the provisions of this Section 20 or of any local restrictive covenant agreement, the Corporation also is entitled to forfeit any portion of the Award that has not vested or been settled yet at the time the Corporation becomes aware of the breach.

(k)    Reimbursement of Fees. If the Participant violates any of the provisions of this Section 20, or any duty of loyalty or confidentiality imposed by law, in addition to any damages that the Participant may be required to pay, the Participant understands and agrees that the Participant shall be required to reimburse the Corporation for all its costs incurred to enforce this Award Agreement, including but not limited to, all attorneys’ fees.

(l)    Beneficiaries. For purposes of this Section 20, the Corporation and each of its Affiliates shall be deemed to be third party beneficiaries with the right to seek enforcement of any of the provisions of this Section 20. Further, for purposes of this Section 20, references to acting directly or indirectly include acting jointly with or through another person.

(m)    Severability. If any provision of this Section 20 is held to be invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such provision shall be deemed to be severed from the Award Agreement and such invalidity, illegality or unenforceability will not affect any other provision of the Award Agreement, all of which shall remain valid and enforceable. Notwithstanding the foregoing, if a court of competent jurisdiction determines that the covenants contained in this Section 20 are unenforceable because they are overbroad in some respect, to the full extent permitted by applicable law, the court should sever, revise or reform any aspect of this Section 20 so as to make the scope of such Section 20 as broad as reasonable under applicable law and enforce this Section 20 as so modified. Without limiting the foregoing, if a court, government agency or other body of competent jurisdiction establishes or the Corporation otherwise determines that the covenants contained in this Award Agreement are unenforceable and/or in violation of applicable rules, the Corporation reserves the right to unilaterally amend the Award Agreement so as to comply with applicable rules.

21.    Forfeiture and Recoupment.
(a)    The RSUs are subject to the compensation recovery provisions of the Plan. In addition, the RSUs are subject to the Kimberly-Clark Corporation Compensation Recoupment Policy (such policy, as it may be amended from time to time, the “Recoupment Policy”) if the Participant is a Leader (as defined in the Recoupment Policy). A recovery under this section may be made by (a) cancelling any RSUs which have not yet vested or been settled; (b) recovering shares of Common Stock or cash equal to the value of the shares of Common Stock issued on settlement of the RSUs, including shares resulting from dividend equivalents; (c) recovering proceeds realized by the Participant on the sale of such Common Stock; (d) withholding compensation otherwise due to the Participant; (e) payment by the Participant; and/or (e) by such other means determined appropriate under the terms of the Recoupment Policy. If the Participant is required to repay the Corporation, the Corporation is entitled to offset the payment in a way that is intended to avoid the application of penalties under Section 409A of the Code, if applicable.
Without limiting the foregoing, if, following a Participant’s termination of employment for a reason other than the Participant’s termination for Cause, the Corporation discovers facts that such Participant’s termination of employment could have been for Cause, such Participant’s termination of employment will be deemed to have been for Cause for all purposes, and as a result, (a) the Corporation will not issue shares of Common Stock or any other benefit otherwise payable to the Participant under the Plan and (b)



the Participant will be required to repay to the Corporation all proceeds received under the Plan that would not have been payable to such Participant had such termination of employment been for Cause.
The Corporation shall have the right to suspend any and all rights or benefits awarded to the Participant hereunder, including vesting and settlement of the RSUs, pending its investigation and final determination with regard to whether the Participant has engaged in conduct constituting Cause or that would warrant application of the Recoupment Policy.
(b)    By accepting the Award Grant and the terms of this Award Agreement, the Participant understands, acknowledges and accepts that the grant, shares of Common Stock issued under the Plan and proceeds realized by the Participant pursuant to the Plan are subject to the terms of the Recoupment Policy and the Corporation may seek recovery by any of the methods described in Section 21(a) or other such means determined appropriate under the terms of the Recoupment Policy.

22.    Whistleblower Statutes. Notwithstanding anything to the contrary in this Award Agreement, nothing in Sections 19 , 20 or 21 of this Award Agreement is intended to or shall limit, prevent, impede or interfere with the Participant's non-waivable right, without prior notice to the Corporation, to provide information to the government, participate in investigations, testify in proceedings regarding the Corporation, Employer or any Affiliate's past or future conduct, engage in any activities protected under whistleblower statutes, or to receive and fully retain a monetary award from a government-administered whistleblower award program for providing information directly to a government agency. The Participant does not need prior authorization from the Corporation to make any such reports or disclosures and is not required to notify the Corporation that the Participant has made such reports or disclosures.

23.    Section 409A. It is the intent of this Award Agreement that it and all payments and benefits hereunder be exempt from, or comply with, the requirements of Section 409A of the Code so that none of the RSUs provided under this Award Agreement or shares of Common Stock issuable thereunder will be subject to the additional tax imposed under Section 409A of the Code, and any ambiguities herein will be interpreted to be so exempt or so comply.
24.    Acceptance of Award Terms and Conditions. A Participant has until the end of the ninety (90) day period beginning from the Grant Date of this Award to accept this Award Agreement. If the Participant does not accept this Award Agreement on or before the end of such ninety (90) day period, then the grant of the Award, as set forth in Section 1, shall not be binding on and shall be voidable by the Corporation, in which case it shall have no further force or effect. Further, as set forth in the fourth paragraph of Section 2(a), the Award will be forfeited if the Participant does not accept any restrictive covenant agreement presented to the Participant by the end of the period noted in Section 2(a).
Acknowledgment of Conditions

The Participant understands, acknowledges and agrees to the following conditions with respect to the Award granted under the Plan:

The Plan is established voluntarily by the Corporation, is discretionary in nature and may be modified, amended, suspended, cancelled or terminated at any time, to the extent permitted by the Plan. The grant of an Award is an exceptional, voluntary and occasional benefit and does not create any contractual or other right to receive an Award or benefits in lieu of an Award in the future, even if Awards have been granted in the past. Future grants, if any, will be at the sole discretion of the Corporation, including, but not limited to, the timing of any grant, the number of Awards and vesting provisions.

Participation in the Plan is voluntary and does not create a right to employment with the Participant’s Employer, shall not be interpreted as forming an employment or service contract with the Corporation, and shall not interfere with the ability of the Employer to terminate the Participant’s employment relationship at any time. The Participant understands that the Corporation has unilaterally, gratuitously and discretionally decided to grant Awards under the Plan to individuals who are employees of the Corporation or its Affiliates throughout the world.



The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Corporation or any of its Affiliates on an ongoing basis. Consequently, the Participant understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Corporation or any of its Affiliates) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. Further, the Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from any gratuitous and discretionary grant since the future value of the Award and the underlying shares is unknown and unpredictable. In addition, the Participant understands that this grant would not be made but for the assumptions and conditions referred to above; thus, the Participant understands, acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then the Award shall be null and void.

The Award and the shares of Common Stock subject to the Award, and the income from and value of same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Corporation or, if different, the Employer, and which are outside the scope of the Participant’s employment contract, if any, and are not intended to replace any pension rights or compensation. As such, the Award, and the income from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, leave-related payments, holiday pay, pension, retirement or welfare benefits or similar payments and in no event shall be considered as compensation for, or relating in any way to, past services for the Corporation, the Employer or any other Affiliate.

Unless otherwise agreed with the Corporation, the Award and shares of Common Stock subject to the Award, and the income from and value of same, are not granted as consideration for, or in connection with, any service the Participant may provide as a director of any Affiliate.

The future value of the underlying shares of Common Stock is unknown, indeterminable, and cannot be predicted with certainty.
No claim or entitlement to compensation or damages shall arise from forfeiture of the Award or the recoupment of any shares of Common Stock acquired under the Plan resulting from (a) the termination of the Participant’s employment by the Corporation or the Employer (regardless of the reason for such termination and whether or not the termination is later found to be invalid or in breach of employment laws); and/or (b) the application of the Corporation's Recoupment Policy or any recovery or clawback policy required by law.
The Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan, or the acquisition or sale of the underlying shares of Common Stock. Further, the Participant understands that he or she should consult with his or her own advisors regarding participation in the Plan before taking any action related to the Plan.
Neither the Corporation, the Employer nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the settlement of the RSUs or the subsequent sale of any shares of Common Stock acquired upon settlement.
Regardless of any action the Corporation or the Employer takes with respect to any or all income tax (including federal, state and local taxes), social insurance, fringe benefit tax, payroll tax, payment on account or other tax-related items related to the Participant’s participation in the Plan and legally applicable to the Participant (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant’s responsibility and may exceed the amount, if any, actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant of the RSUs, the vesting of RSUs, the conversion of the RSUs into shares or the receipt of an equivalent cash payment, the subsequent sale of any shares acquired at vesting and the receipt of any



dividends or dividend equivalents; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Corporation and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
In connection with the relevant taxable or tax withholding event, as applicable, the Participant shall pay or make adequate arrangements satisfactory to the Corporation and/or the Employer to satisfy or account for all applicable withholding obligations for Tax-Related Items. In this regard, the Participant authorizes the Corporation or the Employer, or their respective agents, at their discretion, to satisfy their withholding obligations, if any, with regard to all Tax-Related Items by one or a combination of the following:
(1)    withholding from the Participant’s wages or other cash compensation paid to the Participant by the Corporation and/or the Employer; or
(2)    withholding from the proceeds of the sale of shares acquired upon vesting of the Award either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant’s behalf, pursuant to this authorization); or
(3)    withholding shares to be issued upon vesting of the Award;
provided, however, that if the Participant is subject to Section 16 of the U.S. Securities Exchange Act of 1934, as amended, then the Corporation will withhold in shares upon the relevant taxable or tax withholding event, as applicable, unless the use of such withholding method is not feasible under applicable tax or law or has materially adverse accounting consequences, in which case, the obligation for Tax-Related Items may be satisfied by one or a combination of methods (1), (2) and (3) above.
The Corporation may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates, including minimum rates or maximum applicable rates in applicable jurisdictions. In the event of over-withholding, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the common stock equivalent), or if not refunded, the Participant may seek a refund from the applicable tax authorities. In the event of under-withholding, the Participant may be required to pay additional Tax-Related Items directly to the applicable tax authorities or to the Corporation or the Employer. If the obligation for Tax-Related Items is satisfied by withholding in shares, for tax purposes, the Participant is deemed to have been issued the full number of shares subject to the Award, notwithstanding that a number of shares is held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Plan.
The Participant shall pay to the Corporation or to the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to deliver shares or the proceeds of the sale of shares to the Participant if he or she fails to comply with his or her obligations in connection with the Tax-Related Items.
The Corporation is located at 351 Phelps Drive Irving, TX 75038, USA and grants employees of the Corporation and its Affiliates the opportunity to participate in the Plan, at the Corporation’s sole discretion. If the Participant would like to participate in the Plan and is an employee in a country outside the European Economic Area, the Participant understands that he or she should review the following information about the Corporation’s data processing practices and declare his or her consent. If the Participant is an employee in a country that is a member of the European Economic Area, the Participant should review the information about the Corporation's data processing practices set forth in Appendix A attached hereto.
(1)Data Collection and Usage. The Corporation collects, processes and uses the Participant’s personal data, including, name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, citizenship, nationality, job title,



any shares of stock or directorships held in the Corporation, and details of all awards, canceled, vested, or outstanding in the Participant’s favor, which the Corporation receives from the Participant or the Participant’s Employer. If the Corporation offers the Participant the opportunity to participate in the Plan, then the Corporation will collect the Participant’s personal data for purposes of allocating stock and implementing, administering and managing the Plan. The Corporation’s legal basis for the processing of the Participant’s personal data would be the Participant’s consent.
(2)Stock Plan Administration Service Providers. The Corporation transfers participant data to Merrill Lynch, an independent service provider based in the United States, which assists the Corporation with the implementation, administration and management of the Plan. In the future, the Corporation may select a different service provider and share the Participant’s data with another company that serves in a similar manner. The Corporation’s service provider will open an account for the Participant. The Participant will be asked to agree on separate terms and data processing practices with the service provider, which is a condition for participation in the Plan.
(3)International Data Transfers. The Corporation and its service providers are based in the United States. If the Participant is outside of the United States, the Participant should note that his or her country may have enacted data privacy laws that are different from the United States. The Corporation’s legal basis for the transfer of the Participant's personal data is the Participant’s consent.
(4)Data Retention. The Corporation will use the Participant’s personal data only as long as is necessary to implement, administer and manage his or her participation in the Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. This period may extend until the Participant’s employment or service with the Corporation is terminated, plus any additional time periods necessary for compliance with law, exercise or defense of legal rights, and archiving, back-up and deletion processes.
(5)Voluntariness and Consequences of Consent Denial or Withdrawal. The Participant’s participation in the Plan and the Participant’s grant of consent is purely voluntary. The Participant may deny or withdraw his or her consent at any time. If the Participant does not consent, or if he or she withdraws their consent, the Participant cannot participate in the Plan. This would not affect the Participant’s salary as an employee; the Participant would merely forfeit the opportunities associated with the Plan.
(6)Data Subject Rights. The Participant has a number of rights under data privacy laws in his or her country. Depending on where the Participant is based, the Participant’s rights may include the right to (i) request access or copies of personal data the Corporation processes, (ii) rectification of incorrect data, (iii) deletion of data, (iv) restrictions on processing, (v) portability of data, (vi) to lodge complaints with competent authorities in the Participant’s country, and/or (vii) a list with the names and addresses of any potential recipients of the Participant’s personal data. To receive clarification regarding the Participant’s rights or to exercise the rights please contact the Corporation at Attn: Long-term Incentive Plan Administration at Kimberly Clark, 351 Phelps Drive Irving, TX 75038, USA.
The Participant also understands that the Corporation may rely on a different legal basis for the processing or transfer of data in the future and/or request that the Participant provides another data privacy consent.  If applicable and upon request of the Corporation, the Participant agrees to provide an executed acknowledgment or data privacy consent form to the Corporation or the Employer (or any other acknowledgments, agreements or consents) that the Corporation and/or the Employer may deem necessary to obtain under the data privacy laws in the Participant’s country, either now or in the future.  The Participant understands that he or she will not be able to participate in the Plan if the Participant fails to execute any such acknowledgment, agreement or consent requested by the Corporation and/or the Employer.

If the Participant agrees with the data processing practices described in this notice, the Participant will declare his or her consent by clicking the "Accept" icon on the Merrill Lynch website.



The Participant understands that he or she is solely responsible for obtaining/providing whatever exchange control approvals, permits, licenses or notices, which may be necessary for the Award, to acquire the shares or to hold or sell the shares subject to the Award. Neither the Corporation nor its Affiliates will be responsible for obtaining such approvals, licenses or permits, or for making any such notices, nor will the Corporation or its Affiliates be liable for any fines or penalties the Participant may incur for failure to obtain any required approvals, permits or licenses or to make any required notices.

In accepting the grant of this Award, the Participant acknowledges that he or she has received a copy of the Plan and the Award Agreement and has reviewed the Plan and the Award Agreement, including Appendix A, in their entirety and fully understands and accepts all provisions of the Plan and the Award Agreement, including Appendix A.

The Participant acknowledges that he or she has read and specifically and expressly approves the following sections of the Award Agreement: Section 2(g) on Payment of Tax-Related Items; Section 5 on No Right of Continued Employment; Section 8 on Governing Law; the section on Acknowledgment of Conditions; and the Data Privacy Notice sections of both the Award Agreement and Appendix A for the Participant’s country.
The provisions of this Award Agreement are severable and if one or more of the provisions of this Award Agreement shall be held invalid, illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nonetheless be binding and enforceable. To the extent that any provisions of this Award Agreement are held to be invalid or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and the invalid, illegal or unenforceable provisions shall be deemed null and void; however, to the extent permissible by law, any provisions which could be deemed null and void shall first be construed, interpreted or revised retroactively to permit this Award Agreement to be construed so as to foster the intent of this Award Agreement and the Plan.
The Participant acknowledges that he or she is sufficiently proficient in English, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the terms and conditions of this Award Agreement. Furthermore, if the Participant has received this Award Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.
Notwithstanding any provisions in this Award Agreement, the Award shall be subject to any additional terms and conditions set forth in Appendix A to this Award Agreement for the Participant’s country. Moreover, if the Participant relocates to any of the countries included in Appendix A, the additional terms and conditions for such country will apply to the Participant, to the extent the Corporation determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. Appendix A constitutes part of this Award Agreement.
The Participant acknowledges that the grant of an Award is expressly conditioned on the non-competition provisions set forth in Sections 19 and 20.
The Corporation reserves the right to impose other requirements on the Participant’s participation in the Plan, on the Award and on any shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by on-line delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third-party designated by the Corporation.



A waiver by the Corporation of breach of any provision of this Award Agreement shall not operate or be construed as a waiver of any other provision of this Award Agreement, or of any subsequent breach by the Participant or any other participant.
The Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, which may affect the Participant’s ability to, directly or indirectly, accept, acquire, sell, or attempt to sell or otherwise dispose of shares of Common Stock or rights to shares of Common Stock (e.g., RSUs) or rights linked to the value of shares of Common Stock during such times as the Participant is considered to have “inside information” regarding the Corporation (as defined by the laws in the applicable jurisdictions or the Participant’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant placed before possessing inside information. Furthermore, the Participant may be prohibited from (i) disclosing the inside information to any third party, including fellow employees (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them to otherwise buy or sell Corporation securities.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Corporation insider trading policy.  The Participant is responsible for ensuring his or her compliance with any applicable restrictions and is advised to speak with his or her personal legal advisor on this matter.
The Participant’s country may have certain foreign asset and/or foreign account reporting requirements, tax and/or exchange controls which may affect the Participant’s ability to acquire or hold shares of Common Stock acquired under the Plan or cash received from participating in the Plan (including from any dividends paid on shares acquired under the Plan) in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in the Participant’s country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of his or her participation in the Plan to the Participant’s country through a designated bank or broker within a certain time after receipt. In addition, the Participant agrees to take any and all actions, and consent to any and all actions taken by the Corporation or the Employer as may be required to allow the Corporation or the Employer to comply with local laws, rules and regulations in the Participant's country of residence (and country of employment, if different). Finally, the Participant agrees to take any and all actions as may be required to comply with their personal legal and tax obligations under local laws, rules and regulations in their country of residence (and country of employment, if different). The Participant should consult his or her personal legal advisor for any details.
The Participant acknowledges that he or she has reviewed the Corporation’s Code of Conduct. The Participant further acknowledges that he or she understands and will comply with the terms and standards contained in that Code of Conduct, including but not limited to the prohibition against retaliation, and specifically acknowledges that he or she has an obligation to report suspected violations of the Code of Conduct pursuant to the Corporation’s Escalation Policy.

Conclusion and Acceptance

The Participant accepts this grant via electronic signature by clicking the "Accept" icon and certifies that he or she has read, understands and agrees to the terms and conditions of the 2021 Equity Participation Plan (the "Plan"), the provisions of the applicable Award Agreement and all other applicable documents (including any country-specific terms applicable to the Participant’s grant). The Participant hereby authorizes the Employer to furnish the Corporation (and any agent administering the Plan or providing recordkeeping services) with such information and data as it shall request in order to facilitate the grant of Awards and enable administration of the Plan and the Participant understands that such information shall be used only as long and to the extent necessary to administer the Participant’s participation in the Plan. The Participant agrees that his or her participation in the Plan and the Awards granted to the Participant under the Plan will be governed solely by provisions of U.S. law.





KIMBERLY-CLARK CORPORATION
ANNUAL TIME-VESTED RESTRICTED STOCK UNIT
AWARD AGREEMENT

APPENDIX A


Certain capitalized terms used but not defined in this Appendix A have the meanings set forth in the Plan and/or the Award Agreement.

This Appendix A includes additional terms and conditions that govern the Award granted to the Participant under the Plan if the Participant resides and/or works in any of the countries listed below.

This Appendix A also includes information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of April 2023. Such laws are often complex and change frequently. As a result, the Participant should not rely on the information noted herein as the only source of information relating to the consequences of the Participant’s participation in the Plan because the information may be out of date at vesting of the Award or the subsequent sale of the shares or receipt of any dividends or dividend equivalents.

In addition, the information is general in nature and may not apply to the Participant’s particular situation, and the Corporation is not in a position to assure the Participant of any particular result. Accordingly, the Participant is advised to seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident of a country other than the one in which the Participant is currently residing and/or working, transferred or transfers employment and or residency after the Award is granted or is considered a resident of another country for local law purposes, the information contained herein may not be applicable to the Participant. The Corporation shall, in its sole discretion, determine to what extent the terms and conditions included herein will apply to the Participant in such circumstances.

EUROPEAN ECONOMIC AREA (INCLUDING THE UNITED KINGDOM) AND SWITZERLAND

Data Protection
For Participants resident in a country in the European Economic Area, Switzerland or the United Kingdom, the following language replaces in its entirety the data privacy section in the Acknowledgment of Conditions section of the Award Agreement:
(1)The Participant is hereby notified of the collection, use and transfer outside of the European Economic Area, as described in the Award Agreement, in electronic or other form, of his or her Personal Data (defined below) by and among, as applicable, the Corporation and certain of its Affiliates for the exclusive and legitimate purpose of implementing, administering and managing the Participant’s participation in the Plan.
(i)The Participant understands that the Corporation and the Employer hold certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares of Common Stock or directorships held in the Corporation, details of all entitlement to shares of Common Stock awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Personal Data”), for the purpose of implementing, administering and managing the Plan.



(ii)The Participant understands that providing the Corporation with this Personal Data is necessary for the performance of the Award Agreement and that the Participant's refusal to provide the Personal Data would make it impossible for the Corporation to perform its contractual obligations and may affect the Participant's ability to participate in the Plan. The Participant's Personal Data shall be accessible within the Corporation only by the persons specifically charged with Personal Data processing operations and by the persons that need to access the Personal Data because of their duties and position in relation to the performance of the Award Agreement.
(iii)The Personal Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. This period may extend until the Participant’s employment or service with the Corporation is terminated, plus any additional time periods necessary for compliance with law, exercise or defense of legal rights, and archiving, back-up and deletion processes. The Participant may, at any time and without cost, contact Long-term Incentive Plan Administration at Kimberly Clark, 351 Phelps Drive Irving, TX 75038, USA to enforce his or her rights under the data protection laws in the Participant's country, which may include the right to (i) request access or copies of Personal Data subject to processing; (ii) request rectification of incorrect Personal Data; (iii) request deletion of Personal Data; (iv) request restriction on processing of Personal Data; (v) request portability of Personal Data; (vi) lodge complaints with competent authorities in the Participant's country; and/or (vii) request a list with the names and addresses of any potential recipients of Personal Data.
(iv)The Corporation provides appropriate safeguards for protecting Personal Data that it receives in the U.S. through its adherence to data transfer agreements entered into between the Corporation and its Affiliates within the European Union.
(v)Further, the Participant understands that the Corporation will transfer Personal Data to Merrill Lynch and/or such other third parties as may be selected by the Corporation, which are assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Personal Data with such other provider(s) serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.
(vi)Merrill Lynch is based in the United States. The Participant's country or jurisdiction may have different data privacy laws and protections than the United States. Notwithstanding, by participating in the Plan, the Participant agrees to the transfer of his or her Personal Data to Merrill Lynch for the exclusive purpose of administering the Participant's participation in the Plan. The Corporation's legal basis, where required, for the transfer of Data to Merrill Lynch is the Participant's consent.
(vii)Finally, the Participant may choose to opt out of allowing the Corporation to share his or her Personal Data with Merrill Lynch and others as described above, although execution of such choice may mean the Corporation cannot grant awards under the Plan to the Participant. For questions about this choice or to make this choice, the Participant should contact Long-term Incentive Plan Administration at Kimberly Clark, 351 Phelps Drive Irving, TX 75038, USA.
ARGENTINA

Securities Law Information
Neither the RSUs nor the underlying shares of Common Stock are publicly offered or listed on any stock exchange in Argentina.



Foreign Asset/Account Reporting Information
Argentine residents must report any shares of Common Stock acquired under the Plan and held on December 31st of each year on their annual tax return for the year.
Exchange Control Information
Please note that exchange control regulations in Argentina are subject to frequent change. The Participant should consult with his or her personal legal advisor regarding any exchange control obligations the Participant may have in connection with the Participant’s participation in the Plan. The Participant must comply with any and all Argentine currency exchange restrictions, approvals and reporting requirements in connection with the vesting of the RSUs, the subsequent sale of any shares acquired at vesting and the receipt of any dividends paid on such shares.
AUSTRALIA
Securities Law Information

This offer is being made under Division 1A, Part 7.12 of the Australia Corporations Act 2001 (Cth). Please note that if the Participant offers shares of Common Stock for sale to a person or entity resident in Australia, the offer may be subject to disclosure requirements under Australian law. The Participant should obtain legal advice regarding the relevant disclosure obligations prior to making any such offer.

Tax Information

The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the “Act”) applies (subject to conditions in the Act).

Compliance with Laws

Notwithstanding anything else in the Plan or the Award Agreement, the Participant will not be entitled to and shall not claim any benefit under the Plan if the provision of such benefit would give rise to a breach of Part 2D.2 of the Corporations Act 2001 (Cth.) (the “Act”), any other provision of the Act, or any other applicable statute, rule or regulation which limits or restricts the giving of such benefits. Further, the Employer is under no obligation to seek or obtain the approval of its shareholders in a general meeting for the purpose of overcoming any such limitation or restriction.

Exchange Control Information

Exchange control reporting is required for cash transactions exceeding AUD 10,000 and for international fund transfers. If an Australian bank is assisting with the transaction, the bank will file the report on the Participant’s behalf. If there is no Australian bank involved in the transaction, the Participant will be required to file the report him or herself.

BAHRAIN

Securities Law Information

The Award Agreement, Plan and all other materials the Participant may receive regarding participation in the Plan do not constitute advertising or the offering of securities in Bahrain, nor do they constitute an allotment of securities in Bahrain. Any shares of Common Stock issued upon settlement of the RSUs will be deposited into a Corporation-designated brokerage account outside Bahrain. In no event will shares of Common Stock be issued or delivered in Bahrain. The issuance of shares of Common Stock pursuant to the RSUs described herein has not and will not be registered in Bahrain and, hence, the shares of Common Stock described herein may not be admitted or



used for offering, placement or public circulation in Bahrain. Accordingly, the Participant may not make any public advertising or announcements regarding the RSUs or shares of Common Stock in Bahrain, promote these shares of Common Stock to legal entities or individuals in Bahrain, or sell shares of Common Stock directly to other legal entities or individuals in Bahrain. Any disposition or sale of such shares of Common Stock must take place outside Bahrain.

BELGIUM

Foreign Asset/Account Reporting Information
Belgian residents are required to report any securities (e.g., shares acquired under the Plan) or bank accounts opened and maintained outside Belgium (e.g., any brokerage account opened in connection with the Plan) on their annual tax returns. Belgian residents are also required to complete a separate report providing the National Bank of Belgium with details regarding any such account, including the account number, the name of the bank in which such account is held and the country in which such account is located. The forms to complete this report are available on the website of the National Bank of Belgium. Belgian residents should consult with their personal tax advisors to determine their personal reporting obligations.
Stock Exchange Tax
A stock exchange tax applies to transactions executed by a Belgian resident through a non-Belgian financial intermediary, such as a U.S. broker. The Stock Exchange Tax likely will apply when the Participant sells shares of Common Stock. The Participant should consult with his or her personal tax advisor for additional details regarding the Participant’s obligations with respect to the Stock Exchange Tax.
Annual Securities Accounts Tax
An annual securities accounts tax may be payable if the total value of securities held in a Belgian or foreign securities account (e.g., shares of Common Stock acquired under the Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such cases, the tax will be due on the value of the qualifying securities held in such account. The Participant should consult with his or her personal tax advisor regarding the application of this tax.
BOLIVIA

There are no country-specific provisions.

BRAZIL

Compliance with Law

By accepting the Award, the Participant acknowledges that he or she agrees to comply with applicable Brazilian laws and pay any and all applicable Tax-Related Items associated with the vesting of the RSUs, the conversion of the RSUs into shares or the receipt of an equivalent cash payment, the receipt of any dividends, and the sale of shares of Common Stock acquired under the Plan.

Labor Law Acknowledgment

By accepting the Award, the Participant agrees that (i) the Participant is making an investment decision; (ii) the shares of Common Stock will be issued to Participant only if the vesting and/or performance conditions are met, and (iii) the value of the underlying shares of Common Stock is not fixed and may increase or decrease in value over the vesting period without compensation to the Participant.

Exchange Control Information




If the Participant is resident or domiciled in Brazil, he or she will be required to submit annually a declaration of assets and rights held outside of Brazil to the Central Bank of Brazil if the aggregate value of such assets and rights is equal to or greater than US$1,000,000. Assets and rights that must be reported include shares of Common Stock, and may include RSUs.
Tax on Financial Transaction (IOF).

Payments to foreign countries and repatriation of funds into Brazil (including proceeds from the sale) and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions. It is the Participant’s responsibility to comply with any applicable Tax on Financial Transactions arising from the Participant’s participation in the Plan. The Participant should consult with his or her personal tax advisor for additional details.

CANADA

Securities Law Information

The Participant is permitted to sell shares acquired through the Plan through the designated broker appointed under the Plan, if any, provided the resale of shares acquired under the Plan takes place outside of Canada through the facilities of a stock exchange on which the shares are listed. The Corporation’s shares are currently listed on New York Stock Exchange.

Acknowledgment of Conditions

The following provision supplements the Acknowledgment of Conditions section of the Award Agreement:

Except as may otherwise be explicitly provided in the Plan or this Award Agreement, for the purposes of this Award Agreement, the Participant's termination of employment will be measured effective as of the date that is the earlier of: (1) the date the Participant's employment is terminated, no matter how the termination arises; and (2) the date the Participant receives notice of termination of employment from the Employer. In either case, the date shall exclude any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under local law. For greater certainty, the Participant will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which the Participant's right to vest terminates, nor will the Participant be entitled to any compensation for lost vesting. Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued vesting during a statutory notice period, the Participant's right to vest in the RSUs, if any, will terminate effective as of the last day of the Participant's minimum statutory notice period, but the Participant will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of the Participant's statutory notice period, nor will the Participant be entitled to any compensation for lost vesting.

The Participant acknowledges and agrees that the vesting schedule may change prospectively in the event the Participant’s service status changes between full- and part-time and/or in the event the Participant is on a leave of absence, in accordance with Corporation’s policies relating to work schedules and vesting of RSUs or as determined by the Committee. In case of any dispute as to whether and when a termination of the Participant’s employment has occurred, the Committee will have sole discretion to determine whether such termination of the Participant’s employment has occurred and the effective date of such termination (including whether the Participant may still be considered to be actively providing services while on a leave of absence).
Language
A French translation of the Plan and the Award Agreement can be made available to the Participant as soon as reasonably practicable upon the Participant’s request. The Participant understands that, from time to time, additional information related to the offering of the Plan might be provided in English and such information may



not be immediately available in French. However, upon request, the Corporation will translate into French documents related to the offering of the Plan as soon as reasonably practicable.
Une traduction française du Plan et de l'Accord d'Attribution êtremise à la disposition de Participant dès que raisonnablement possible à la demande de l'Participant. Le Participant comprend que, de temps à autre, des informations supplémentaires liées à l'offre du Plan peuvent être fournies en anglais et que ces informations peuvent ne pas être immédiatement disponibles en français. Cependant, sur demande, la Société traduira en français les documents relatifs à l'offre du Plan dès que raisonnablement possible.
Authorization to Release and Transfer Necessary Personal Information

The Participant hereby authorizes the Corporation and the Corporation’s representatives, including the broker(s) designated by the Corporation, to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. The Participant further authorizes the Corporation, any Affiliate and the plan administrators to disclose and discuss the Plan with their advisors. The Participant further authorizes the Corporation and any Affiliate to record such information and to keep such information in the Participant’s employee file. The Participant acknowledges that the Participant’s personal information, including any sensitive personal information, may be transferred or disclosed outside the Province of Quebec, including to the United States. Finally, the Participant acknowledges that the Corporation, the Employer or any other Affiliate or other parties involved in the administration of the Plan use technology for profiling purposes and to make automated decisions that may have an impact on the Participant or the administration of the Plan.
Foreign Asset/Account Reporting Information

Foreign specified property (including shares of Common Stock) held by Canadian residents must be reported annually on Form T1135 (Foreign Income Verification Statement) if the total cost of such foreign specified property exceeds C$100,000 at any time during the year. Foreign specified property includes shares of Common Stock acquired under the Plan and may include the RSUs. The RSUs must be reported - generally at a nil cost - if the $100,000 cost threshold is exceeded because of other foreign property the Participant holds. If shares of Common Stock are acquired, their cost generally is the adjusted cost base (“ACB”) of the shares. The ACB would normally equal the Fair Market Value of the shares at vesting, but if the Participant owns other shares, this ACB may have to be averaged with the ACB of the other shares owned by the Participant. If due, the Form must be filed by April 30 of the following year. The Participant should speak with a personal tax advisor to determine the scope of foreign property that must be considered for purposes of this requirement.

CHILE

Securities Law Information

The RSUs are granted and are made subject to general ruling n° 336 of the Chilean Commission for the Financial Market (“CMF”). This offer refers to securities not registered at the securities registry or at the foreign securities registry of the CMF, and therefore such securities are not subject to its oversight. Given that these securities are not registered in Chile, there is no obligation from the issuer to provide public information on them in Chile. These securities cannot be subject to public offering in Chile while they are not registered at the corresponding securities registry in Chile.

La oferta privada de estos RSUs se inicia y se acoge a las disposiciones de la norma de carácter general nº 336 de la Comisón para el Mercado Financiero (“CMF”). Esta oferta versa sobre valores no inscritos en el registro de valores o en el registro de valores extranjeros que lleva la CMF, por lo que tales valores no están sujetos a la fiscalización de ésta. Por tratarse de valores no inscritos en Chile, no existe la obligación por parte del emisor de entregar en Chile información pública respecto de los mismos. Estos valores no podrán ser objeto de oferta pública en Chile mientras no sean inscritos en el registro de valores correspondiente.




Exchange Control Information

The Participant is not required to repatriate funds obtained from the sale of shares or the receipt of any dividends. However, if the Participant decides to repatriate such funds, the Participant must do so through the Formal Exchange Market if the amount of the funds exceeds US$10,000. In such case, the Participant must report the payment to a commercial bank or registered foreign exchange office receiving the funds.

Foreign Asset/Account Reporting Information

The Chilean Internal Revenue Service (the “CIRS”) requires all taxpayers to provideinformation annually regarding (i) the results of investments held abroad and (ii) any taxes paidabroad which the taxpayers will use as a credit against Chilean income tax. The sworn statements disclosing this information (or Formularios) must be submitted electronically through the CIRS website, www.sii.cl, using Form 1929, which is due on July 1 each year.

CHINA

The following provisions apply only to Participants who are subject to exchange control restrictions imposed by the State Administration of Foreign Exchange ("SAFE"), as determined by the Corporation in its sole discretion:

Vesting of RSUs

The Participant's Employer, Corporation any other Affiliate to which the Participant provides service must be registered with SAFE prior to settlement of the RSUs. If the Corporation is unable to obtain registration approval or is required to obtain further approvals on behalf of the Employer, Corporation or any other Affiliate, the vesting or settlement of the RSUs may be suspended or delayed. Further, the Corporation is under no obligation to vest the RSUs and/or issues shares of Common Stock if the Corporation’s SAFE approval becomes invalid or ceases to be in effect by the time the Participant vests in the RSUs.
Shutdown or Divestiture

The following provision replaces Section 2(d) of the Award Agreement.

In the event that the Participant’s termination of employment is due to the shutdown or divestiture of the Corporation’s or its Affiliate’s business, it shall result in pro rata vesting, as determined by the Committee, and the number of shares that are considered to vest shall be calculated as (1) the total number of RSUs granted under the Award minus the number of RSUs already vested under the Award multiplied by (2) the number of full months of employment during the Restricted Period divided by 36. Any fractional share of the Corporation resulting from such a prorated award shall be rounded to the nearest whole share and shall be paid, along with any other shares earned under such prorated award, within 70 days following the Participant's termination of employment. For the purposes of this Award, a shutdown or divestiture of the Corporation’s or its Affiliate’s business unit is defined as one for which the charges related to the shutdown or divestiture are accounted for, and reported externally, as an exit activity in the Corporation's applicable SEC filings. The Corporation has complete discretion to determine whether a shutdown or divestiture of a business unit has occurred under the terms of the Plan.

Termination of Employment

Except for termination of employment due to Retirement or the shutdown or divestiture of a business unit, as described above, and notwithstanding any other provision in the Award Agreement, the Participant shall forfeit any unvested Award, including any accrued dividend equivalents, upon any termination of employment including, but not limited to, any termination that is due to a Qualified Termination of Employment, death or Total and Permanent Disability.




In the event that, more than six months after the Grant Date, the Participant’s termination of employment is due to Retirement, then provided that, in the sole discretion of the Corporation, (i) no circumstances exist that could lead to a determination that the Participant should be, or could have been, terminated for Cause; and (ii) the Participant has not engaged in conduct that would trigger the Committee’s right of recoupment under the Corporation's Recoupment Policy (as defined in Section 21 of this Award Agreement), it shall result in 100% vesting of any RSUs that are outstanding and unvested under this Award grant and such Award shall be paid within 70 days following the Participant’s termination of employment or such later period as permitted by Section 409A of the Code, subject to Section 20(l) of the Plan, if applicable.

The Participant acknowledges and agrees that he or she must sell any shares of Common Stock issued to him or her upon vesting of the RSUs as soon as practicable following the Participant's termination of employment for any reason and in no event later than three months following the Participant's termination of employment. The Participant agrees that if he or she continues to hold any of such shares of Common Stock after this time, the shares of Common Stock may be sold by the Corporation’s designated broker on the Participant's behalf at the instruction of the Corporation. Therefore, by accepting the RSUs, the Participant understands and agrees that the Corporation is authorized to, and may in its sole discretion, instruct its designated broker to assist with the mandatory sale of shares of Common Stock (on the Participant’s behalf pursuant to this authorization) and that the Participant expressly authorizes the Corporation’s designated broker to complete the sale of such shares of Common Stock. The Participant acknowledges that the Corporation’s designated broker is under no obligation to arrange for the sale of the shares of Common Stock at any particular price. Upon the sale of the shares of Common Stock, the proceeds, less any Tax-Related Items and brokerage fees or commissions will be remitted to the Participant pursuant to the procedures described in the “Exchange Control Information” section below.

Exchange Control Information

Shares of Common Stock issued to the Participant under the Plan must be maintained in an account with Merrill Lynch or such other broker as may be designated by the Corporation until the shares of Common Stock are sold through that broker. If the Corporation changes its broker, the Participant acknowledges and agrees that the Corporation may transfer any shares of Common Stock issued under the Plan to the new designated broker if necessary for legal or administrative reasons. The Participant agrees to sign any documentation necessary to facilitate the transfer. In addition, the Participant may be required to sell any shares of Common Stock obtained under the Plan if the Corporation determines that the application of such condition is necessary or advisable for China SAFE exchange control, legal or other administrative reasons.
The Participant understands and agrees that, to facilitate compliance with exchange control requirements, the Participant will be required to immediately repatriate to China the cash proceeds from the sale of shares of Common Stock acquired upon vesting of the RSUs or from any dividends or dividend equivalents paid on the shares of Common Stock. The Participant further understands that, under local law, such repatriation of the cash proceeds will be effectuated through a special exchange control account established by the Corporation or one of its Affiliates in China, and the Participant hereby consents and agrees that the cash proceeds related to the Participant's participation in the Plan may be transferred to such special account prior to being delivered to the Participant. The Corporation may deliver the proceeds to the Participant in U.S. dollars or local currency at the Corporation's discretion. If the proceeds are paid in U.S. dollars, the Participant understands that he or she will be required to set up a U.S. dollar bank account in China so that the proceeds may be deposited into this account. If the proceeds are converted to local currency, there may be delays in delivering the proceeds to the Participant. The Participant agrees to bear the risk of any currency fluctuation between the time the shares of Common Stock are sold, either through voluntary sale or through a mandatory sale arranged by the Corporation, or proceeds are otherwise realized under the Plan and the time such proceeds are distributed to the Participant through the special exchange control account.
The Participant further agrees to comply with any other requirements that may be imposed by the Corporation in the future to facilitate compliance with exchange control requirements in China.



COLOMBIA
Securities Law Information
The shares of Common Stock are not and will not be registered in the Colombian registry of publicly traded securities (Registro Nacional de Valores y Emisores) and therefore the shares of Common Stock may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia. An offer of shares of Common Stock to employees will not be considered a public offer provided that it meets the conditions set forth in Article 6.1.1.1.1 in Decree 2555,2010. In the event that the Corporation, in its sole discretion, determines that the offer of the Awards in Colombia may constitute a “public offer of securities”, the Participant understands and agrees that the Corporation may, in its sole discretion, cease to offer participation in the Plan in Colombia. In the event that the Corporation exercises its discretion to cease offering the Plan in Colombia, the Participant will no longer be permitted to participate in the Plan as of the date established by the Corporation.
Exchange Control Information
Colombian residents must register shares of Common Stock acquired under the Plan, regardless of value, with the Central Bank of Colombia (Banco de la República) as foreign investment held abroad. In addition, the liquidation of such investments must be transferred through the Colombian foreign exchange market (e.g. local banks), which includes the obligation of correctly completing and filing the appropriate foreign exchange form (declaración de cambio). The Participant is responsible for complying with applicable exchange control requirements in Colombia.
Foreign Asset/Account Reporting Information
The Participant must file an informative return with the Colombian Tax Office detailing any assets held abroad. If the individual value of any of these assets exceeds a certain threshold, the Participant must describe each asset and indicate the jurisdiction in which it is located, its nature and its value.
Acknowledgment of Conditions
The following provision supplements the Acknowledgment of Conditions section of the Award Agreement:
The Participant acknowledges that pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component of the Participant's “salary” for any legal purpose. To this extent, they will not be included for purposes of calculating any labor benefits, such as legal/fringe benefits, vacation, indemnities, payroll taxes, social insurance contributions and/or any other labor-related amount which may be payable.

COSTA RICA

There are no country-specific provisions.

CZECH REPUBLIC

Exchange Control Information

The Czech National Bank may require the Participant to fulfill certain notification duties in relation to the acquisition of shares of Common Stock and the opening and maintenance of a foreign account (e.g., may be required to report foreign direct investment, financial credits from abroad, investment in foreign securities, and associated collections and payments). However, because exchange control regulations change frequently and without notice, the Participant should consult with his or her personal legal advisor prior to the vesting of the RSUs and the sale of Common Stock to ensure compliance with current regulations. It is the Participant’s responsibility to comply with any applicable Czech exchange control laws.




DOMINICAN REPUBLIC

There are no country-specific provisions.

ECUADOR

There are no country-specific provisions.

EL SALVADOR

There are no country-specific provisions.

FRANCE

RSUs Not Tax-Qualified

The Participant understands that this Award is not intended to be French tax-qualified.

Consent to Receive Information in English

By accepting the Award Agreement providing for the terms and conditions of the Participant’s grant, the Participant confirms having read and understood the documents relating to this grant (the Plan and this Award Agreement) which were provided in English language. The Participant accepts the terms of those documents accordingly.

En acceptant le Contrat d'Attribution décrivant les termes et conditions de l’attribution, le participant confirme ainsi avoir lu et compris les documents relatifs à cette attribution (le Plan U.S. et ce Contrat d'Attribution) qui ont été communiqués en langue anglaise. Le participant accepte les termes en connaissance de cause.

Foreign Asset/Account Reporting Information

French residents holding shares of Common Stock outside of France or maintaining a foreign bank account are required to report such to the French tax authorities when filing their annual tax returns, including any accounts that were closed during the year. Further, failure to comply could trigger significant penalties.

GERMANY

Exchange Control Information

Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank. No report is required for payments less than €12,500. In case of payments in connection with securities (including proceeds realized upon the sale of shares of Common Stock), the report must be made by the 5th day of the month following the month in which the payment was received. Effective from September 2013, the report must be filed electronically. The form of report (“Allgemeine Meldeportal Statistik”) can be accessed via the Bundesbank’s website (www.bundesbank.de) and is available in both German and English. The Participant is responsible for satisfying the reporting obligation.

Foreign Asset/Account Reporting Information

If the Participant’s acquisition of shares of Common Stock leads to a so-called qualified participation at any point during the calendar year, the Participant will need to report the acquisition when he or she files a tax return for the relevant year. A qualified participation occurs only if (i) the Participant owns 1% or more of the Corporation and



the value of the shares of Common Stock exceeds €150,000 or (ii) the Participant holds shares of Common Stock exceeding 10% of the Corporation’s total Common Stock.

GUATEMALA

Language Waiver

By participating in the Plan, the Participant acknowledges that he or she is proficient in reading and understanding English and fully understands the terms of the Plan, or, alternatively, that the Participant will seek appropriate assistance to understand the terms and conditions in the Award Agreement and this Appendix A.

HONDURAS

There are no country-specific provisions.

HONG KONG

Securities Law Warning

The offer of this Award and the shares of Common Stock subject to this Award do not constitute a public offering of securities under Hong Kong law and are available only to employees of the Corporation or its Affiliates participating in the Plan. The Participant should be aware that the Plan, the Plan prospectus and the contents of this Award Agreement (i) have not been prepared in accordance with and are not intended to constitute a “prospectus” for a public offering of securities under the applicable securities legislation in Hong Kong, (ii) have not been reviewed by any regulatory authority in Hong Kong, and (iii) are intended only for the personal use of each Participant and may not be distributed to any other person. The Participant is advised to exercise caution in relation to the offer. If the Participant is in any doubt about any of the contents of the Award Agreement, including this Appendix A, or the Plan, the Participant should obtain independent professional advice.

Award Payable Only in Shares

Awards granted to Participants in Hong Kong shall be paid in shares of Common Stock only and do not provide any right for the Participant to receive a cash payment.

Sale of Shares

In the event the Award vests within six months of the Grant Date, the Participant agrees that he or she will not offer to the public or otherwise dispose of the shares acquired prior to the six-month anniversary of the Grant Date. Any shares of Common Stock acquired under the Plan are accepted as a personal investment.

INDIA

Awards Payable in Cash Only

Notwithstanding anything in the Award Agreement, Awards granted to Participants in India do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.




ISRAEL

Securities Law Information

The offer of this Award does not constitute a public offering under Securities Law, 1968.

Broker Designation

Shares of Common Stock issued to the Participant under the Plan must be maintained in an account with Merrill Lynch or such other broker as may be designated by the Corporation until the shares of Common Stock are sold through that broker.

Restricted from Online Brokerage Transactions

The Participant acknowledges and agrees that he or she will be restricted from online brokerage account transactions the Corporation’s designated broker. Therefore, by accepting the Awards, the Participant understands and agrees that the Participant will call the Corporation’s designated broker to initiate any sale or transfer of any shares of Common Stock issued to him or her upon vesting of the Awards. The Participant acknowledges that the Corporation’s designated broker is under no obligation to arrange for the sale of the shares of Common Stock at any particular price.

ITALY

Plan Document Acknowledgment

In accepting the grant of this Award, the Participant acknowledges that he or she has received a copy of the Plan and the Award Agreement and has reviewed the Plan and the Award Agreement, including this Appendix A, in their entirety and fully understands and accepts all provisions of the Plan and the Award Agreement, including this Appendix A.

The Participant acknowledges that he or she has read and specifically and expressly approves the following sections of the Award Agreement: Section 2(g) on Payment of Withholding Taxes; Section 5 on No Right of Continued Employment; Section 8 on Delaware Law to Govern; the section on Acknowledgment of Conditions; and the Data Privacy Notice section included in this Appendix A.

Foreign Asset/Account Reporting Information

Italian residents who, at any time during the fiscal year, hold foreign financial assets (including cash and shares of Common Stock) which may generate income taxable in Italy are required to report these assets on their annual tax returns (UNICO Form, RW Schedule) for the year during which the assets are held, or on a special form if no tax return is due. These reporting obligations will also apply to Italian residents who are the beneficial owners of foreign financial assets under Italian money laundering provisions.

Foreign Asset Tax Information

The value of financial assets held outside of Italy (including shares of Common Stock) by Italian residents is subject to a foreign asset tax. The taxable amount will be the fair market value of the financial assets (e.g., shares of Common Stock acquired under the Plan) assessed at the end of the calendar year.




KAZAKHSTAN

Securities Law Notification

This offer is addressed only to certain eligible employees in the form of the shares of Common Stock to be issued by the Corporation. Neither the Plan nor the Award Agreement has been approved, nor do they need to be approved, by the National Bank of Kazakhstan. This offer is intended only for the original recipient and is not for general circulation in the Republic of Kazakhstan.

Exchange Control Information

Residents of Kazakhstan may be required to notify the National Bank of Kazakhstan when they acquire shares of Common Stock under the Plan if the value of such shares of Common Stock exceeds US$100,000.

Please note that the exchange control regulations in Kazakhstan are subject to change. The Participant should consult with his or her personal legal advisor regarding any exchange control obligations that the Participant may have prior to vesting or receiving proceeds from the sale of shares of Common Stock acquired under the Plan. The Participant is responsible for ensuring compliance with all exchange control laws in Kazakhstan.

KENYA

Tax Registration Notification

Under Tax Procedure Act, 2015, the Participant is required to complete and submit a tax registration application to the Commissioner of Income Tax with 30 days of first vesting of the RSUs. The registration should be completed through the online portal “I TAX” and is a one-time only registration. The Participant is solely responsible for ensuring compliance with all registration requirements in Kenya.

KOREA

Awards Payable in Cash Only

Notwithstanding anything in the Award Agreement, Awards granted to Participants in Korea do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.

MALAYSIA

Data Privacy Notice
This provision replaces in its entirety the data privacy section in the Acknowledgment of Conditions section of the Award Agreement:
The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant's personal data as described in this Award Agreement by and among, as applicable, the Participant's Employer, the Corporation, and its other Affiliates for the exclusive purpose of implementing, administering and managing the Participant's participation in the Plan.
The Participant understands that the Corporation and the Participant's Employer may hold certain personal information about the Participant, including, but not limited to, the Participant's name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality,



job title, any shares of Common Stock or directorships held in the Corporation, details of all Awards or any other entitlement to shares awarded, canceled, vested, unvested or outstanding in the Participant's favor (“Data”), for the purpose of implementing, administering and managing the Plan.
The Participant understands that Data will be transferred to Merrill Lynch, or such other stock plan service provider as may be selected by the Corporation in the future, which is assisting the Corporation with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant's country. The Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative LiLin.Ng@kcc.com at telephone number 603 78068288. The Participant authorizes the Corporation, Merrill Lynch and any other possible recipients which may assist the Corporation (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Participant's participation in the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant's participation in the Plan. The Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative. Further, the Participant understands that he or she is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or later seeks to revoke his or her consent, the Participant's employment status or service and career with the Employer will not be affected; the only consequence of refusing or withdrawing consent is that the Corporation would not be able to grant the Participant RSUs or other equity awards or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing consent may affect the Participant's ability to participate in the Plan. For more information on the consequences of the Participant's refusal to consent or withdrawal of consent, the Participant understands that he or she may contact his or her local human resources representative.
Malaysian Translation:
Peserta dengan ini secara eksplisit dan tanpa sebarang keraguan mengizinkan pengumpulan, penggunaan dan pemindahan, dalam bentuk elektronik atau lain-lain, data peribadi Peserta seperti yang diterangkan dalam Perjanjian Penganugerahan dan apa-apa bahan geran opsyen lain oleh dan di antara, seperti mana yang terpakai, Majikan, Syarikat dan Anak-Anak Syarikat Sekutunya untuk tujuan ekslusif bagi melaksanakan, mentadbir dan menguruskan penyertaan peserta dalam Pelan.
Peserta memahami bahawa Syarikat dan Majikan mungkin memegang maklumat peribadi tertentu tentang Peserta , termasuk, tetapi tidak terhad kepada, nama Peserta , alamat rumah dan nombor telefon, tarikh lahir, nombor insurans sosial atau nombor pengenalan lain, gaji, kewarganegaraan, jawatan, apa-apa syer dalam saham atau jawatan pengarah yang dipegang di Syarikat, butir-butir semua opsyen atau apa-apa hak lain atas syer dalam saham biasa yang dianugerahkan, dibatalkan, dilaksanakan, terletak hak, tidak diletak hak ataupun yang belum dijelaskan bagi faedah Peserta ("Data"), untuk tujuan eksklusif bagi melaksanakan, mentadbir dan menguruskan Pelan.
Peserta memahami bahawa Data akan dipindahkan kepada Merrill Lynch, atau pembekal perkhidmatan pelan saham yang mungkin ditetapkan oleh Syarikat pada masa depan yang membantu Syarikat dengan pelaksanaan, pentadbiran dan pengurusan Pelan. Peserta memahami bahawa penerim a-penerima Data mungkin berada di Amerika Syarikat atau mana-mana tempat lain dan bahawa negara penerima-penerima (contohnya di Amerika Syarikat) mungkin mempunyai undang-undang privasi data dan perlindungan yang berbeza daripada negara Peserta. Peserta memahami bahawa Peserta boleh meminta satu senarai yang mengandungi nama dan alamat penerima-penerima Data yang berpotensi dengan menghubungi wakil sumber manusia tempatan Peserta LiLin.Ng@kcc.com, T: 603 78068288. Peserta memberi kuasa kepada Syarikat, Merrill Lynch dan mana-mana penerima-penerima lain yang mungkin membantu Syarikat (pada masa sekarang atau pada masa depan) dengan melaksanakan, mentadbir dan menguruskan Pelan untuk menerima,



memiliki, menggunakan, mengekalkan dan memindahkan Data, dalam bentuk elektronik atau lain-lain, semata-mata dengan tujuan untuk melaksanakan, mentadbir dan menguruskan penyertaan Peserta dalam Pelan. Peserta memahami bahawa Data hanya akan disimpan untuk tempoh yang perlu bagi melaksanakan, mentadbir, dan menguruskan penyertaan Peserta dalam Pelan. Peserta memahami bahawa Peserta boleh, pada bila-bila masa, melihat Data, meminta maklumat tambahan mengenai penyimpanan dan pemprosesan Data, meminta bahawa pindaan-pindaan dilaksanakan ke atas Data atau menolak atau menarik balik persetujuan dalam ini, dalam mana-mana kes, tanpa kos, dengan menghubungi secara bertulis wakil sumber manusia tempatan Peserta . Peserta selanjutnya memahami bahawa Peserta memberi persetujuan ini secara sukarela. Sekiranya Peserta tidak bersetuju, atau kemudian membatalkan persetujuan Peserta , status pekerjaan atau perkhidmatan dan kerjaya Peserta dengan Majikan tidak akan terjejas; satunya akibat jika Peserta tidak bersetuju atau menarik balik persetujuan Peserta adalah bahawa Syarikat tidak akan dapat menganugerahkan kepada RSUs atau anugerah ekuiti lain atau mentadbir atau mengekalkan anugerah tersebut. Oleh itu, Peserta memahami bahawa keengganan atau penarikan balik persetujuan Peserta boleh menjejaskan keupayaan Peserta untuk mengambil bahagian dalam Pelan. Untuk maklumat lanjut mengenai akibat keengganan Peserta untuk memberikan keizinan atau penarikan balik keizinan, Peserta boleh menghubungi wakil sumber manusia tempatan.
Director Notification Obligation
If the Participant is a director of the Corporation’s Malaysian Affiliate, the Participant is subject to certain notification requirements under the Malaysian Companies Act. Among these requirements is an obligation to notify the Malaysian Affiliate in writing when the Participant receives or disposes of an interest (e.g., an Award or shares) in the Corporation or any related company. Such notifications must be made within 14 days of receiving or disposing of any interest in the Corporation or any related company.
MEXICO

Modification

By accepting the Award, the Participant understands and agrees that any modification of the Plan or the Award Agreement or its termination shall not constitute a change or impairment of the terms and conditions of employment.

Acknowledgment of the Grant

In accepting the Award, the Participant acknowledges that the Participant has received a copy of the Plan and the Award Agreement, including this Appendix A, has reviewed the Plan and the Award Agreement, including this Appendix A, in their entirety and fully understands and accepts all provisions of the Plan and the Award Agreement, including this Appendix A. The Participant further acknowledges that the Participant has read and specifically and expressly approves the Acknowledgment of Conditions section of the Award Agreement, in which the following is clearly described and established:

    (1)    The Participant’s participation in the Plan does not constitute an acquired right.
    (2)    The Plan and the Participant’s participation in the Plan are offered by the Corporation on a wholly discretionary basis.
    (3)    The Participant’s participation in the Plan is voluntary.
    (4)    Neither the Corporation nor any Affiliates are responsible for any decrease in the value of the Award granted and/or shares of Common Stock issued under the Plan.

Labor Acknowledgment and Policy Statement

In accepting the grant of this Award, the Participant expressly recognizes that the Corporation, with registered offices at 351 Phelps Drive, Irving, Texas 75038, U.S.A., is solely responsible for the administration of the Plan and that the Participant’s participation in the Plan and acquisition of shares of Common Stock do not constitute an



employment relationship between the Participant and the Corporation since the Participant is participating in the Plan on a wholly commercial basis and his or her sole Employer is K-C AFC Manufacturing S. de R.L. de C.V. (“KCC-Mexico”). Based on the foregoing, the Participant expressly recognizes that the Plan and the benefits that he or she may derive from participating in the Plan do not establish any rights between the Participant and the Employer, KCC-Mexico and do not form part of the employment conditions and/or benefits provided by KCC-Mexico, and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of the Participant’s employment.

The Participant further understands that his or her participation in the Plan is as a result of a unilateral and discretionary decision of the Corporation; therefore, the Corporation reserves the absolute right to amend and/or discontinue the Participant’s participation at any time without any liability to the Participant.

Finally, the Participant hereby declares that he or she does not reserve to him- or herself any action or right to bring any claim against the Corporation for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and the Participant therefore grants a full and broad release to the Corporation, its Affiliates, branches, representation offices, its shareholders, officers, agents, or legal representatives with respect to any claim that may arise.

Spanish Translation

Modificación

Al aceptar el Premio, el Participante entiende y acuerda que cualquier modificación al Plan o al Acuerdo o su terminación, no cambiará o disminuirá los términos y condiciones de empleo.

Reconocimiento del Otorgamiento

Al aceptar el Premio, el Participante está de acuerdo en haber recibido una copia del Plan, del Acuerdo incluyendo el presente Anexo “A” y ha revisado el Plan y el Acuerdo, incluyendo este Anexo “A” en su totalidad y comprende y acepta todas las disposiciones previstas en el Plan, en el Acuerdo, incluyendo el presente Anexo “A”. Asimismo, el Participante reconoce que ha leído y manifiesta su específica y expresa conformidad con los términos y condiciones establecidos del Acuerdo, en el cual claramente se describe y establece lo siguiente:

    (1)    La participación del Participante en el Plan no constituye un derecho adquirido.
    (2)    El Plan y la participación del Participante en el Plan se ofrecen por la Compañía de forma completamente discrecional.
    (3)    La participación del Participante en el Plan es voluntaria.
    (4)    Ni la Compañía ni sus Afiliadas son responsables por la reducción del valor del Premio y/o Acciones Ordinarias emitidas bajo el Plan.

Reconocimiento de la Legislación Laboral y Declaración de la Política

Al aceptar el otorgamiento de este Premio, el Participante expresamente reconoce que Kimberly-Clark Corporación con oficinas registradas en 351 Phelps Drive, Irving, Texas 75038, EE.UU., es la única responsable por la administración del Plan y que la participación del Participante en el Plan y en su caso la adquisición de las Opciones de Compra de Acciones o Acciones no constituyen ni podrán interpretarse como una relación de trabajo entre el Participante y Kimberly-Clark Corporación, ya que el Participante participa en el Plan en un marco totalmente comercial y su único Patrón lo es K-C AFC Manufacturing S. de R.L. de C.V. (“KCC-Mexico”). Derivado de lo anterior, el Participante expresamente reconoce que el Plan y los beneficios que pudieran derivar de la participación en el Plan no establecen derecho alguno entre el Participante y el Patrón, KCC-Mexico y no forma parte de las condiciones de trabajo y/o las prestaciones otorgadas por KCC-Mexico y que cualquier modificación al Plan o su terminación no constituye un cambio o impedimento de los términos y condiciones de la relación de trabajo del Participante.




Asimismo, el Participante reconoce que su participación en el Plan es resultado de una decisión unilateral y discrecional de Kimberly-Clark Corporación por lo tanto, Kimberly-Clark Corporación se reserva el absoluto derecho de modificar y/o terminar la participación del Participante en cualquier momento y sin responsabilidad alguna frente el Participante.

Finalmente, el Participante por este medio declara que no se reserva derecho o acción alguna que ejercitar en contra de Kimberly-Clark Corporación por cualquier compensación o daño en relación con las disposiciones del Plan o de los beneficios derivados del Plan y por lo tanto, el Participante otorga el más amplio finiquito que en derecho proceda a Kimberly-Clark Corporación, sus afiliadas, subsidiarias, oficinas de representación, sus accionistas, funcionarios, agentes o representantes legales en relación con cualquier demanda que pudiera surgir.

Securities Law Notification
The RSUs and the shares of Common Stock offered under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the Plan, the Award Agreement and any other document relating to the RSUs may not be publicly distributed in Mexico. These materials are addressed to the Participant only because of their existing relationship with the Corporation and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Mexican subsidiary of the Corporation made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.

NETHERLANDS

There are no country-specific provisions

NEW ZEALAND

Securities Law Information

The Participant is being offered RSUs which, if vested, will entitle the Participant to acquire shares of Common Stock in accordance with the terms of the Award Agreement and the Plan. The shares of Common Stock, if issued, will give the Participant a stake in the ownership of the Corporation. The Participant may receive a return if dividends are paid.

If the Corporation runs into financial difficulties and is wound up, the Participant will be paid only after all creditors and holders of preferred shares (if any) have been paid. The Participant may lose some or all of the Participant’s investment, if any.

New Zealand law normally requires people who offer financial products to give information to investors before they invest. This information is designed to help investors to make an informed decision. The usual rules do not apply to this offer because it is made under an employee share scheme. As a result, the Participant may not be given all the information usually required. The Participant will also have fewer other legal protections for this investment. The Participant is advised to ask questions, read all documents carefully, and seek independent financial advice before committing.

The shares of Common Stock are quoted on the New York Stock Exchange (“NYSE”). This means that if the Participant acquires shares of Common Stock under the Plan, the Participant may be able to sell the shares of Common Stock on the NYSE if there are interested buyers. The Participant may get less than the Participant invested. The price will depend on the demand for the shares of Common Stock.

For a copy of the Corporation’s most recent financial statements (and, where applicable, a copy of the auditor’s report on those financial statements), as well as information on risk factors impacting the Corporation’s business



that may affect the value of the shares pf Common Stock, the Participant should refer to the risk factors discussion on the Corporation’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available online at www.sec.gov, as well as on the Corporation’s “Investor Relations” website at http://investor.kimberly-clark.com/index.cfm.

NIGERIA

There are no country-specific provisions.

PANAMA

Securities Law Information

Neither this Award nor any shares of Common Stock that the Participant may acquire at vesting of this Award constitute a public offering of securities, as they are available only to eligible employees of the Corporation and its Affiliates.

PARAGUAY

There are no country-specific provisions.

PERU

Securities Law Information

The offer of this Award is considered a private offering in Peru; therefore, it is not subject to registration in Peru. For more information concerning the offer, please refer to the Plan, the Award Agreement and any other materials or documentation made available by the Corporation. For more information regarding the Corporation, please refer to the Corporation’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available at www.sec.gov, as well as the Corporation’s “Investor Relations” website at: http://investor.kimberly-clark.com/

Labor Law Acknowledgment

By accepting the Award, the Participant acknowledges that the RSUs are being granted ex gratia to the Participant.

PHILIPPINES

Awards Payable in Cash Only

Notwithstanding anything in the Award Agreement, Awards granted to Participants in the Philippines do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash in an amount equal to the value of the shares of Common Stock at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.

Fringe Benefit Tax Obligation

By accepting the Award, the Participant consents and agrees to assume any and all liability for fringe benefit tax that may be payable by the Corporation and/or the Employer (as determined by the Corporation or the Employer in their discretion) in connection with the Award and any awards previously granted by the Corporation. Further, by accepting the Award, the Participant agrees that the Corporation and/or the Employer may collect the fringe benefit tax from the Participant by any of the means set forth in the Acknowledgment of Conditions section of the



Award Agreement, or any other reasonable method established by the Corporation. The Participant agrees to execute other consents or elections to accomplish the foregoing, promptly upon request by the Corporation or the Employer.

POLAND

Foreign Asset/Account Reporting Information
Polish residents holding foreign securities (e.g., shares of Common Stock) and/or maintaining accounts abroad must report information to the National Bank of Poland on transactions and balances regarding such securities and cash deposited in such accounts if the value of such securities and cash (when combined with all other assets possessed abroad) exceeds certain thresholds. If required, the reports must be filed on a quarterly basis on special forms that are available on the website of the National Bank of Poland. Polish residents should consult with their personal tax advisor to determine their personal reporting obligations.

Exchange Control Information
Transfers of funds into and out of Poland in excess of €15,000 (or PLN 15,000 if such transfer of funds is connected with business activity of an entrepreneur) must be made via a bank account held at a bank in Poland. Additionally, Polish residents are required to store all documents connected with any foreign exchange transactions that Polish residents are engaged in for a period of five years, as measured from the end of the year in which such transaction occurred.
PUERTO RICO

There are no country specific provisions.

RUSSIA
Settlement of RSUs
Depending on applicable restrictions then in effect, the Corporation has the sole discretion to postpone the vesting and/or settlement of any RSUs, to determine whether to settle any vested RSUs in shares of Common Stock or in cash, or to cancel such RSUs for no consideration.
Securities Law Information
This Award Agreement, the Plan and all other materials the Participant may receive regarding participation in the Plan do not constitute advertising or an offering of securities in Russia. Absent any requirement under local law, the issuance of shares of Common Stock under the Plan has not and will not be registered in Russia and hence the shares described in any Plan-related documents may not be offered or placed in public circulation in Russia.
US Transaction
The Participant understands that the RSUs and any shares of Common Stock under the Plan are to be issued and sold solely in the United States. Any shares of Common Stock issued to the Participant upon vesting of the RSUs shall be delivered to the Participant’s brokerage account in the United States, where such shares of Common Stock must be held until the time of sale. In no event will shares of Common Stock be delivered to the Participant in Russia.
Exchange Control Information  
All restrictions on the payment of funds by non-residents into a Russian resident’s declared foreign brokerage account, including dividends and proceeds from the sale of shares of Common Stock have been abolished. Russian



residents may now receive, hold and remit dividends and proceeds from the sale of shares (including shares of Common Stock acquired under the Plan) into and out of a brokerage account without any requirement to first repatriate such funds to an authorized bank in Russia. The Participant should be aware that the rules related to foreign bank accounts are different and that certain restrictions with respect to payments by non-residents into a Russian currency resident’s foreign bank account may continue to apply where the foreign bank account is located in the U.S. The Participant should contact his or her personal advisor to confirm the application of the exchange control restrictions prior to vesting in the RSUs and selling shares of Common Stock, as significant penalties may apply in the case of non-compliance with the exchange control restrictions and because such exchange control restrictions are subject to change.
Foreign Asset/Account Reporting Information
Russian residents are required to report the opening, closing or change in account details of any foreign bank account to the Russian tax authorities within one month of the opening, closing or change of such account. Russian residents are also required to report to the Russian tax authorities on or before June 1 of the following year (i) the beginning and ending balances in a foreign bank account each year and (ii) transactions related to such foreign account during the year. Foreign brokerage accounts and foreign accounts with other financial institutions (financial market organizations) must also be reported. Certain specific exemptions from reporting requirements may apply. Non-compliance with the reporting obligations could impact the Participant's ability to vest, receive shares of Common Stock pursuant to the RSUs, maintain the account outside of Russia and participate in the Plan. The Participant should consult with his or her personal legal advisor to determine how these reporting requirements may apply to any account opened in connection with the Participant’s participation in the Plan.
Data Privacy Notice
This provision supplements the Data Privacy section in the Acknowledgment and Conditions section of the Award Agreement:
The Participant understands and agrees that he or she must complete and return a Consent to Processing of Personal Data (the “Consent”) form to the Corporation if requested. Further, the Participant understands and agrees that if the Participant does not complete and return a Consent form to the Corporation if requested, the Corporation will not be able to grant RSUs to the Participant or other awards or administer or maintain such awards. Therefore, the Participant understands that refusing to complete a Consent form or withdrawing his or her consent may affect the Participant’s ability to participate in the Plan.
Anti-Corruption Information
Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (e.g., shares of foreign companies such as the Corporation). Accordingly, the Participant should inform the Corporation if he or she is covered by these laws because the Participant should not hold shares of common stock acquired under the Plan.
Labor Law Information
If the Participant continues to hold shares of Common Stock acquired at vesting of the RSUs after an involuntary termination of employment, he or she may not be eligible to receive unemployment benefits in Russia.
SAUDI ARABIA

Securities Law Information.
This document may not be distributed in the Kingdom except to such persons as are permitted under the Rules on the Offer of Securities and Continuing Obligations issued by the Capital Market Authority.



The Capital Market Authority does not make any representation as to the accuracy or completeness of this document, and expressly disclaims any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this document. Prospective purchasers of the securities offered hereby should conduct their own due diligence on the accuracy of the information relating to the securities. If the Participant does not understand the contents of this document, the Participant should consult an authorized financial adviser.
SINGAPORE
Sale Restriction
The Participant agrees that any shares of Common Stock acquired pursuant to the RSUs will not be offered for sale in Singapore prior to the six-month anniversary of the Grant Date, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”), or pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA.
Securities Law Information
The grant of the RSUs is being made pursuant to the “Qualifying Person” exemption” under section 273(1)(f) of the SFA under which it is exempt from the prospectus and registration requirements and is not made with a view to the underlying shares of Common Stock being subsequently offered for sale to any other party. The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore.
Director Notification Obligation
If the Participant is a director, associate director or shadow director of the Corporation’s Singapore Affiliate, the Participant is subject to certain notification requirements under the Singapore Companies Act (Cap. 50, Rev Ed 2006). Among these requirements is an obligation to notify the Corporation’s Singapore Affiliate in writing when the Participant receives an interest (e.g., an Award or shares) in the Corporation or any Affiliate. In addition, the Participant must notify the Corporation’s Singapore Affiliate when he or she sells shares of the Corporation or of any Affiliate (including when the Participant sells shares issued upon vesting and settlement of the Award). These notifications must be made within two business days of (i) acquiring or disposing of any interest in the Corporation or any Affiliate, or (ii) any change in a previously-disclosed interest (e.g., upon vesting of the Award or when shares of Common Stock acquired under the Plan are subsequently sold). In addition, a notification of the Participant’s interests in the Corporation or any Affiliate must be made within two business days of becoming a director, associate director or shadow director.
SLOVAK REPUBLIC
Foreign Asset/Account Reporting Information

If the Participant permanently resides in the Slovak Republic and, apart from being employed, carries on business activities as an independent entrepreneur (in Slovakian, podnikatel), the Participant will be obligated to report his or her foreign assets (including any foreign securities) to the National Bank of Slovakia (provided that the value of the foreign assets exceeds an amount of €2,000,000). These reports must be submitted on a monthly basis by the 15th day of the respective calendar month, as well as on a quarterly basis by the 15th day of the calendar month following the respective calendar quarter, using notification form DEV (NBS) 1-12, which may be found at the National Bank of Slovakia’s website at www.nbs.sk.



SOUTH AFRICA

Tax Acknowledgment

By accepting the Award, the Participant agrees to notify the Employer of the amount of any gain realized upon vesting of the Award. If the Participant fails to advise the Employer of the gain realized upon vesting, the Participant may be liable for a fine. The Participant will be responsible for paying any difference between the actual tax liability and the amount withheld.

Exchange Control Information

To participate in the Plan, the Participant must comply with exchange control regulations and rulings (the “Exchange Control Regulations”) in South Africa.

Because the Exchange Control Regulations change frequently and without notice, the Participant understands that he or she should consult a legal advisor prior to the acquisition or sale of shares under the Plan to ensure compliance with current regulations. The Participant understands that it is his or her responsibility to comply with South African exchange control laws, and neither the Corporation nor the Employer will be liable for any fines or penalties resulting from failure to comply with applicable laws.

Securities Law Information

In compliance with South African securities law, the Participant acknowledges that the documents listed below are available for review at the addresses listed below:

1)The Corporation's most recent annual financial statements: http://investor.kimberly-clark.com/sec.cfm?DocType=Annual&Year=

2)The Corporation's most recent Plan prospectus may be accessed online through Merrill Lynch, or such other stock plan service provider as may be selected by the Corporation in the future, at www.mybenefits.ml.com in the Document Library.

A copy of the above documents will be sent free of charge upon written request to Stock Plan Administrator, P.O. Box 619100, Dallas, Texas 75261-9100. In addition, the Participant should contact his or her tax advisor for specific information concerning his or her personal tax situation with regard to Plan participation.

SPAIN

Securities Law Information
No “offer of securities to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of the Award. The Award Agreement (including this Appendix A) has not been, nor will it be, registered with the Comisión Nacional del Mercado de Valores, and does not constitute a public offering prospectus.

Labor Law Acknowledgment

By accepting the Award, the Participant acknowledges that he or she understands and agrees to participation in the Plan and that he or she has received a copy of the Plan.

The Participant understands that the Corporation has unilaterally, gratuitously and discretionally decided to grant Awards under the Plan to individuals who may be employees of the Corporation or its Affiliates throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Corporation or any of its Affiliates on an ongoing basis.



Consequently, the Participant understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Corporation or any of its Affiliates) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. Further, the Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from any gratuitous and discretionary grant since the future value of the Award and the underlying shares is unknown and unpredictable. In addition, the Participant understands that this grant would not be made but for the assumptions and conditions referred to above; thus, the Participant understands, acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then the Award shall be null and void.
Further, the Participant understands that the Award is a conditional right. Participant shall forfeit any unvested Award upon termination of employment unless such termination is (i) due to a Qualified Termination of Employment, or (ii) due to death, Total and Permanent Disability, or the shutdown or divestiture of a business unit. Vesting will cease, for example, regardless of whether (1) the Participant is considered to be unfairly dismissed without good cause (i.e., subject to a “despido improcedente”); (2) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal; (3) the Participant terminates his or her employment or service relationship due to a change of work location, duties or any other employment or contractual condition; and (4) the Participant terminates his or her employment or service relationship due to a unilateral breach of contract by the Corporation or an Affiliate. Consequently, upon termination of the Participant’s employment or service relationship for any of the above reasons, the Participant may automatically lose any rights to the RSUs that were not vested on the date of termination of the Participant’s employment or service relationship, as described in the Plan and the Award Agreement.
Exchange Control Information
If the Participant holds 10% or more of the Corporation’s share capital, the Participant must declare the acquisition, ownership and disposition of shares of Common Stock to the Spanish Dirección General de Comercio e Inversiones (the “DGCI”) of the Ministry of Economy and Competitiveness.
In addition, the Participant may be required to declare electronically to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), any foreign instruments (including any shares of Common Stock acquired under the Plan) and any transactions with non-Spanish residents (including any payments of shares of Common Stock made to the Participant by the Corporation) depending on the value of such accounts and instruments and the amount of the transactions during the relevant year as of December 31 of the relevant year.
Foreign Asset/Account Reporting Information
If the Participant holds rights or assets (e.g., shares of Common Stock or cash held in a bank or brokerage account) outside of Spain with a value in excess of €50,000 per type of right or asset (e.g., shares of Common Stock, cash, etc.) as of December 31 each year, the Participant is required to report certain information regarding such rights and assets on tax form 720.  After such rights and/or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than €20,000 or if the ownership of the assets is transferred or relinquished during the year.  The reporting must be completed by the following March 31. 
SWITZERLAND

Securities Law Information

Neither this document nor any other materials relating to the Awards (i) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (“FinSA”) (ii) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than a participant or (iii) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (“FINMA”).




TAIWAN

Data Privacy

The following provision supplements the data privacy section in the Acknowledgment of Conditions section of the Award Agreement:

The Participant acknowledges that he or she has read and understands the terms regarding collection, processing and transfer of data contained in the Acknowledgment of Conditions section of the Award Agreement and, by participating in the Plan the Participant agrees to such terms. In this regard, upon request of the Corporation or the Employer, the Participant agrees to provide any executed data privacy consent form to the Employer or the Corporation (or any other agreements or consents that may be required by the Employer or the Corporation) that the Corporation and/or the Employer may deem necessary to obtain under the data privacy laws now or in the future. The Participant understands that he or she will not be able to participate in the Plan if the Participant fails to execute any such consent or agreement.

Securities Law Information

The offer of participation in the Plan is available only for employees of the Corporation and its Affiliates. The offer of participation in the Plan is not a public offer of securities by a Taiwanese company.

Exchange Control Information

Taiwanese residents may acquire and remit foreign currency (including proceeds from the sale of shares of Common Stock or the receipt of dividends) into and out of Taiwan up to US$5,000,000 per year. If the transaction amount is TWD500,000 or more in a single transaction, the Participant must submit a foreign exchange transaction form and also provide supporting documentation to the satisfaction of the remitting bank.

THAILAND
Exchange Control Information
If the proceeds from the sale of shares of Common Stock or the receipt of dividends paid on such shares are equal to or greater than US$1,000,000 in a single transaction, Thai residents must repatriate all cash proceeds to Thailand immediately following the receipt of the cash proceeds and then either convert such proceeds to Thai Baht or deposit the proceeds into a foreign currency account opened with a commercial bank in Thailand within 360 days of repatriation. In addition, Thai residents must specifically report the inward remittance to the Bank of Thailand on a foreign exchange transaction form.
Failure to comply with the above obligations may lead to penalties being assessed by the Bank of Thailand. Because exchange control regulations change frequently and without notice, the Participant should consult with his or her legal advisor before selling any shares of Common Stock (or receiving any other funds in connection with the Plan) to ensure compliance with current regulations. It is the Participant’s responsibility to comply with exchange control laws in Thailand and neither the Corporation nor the Employer will be liable for any fines or penalties resulting from failure to comply with applicable laws.

TURKEY

Securities Law Information

Turkish residents are not permitted to sell shares of Common Stock acquired under the Plan in Turkey. Turkish residents must sell the shares of Common Stock acquired under the Plan outside of Turkey. The Shares are



currently traded on the New York Stock Exchange in the U.S. under the ticker symbol “KMB” and shares of Common Stock may be sold on this exchange.

Exchange Control Information

Under Turkish law, Turkish residents are permitted to purchase and sell securities or derivatives traded on exchanges abroad only through a financial intermediary licensed in Turkey.  Therefore, the Participant may be required to appoint a Turkish broker to assist him or her with the sale of the shares of Common Stock acquired under the Plan.  The Participant should consult his or her personal legal advisor before selling any shares of Common Stock acquired under the Plan to confirm the applicability of this requirement to the Participant.

UKRAINE

Awards Payable in Cash Only1

Notwithstanding anything in the Award Agreement, Awards granted to Participants in Ukraine do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to Participant through local payroll. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.

UNITED ARAB EMIRATES

Securities Law Information
The offer of the Award is available only for select employees of the Corporation and its Affiliates and is in the nature of providing employee incentives in the United Arab Emirates. The Plan and the Award Agreement are intended for distribution only to such employees and must not be delivered to, or relied on, by any other person. Prospective purchasers of securities should conduct their own due diligence.
The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the Plan and the Award Agreement, or any other incidental communication materials distributed in connection with the Award. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the Plan and the Award Agreement should obtain independent professional advice.

UNITED KINGDOM

Tax Acknowledgment

The following information supplements the information regarding Tax-Related Items in the Acknowledgment of Conditions section of the Award Agreement:

Without limitation to the information regarding Tax-Related Items in the Award Agreement, the Participant agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Corporation or, if different, the Employer or by HM & Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant agrees to indemnify and keep indemnified the Corporation and/or the Employer for all Tax-Related Items that they are required to pay, or withhold or have paid
1 KCC discussing tax considerations with E&Y and will determine whether to share-settle. Please let Baker know so we can update if needed.



or will pay to HMRC on the Participant’s behalf (or any other tax authority or any other relevant authority) and authorizes the Corporation and/or the Employer to recover such amounts by any of the means referred to in the Acknowledgment of Conditions section of the Award Agreement.

Notwithstanding the foregoing, if the Participant is an executive officer or director (as within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), the Participant understands that he or she may not be able to indemnify the Corporation for the amount of any Tax-Related Items not collected from or paid by the Participant, if the indemnification could be considered a loan. In this case, the Tax-Related Items not collected or paid may constitute a benefit to the Participant on which additional income tax and National Insurance contributions (“NICs”) may be payable.

The Participant acknowledges that the Participant ultimately will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Corporation or the Employer (as appropriate) the amount of any NICs due on this additional benefit, which the Corporation and/or the Employer may also recover from the Participant at any time thereafter by any of the means referred to in the Acknowledgment of Conditions section of the Award Agreement.

URUGUAY

There are no country-specific provisions.

VIETNAM

Awards Payable in Cash Only

Notwithstanding anything in the Award Agreement, Awards granted to Participants in Vietnam do not provide any right for the Participant to receive shares of Common Stock and shall be paid only in cash through local payroll in an amount equal to the value of the shares at vesting less any Tax-Related Items. The Participant agrees to bear any currency fluctuation risk between the time the Awards vest and the time the cash payment is distributed to the Participant through local payroll. The Corporation reserves the right to settle the Awards in shares of Common Stock to the extent the Corporation determines it is necessary or advisable for legal or administrative reasons.

EX-31.A 5 kmb10qq22023exhibit31a.htm CERTIFICATION OF CEO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) Document

Exhibit (31)a
CERTIFICATIONS
I, Michael D. Hsu, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Kimberly-Clark Corporation (the “registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



 /s/ Michael D. Hsu
 Michael D. Hsu
 Chief Executive Officer
July 25, 2023 




EX-31.B 6 kmb10qq22023exhibit31b.htm CERTIFICATION OF CFO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) Document

Exhibit (31)b
CERTIFICATIONS
I, Nelson Urdaneta, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Kimberly-Clark Corporation (the “registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


 /s/ Nelson Urdaneta
 Nelson Urdaneta
 Chief Financial Officer
July 25, 2023 




EX-32.A 7 kmb10qq22023exhibit32a.htm CERTIFICATION OF CEO AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) Document

Exhibit (32)a
Certification of Chief Executive Officer
Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code
I, Michael D. Hsu, Chief Executive Officer of Kimberly-Clark Corporation, certify that, to my knowledge:
(1)the Form 10-Q, filed with the Securities and Exchange Commission on July 25, 2023 (“accompanied report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the accompanied report fairly presents, in all material respects, the financial condition and results of operations of Kimberly-Clark Corporation.


 /s/ Michael D. Hsu
 Michael D. Hsu
 Chief Executive Officer
July 25, 2023 


EX-32.B 8 kmb10qq22023exhibit32b.htm CERTIFICATION OF CFO REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) Document

Exhibit (32)b
Certification of Chief Financial Officer
Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code
I, Nelson Urdaneta, Chief Financial Officer of Kimberly-Clark Corporation, certify that, to my knowledge:
(1)the Form 10-Q, filed with the Securities and Exchange Commission on July 25, 2023 (“accompanied report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the accompanied report fairly presents, in all material respects, the financial condition and results of operations of Kimberly-Clark Corporation.

 /s/ Nelson Urdaneta
 Nelson Urdaneta
 Chief Financial Officer
July 25, 2023 


EX-101.SCH 9 kmb-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Consolidated Income Statement link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Consolidated Statement Of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Consolidated Balance Sheet link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Consolidated Balance Sheet Parenthetical link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Statement of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Statement of Stockholders' Equity Stockholders' Equity Parentheticals link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Consolidated Cash Flow Statement link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - Supplemental Balance Sheet Data Narrative link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Acquisition link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Impairment of Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Fair Value Information link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Objectives And Strategies For Using Derivatives link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Description Of Business Segments link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Supplemental Balance Sheet Data link:presentationLink link:calculationLink link:definitionLink 9954701 - Disclosure - Supplemental Balance Sheet Data (Policies) link:presentationLink link:calculationLink link:definitionLink 9954702 - Disclosure - Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 9954703 - Disclosure - Impairment of Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954704 - Disclosure - Fair Value Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954705 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954706 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 9954707 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954708 - Disclosure - Objectives And Strategies For Using Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 9954709 - Disclosure - Description Of Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954710 - Disclosure - Summary of Balance Sheet Data (Tables) link:presentationLink link:calculationLink link:definitionLink 9954711 - Disclosure - Accounting Policies Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954712 - Disclosure - Acquisition Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954713 - Disclosure - Acquisition (Schedule of Recognized Identified Assets Acquired and Liabilities Assumed) (Details) link:presentationLink link:calculationLink link:definitionLink 9954714 - Disclosure - Impairment of Intangible Assets Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954715 - Disclosure - Impairment of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954716 - Disclosure - Fair Value Information (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954717 - Disclosure - Fair Value Information (Fair Value Of Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 9954718 - Disclosure - Earnings Per Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954719 - Disclosure - Earnings Per Share (Average Common Shares Outstanding Basic And Diluted) (Details) link:presentationLink link:calculationLink link:definitionLink 9954720 - Disclosure - Stockholders' Equity (Components of Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 9954721 - Disclosure - Leases (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954722 - Disclosure - Lease (Tables) (Details) link:presentationLink link:calculationLink link:definitionLink 9954723 - Disclosure - Lease, Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954724 - Disclosure - Leases Schedule of Lease Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954725 - Disclosure - Leases Lessee, Operating Lease, Liability, Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954726 - Disclosure - Leases Schedule of Future Minimum Rental Payments for Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 9954727 - Disclosure - Objectives And Strategies For Using Derivatives (Narratives) (Details) link:presentationLink link:calculationLink link:definitionLink 9954728 - Disclosure - Description Of Business Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9954729 - Disclosure - Description Of Business Segments Sales of Principle Products (Details) link:presentationLink link:calculationLink link:definitionLink 9954730 - Disclosure - Supplemental Balance Sheet Data - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 9954731 - Disclosure - Supplemental Balance Sheet Data - Property Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 kmb-20230630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 kmb-20230630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 kmb-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Net (income) loss attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items] Accrued expenses and other current liabilities Accrued Liabilities, Current Total Current Assets Assets, Current Other Intangible Assets, Net Other Intangible Assets, Net LIFO LIFO [Member] LIFO [Member] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Cash Flow Hedges and Other Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Asset impairments Asset Impairment Charges Sales of Principal Products Revenue from External Customers by Products and Services [Table Text Block] Equity Award [Domain] Award Type [Domain] Impairment of Intangible Assets (Excluding Goodwill) Impairment of Intangible Assets (Excluding Goodwill) Nonoperating expense Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Payments to Acquire Businesses, Gross Payments to Acquire Businesses, Gross Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Effect of Exchange Rate Changes on Cash and Cash Equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Defined benefit and other postretirement benefit plans - Beginning balance Defined benefit and other postretirement benefit plans - Ending balance Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Deferred Income Taxes Deferred Income Tax Liabilities, Net Segment Reporting [Abstract] Segment Reporting [Abstract] Trade accounts payable Accounts Payable, Current Net sales of K-C Argentina, percent Concentration Risk, Percentage Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Schedule of Product Information [Table] Schedule of Product Information [Table] Schedule of Accumulated Other Comprehensive Income (Loss), Attributable to Kimberly-Clark Corporation Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Preferred Stock, Shares Authorized Preferred Stock, Shares Authorized Cash Surrender Value, Fair Value Disclosure Cash Surrender Value, Fair Value Disclosure Personal Care [Member] Personal Care Personal Care [Member] Personal Care [Member] Construction in progress Construction in Progress, Gross Other Postretirement Benefit Plans Other Postretirement Benefits Plan [Member] Stockholders' Equity Equity [Text Block] Cash Provided by Operations Net Cash Provided by (Used in) Operating Activities Class of Stock [Axis] Class of Stock [Axis] Entities [Table] Entities [Table] Geographical [Axis] Geographical [Axis] Treasury Stock, Value [Abstract] Treasury Stock, Value [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Cash flow hedges and other Other Comprehensive Income, Other, Net of Tax Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Other (income) and expense, net Other Operating Income (Expense), Net Current Liabilities Liabilities, Current [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Information [Line Items] Entity Information [Line Items] Gain (Loss) on Disposition of Business Gain (Loss) on Disposition of Business Preferred Stock, Par or Stated Value Per Share Preferred Stock, Par or Stated Value Per Share Total Kimberly-Clark Corporation Stockholders' Equity Equity, Attributable to Parent Preferred Stock, Value, Issued Preferred Stock, Value, Issued Proceeds from Divestiture of Businesses Proceeds from Divestiture of Businesses Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain Derivative Instruments, Gain (Loss) Derivative Instruments, Gain (Loss) [Line Items] Diluted Earnings Per Share, Diluted Additional Paid in Capital [Abstract] Additional Paid in Capital [Abstract] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Hedging Relationship [Axis] Hedging Relationship [Axis] Treasury Stock, Value Treasury Stock, Value Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Land Land Unrealized currency translation adjustments Net current period other comprehensive income (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Concentration Risk Type [Axis] Concentration Risk Type [Axis] Fair Value, Inputs, Level 3 Fair Value, Inputs, Level 3 [Member] Treasury Stock, Common, Shares Treasury Stock, Common, Shares Long-Term Debt Long-Term Debt and Lease Obligation Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Share-based Payment Arrangement, Accelerated Cost Share-Based Payment Arrangement, Accelerated Cost Trading Symbol Trading Symbol Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Restructuring Plan [Domain] Restructuring Plan [Domain] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Preferred Stock, Shares Issued Preferred Stock, Shares Issued Hedging Designation [Domain] Hedging Designation [Domain] Divestiture Net Benefit Divestiture Net Benefit Divestiture Net Benefit Long-term debt Long-term Debt, Fair Value Long-Term Debt, Fair Value Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Net Income Attributable to Kimberly-Clark Corporation Net Income (Loss) Total Current Liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Net Investment Hedging Net Investment Hedging [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Capital spending Payments to Acquire Productive Assets Supplies and other Other Inventory, Supplies, Gross Finished goods Inventory, Finished Goods, Gross Common Stock, Shares, Issued Shares, Issued LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] (Income)/loss reclassified from AOCI Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Document Fiscal Period Focus Document Fiscal Period Focus Inventory, Gross Inventory, Gross Cost of products sold Cost of Goods and Services Sold Costs Related to Divestiture Costs Related to Divestiture Costs Related to Divestiture Intangible Assets Impaired, Fair Value Disclosure Intangible Assets, Fair Value Disclosure - Softex, Thinx, Inc. Intangible Assets, Fair Value Disclosure - Softex, Thinx, Inc. Acquisition of business, net of cash acquired Proceeds from Sale of Productive Assets Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Gain (loss) on undesignated foreign exchange hedging instruments Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Foreign currency exchange contracts Foreign Exchange Contract [Member] Common Stock Common Stock Common Stock [Member] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Employee postretirement benefits Net current period other comprehensive income (loss) Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Carrying (Reported) Amount, Fair Value Disclosure Reported Value Measurement [Member] Product and Service [Axis] Product and Service [Axis] Earnings Per Share Earnings Per Share [Text Block] Goodwill Goodwill Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Buildings Buildings and Improvements, Gross Hedging Relationship [Domain] Hedging Relationship [Domain] Inventory, LIFO Reserve Inventory, LIFO Reserve Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total Stockholders' Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Equity, Including Portion Attributable to Noncontrolling Interest 0.625% Notes Due 2024 [Member] 0.625% Notes Due 2024 [Member] 0.625% Notes Due 2024 [Member] Measurement Basis [Axis] Measurement Basis [Axis] Closing Date Adjustment Closing Date Adjustment Closing Date Adjustment Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain, Transaction and Related Costs, Net Benefit Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain, Transaction and Related Costs, Net Benefit Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain, Transaction and Related Costs, Net Benefit Entity Small Business Entity Small Business Inventory [Domain] Inventory [Domain] Local Phone Number Local Phone Number Property, Plant and Equipment, Net Total Property, Plant and Equipment, Net Fair Value Measurement [Domain] Fair Value Measurement [Domain] Other comprehensive income/(loss) before reclassifications Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax Transaction [Domain] Transaction [Domain] Change in short-term debt Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less Derivative, Notional Amount Derivative, Notional Amount Supplier Finance Program, Obligation Supplier Finance Program, Obligation Dividends declared Common Stock, Dividends, Per Share, Declared Inventory, Work in Process and Raw Materials [Abstract] Inventory, Work in Process and Raw Materials [Abstract] Total Other Comprehensive Income (Loss), Net of Tax Other Comprehensive Income, Net of Tax Total Other Comprehensive Income (Loss), Net of Tax Other Comprehensive Income (Loss), Net of Tax Measurement Frequency [Axis] Measurement Frequency [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] After Tax After Tax [Member] After Tax [Member] Dividends, Common Stock, Cash Dividends, Common Stock, Cash ASSETS Assets [Abstract] Short-term debt Short-Term Debt, Fair Value Debt proceeds Proceeds from Issuance of Long-Term Debt Revenue from External Customer Consolidated Revenue from External Customer [Line Items] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Income Before Income Taxes and Equity Interests Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax Thinx Inc Thinx Inc [Member] Thinx Inc Net income Net Income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Cash Used for Financing Net Cash Provided by (Used in) Financing Activities Retirement Plan Type [Axis] Retirement Plan Type [Axis] Other comprehensive income/(loss) before reclassifications Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Marketing, research and general expenses Marketing, research and general expenses The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. The aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Other Payments for (Proceeds from) Other Investing Activities Transaction Type [Axis] Transaction Type [Axis] Retained Earnings Retained Earnings [Member] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table] Noncurrent Employee Benefits Liability, Defined Benefit Plan, Noncurrent TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Other Assets Other Assets, Noncurrent Basic Earnings Per Share, Basic Accounting Policies [Abstract] Accounting Policies [Abstract] Consumer Tissue Consumer Tissue Products Consumer Tissue [Member] Consumer Tissue [Member] Accruals, Common Securities Redeemed Obligation to Noncontrolling Interests Obligation to Noncontrolling Interests Net (gains) losses on asset and business dispositions Gain (Loss) on Disposition of Assets Net Sales Revenues Fair value of financial instruments Fair Value, by Balance Sheet Grouping [Table Text Block] Other (income) and expense, net Other income and expense, net [Member] Other income and expense, net [Member] Product and Service [Domain] Product and Service [Domain] Tax Effect [Domain] Tax Effect [Domain] [Domain] for Tax Effect [Axis] Entity Address, City or Town Entity Address, City or Town Information Concerning Consolidated Operations by Business Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Net Asset Value Investments [Domain] Net Asset Value Investments [Domain] [Domain] for Net Asset Value Investments [Axis] Tax Effect [Axis] Tax Effect [Axis] Tax Effect [Axis] Unrealized Translation Unrealized Translation [Member] Unrealized Translation [Member] Business Combination, Acquisition Related Costs Business Combination, Acquisition Related Costs Award Type [Axis] Award Type [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Time deposits Time Deposits Fair Value Disclosure Time Deposits Fair Value Disclosure Document Quarterly Report Document Quarterly Report Interest expense Interest Expense Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Additional Financial Information Disclosure Additional Financial Information Disclosure [Text Block] Document Transition Report Document Transition Report Hedging Designation [Axis] Hedging Designation [Axis] Property, Plant and Equipment, Gross Property, Plant and Equipment, Gross Equity companies' earnings (in excess of) less than dividends paid Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Business Combinations [Abstract] Unrealized translation - Beginning balance Unrealized translation - Ending balance Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Common Stock, Shares Authorized Common Stock, Shares Authorized Sale of Brazil tissue assets Sale of Brazil tissue assets [Member] Sale of Brazil tissue assets Raw materials Inventory, Raw Materials, Gross Entity File Number Entity File Number Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] Entity Shell Company Entity Shell Company Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Property, Plant and Equipment Property, Plant and Equipment [Line Items] Non-LIFO Non-LIFO [Member] Non LIFO [Member] Cash and Cash Equivalents - Beginning of Period Cash and Cash Equivalents - End of Period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Interest income Investment Income, Interest Additional Paid in Capital Additional Paid in Capital Common Stock, Shares, Issued Common Stock, Shares, Issued Business Combination, Consideration Transferred Business Combination, Consideration Transferred Gross Profit Gross Profit Inventory [Axis] Inventory [Axis] Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Derivatives Assets Derivative Asset Derivative Asset Security Exchange Name Security Exchange Name Deferred income taxes Deferred Income Tax Expense (Benefit) Restructuring Plan [Axis] Restructuring Plan [Axis] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Accumulated Other Comprehensive Income (loss) Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Objectives And Strategies For Using Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Debt payable within one year Debt, Current Work in process Inventory, Work in Process, Gross Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Other Proceeds from (Payments for) Other Financing Activities Comprehensive Income Attributable to Kimberly-Clark Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document Type Document Type Geographic Concentration Risk Geographic Concentration Risk [Member] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - After Tax us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - After Tax us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - After Tax K-C Argentina K-C Argentina [Member] K-C Argentina [Member] Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Entity Address, Address Line One Entity Address, Address Line One Divesture Base Purchase Price Divesture Base Purchase Price Divesture Base Purchase Price Treasury Stock, Value, Acquired, Cost Method Treasury Stock, Value, Acquired, Cost Method Machinery and equipment Machinery and Equipment, Gross Entity Registrant Name Entity Registrant Name Dilutive effect of stock options and restricted share unit awards Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Average Common Shares Outstanding Basic and Diluted [Table] Average Common Shares Outstanding Basic and Diluted [Table] Average Common Shares Outstanding Basic and Diluted [Table] Postretirement benefits Pension and Other Postretirement Benefits Cost (Reversal of Cost) Exchange [Domain] Exchange [Domain] Noncontrolling Interests Noncontrolling Interests Equity, Attributable to Noncontrolling Interest Document Period End Date Document Period End Date Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Business Acquisition [Axis] Business Acquisition [Axis] Net sales Sales [Member] Corporate and Other Corporate and Other [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Debt repayments Repayments of Long-Term Debt Treasury Stock, Common Treasury Stock, Common [Member] Entity Central Index Key Entity Central Index Key Operating Profit, Percent Change Operating Income (Loss), Percent Change Operating Income (Loss), Percent Change Equity Method Investments, Fair Value Disclosure Equity Method Investments, Fair Value Disclosure Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] NEW YORK STOCK EXCHANGE, INC. NEW YORK STOCK EXCHANGE, INC. [Member] (Provision for) benefit from income taxes Income Tax Expense (Benefit) Income Statement [Abstract] Income Statement [Abstract] Title of 12(b) Security Title of 12(b) Security Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Redeemable Preferred Securities Of Subsidiaries Fair Value Disclosure Redeemable Preferred Securities Of Subsidiaries Fair Value Disclosure Fair value of redeemable preferred securities of subsidiaries Fair Value Information Fair Value Disclosures [Text Block] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Derivatives Liability Derivative Liability Derivative Liability Payments of Ordinary Dividends, Noncontrolling Interest Payments of Ordinary Dividends, Noncontrolling Interest Average Common Shares Outstanding Basic and Diluted Average Common Shares Outstanding Basic and Diluted [Line Items] [Line Items] for Average Common Shares Outstanding Basic and Diluted [Table] Equity [Abstract] Equity [Abstract] Stock-based awards exercised or vested Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Dividends payable Dividends Payable, Current Other current assets Other Assets, Current Entity Listings, Exchange [Axis] Entity Listings, Exchange [Axis] Amendment Flag Amendment Flag All Other All Other [Member] All Other [Member] Payments to Noncontrolling Interests Payments to Noncontrolling Interests Payments to Noncontrolling Interests Intangible Assets Disclosure Intangible Assets Disclosure [Text Block] Fair Value Hedging Fair Value Hedging [Member] Entity Tax Identification Number Entity Tax Identification Number Sales Revenue, Net, Percent Change Sales Revenue, Net, Percent Change Sales Revenue, Net, Percent Change Investments in Equity Companies Equity Method Investments Inventories Total Inventory, Net Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Payments to Acquire Businesses, Net of Cash Acquired Payments to Acquire Businesses, Net of Cash Acquired Comprehensive Income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Entity Interactive Data Current Entity Interactive Data Current Treasury Stock, Shares, Acquired Treasury Stock, Shares, Acquired Acquisitions of common stock for the treasury Payments for Repurchase of Common Stock Operating working capital Increase (Decrease) in Operating Capital Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Diluted Weighted Average Number of Shares Outstanding, Diluted Mergers, Acquisitions and Dispositions Disclosures Mergers, Acquisitions and Dispositions Disclosures [Text Block] Reporting Segment [Domain] Segments [Domain] Interest Rate Contract Interest Rate Contract [Member] Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Retained Earnings (Accumulated Deficit) Retained Earnings Retained Earnings (Accumulated Deficit) Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Additional Paid-in Capital Additional Paid-in Capital [Member] Current Assets Assets, Current [Abstract] Leases [Abstract] Leases [Abstract] TOTAL ASSETS Assets Share of net income of equity companies Income (Loss) from Equity Method Investments Entity Address, State or Province Entity Address, State or Province Redeemable Common and Preferred Securities of Subsidiaries Redeemable Common and Preferred Securities of Subsidiaries Redeemable Common and Preferred Securities of Subsidiaries Cover page. Cover [Abstract] Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Recognition of stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Common shares outstanding Common Stock, Shares, Outstanding Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Cash dividends paid Payments of Dividends Other Liabilities Other Liabilities, Noncurrent Per Share Basis Earnings Per Share, Basic [Abstract] Other Stockholders' Equity, Other Maturities of time deposits Maturities of time deposits Maturities of time deposits Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Cash Flow Hedging Cash Flow Hedging [Member] Defined Benefit Pension Plans Pension Plan [Member] Sale of Stock, Percentage of Ownership after Transaction Sale of Stock, Percentage of Ownership after Transaction Business Segment Information Segment Reporting Disclosure [Text Block] Other Other Operating Activities, Cash Flow Statement Net Asset Value Investments [Axis] Net Asset Value Investments [Axis] Net Asset Value Investments [Axis] Income Before Equity Interests Income Before Equity Interest Income Before Equity Interest Change in Cash and Cash Equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Net Asset Value or Its Equivalent Net Asset Value or Its Equivalent [Member] Net Asset Value or Its Equivalent Common Stock, Par or Stated Value Per Share Common Stock, Par or Stated Value Per Share Equity Component [Domain] Equity Component [Domain] Retained Earnings (Accumulated Deficit) [Abstract] Retained Earnings (Accumulated Deficit) [Abstract] Cash Used for Investing Net Cash Provided by (Used in) Investing Activities Class of Stock [Domain] Class of Stock [Domain] us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - Before Tax us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - Before Tax us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - Before Tax Schedule of Inventory, Current Schedule of Inventory, Current [Table Text Block] Text Block [Abstract] Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share Turkey TÜRKIYE Basic Weighted Average Number of Shares Outstanding, Basic Average Common Shares Outstanding Basic and Diluted Schedule of Average Common Shares Outstanding Basic and Diluted [Text Block] Schedule of average common shares outstanding, basic and diluted [Text Block]. Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Operating Profit Operating Income (Loss) Baby and Child Care Products Baby and child care products [Member] Baby and Child Care Products [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] K-C Professional Away-from-home Professional Products K-C Professional [Member] K-C Professional [Member] AOCI Attributable to Parent AOCI Attributable to Parent [Member] Fair Value, Measurement Frequency [Domain] Measurement Frequency [Domain] Accounting Policies Product Information [Line Items] Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex - Before Tax us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex - Before Tax us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex - Before Tax Before Tax Before Tax [Member] Before Tax [Member] Business Segments [Axis] Segments [Axis] Statement Statement [Line Items] Estimated Fair Value, Fair Value Disclosure Estimate of Fair Value Measurement [Member] Other Comprehensive Income (Loss), Net of Tax Other Comprehensive Income (Loss), Net of Tax [Abstract] (Income)/loss reclassified from AOCI Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Investments in time deposits Investments in time deposits Investments in time deposits Earnings Per Share [Abstract] Earnings Per Share [Abstract] Common Stock, Value, Issued Common Stock, Value, Issued Stockholders' Equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Noncontrolling Interests Noncontrolling Interest [Member] EX-101.PRE 13 kmb-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 kmb-20230630_g1.jpg K-C LOGO begin 644 kmb-20230630_g1.jpg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end XML 15 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2023
Jul. 18, 2023
Entity Information [Line Items]    
Document Type 10-Q  
Document Period End Date Jun. 30, 2023  
Entity File Number 1-225  
Entity Registrant Name KIMBERLY-CLARK CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 39-0394230  
Entity Address, Address Line One P.O. Box 619100  
Entity Address, City or Town Dallas,  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75261-9100  
City Area Code (972)  
Local Phone Number 281-1200  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Common Stock, Shares Outstanding   338,185,161
Document Quarterly Report true  
Document Transition Report false  
Entity Shell Company false  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Entity Central Index Key 0000055785  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Common Stock | NEW YORK STOCK EXCHANGE, INC.    
Entity Information [Line Items]    
Title of 12(b) Security Common Stock  
Trading Symbol KMB  
Security Exchange Name NYSE  
0.625% Notes Due 2024 [Member] | NEW YORK STOCK EXCHANGE, INC.    
Entity Information [Line Items]    
Title of 12(b) Security 0.625% Notes due 2024  
Trading Symbol KMB24  
Security Exchange Name NYSE  
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Income Statement - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Net Sales $ 5,134 $ 5,063 $ 10,329 $ 10,158
Cost of products sold 3,403 3,534 6,872 7,109
Gross Profit 1,731 1,529 3,457 3,049
Marketing, research and general expenses 1,015 906 1,939 1,792
Impairment of Intangible Assets (Excluding Goodwill) 658 0 658 0
Other (income) and expense, net (55) 2 (40) (57)
Operating Profit 113 621 900 1,314
Nonoperating expense (42) (27) (58) (31)
Interest income 9 1 16 3
Interest expense (76) (68) (149) (133)
Income Before Income Taxes and Equity Interests 4 527 709 1,153
(Provision for) benefit from income taxes 32 (115) (141) (229)
Income Before Equity Interests 36 412 568 924
Share of net income of equity companies 50 29 93 52
Net income 86 441 661 976
Net (income) loss attributable to noncontrolling interests 16 (4) 7 (16)
Net Income Attributable to Kimberly-Clark Corporation $ 102 $ 437 $ 668 $ 960
Per Share Basis        
Basic $ 0.30 $ 1.30 $ 1.98 $ 2.85
Diluted $ 0.30 $ 1.29 $ 1.97 $ 2.84
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statement Of Comprehensive Income - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net Income $ 86 $ 441 $ 661 $ 976
Other Comprehensive Income (Loss), Net of Tax        
Unrealized currency translation adjustments (52) (267) 41 (214)
Employee postretirement benefits 24 5 16 16
Cash flow hedges and other 47 43 (31) 34
Total Other Comprehensive Income (Loss), Net of Tax 19 (219) 26 (164)
Comprehensive Income 105 222 687 812
Comprehensive income attributable to noncontrolling interests 20 6 12 (2)
Comprehensive Income Attributable to Kimberly-Clark Corporation $ 125 $ 228 $ 699 $ 810
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheet - USD ($)
shares in Millions, $ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 580 $ 427
Accounts receivable, net 2,359 2,280
Inventories 2,128 2,269
Other current assets 677 753
Total Current Assets 5,744 5,729
Property, Plant and Equipment, Net 7,815 7,885
Investments in Equity Companies 299 238
Goodwill 2,086 2,074
Other Intangible Assets, Net 208 851
Other Assets 1,231 1,193
TOTAL ASSETS 17,383 17,970
Current Liabilities    
Debt payable within one year 188 844
Trade accounts payable 3,713 3,813
Accrued expenses and other current liabilities 2,302 2,289
Dividends payable 395 388
Total Current Liabilities 6,598 7,334
Long-Term Debt 7,947 7,578
Noncurrent Employee Benefits 639 654
Deferred Income Taxes 490 647
Other Liabilities 848 799
Redeemable Common and Preferred Securities of Subsidiaries $ 210 $ 258
Preferred Stock, Shares Issued 0 0
Stockholders' Equity    
Preferred Stock, Value, Issued $ 0 $ 0
Common Stock, Value, Issued 473 473
Total Kimberly-Clark Corporation Stockholders' Equity 500 547
Noncontrolling Interests 151 153
Total Stockholders' Equity 651 700
Treasury Stock, Value [Abstract]    
Treasury Stock, Value (5,071) (5,137)
Additional Paid in Capital [Abstract]    
Additional Paid in Capital 697 679
Retained Earnings (Accumulated Deficit) [Abstract]    
Retained Earnings (Accumulated Deficit) 8,040 8,201
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 17,383 17,970
Accumulated Other Comprehensive Income (loss) $ (3,639) $ (3,669)
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheet Parenthetical - $ / shares
shares in Millions
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred Stock, Par or Stated Value Per Share $ 0 $ 0
Preferred Stock, Shares Authorized 20.0 20.0
Preferred Stock, Shares Issued 0.0 0.0
Common Stock, Par or Stated Value Per Share $ 1.25 $ 1.25
Common Stock, Shares Authorized 1,200.0 1,200.0
Common Stock, Shares, Issued 378.6 378.6
Treasury Stock, Common, Shares 40.4 41.1
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Statement of Stockholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
AOCI Attributable to Parent
Noncontrolling Interests
Treasury Stock, Common
Common Stock, Shares, Issued   378,597          
Common Stock, Value, Issued   $ 473          
Additional Paid in Capital     $ 605        
Treasury Stock, Value             $ (5,183)
Retained Earnings       $ 7,858      
Accumulated Other Comprehensive Income (Loss)         $ 3,239    
Noncontrolling Interests           $ 223  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 737            
Treasury Stock, Common, Shares             41,762
Net income 976     960      
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest           21  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share 981            
Other Comprehensive Income, Net of Tax 164       150 (13)  
Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share (163)            
Stock-based awards exercised or vested 43   (79)       $ 122
Treasury Stock, Shares, Acquired             388
Treasury Stock, Value, Acquired, Cost Method             $ (50)
Recognition of stock-based compensation 67   67        
Dividends, Common Stock, Cash (864)     (783)      
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders           81  
Other $ 9   5 (13)   (1)  
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures             (1,188)
Dividends declared $ 2.32            
Common Stock, Shares, Issued   378,597          
Common Stock, Value, Issued   $ 473          
Additional Paid in Capital     599        
Treasury Stock, Value             $ (5,175)
Retained Earnings       7,988      
Accumulated Other Comprehensive Income (Loss)         3,180    
Noncontrolling Interests           149  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 854            
Treasury Stock, Common, Shares             41,630
Net income 441     437      
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest           9  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share 446            
Other Comprehensive Income, Net of Tax 219       209 (9)  
Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share (218)            
Stock-based awards exercised or vested 34   (53)       $ 87
Treasury Stock, Shares, Acquired             173
Treasury Stock, Value, Acquired, Cost Method             $ (23)
Recognition of stock-based compensation 51   51        
Dividends, Common Stock, Cash (391)     (392)      
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders           1  
Other $ 11   1 (11)   (1)  
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures             (841)
Dividends declared $ 1.16            
Common Stock, Shares, Issued   378,597          
Common Stock, Value, Issued   $ 473          
Additional Paid in Capital     598        
Treasury Stock, Value             $ (5,111)
Retained Earnings       8,022      
Accumulated Other Comprehensive Income (Loss)         3,389    
Noncontrolling Interests           149  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 742            
Treasury Stock, Common, Shares             40,962
Common Stock, Shares, Issued   378,597          
Common Stock, Value, Issued 473 $ 473          
Additional Paid in Capital 679   679        
Treasury Stock, Value (5,137)           $ (5,137)
Retained Earnings 8,201     8,201      
Accumulated Other Comprehensive Income (Loss) 3,669       3,669    
Noncontrolling Interests 153         153  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 700            
Total Kimberly-Clark Corporation Stockholders' Equity $ 547            
Treasury Stock, Common, Shares 41,100           41,135
Net income $ 661     668      
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest           20  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share 688            
Other Comprehensive Income, Net of Tax (26)       (31) (6)  
Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share 25            
Stock-based awards exercised or vested 72   (59)       $ 131
Treasury Stock, Shares, Acquired             485
Treasury Stock, Value, Acquired, Cost Method             $ (65)
Recognition of stock-based compensation 68   68        
Dividends, Common Stock, Cash (813)     (797)      
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders           16  
Other $ 24   9 (32) 1 0  
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures             (1,238)
Dividends declared $ 2.36            
Common Stock, Shares, Issued   378,597          
Common Stock, Value, Issued   $ 473          
Additional Paid in Capital     694        
Treasury Stock, Value             $ (5,153)
Retained Earnings       8,365      
Accumulated Other Comprehensive Income (Loss)         3,660    
Noncontrolling Interests           142  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 861            
Treasury Stock, Common, Shares             41,231
Net income 86     102      
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest           10  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share 112            
Other Comprehensive Income, Net of Tax (19)       (23) (3)  
Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share 20            
Stock-based awards exercised or vested 66   (47)       $ 113
Treasury Stock, Shares, Acquired             220
Treasury Stock, Value, Acquired, Cost Method             $ (31)
Recognition of stock-based compensation 45   45        
Dividends, Common Stock, Cash (399)     (399)      
Other $ 23   5 (28) 2 2  
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures             (1,069)
Dividends declared $ 1.18            
Common Stock, Shares, Issued   378,597          
Common Stock, Value, Issued $ 473 $ 473          
Additional Paid in Capital 697   $ 697        
Treasury Stock, Value (5,071)           $ (5,071)
Retained Earnings 8,040     $ 8,040      
Accumulated Other Comprehensive Income (Loss) 3,639       $ 3,639    
Noncontrolling Interests 151         $ 151  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 651            
Total Kimberly-Clark Corporation Stockholders' Equity $ 500            
Treasury Stock, Common, Shares 40,400           40,382
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Statement of Stockholders' Equity Stockholders' Equity Parentheticals - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Statement of Stockholders' Equity [Abstract]        
Dividends declared $ 1.18 $ 1.16 $ 2.36 $ 2.32
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Cash Flow Statement - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating Activities    
Net income $ 661 $ 976
Depreciation and amortization 377 380
Asset impairments 676 0
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 0 (85)
Stock-based compensation 71 68
Deferred income taxes (238) (35)
Net (gains) losses on asset and business dispositions (71) 13
Equity companies' earnings (in excess of) less than dividends paid (60) (21)
Operating working capital (35) (348)
Postretirement benefits 26 (1)
Other (7) (3)
Cash Provided by Operations 1,400 944
Investing Activities    
Capital spending (389) (470)
Payments to Acquire Businesses, Net of Cash Acquired 0 46
Acquisition of business, net of cash acquired 218 1
Investments in time deposits (388) (300)
Maturities of time deposits 470 545
Other 14 (7)
Cash Used for Investing (75) (277)
Financing Activities    
Cash dividends paid (790) (775)
Change in short-term debt (307) 553
Debt proceeds 357 0
Debt repayments (350) (300)
Proceeds from exercise of stock options 96 75
Acquisitions of common stock for the treasury (63) (49)
Payments to Noncontrolling Interests (48) 0
Payments of Ordinary Dividends, Noncontrolling Interest (16) (82)
Other (31) (42)
Cash Used for Financing (1,152) (620)
Effect of Exchange Rate Changes on Cash and Cash Equivalents (20) (6)
Change in Cash and Cash Equivalents 153 41
Cash and Cash Equivalents - Beginning of Period 427 270
Cash and Cash Equivalents - End of Period $ 580 $ 311
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Supplemental Balance Sheet Data Narrative
$ in Billions
Jun. 30, 2023
USD ($)
Statement of Financial Position [Abstract]  
Supplier Finance Program, Obligation $ 1.0
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Accounting Policies
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Accounting Policies Accounting Policies
Basis of Presentation
The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all material adjustments which are of a normal and recurring nature necessary for a fair presentation of the results for the periods presented have been reflected. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted.
For further information, refer to the consolidated financial statements and footnotes included in our Annual Report on Form 10-K for the year ended December 31, 2022. The terms "Corporation," "Kimberly-Clark," "K-C," "we," "our" and "us" refer to Kimberly-Clark Corporation and its consolidated subsidiaries.
Highly Inflationary Accounting
GAAP guidance requires the use of highly inflationary accounting for countries whose cumulative three-year inflation exceeds 100 percent. Under highly inflationary accounting, the countries’ functional currency becomes the U.S. dollar, and its income statement and balance sheet are measured in U.S. dollars using both current and historical rates of exchange. In the second quarter of 2018, published inflation indices indicated that the three-year cumulative inflation in Argentina exceeded 100 percent, and as of July 1, 2018, we elected to adopt highly inflationary accounting for our subsidiaries in Argentina (“K-C Argentina”). The effect of changes in exchange rates on peso-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material. As of June 30, 2023, K-C Argentina had a small net peso monetary position. Net sales of K-C Argentina were approximately 1 percent of our consolidated net sales for the six months ended June 30, 2023 and 2022.
In the first quarter of 2022, published inflation indices indicated that the three-year cumulative inflation in Turkey exceeded 100 percent, and as of April 1, 2022, we elected to adopt highly inflationary accounting for our subsidiary in Turkey (“K-C Turkey”). The effect of changes in exchange rates on lira-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material. As of June 30, 2023, K-C Turkey had a small net lira monetary position. Net sales of K-C Turkey were less than 1 percent of our consolidated net sales for the six months ended June 30, 2023 and 2022.
Recently Adopted Accounting Standard
In September 2022, the Financial Accounting Standards Board issued Accounting Standard Update (“ASU”) No. 2022-04, Liabilities – Supplier Finance Programs (Subtopic 405-50). The new guidance requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. This ASU was effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the provision on roll forward information, which is effective for fiscal years beginning after December 15, 2023. We adopted this ASU as of January 1, 2023, except for the amendment on roll forward information which will be adopted January 1, 2024. As the guidance requires only additional disclosure, there were no effects of this standard on our financial position, results of operations or cash flows. See disclosure contained in Note 9.
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisition
6 Months Ended
Jun. 30, 2023
Business Combinations [Abstract]  
Mergers, Acquisitions and Dispositions Disclosures Acquisition and Divestiture
Acquisition
On February 24, 2022, we completed our acquisition of a majority and controlling share of Thinx Inc. (“Thinx”), an industry leader in the reusable period and incontinence underwear category, for total consideration of $181 consisting of cash of $53, the fair value of our previously held equity investment of $127, and certain share-based award costs of $1.
We previously accounted for our ownership interest in Thinx as an equity method investment, but upon increasing our ownership to 58 percent, we began consolidating the operations of Thinx into our financial statements at the end of the first quarter of 2022. The consolidated results of operations for Thinx are reported in our Personal Care business segment on a one-month lag. The share of Thinx net income and equity attributable to the third-party minority owner of Thinx is classified in our consolidated income statement within Net income attributable to noncontrolling interests and in our consolidated balance sheet
within Redeemable Common and Preferred Securities of Subsidiaries. This noncontrolling equity interest is measured at the estimated redemption value, which approximates fair value.
During the first quarter of 2022, we substantially completed an initial purchase price allocation in which we utilized several generally accepted valuation methodologies to estimate the fair value of certain acquired assets. The primary valuation methods included two forms of the Income Approach (i.e., the multi-period excess earnings method [distributor method] and the relief-from-royalty method). The purchase price allocation was finalized in the first quarter of 2023 with immaterial measurement period adjustments recorded.
The total purchase price consideration was allocated to the net assets acquired based upon their respective final estimated fair values as follows:
Current Assets$28 
Property, Plant and Equipment, Net
Goodwill298 
Other Intangible Assets, Net123 
Other Assets
Current Liabilities(18)
Deferred Income Taxes(18)
Other Liabilities(4)
Fair value of net assets acquired415 
Less fair value of non-controlling interest(234)
Total purchase price consideration$181 
Other Intangible Assets, Net includes brands and customer relationships which have estimated useful lives of 4 to 15 years, primarily 15 years.
Goodwill of $298 was allocated to the Personal Care business segment. The goodwill is primarily attributable to future growth opportunities and any intangible assets that did not qualify for separate recognition. For tax purposes, the acquisition of additional Thinx shares was treated as a stock acquisition, and the goodwill acquired is not tax deductible.
As a result of this transaction during the quarter ended March 31, 2022, an $85 non-recurring, non-cash gain was recognized in Other (income) expense, net as a result of the remeasurement of the carrying value of our previously held equity investment to fair value, and related transaction and integration costs of $21 were recorded in Marketing, research and general expenses. This recognition resulted in a net benefit of $64 pre-tax ($68 after tax) being included in our consolidated income statement for the quarter ended March 31, 2022. In addition, we removed the non-cash gain impact from Operating Activities in our consolidated cash flow statements for the six months ended June 30, 2022.
In the first quarter of 2023, we delivered a redemption notice to the third-party minority owner with respect to a portion of the remaining common securities of Thinx and reclassified $48 to Accrued expenses and other current liabilities from Redeemable Common and Preferred Securities. This redemption closed in the second quarter of 2023, and we acquired additional ownership of Thinx for $48, increasing our controlling ownership to 70 percent. As the purchase of additional ownership in an already controlled subsidiary represents an equity transaction, no gain or loss was recognized in consolidated net income or comprehensive income, and the transaction was recorded through a reduction in Accrued expenses and other current liabilities.
Divestiture
On June 1, 2023, we completed the sale transaction, announced on October 24, 2022, of our Neve tissue brand and related consumer and K-C Professional tissue assets in Brazil for $212, including the base purchase price of $175 and preliminary working capital and other closing adjustments of $37. This transaction also included a licensing agreement to allow the acquirer to manufacture and market in Brazil the Kleenex, Scott and Wypall brands to consumers and away-from-home customers for a period of time. The assets included in the sale agreement were reclassified to Other current assets as of December 31, 2022, and upon closure of the transaction, a gain of $74 pre-tax was recognized in Other (income) and expense, net. We incurred divestiture-related costs of $30 pre-tax during the three months ended June 30, 2023, which were recorded in Cost of products sold and Marketing, research and general expenses, resulting in a net benefit of $44 pre-tax ($26 after tax).
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Impairment of Intangible Assets
6 Months Ended
Jun. 30, 2023
Text Block [Abstract]  
Intangible Assets Disclosure Impairment of Intangible Assets
In the second quarter of 2023, we conducted forecasting and strategic reviews and integration assessments of our Softex Indonesia business, acquired in the fourth quarter of 2020, and with performance below expectations since acquisition, we revised internal financial projections of the business to reflect updated expectations of future financial performance. These reviews and the subsequent revisions in the projections highlighted challenges for the Softex business arising from modified consumer shopping behavior in the post-COVID-19 period, inflationary pressures and other macroeconomic factors and increased competitive activity in the region. As a result of separate management reviews, we also have revised internal financial projections associated with our acquisition of a controlling interest in Thinx as a result of performance below expectations due to the impact of modified consumer shopping behavior in the post-COVID-19 period.
These revisions were considered triggering events requiring interim impairment assessments to be performed relative to the intangible assets that had been recorded as part of these acquisitions. These intangible assets were recorded as part of the Personal Care business segment and included indefinite-lived and finite-lived brands and finite-lived distributor and customer relationships. As a result of the interim impairment assessments, we recognized impairment charges, principally arising from the impairment charge of $593 related to the Softex business, totaling $658 pre-tax ($483 after tax) to write-down these intangible assets to their respective fair values aggregating to $188 as of June 30, 2023. The valuation methods used in the assessments included the relief from royalty and distributor and customer relationships methods. This noncash charge was included in Impairment of intangible assets in our consolidated income statement and in Asset impairments within Operating Activities in our consolidated cash flow statement.
We believe our estimates and assumptions used in the valuations are reasonable and comparable to those that would be used by other market participants; however, actual events and results could differ substantially from those used in the valuation, and to the extent such factors result in a failure to achieve the projected cash flows used to estimate fair value, additional noncash impairment charges could be required in the future.
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Information
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Information Fair Value Information
The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are:
Level 1 – Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities.
Level 2 – Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly.
Level 3 – Prices or valuations that require inputs that are significant to the valuation and are unobservable.
A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
During the six months ended June 30, 2023 and for the full year 2022, there were no significant transfers to or from level 3 fair value determinations.
Derivative assets and liabilities are measured on a recurring basis at fair value. At June 30, 2023 and December 31, 2022, derivative assets were $89 and $99, respectively, and derivative liabilities were $328 and $318, respectively. The fair values of derivatives used to manage interest rate risk are based on the Secured Overnight Financing Rate ("SOFR") as of June 30, 2023, and on LIBOR rates as of December 31, 2022, and interest rate swap curves. The fair values of derivatives used to manage commodity price risk are based on commodity price quotations. The fair values of hedging instruments used to manage foreign currency risk are based on published quotations of spot currency rates and forward points, which are converted into implied forward currency rates. Measurement of our derivative assets and liabilities is considered a level 2 measurement. Additional information on our classification and use of derivative instruments is contained in Note 7.
Redeemable common and preferred securities of subsidiaries are measured on a recurring basis at their estimated redemption values, which approximate fair value. As of June 30, 2023 and December 31, 2022, the securities were valued at $210 and $258, respectively. The securities are not traded in active markets, and their measurement is considered a level 3 measurement. In the first quarter of 2023, we delivered a redemption notice to the third-party minority owner with respect to a portion of the remaining common securities of Thinx, and the amount associated with the expected redemption was reclassified to Accrued expenses and other current liabilities, reducing our outstanding redeemable common securities by $48. In the second quarter of 2023, we closed on the redemption. Additional information on this transaction is contained in Note 2.
Company-owned life insurance ("COLI") assets are measured on a recurring basis at fair value. COLI assets were $65 and $63 at June 30, 2023 and December 31, 2022, respectively. The COLI policies are a source of funding primarily for our nonqualified employee benefits and are included in Other Assets. The COLI policies are measured at fair value using the net asset value per share practical expedient, and therefore, are not classified in the fair value hierarchy.
The following table includes the fair value of our financial instruments for which disclosure of fair value is required:
Fair Value Hierarchy LevelCarrying AmountEstimated Fair ValueCarrying AmountEstimated Fair Value
June 30, 2023December 31, 2022
Assets
Cash and cash equivalents(a)
1$580 $580 $427 $427 
Time deposits(b)
1182 182 268 268 
Liabilities
Short-term debt(c)
267 67 373 373 
Long-term debt(d)
28,068 7,530 8,049 7,403 
(a)Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.
(b)Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value.
(c)Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.
(d)Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share ("EPS")
There are no adjustments required to be made to net income for purposes of computing basic and diluted EPS. The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows:
Three Months Ended
June 30
Six Months Ended
June 30
(Millions of shares)2023202220232022
Basic338.0 337.4 337.7 337.2 
Dilutive effect of stock options and restricted share unit awards0.9 0.9 1.0 1.1 
Diluted338.9 338.3 338.7 338.3 
The impact of options outstanding that were not included in the computation of diluted EPS because their exercise price was greater than the average market price of the common shares was insignificant. The number of common shares outstanding as of June 30, 2023 and 2022 was 338.2 million and 337.6 million, respectively.
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Stockholders' Equity Stockholders' Equity
Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in Accumulated Other Comprehensive Income ("AOCI"). For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation.
Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.
The change in net unrealized currency translation for the six months ended June 30, 2023 was primarily due to the strengthening of certain foreign currencies versus the U.S. dollar.
The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows:
Unrealized TranslationDefined Benefit Pension PlansOther Postretirement Benefit PlansCash Flow Hedges and Other
Balance as of December 31, 2021$(2,422)$(803)$(34)$20 
Other comprehensive income (loss) before reclassifications
(199)(11)(3)42 
(Income) loss reclassified from AOCI— 30 (a)— (a)(9)
Net current period other comprehensive income (loss)(199)19 (3)33 
Balance as of June 30, 2022$(2,621)$(784)$(37)$53 
Balance as of December 31, 2022$(2,769)$(789)$52 $(163)
Other comprehensive income (loss) before
    reclassifications
46 (18)(1)(103)
(Income) loss reclassified from AOCI 35 (a) (a)71 
Net current period other comprehensive income (loss)46 17 (1)(32)
Balance as of June 30, 2023$(2,723)$(772)$51 $(195)
(a)    Included in computation of net periodic benefit costs.
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Objectives And Strategies For Using Derivatives
6 Months Ended
Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Objectives And Strategies For Using Derivatives Objectives and Strategies for Using Derivatives
As a multinational enterprise, we are exposed to financial risks, such as changes in foreign currency exchange rates, interest rates, and commodity prices. We employ a number of practices to manage these risks, including operating and financing activities and, where appropriate, the use of derivative instruments.
At June 30, 2023 and December 31, 2022, derivative assets were $89 and $99, respectively, and derivative liabilities were $328 and $318, respectively, primarily comprised of foreign currency exchange and commodity price contracts. Derivative assets are recorded in Other current assets or Other Assets, as appropriate, and derivative liabilities are recorded in Accrued expenses and other current liabilities or Other Liabilities, as appropriate.
Foreign Currency Exchange Rate Risk
Translation adjustments result from translating foreign entities' financial statements into U.S. dollars from their functional currencies. The risk to any particular entity's net assets is reduced to the extent that the entity is financed with local currency borrowings. A portion of our balance sheet translation exposure for certain affiliates, which results from changes in translation rates between the affiliates’ functional currencies and the U.S. dollar, is hedged with cross-currency swap contracts and certain foreign denominated debt which are designated as net investment hedges. The foreign currency exposure on certain non-functional currency denominated monetary assets and liabilities, primarily intercompany loans and accounts payable, is hedged with primarily undesignated derivative instruments.
Derivative instruments are entered into to hedge a portion of forecasted cash flows denominated in foreign currencies for non-U.S. operations' purchases of raw materials, which are priced in U.S. dollars, and imports of intercompany finished goods and work-in-process priced predominantly in U.S. dollars and euros. The derivative instruments used to manage these exposures are designated as cash flow hedges.
Interest Rate Risk
Interest rate risk is managed using a portfolio of variable and fixed-rate debt composed of short and long-term instruments. Interest rate swap contracts may be used to facilitate the maintenance of the desired ratio of variable and fixed-rate debt and are designated as fair value hedges. From time to time, we also hedge the anticipated issuance of fixed-rate debt, and these contracts are designated as cash flow hedges.
Commodity Price Risk
We use derivative instruments, such as forward contracts, to hedge a portion of our exposure to market risk arising from changes in prices of certain commodities. These derivatives are designated as cash flow hedges of specific quantities of the underlying commodity expected to be purchased in future months. In addition, we utilize negotiated contracts of varying durations along with strategic pricing mechanisms to manage volatility for a portion of our commodity costs.
Fair Value Hedges
Derivative instruments that are designated and qualify as fair value hedges are predominantly used to manage interest rate risk. The fair values of these interest rate derivative instruments are recorded as an asset or liability, as appropriate, with the offset recorded in Interest expense. The offset to the change in fair values of the related debt is also recorded in Interest expense. Any realized gain or loss on the derivatives that hedge interest rate risk is amortized to Interest expense over the life of the related debt. As of June 30, 2023, the aggregate notional values and carrying values of debt subject to outstanding interest rate contracts designated as fair value hedges were $525 and $471, respectively. For the six months ended June 30, 2023 and 2022, gains or losses recognized in Interest expense for interest rate swaps were not significant.
Cash Flow Hedges
For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same income statement line and period that the hedged exposure affects earnings. As of June 30, 2023, outstanding commodity forward contracts were in place to hedge a portion of our estimated requirements of the related underlying commodities in the remainder of 2023 and future periods. As of June 30, 2023, the aggregate notional value of outstanding foreign exchange derivative contracts designated as cash flow hedges was $2.8 billion. For the six months ended June 30, 2023 and 2022, no significant gains or losses were reclassified into Interest expense, Cost of products sold or Other (income) and expense, net as a result of the discontinuance of cash flow hedges due to the original forecasted transaction no longer being probable of occurring. At June 30, 2023, amounts to be reclassified from AOCI into Interest expense, Cost of products sold or Other (income) and expense, net during the next twelve months are not expected to be material. The maximum maturity of cash flow hedges in place at June 30, 2023 is June 2026.
Net Investment Hedges
For derivative instruments that are designated and qualify as net investment hedges, the aggregate notional value was $1.7 billion at June 30, 2023. We exclude the interest accruals on cross-currency swap contracts and the forward points on foreign exchange forward contracts from the assessment and measurement of hedge effectiveness.  We recognize the interest accruals on cross-currency swap contracts in earnings within Interest expense.  We amortize the forward points on foreign exchange contracts into earnings within Interest expense over the life of the hedging relationship.  Changes in fair value of net investment hedges are recorded in AOCI and offset the change in the value of the net investment being hedged.  For the six months ended June 30, 2023, unrealized losses of $15 related to net investment hedge fair value changes were recorded in AOCI and no significant amounts were reclassified from AOCI to Interest expense.
No significant amounts were excluded from the assessment of net investment, fair value or cash flow hedge effectiveness as of June 30, 2023.
Undesignated Hedging Instruments
Gains or losses on undesignated foreign exchange hedging instruments are immediately recognized in Other (income) and expense, net. Losses of $14 and $1 were recorded in the three months ended June 30, 2023 and 2022, respectively. Losses of $6 and $35 were recorded in the six months ended June 30, 2023 and 2022. The effect on earnings from the use of these non-designated derivatives is substantially neutralized by the transactional gains and losses recorded on the underlying assets and liabilities. At June 30, 2023, the notional value of these undesignated derivative instruments was approximately $2.6 billion.
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Description Of Business Segments
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Business Segment Information Business Segment InformationWe are organized into operating segments based on product groupings. These operating segments have been aggregated into three reportable global business segments: Personal Care, Consumer Tissue and K-C Professional. The reportable segments were determined in accordance with how our chief operating decision maker and our executive managers develop and execute global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit.
Segment operating profit excludes Other (income) and expense, net and income and expense not associated with ongoing operations of the business segments.
The principal sources of revenue in each global business segment are described below:
Personal Care brands offer our consumers a trusted partner in caring for themselves and their families by delivering confidence, protection and discretion through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products.  Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex and other brand names.
Consumer Tissue offers a wide variety of innovative solutions and trusted brands that responsibly improve everyday living for families around the world.  Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Andrex, Viva, Scottex and other brand names.
K-C Professional partners with businesses to create Exceptional Workplaces, helping to make them healthier, safer and more productive through a range of solutions and supporting products such as wipers, tissue, towels, apparel, soaps and sanitizers. Our brands, including Kleenex, Scott, WypAll, Kimtech and KleenGuard are well known for quality and trusted to help people around the world work better.
Information concerning consolidated operations by business segment is presented in the following tables:
Three Months Ended June 30Six Months Ended June 30
20232022Change20232022Change
NET SALES
Personal Care$2,685 $2,710 -1 %$5,389 $5,439 -1 %
Consumer Tissue1,549 1,537 +1 %3,183 3,105 +3 %
K-C Professional887 802 +11 %1,734 1,582 +10 %
Corporate & Other13 14 N.M.23 32 N.M.
TOTAL NET SALES$5,134 $5,063 +1 %$10,329 $10,158 +2 %
OPERATING PROFIT
Personal Care$472 $466 +1 %$959 $941 +2 %
Consumer Tissue200 178 +12 %440 349 +26 %
K-C Professional187 85 +120 %346 175 +98 %
Corporate & Other(a)
(801)(106)N.M.(885)(208)N.M.
Other (income) and expense, net(a)
(55)N.M.(40)(57)-30 %
TOTAL OPERATING PROFIT$113 $621 -82 %$900 $1,314 -32 %
(a)    Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.
N.M. - Not Meaningful
Sales of Principal Products:
Three Months Ended June 30Six Months Ended June 30
(Billions of dollars)2023202220232022
Baby and child care products$1.8 $1.9 $3.5 $3.7 
Consumer tissue products1.5 1.5 3.2 3.1 
Away-from-home professional products0.9 0.8 1.7 1.6 
All other0.9 0.9 1.9 1.8 
Consolidated$5.1 $5.1 $10.3 $10.2 
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Supplemental Balance Sheet Data
6 Months Ended
Jun. 30, 2023
Statement of Financial Position [Abstract]  
Additional Financial Information Disclosure Supplemental Balance Sheet Data
The following schedule presents a summary of inventories by major class:
June 30, 2023December 31, 2022
LIFONon-LIFOTotalLIFONon-LIFOTotal
Raw materials$139 $363 $502 $147 $425 $572 
Work in process113 107 220 139 107 246 
Finished goods532 770 1,302 518 870 1,388 
Supplies and other 315 315 — 302 302 
784 1,555 2,339 804 1,704 2,508 
Excess of FIFO or weighted-average cost over
  LIFO cost
(211) (211)(239)— (239)
Total$573 $1,555 $2,128 $565 $1,704 $2,269 
Inventories are valued at the lower of cost or net realizable value, determined on the FIFO or weighted-average cost methods, and at the lower of cost or market, determined on the LIFO cost method.
The following schedule presents a summary of property, plant and equipment, net:
June 30, 2023December 31, 2022
Land$159 $156 
Buildings3,046 3,062 
Machinery and equipment14,778 14,655 
Construction in progress741 676 
18,724 18,549 
Less accumulated depreciation(10,909)(10,664)
Total$7,815 $7,885 
Supplier Finance Program
We have a supplier finance program managed through two global financial institutions under which we agree to pay the financial institutions the stated amount of confirmed invoices from our participating suppliers on the invoice due date. We, or the global financial institutions, may terminate our agreements at any time upon 30 days written notice. The global financial institutions may terminate our agreements at any time upon three days written notice in the event there are insufficient funds available for disbursement. We do not provide any forms of guarantees under these agreements. Supplier participation in the program is solely up to the supplier, and the participating suppliers negotiate their arrangements directly with the global financial institutions. We have no economic interest in a supplier’s decision to participate in the program, and their participation has no bearing on our payment terms or amounts due. The payment terms that we have with our suppliers under this program generally range from 75 to 180 days and are considered commercially reasonable. The outstanding amount related to the suppliers participating in this program was $1.0 billion as of June 30, 2023 and December 31, 2022, and was recorded within Trade accounts payable.
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisition (Tables)
3 Months Ended
Mar. 31, 2023
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The total purchase price consideration was allocated to the net assets acquired based upon their respective final estimated fair values as follows:
Current Assets$28 
Property, Plant and Equipment, Net
Goodwill298 
Other Intangible Assets, Net123 
Other Assets
Current Liabilities(18)
Deferred Income Taxes(18)
Other Liabilities(4)
Fair value of net assets acquired415 
Less fair value of non-controlling interest(234)
Total purchase price consideration$181 
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Information (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Fair value of financial instruments
The following table includes the fair value of our financial instruments for which disclosure of fair value is required:
Fair Value Hierarchy LevelCarrying AmountEstimated Fair ValueCarrying AmountEstimated Fair Value
June 30, 2023December 31, 2022
Assets
Cash and cash equivalents(a)
1$580 $580 $427 $427 
Time deposits(b)
1182 182 268 268 
Liabilities
Short-term debt(c)
267 67 373 373 
Long-term debt(d)
28,068 7,530 8,049 7,403 
(a)Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.
(b)Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value.
(c)Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.
(d)Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Average Common Shares Outstanding Basic and Diluted The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows:
Three Months Ended
June 30
Six Months Ended
June 30
(Millions of shares)2023202220232022
Basic338.0 337.4 337.7 337.2 
Dilutive effect of stock options and restricted share unit awards0.9 0.9 1.0 1.1 
Diluted338.9 338.3 338.7 338.3 
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss), Attributable to Kimberly-Clark Corporation
The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows:
Unrealized TranslationDefined Benefit Pension PlansOther Postretirement Benefit PlansCash Flow Hedges and Other
Balance as of December 31, 2021$(2,422)$(803)$(34)$20 
Other comprehensive income (loss) before reclassifications
(199)(11)(3)42 
(Income) loss reclassified from AOCI— 30 (a)— (a)(9)
Net current period other comprehensive income (loss)(199)19 (3)33 
Balance as of June 30, 2022$(2,621)$(784)$(37)$53 
Balance as of December 31, 2022$(2,769)$(789)$52 $(163)
Other comprehensive income (loss) before
    reclassifications
46 (18)(1)(103)
(Income) loss reclassified from AOCI 35 (a) (a)71 
Net current period other comprehensive income (loss)46 17 (1)(32)
Balance as of June 30, 2023$(2,723)$(772)$51 $(195)
(a)    Included in computation of net periodic benefit costs.
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Description Of Business Segments (Tables)
6 Months Ended
Jun. 30, 2023
Revenue from External Customer  
Information Concerning Consolidated Operations by Business Segment
Information concerning consolidated operations by business segment is presented in the following tables:
Three Months Ended June 30Six Months Ended June 30
20232022Change20232022Change
NET SALES
Personal Care$2,685 $2,710 -1 %$5,389 $5,439 -1 %
Consumer Tissue1,549 1,537 +1 %3,183 3,105 +3 %
K-C Professional887 802 +11 %1,734 1,582 +10 %
Corporate & Other13 14 N.M.23 32 N.M.
TOTAL NET SALES$5,134 $5,063 +1 %$10,329 $10,158 +2 %
OPERATING PROFIT
Personal Care$472 $466 +1 %$959 $941 +2 %
Consumer Tissue200 178 +12 %440 349 +26 %
K-C Professional187 85 +120 %346 175 +98 %
Corporate & Other(a)
(801)(106)N.M.(885)(208)N.M.
Other (income) and expense, net(a)
(55)N.M.(40)(57)-30 %
TOTAL OPERATING PROFIT$113 $621 -82 %$900 $1,314 -32 %
(a)    Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.
N.M. - Not Meaningful
[1]
Sales of Principal Products
Sales of Principal Products:
Three Months Ended June 30Six Months Ended June 30
(Billions of dollars)2023202220232022
Baby and child care products$1.8 $1.9 $3.5 $3.7 
Consumer tissue products1.5 1.5 3.2 3.1 
Away-from-home professional products0.9 0.8 1.7 1.6 
All other0.9 0.9 1.9 1.8 
Consolidated$5.1 $5.1 $10.3 $10.2 
[1] Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.N.M. - Not Meaningful
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Balance Sheet Data (Tables)
6 Months Ended
Jun. 30, 2023
Statement of Financial Position [Abstract]  
Schedule of Inventory, Current The following schedule presents a summary of inventories by major class:
June 30, 2023December 31, 2022
LIFONon-LIFOTotalLIFONon-LIFOTotal
Raw materials$139 $363 $502 $147 $425 $572 
Work in process113 107 220 139 107 246 
Finished goods532 770 1,302 518 870 1,388 
Supplies and other 315 315 — 302 302 
784 1,555 2,339 804 1,704 2,508 
Excess of FIFO or weighted-average cost over
  LIFO cost
(211) (211)(239)— (239)
Total$573 $1,555 $2,128 $565 $1,704 $2,269 
Property, Plant and Equipment The following schedule presents a summary of property, plant and equipment, net:
June 30, 2023December 31, 2022
Land$159 $156 
Buildings3,046 3,062 
Machinery and equipment14,778 14,655 
Construction in progress741 676 
18,724 18,549 
Less accumulated depreciation(10,909)(10,664)
Total$7,815 $7,885 
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Accounting Policies Narrative (Details) - Net sales - Geographic Concentration Risk
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
K-C Argentina    
Accounting Policies    
Net sales of K-C Argentina, percent 1.00% 1.00%
Turkey    
Accounting Policies    
Net sales of K-C Argentina, percent 1.00% 1.00%
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisition Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Feb. 24, 2022
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]              
Goodwill   $ 2,086     $ 2,086   $ 2,074
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain         0 $ (85)  
Payments to Noncontrolling Interests         48 $ 0  
Sale of Brazil tissue assets              
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]              
Closing Date Adjustment   37          
Divesture Base Purchase Price   175          
Gain (Loss) on Disposition of Business   74          
Costs Related to Divestiture   30          
Closing Date Adjustment   37          
Proceeds from Divestiture of Businesses   212          
Divesture Base Purchase Price   175          
Gain (Loss) on Disposition of Business   74          
Costs Related to Divestiture   30          
Before Tax | Sale of Brazil tissue assets              
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]              
Divestiture Net Benefit   44          
Divestiture Net Benefit   44          
After Tax | Sale of Brazil tissue assets              
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]              
Divestiture Net Benefit   26          
Divestiture Net Benefit   $ 26          
Thinx Inc              
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]              
Business Combination, Consideration Transferred $ 181   $ 181        
Payments to Acquire Businesses, Gross 53            
Equity Method Investments, Fair Value Disclosure 127            
Share-based Payment Arrangement, Accelerated Cost $ 1            
Sale of Stock, Percentage of Ownership after Transaction 58.00%            
Goodwill     298        
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain       $ (85)      
Business Combination, Acquisition Related Costs       21      
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions   70.00%          
Payments to Noncontrolling Interests   $ 48          
Accruals, Common Securities Redeemed     $ 48        
Thinx Inc | Before Tax              
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]              
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain, Transaction and Related Costs, Net Benefit       64      
Thinx Inc | After Tax              
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]              
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain, Transaction and Related Costs, Net Benefit       $ 68      
Thinx Inc | Personal Care [Member]              
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]              
Goodwill   $ 298     $ 298    
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisition (Schedule of Recognized Identified Assets Acquired and Liabilities Assumed) (Details) - USD ($)
$ in Millions
3 Months Ended
Feb. 24, 2022
Mar. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]        
Goodwill     $ 2,086 $ 2,074
Thinx Inc        
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents   $ 28    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment   2    
Goodwill   298    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles   123    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other   4    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities   (18)    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities   (18)    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other   (4)    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net   415    
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value   (234)    
Business Combination, Consideration Transferred $ 181 $ 181    
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Impairment of Intangible Assets Narrative (Details)
$ in Millions
3 Months Ended
Jun. 30, 2023
USD ($)
Text Block [Abstract]  
us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex - Before Tax $ 593
us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - Before Tax 658
us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - After Tax 483
Intangible Assets Impaired, Fair Value Disclosure $ 188
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Information (Narrative) (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Fair Value, Inputs, Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Redeemable Preferred Securities Of Subsidiaries Fair Value Disclosure $ 210 $ 258
Fair Value, Measurements, Recurring | Net Asset Value or Its Equivalent    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Cash Surrender Value, Fair Value Disclosure 65 63
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Derivatives Assets 89 99
Derivatives Liability $ 328 $ 318
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Information (Fair Value Of Financial Instruments) (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Carrying (Reported) Amount, Fair Value Disclosure | Fair Value, Inputs, Level 1    
Fair Value, Balance Sheet Grouping, Financial Statement Captions    
Cash and cash equivalents [1] $ 580 $ 427
Time deposits [2] 182 268
Carrying (Reported) Amount, Fair Value Disclosure | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions    
Short-term debt [3] 67 373
Long-term debt [4] 8,068 8,049
Estimated Fair Value, Fair Value Disclosure | Fair Value, Inputs, Level 1    
Fair Value, Balance Sheet Grouping, Financial Statement Captions    
Cash and cash equivalents [1] 580 427
Time deposits [2] 182 268
Estimated Fair Value, Fair Value Disclosure | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions    
Short-term debt [3] 67 373
Long-term debt [4] $ 7,530 $ 7,403
[1] Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.
[2] Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value.
[3] Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.
[4] Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share (Narrative) (Details) - shares
shares in Millions
Jun. 30, 2023
Jun. 30, 2022
Earnings Per Share [Abstract]    
Common shares outstanding 338.2 337.6
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share (Average Common Shares Outstanding Basic And Diluted) (Details) - shares
shares in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Average Common Shares Outstanding Basic and Diluted        
Basic 338.0 337.4 337.7 337.2
Dilutive effect of stock options and restricted share unit awards 0.9 0.9 1.0 1.1
Diluted 338.9 338.3 338.7 338.3
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity (Components of Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Net current period other comprehensive income (loss) $ (52) $ (267) $ 41 $ (214)    
Net current period other comprehensive income (loss) 24 5 16 16    
Total Other Comprehensive Income (Loss), Net of Tax 19 (219) 26 (164)    
Accumulated Other Comprehensive Income (loss) (3,639)   (3,639)   $ (3,669)  
Defined Benefit Pension Plans            
Defined benefit and other postretirement benefit plans - Beginning balance     (789) (803)    
Other comprehensive income/(loss) before reclassifications     (18) (11)    
(Income)/loss reclassified from AOCI [1]     35 30    
Net current period other comprehensive income (loss)     17 19    
Defined benefit and other postretirement benefit plans - Ending balance (772) (784) (772) (784)    
Other Postretirement Benefit Plans            
Defined benefit and other postretirement benefit plans - Beginning balance     52 (34)    
Other comprehensive income/(loss) before reclassifications     (1) (3)    
(Income)/loss reclassified from AOCI [1]     0 0    
Net current period other comprehensive income (loss)     (1) (3)    
Defined benefit and other postretirement benefit plans - Ending balance 51 (37) 51 (37)    
Unrealized Translation            
Unrealized translation - Beginning balance     (2,769) (2,422)    
Other comprehensive income/(loss) before reclassifications     46 (199)    
(Income)/loss reclassified from AOCI     0 0    
Net current period other comprehensive income (loss)     46 (199)    
Unrealized translation - Ending balance (2,723) (2,621) (2,723) (2,621)    
Cash Flow Hedges and Other            
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax     (103) 42    
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax     71 (9)    
Total Other Comprehensive Income (Loss), Net of Tax     (32) 33    
Accumulated Other Comprehensive Income (loss) $ (195) $ 53 $ (195) $ 53 $ (163) $ 20
[1] Included in computation of net periodic benefit costs.
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Objectives And Strategies For Using Derivatives (Narratives) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Derivative Instruments, Gain (Loss)          
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax     $ 15    
Not Designated as Hedging Instrument          
Derivative Instruments, Gain (Loss)          
Gain (loss) on undesignated foreign exchange hedging instruments $ 14 $ 1 6 $ 35  
Foreign currency exchange contracts | Not Designated as Hedging Instrument          
Derivative Instruments, Gain (Loss)          
Derivative, Notional Amount 2,600   2,600    
Fair Value Hedging | Interest Rate Contract          
Derivative Instruments, Gain (Loss)          
Long-term Debt, Fair Value 471   471    
Derivative, Notional Amount 525   525    
Cash Flow Hedging | Foreign currency exchange contracts          
Derivative Instruments, Gain (Loss)          
Derivative, Notional Amount 2,800   2,800    
Net Investment Hedging          
Derivative Instruments, Gain (Loss)          
Derivative, Notional Amount 1,700   1,700    
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2          
Derivative Instruments, Gain (Loss)          
Derivative Asset 89   89   $ 99
Derivative Liability $ 328   $ 328   $ 318
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Description Of Business Segments (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Net Sales $ 5,134 $ 5,063 $ 10,329 $ 10,158
Sales Revenue, Net, Percent Change 1.00%   2.00%  
Operating Profit $ 113 621 $ 900 1,314
Other (income) and expense, net $ (55) 2 $ (40) (57)
Operating Profit, Percent Change (82.00%)   (32.00%)  
Personal Care        
Net Sales $ 2,685 2,710 $ 5,389 5,439
Sales Revenue, Net, Percent Change (1.00%)   (1.00%)  
Operating Profit $ 472 466 $ 959 941
Operating Profit, Percent Change 1.00%   2.00%  
Consumer Tissue        
Net Sales $ 1,549 1,537 $ 3,183 3,105
Sales Revenue, Net, Percent Change 1.00%   3.00%  
Operating Profit $ 200 178 $ 440 349
Operating Profit, Percent Change 12.00%   26.00%  
K-C Professional        
Net Sales $ 887 802 $ 1,734 1,582
Sales Revenue, Net, Percent Change 11.00%   10.00%  
Operating Profit $ 187 85 $ 346 175
Operating Profit, Percent Change 120.00%   98.00%  
Corporate and Other        
Net Sales $ 13 14 $ 23 32
Operating Profit [1] (801) (106) (885) (208)
Other (income) and expense, net        
Other (income) and expense, net [1] $ (55) $ 2 $ (40) $ (57)
Operating Profit, Percent Change     (30.00%)  
[1] Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.N.M. - Not Meaningful
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Description Of Business Segments Sales of Principle Products (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Consolidated        
Net Sales $ 5,134 $ 5,063 $ 10,329 $ 10,158
Consumer Tissue Products        
Consolidated        
Net Sales 1,500 1,500 3,200 3,100
Baby and Child Care Products        
Consolidated        
Net Sales 1,800 1,900 3,500 3,700
Away-from-home Professional Products        
Consolidated        
Net Sales 900 800 1,700 1,600
All Other        
Consolidated        
Net Sales $ 900 $ 900 $ 1,900 $ 1,800
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Supplemental Balance Sheet Data - Inventory (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Raw materials $ 502 $ 572
Work in process 220 246
Finished goods 1,302 1,388
Supplies and other 315 302
Inventory, Gross 2,339 2,508
Inventory, LIFO Reserve (211) (239)
Total 2,128 2,269
LIFO    
Raw materials 139 147
Work in process 113 139
Finished goods 532 518
Supplies and other 0 0
Inventory, Gross 784 804
Inventory, LIFO Reserve (211) (239)
Total 573 565
Non-LIFO    
Raw materials 363 425
Work in process 107 107
Finished goods 770 870
Supplies and other 315 302
Inventory, Gross 1,555 1,704
Inventory, LIFO Reserve 0 0
Total $ 1,555 $ 1,704
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Supplemental Balance Sheet Data - Property Plant and Equipment (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment    
Land $ 159 $ 156
Buildings 3,046 3,062
Machinery and equipment 14,778 14,655
Construction in progress 741 676
Property, Plant and Equipment, Gross 18,724 18,549
Less accumulated depreciation (10,909) (10,664)
Total $ 7,815 $ 7,885
XML 53 kmb-20230630_htm.xml IDEA: XBRL DOCUMENT 0000055785 2023-01-01 2023-06-30 0000055785 us-gaap:CommonStockMember exch:XNYS 2023-01-01 2023-06-30 0000055785 kmb:A0.625NotesDue2024Member exch:XNYS 2023-01-01 2023-06-30 0000055785 2023-07-18 0000055785 2023-04-01 2023-06-30 0000055785 2022-04-01 2022-06-30 0000055785 2022-01-01 2022-06-30 0000055785 2023-06-30 0000055785 2022-12-31 0000055785 us-gaap:CommonStockMember 2023-03-31 0000055785 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000055785 us-gaap:TreasuryStockCommonMember 2023-03-31 0000055785 us-gaap:RetainedEarningsMember 2023-03-31 0000055785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000055785 us-gaap:NoncontrollingInterestMember 2023-03-31 0000055785 2023-03-31 0000055785 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000055785 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0000055785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000055785 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000055785 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0000055785 us-gaap:CommonStockMember 2023-06-30 0000055785 us-gaap:TreasuryStockCommonMember 2023-06-30 0000055785 us-gaap:NoncontrollingInterestMember 2023-06-30 0000055785 us-gaap:CommonStockMember 2022-12-31 0000055785 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000055785 us-gaap:TreasuryStockCommonMember 2022-12-31 0000055785 us-gaap:RetainedEarningsMember 2022-12-31 0000055785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000055785 us-gaap:NoncontrollingInterestMember 2022-12-31 0000055785 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0000055785 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-06-30 0000055785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0000055785 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0000055785 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0000055785 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000055785 us-gaap:RetainedEarningsMember 2023-06-30 0000055785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000055785 us-gaap:CommonStockMember 2022-03-31 0000055785 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000055785 us-gaap:TreasuryStockCommonMember 2022-03-31 0000055785 us-gaap:RetainedEarningsMember 2022-03-31 0000055785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000055785 us-gaap:NoncontrollingInterestMember 2022-03-31 0000055785 2022-03-31 0000055785 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000055785 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0000055785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0000055785 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000055785 us-gaap:TreasuryStockCommonMember 2022-04-01 2022-06-30 0000055785 us-gaap:CommonStockMember 2022-06-30 0000055785 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000055785 us-gaap:TreasuryStockCommonMember 2022-06-30 0000055785 us-gaap:RetainedEarningsMember 2022-06-30 0000055785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000055785 us-gaap:NoncontrollingInterestMember 2022-06-30 0000055785 2022-06-30 0000055785 us-gaap:CommonStockMember 2021-12-31 0000055785 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000055785 us-gaap:TreasuryStockCommonMember 2021-12-31 0000055785 us-gaap:RetainedEarningsMember 2021-12-31 0000055785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000055785 us-gaap:NoncontrollingInterestMember 2021-12-31 0000055785 2021-12-31 0000055785 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0000055785 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-06-30 0000055785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0000055785 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0000055785 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-06-30 0000055785 kmb:KCArgentinaMember us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-06-30 0000055785 kmb:KCArgentinaMember us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-06-30 0000055785 country:TR us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-06-30 0000055785 country:TR us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-06-30 0000055785 kmb:ThinxIncMember 2022-02-24 2022-02-24 0000055785 kmb:ThinxIncMember 2022-02-24 0000055785 2023-01-01 2023-03-31 0000055785 kmb:ThinxIncMember 2023-03-31 0000055785 kmb:ThinxIncMember 2023-01-01 2023-03-31 0000055785 kmb:ThinxIncMember kmb:PersonalCareMember 2023-06-30 0000055785 kmb:ThinxIncMember 2022-01-01 2022-03-31 0000055785 kmb:ThinxIncMember kmb:BeforeTaxMember 2022-01-01 2022-03-31 0000055785 kmb:ThinxIncMember kmb:AfterTaxMember 2022-01-01 2022-03-31 0000055785 kmb:ThinxIncMember 2023-04-01 2023-06-30 0000055785 kmb:SaleOfBrazilTissueAssetsMember 2023-04-01 2023-06-30 0000055785 kmb:SaleOfBrazilTissueAssetsMember kmb:BeforeTaxMember 2023-04-01 2023-06-30 0000055785 kmb:SaleOfBrazilTissueAssetsMember kmb:AfterTaxMember 2023-04-01 2023-06-30 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000055785 us-gaap:FairValueInputsLevel3Member 2023-06-30 0000055785 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000055785 us-gaap:FairValueMeasurementsRecurringMember kmb:NetAssetValueorItsEquivalentMember 2023-06-30 0000055785 us-gaap:FairValueMeasurementsRecurringMember kmb:NetAssetValueorItsEquivalentMember 2022-12-31 0000055785 us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-06-30 0000055785 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-06-30 0000055785 us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0000055785 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-06-30 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-06-30 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0000055785 kmb:UnrealizedTranslationMember 2021-12-31 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-12-31 0000055785 kmb:UnrealizedTranslationMember 2022-01-01 2022-06-30 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-06-30 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-06-30 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-06-30 0000055785 kmb:UnrealizedTranslationMember 2022-06-30 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2022-06-30 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-06-30 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-06-30 0000055785 kmb:UnrealizedTranslationMember 2022-12-31 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-12-31 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-12-31 0000055785 kmb:UnrealizedTranslationMember 2023-01-01 2023-06-30 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-06-30 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-01-01 2023-06-30 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2023-01-01 2023-06-30 0000055785 kmb:UnrealizedTranslationMember 2023-06-30 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2023-06-30 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-06-30 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2023-06-30 0000055785 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2023-06-30 0000055785 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2023-06-30 0000055785 us-gaap:NetInvestmentHedgingMember 2023-06-30 0000055785 us-gaap:NondesignatedMember 2023-04-01 2023-06-30 0000055785 us-gaap:NondesignatedMember 2022-04-01 2022-06-30 0000055785 us-gaap:NondesignatedMember 2023-01-01 2023-06-30 0000055785 us-gaap:NondesignatedMember 2022-01-01 2022-06-30 0000055785 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-06-30 0000055785 kmb:PersonalCareMember 2023-04-01 2023-06-30 0000055785 kmb:PersonalCareMember 2022-04-01 2022-06-30 0000055785 kmb:PersonalCareMember 2023-01-01 2023-06-30 0000055785 kmb:PersonalCareMember 2022-01-01 2022-06-30 0000055785 kmb:ConsumerTissueMember 2023-04-01 2023-06-30 0000055785 kmb:ConsumerTissueMember 2022-04-01 2022-06-30 0000055785 kmb:ConsumerTissueMember 2023-01-01 2023-06-30 0000055785 kmb:ConsumerTissueMember 2022-01-01 2022-06-30 0000055785 kmb:KCProfessionalMember 2023-04-01 2023-06-30 0000055785 kmb:KCProfessionalMember 2022-04-01 2022-06-30 0000055785 kmb:KCProfessionalMember 2023-01-01 2023-06-30 0000055785 kmb:KCProfessionalMember 2022-01-01 2022-06-30 0000055785 us-gaap:CorporateAndOtherMember 2023-04-01 2023-06-30 0000055785 us-gaap:CorporateAndOtherMember 2022-04-01 2022-06-30 0000055785 us-gaap:CorporateAndOtherMember 2023-01-01 2023-06-30 0000055785 us-gaap:CorporateAndOtherMember 2022-01-01 2022-06-30 0000055785 kmb:OtherincomeandexpensenetMember 2023-04-01 2023-06-30 0000055785 kmb:OtherincomeandexpensenetMember 2022-04-01 2022-06-30 0000055785 kmb:OtherincomeandexpensenetMember 2023-01-01 2023-06-30 0000055785 kmb:OtherincomeandexpensenetMember 2022-01-01 2022-06-30 0000055785 kmb:BabyandchildcareproductsMember 2023-04-01 2023-06-30 0000055785 kmb:BabyandchildcareproductsMember 2022-04-01 2022-06-30 0000055785 kmb:BabyandchildcareproductsMember 2023-01-01 2023-06-30 0000055785 kmb:BabyandchildcareproductsMember 2022-01-01 2022-06-30 0000055785 kmb:ConsumerTissueMember 2023-04-01 2023-06-30 0000055785 kmb:ConsumerTissueMember 2022-04-01 2022-06-30 0000055785 kmb:ConsumerTissueMember 2023-01-01 2023-06-30 0000055785 kmb:ConsumerTissueMember 2022-01-01 2022-06-30 0000055785 kmb:KCProfessionalMember 2023-04-01 2023-06-30 0000055785 kmb:KCProfessionalMember 2022-04-01 2022-06-30 0000055785 kmb:KCProfessionalMember 2023-01-01 2023-06-30 0000055785 kmb:KCProfessionalMember 2022-01-01 2022-06-30 0000055785 kmb:AllOtherMember 2023-04-01 2023-06-30 0000055785 kmb:AllOtherMember 2022-04-01 2022-06-30 0000055785 kmb:AllOtherMember 2023-01-01 2023-06-30 0000055785 kmb:AllOtherMember 2022-01-01 2022-06-30 0000055785 kmb:LifoMember 2023-06-30 0000055785 kmb:NonLifoMember 2023-06-30 0000055785 kmb:LifoMember 2022-12-31 0000055785 kmb:NonLifoMember 2022-12-31 shares iso4217:USD iso4217:USD shares pure 0000055785 --12-31 2023 Q2 false 10-Q true 2023-06-30 false 1-225 KIMBERLY-CLARK CORPORATION DE 39-0394230 P.O. Box 619100 Dallas, TX 75261-9100 (972) 281-1200 Common Stock KMB NYSE 0.625% Notes due 2024 KMB24 NYSE Yes Yes Large Accelerated Filer false false false 338185161 5134000000 5063000000 10329000000 10158000000 3403000000 3534000000 6872000000 7109000000 1731000000 1529000000 3457000000 3049000000 1015000000 906000000 1939000000 1792000000 658000000 0 658000000 0 55000000 -2000000 40000000 57000000 113000000 621000000 900000000 1314000000 -42000000 -27000000 -58000000 -31000000 9000000 1000000 16000000 3000000 76000000 68000000 149000000 133000000 4000000 527000000 709000000 1153000000 -32000000 115000000 141000000 229000000 36000000 412000000 568000000 924000000 50000000 29000000 93000000 52000000 86000000 441000000 661000000 976000000 -16000000 4000000 -7000000 16000000 102000000 437000000 668000000 960000000 0.30 1.30 1.98 2.85 0.30 1.29 1.97 2.84 86000000 441000000 661000000 976000000 -52000000 -267000000 41000000 -214000000 -24000000 -5000000 -16000000 -16000000 47000000 43000000 -31000000 34000000 19000000 -219000000 26000000 -164000000 105000000 222000000 687000000 812000000 -20000000 -6000000 -12000000 2000000 125000000 228000000 699000000 810000000 580000000 427000000 2359000000 2280000000 2128000000 2269000000 677000000 753000000 5744000000 5729000000 7815000000 7885000000 299000000 238000000 2086000000 2074000000 208000000 851000000 1231000000 1193000000 17383000000 17970000000 188000000 844000000 3713000000 3813000000 2302000000 2289000000 395000000 388000000 6598000000 7334000000 7947000000 7578000000 639000000 654000000 490000000 647000000 848000000 799000000 210000000 258000000 0 0 20000000.0 20000000.0 0 0 0 0 1.25 1.25 1200000000 1200000000 378600000 378600000 473000000 473000000 697000000 679000000 40400000 41100000 5071000000 5137000000 8040000000 8201000000 -3639000000 -3669000000 500000000 547000000 151000000 153000000 651000000 700000000 17383000000 17970000000 378597000 473000000 694000000 41231000 5153000000 8365000000 -3660000000 142000000 861000000 102000000 10000000 112000000 23000000 3000000 20000000 -47000000 1069000 113000000 66000000 220000 31000000 31000000 45000000 45000000 1.18 399000000 399000000 -5000000 28000000 -2000000 -2000000 -23000000 378597000 473000000 697000000 40382000 5071000000 8040000000 -3639000000 151000000 651000000 378597000 473000000 679000000 41135000 5137000000 8201000000 -3669000000 153000000 700000000 668000000 20000000 688000000 31000000 6000000 25000000 -59000000 1238000 131000000 72000000 485000 65000000 65000000 68000000 68000000 2.36 797000000 16000000 813000000 -9000000 32000000 -1000000 0 -24000000 378597000 473000000 697000000 40382000 5071000000 8040000000 -3639000000 151000000 651000000 378597000 473000000 599000000 41630000 5175000000 7988000000 -3180000000 149000000 854000000 437000000 9000000 446000000 -209000000 9000000 -218000000 -53000000 841000 87000000 34000000 173000 23000000 23000000 51000000 51000000 1.16 392000000 1000000 391000000 -1000000 11000000 1000000 -11000000 378597000 473000000 598000000 40962000 5111000000 8022000000 -3389000000 149000000 742000000 378597000 473000000 605000000 41762000 5183000000 7858000000 -3239000000 223000000 737000000 960000000 21000000 981000000 -150000000 13000000 -163000000 -79000000 1188000 122000000 43000000 388000 50000000 50000000 67000000 67000000 2.32 783000000 81000000 864000000 -5000000 13000000 1000000 -9000000 378597000 473000000 598000000 40962000 5111000000 8022000000 -3389000000 149000000 742000000 661000000 976000000 377000000 380000000 676000000 0 0 85000000 71000000 68000000 -238000000 -35000000 71000000 -13000000 60000000 21000000 35000000 348000000 26000000 -1000000 -7000000 -3000000 1400000000 944000000 389000000 470000000 0 46000000 218000000 1000000 388000000 300000000 470000000 545000000 -14000000 7000000 -75000000 -277000000 790000000 775000000 -307000000 553000000 357000000 0 350000000 300000000 96000000 75000000 63000000 49000000 48000000 0 16000000 82000000 -31000000 -42000000 -1152000000 -620000000 -20000000 -6000000 153000000 41000000 427000000 270000000 580000000 311000000 Accounting Policies<div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Basis of Presentation</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all material adjustments which are of a normal and recurring nature necessary for a fair presentation of the results for the periods presented have been reflected. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information, refer to the consolidated financial statements and footnotes included in our Annual Report on Form 10-K for the year ended December 31, 2022. The terms "Corporation," "Kimberly-Clark," "K-C," "we," "our" and "us" refer to Kimberly-Clark Corporation and its consolidated subsidiaries.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Highly Inflationary Accounting</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP guidance requires the use of highly inflationary accounting for countries whose cumulative three-year inflation exceeds 100 percent. Under highly inflationary accounting, the countries’ functional currency becomes the U.S. dollar, and its income statement and balance sheet are measured in U.S. dollars using both current and historical rates of exchange. In the second quarter of 2018, published inflation indices indicated that the three-year cumulative inflation in Argentina exceeded 100 percent, and as of July 1, 2018, we elected to adopt highly inflationary accounting for our subsidiaries in Argentina (“K-C Argentina”). The effect of changes in exchange rates on peso-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material. As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, K-C Argentina had a small net peso monetary position. Net sales of K-C Argentina were approximately 1 percent of our consolidated net sales for the six months ended June 30, 2023 and 2022.</span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, published inflation indices indicated that the three-year cumulative inflation in Turkey exceeded 100 percent, and as of April 1, 2022, we elected to adopt highly inflationary accounting for our subsidiary in Turkey (“K-C Turkey”). The effect of changes in exchange rates on lira-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net and was not material. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, K-C Turkey h</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ad a small net lira monetary position. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of K-C Turkey were less t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">han 1 per</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cent of our consolidated net sales for the six months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2022.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recently Adopted Accounting Standard</span></div><div style="margin-top:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board issued Accounting Standard Update (“ASU”) No. 2022-04, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities – Supplier Finance Programs (Subtopic 405-50)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new guidance requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. This ASU was effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the provision on roll forward information, which is effective for fiscal years beginning after December 15, 2023. We adopted this ASU as of January 1, 2023, except for the amendment on roll forward information which will be adopted January 1, 2024. As the guidance requires only additional disclosure, there were no effects of this standard on our financial position, results of operations or cash flows. See disclosure contained in Note 9.</span></div> 0.01 0.01 0.01 0.01 Acquisition and Divestiture<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2022, we completed our acquisition of a majority and controlling share of Thinx Inc. (“Thinx”), an industry leader in the reusable period and incontinence underwear category, for total consideration of $181 consisting of cash of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$53</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the fair value of our previously held equity investment of $127, and certain share-based award costs of $1. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously accounted for our ownership interest in Thinx as an equity method investment, but upon increasing our ownership to</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 58 percent, w</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e began consolidating the operations of Thinx into our financial statements at the end of the first quarter of 2022. The consolidated results of operations for Thinx are reported in our Personal Care business segment on a one-month lag. The share of Thinx net income and equity attributable to the third-party minority owner of Thinx is classified in our consolidated income statement within Net income attributable to noncontrolling interests and in our consolidated balance sheet </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within Redeemable Common and Preferred Securities of Subsidiaries. This noncontrolling equity interest is measured at the estimated redemption value, which approximates fair value.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, we substantially completed an initial purchase price allocation in which we utilized several generally accepted valuation methodologies to estimate the fair value of certain acquired assets. The primary valuation methods included two forms of the Income Approach (i.e., the multi-period excess earnings method [distributor method] and the relief-from-royalty method). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation was finalized in the first quarter of 2023 with immaterial measurement period adjustments recorded. </span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price consideration was allocated to the n</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et assets acquired based upon their respective final estimated fair values as follows: </span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment, Net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Intangible Assets, Net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less fair value of non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Intangible Assets, Net includes brands and customer relationships which have estimated useful lives of 4 to 15 years, primarily 15 years. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$298 w</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as allocated to the Personal Care business segment. The goodwill is primarily attributable to future growth opportunities and any intangible assets that did not qualify for separate recognition. For tax purposes, the acquisition of additional Thinx shares was treated as a stock acquisition, and the goodwill acquired is not tax deductible.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction during the quarter ended March 31, 2022, an $85</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> non-recurring, non-cash gain was recognized in Other (income) expense, net as a result of the remeasurement of the carrying value of our previously held equity investment to fair value, and related transaction and integration costs of $21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were recorded in Marketing, research and general expenses. This recognition resulted in a net benefit of $64 pre-tax ($68 after tax) being included in our consolidated income statement for the quarter ended March 31, 2022. In addition, we removed the non-cash gain impact from Operating Activities in our consolidated cash flow statements for the six months ended June 30, 2022.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the first quarter of 2023, we delivered a redemption notice to the third-party minority owner with respect to a portion of the remaining common securities of Thinx and reclassified $48 to Accrued expenses and other current liabilities from Redeemable Common and Preferred Securities. This redemption closed in the second quarter of 2023, and we acquired additional ownership of Thinx for $48, increasing our controlling ownership to 70 percent. As the purchase of additional ownership in an already controlled subsidiary represents an equity transaction, no gain or loss was recognized in consolidated net income or comprehensive income, and the transaction was recorded through a reduction in Accrued expenses and other current liabilities.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Divestiture</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2023, we completed the sale transaction, announced on October 24, 2022, of our Neve tissue brand and related consumer and K-C Professional tissue assets in Brazil for $212, including the base purchase price of $175 and preliminary working capital and other closing adjustments of $37. This transaction also included a licensing agreement to allow the acquirer to manufacture and market in Brazil the Kleenex, Scott and Wypall brands to consumers and away-from-home customers for a period of time. The assets included in the sale agreement were reclassified to Other current assets as of December 31, 2022, and upon closure of the transaction, a gain of $74 pre-tax was recognized in Other (income) and expense, net. We incurred divestiture-related costs of $30 pre-tax during the three months ended June 30, 2023, which were recorded in Cost of products sold and Marketing, research and general expenses, resulting in a net benefit of $44 pre-tax ($26 after tax).</span></div> 181000000 53000000 127000000 1000000 0.58 <div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price consideration was allocated to the n</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et assets acquired based upon their respective final estimated fair values as follows: </span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment, Net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Intangible Assets, Net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less fair value of non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 28000000 2000000 298000000 123000000 4000000 18000000 18000000 4000000 415000000 234000000 181000000 298000000 85000000 21000000 64000000 68000000 48000000 48000000 0.70 212000000 175000000 37000000 74000000 30000000 44000000 26000000 Impairment of Intangible Assets<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2023, we conducted forecasting and strategic reviews and integration assessments of our Softex Indonesia business, acquired in the fourth quarter of 2020, and with performance below expectations since acquisition, we revised internal financial projections of the business to reflect updated expectations of future financial performance. These reviews and the subsequent revisions in the projections highlighted challenges for the Softex business arising from modified consumer shopping behavior in the post-COVID-19 period, inflationary pressures and other macroeconomic factors and increased competitive activity in the region. As a result of separate management reviews, we also have revised internal financial projections associated with our acquisition of a controlling interest in Thinx as a result of performance below expectations due to the impact of modified consumer shopping behavior in the post-COVID-19 period. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These revisions were considered triggering events requiring interim impairment assessments to be performed relative to the intangible assets that had been recorded as part of these acquisitions. These intangible assets were recorded as part of the Personal Care business segment and included indefinite-lived and finite-lived brands and finite-lived distributor and customer relationships. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the interim impairment assessments, we recognized impairment charges, principally arising from the impairment charge of $593 related to the Softex business, totaling $658 pre-tax ($483 after tax) to write-down these intangible assets to their respective fair values aggregating to $188 as of June 30, 2023. The valuation methods used in the assessments included the relief from royalty and distributor and customer relationships methods. This noncash charge was included in Impairment of intangible assets in our consolidated income statement and in Asset impairments within Operating Activities in our consolidated cash flow statement.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our estimates and assumptions used in the valuations are reasonable and comparable to those that would be used by other market participants; however, actual events and results could differ substantially from those used in the valuation, and to the extent such factors result in a failure to achieve the projected cash flows used to estimate fair value, additional noncash impairment charges could be required in the future.</span></div> 593000000 658000000 483000000 188000000 Fair Value Information<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are:</span></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 – Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities.</span></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 – Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly.</span></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 – Prices or valuations that require inputs that are significant to the valuation and are unobservable.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023 and for the full year 2022, there were no</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significant transfers to or from level 3 fair value determinations. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative assets and liabilities are measured on a recurring basis at fair value. At June 30, 2023 and December 31, 2022, derivative assets were $89 and $99, respectively, and derivative liabilities were $328 and $318, respectively. The fair values of derivatives used to manage interest rate risk are based on the Secured Overnight Financing Rate ("SOFR") as of June 30, 2023, and on LIBOR rates as of December 31, 2022, and interest rate swap curves. The fair values of derivatives used to manage commodity price risk are based on commodity price quotations. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of hedging instruments used to manage foreign currency risk are based on published quotations of spot currency rates and forward points, which are converted into implied forward currency rates. Measurement of our derivative assets and liabilities is considered a level 2 measurement. Additional information on our classification and use of derivative instruments is contained in Note 7.</span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable common and preferred securities of subsidiaries are measured on a recurring basis at their estimated redemption values, which approximate fair value. As of June 30, 2023 and December 31, 2022, the securities were valued at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$210 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$258, re</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">spectively. The securities are not traded in active markets, and their measurement is considered a level 3 measurement. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, we delivered a redemption notice to the third-party minority owner with respect to a portion of the remaining common securities of Thinx, and the amount associated with the expected redemption was reclassified to Accrued expenses and other current liabilities, reducing our outstanding redeemable common securities by $48. In the second quarter of 2023, we closed on the redemption. Additional information on this transaction is contained in Note 2.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company-owned life insurance ("COLI") assets are measured on a recurring basis at fair value. COLI assets were $65 and $63 at June 30, 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. The COLI policies are a source of funding primarily for our nonqualified employee benefits and are included in Other Assets. The COLI policies are measured at fair value using the net asset value per share practical expedient, and therefore, are not classified in the fair value hierarchy.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the fair value of our financial instruments for which disclosure of fair value is required:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.261%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Hierarchy Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 5.5pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,068</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,530</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,049 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,403 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.63pt">Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value. </span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.18pt">Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value. </span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.63pt">Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.</span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.18pt">Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.</span></div> 89000000 99000000 328000000 318000000 -210000000 -258000000 48000000 65000000 63000000 <div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the fair value of our financial instruments for which disclosure of fair value is required:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.261%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Hierarchy Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 5.5pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,068</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,530</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,049 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,403 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.63pt">Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value. </span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.18pt">Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value. </span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.63pt">Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.</span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.18pt">Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.</span></div> 580000000 580000000 427000000 427000000 182000000 182000000 268000000 268000000 67000000 67000000 373000000 373000000 8068000000 7530000000 8049000000 7403000000 Earnings Per Share ("EPS")<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no adjustments required to be made to net income for purposes of computing basic and diluted EPS. The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of shares)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">338.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">337.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and restricted share unit awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">338.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">338.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of options outstanding that were not included in the computation of diluted EPS because their exercise price was greater than the average market price of the common shares was insignificant. The number of common shares outstanding as of June 30, 2023 and 2022 was 338.2 million and 337.6 million, respectively.</span></div> The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of shares)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">338.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">337.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and restricted share unit awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">338.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">338.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 338000000.0 337400000 337700000 337200000 900000 900000 1000000.0 1100000 338900000 338300000 338700000 338300000 338200000 337600000 Stockholders' Equity<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in Accumulated Other Comprehensive Income ("AOCI"). For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in net unrealized currency translation for the six months ended June 30, 2023 was primarily due to the strengthening of certain foreign currencies versus the U.S. dollar.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges and Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,422)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(803)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,621)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>    reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(103)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,723)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(772)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(195)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)    Included in computation of net periodic benefit costs.</span></div> <div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges and Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,422)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(803)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,621)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>    reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(103)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,723)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(772)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(195)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)    Included in computation of net periodic benefit costs.</span></div> -2422000000 803000000 34000000 20000000 -199000000 11000000 3000000 42000000 0 -30000000 0 9000000 -199000000 -19000000 3000000 33000000 -2621000000 784000000 37000000 53000000 -2769000000 789000000 -52000000 -163000000 46000000 18000000 1000000 -103000000 0 -35000000 0 -71000000 46000000 -17000000 1000000 -32000000 -2723000000 772000000 -51000000 -195000000 Objectives and Strategies for Using Derivatives<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a multinational enterprise, we are exposed to financial risks, such as changes in foreign currency exchange rates, interest r</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ates, and commodity prices. We employ a number of practices to manage these risks, including operating and financing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activities and, where appropriate, the use of derivative instruments.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2023 and December 31, 2022, derivative assets were $89 and $99, respectively, and derivative liabilities were $328 and $318, respectively, primarily comprised of foreign currency exchange and commodity price contracts. Derivative assets are recorded in Other current assets or Other Assets, as appropriate, and derivative liabilities are recorded in Accrued expenses and other current liabilities or Other Liabilities, as appropriate.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Currency Exchange Rate Risk</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Translation adjustments result from translating foreign entities' financial statements into U.S. dollars from their functional currencies. The risk to any particular entity's net assets is reduced to the extent that the entity is financed with local currency borrowings. A portion of our balance sheet translation exposure for certain affiliates, which results from changes in translation rates between the affiliates’ functional currencies and the U.S. dollar, is hedged with cross-currency swap contracts and certain foreign denominated debt which are designated as net investment hedges. The foreign currency exposure on certain non-functional currency denominated monetary assets and liabilities, primarily intercompany loans and accounts payable, is hedged with primarily undesignated derivative instruments. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments are entered into to hedge a portion of forecasted cash flows denominated in foreign currencies for non-U.S. operations' purchases of raw materials, which are priced in U.S. dollars, and imports of intercompany finished goods and work-in-process priced predominantly in U.S. dollars and euros. The derivative instruments used to manage these exposures are designated as cash flow hedges.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Risk</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk is managed using a portfolio of variable and fixed-rate debt composed of short and long-term instruments. Interest rate swap contracts may be used to facilitate the maintenance of the desired ratio of variable and fixed-rate debt and are designated as fair value hedges. From time to time, we also hedge the anticipated issuance of fixed-rate debt, and these contracts are designated as cash flow hedges.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commodity Price Risk</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We use derivative instruments, such as forward contracts, to hedge a portion of our exposure to market risk arising from changes in prices of certain commodities. These derivatives are designated as cash flow hedges of specific quantities of the underlying commodity expected to be purchased in future months. In addition, we utilize negotiated contracts of varying durations along with strategic pricing mechanisms to manage volatility for a portion of our commodity costs.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Hedges</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments that are designated and qualify as fair value hedges are predominantly used to manage interest rate risk. The fair values of these interest rate derivative instruments are recorded as an asset or liability, as appropriate, with the offset recorded in Interest expense. The offset to the change in fair values of the related debt is also recorded in Interest expense. Any realized gain or loss on the derivatives that hedge interest rate risk is amortized to Interest expense over the life of the related debt. As of June 30, 2023, the aggregate notional values and carrying values of debt subject to outstanding interest rate contracts designated as fair value hedges were $525 and $471, respectively. For the six months ended June 30, 2023 and 2022, gains or losses recognized in Interest expense for interest rate swaps were not significant. </span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Hedges</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same income statement line and period that the hedged exposure affects earnings. As of June 30, 2023, outstanding commodity forward contracts were in place to hedge a portion of our estimated requirements of the related underlying commodities in the remainder of 2023 and future periods. As of June 30, 2023, the aggregate notional value of outstanding foreign exchange derivative contracts designated as cash flow hedges was $2.8 billion. For the six months ended June 30, 2023 and 2022, no significant gains or losses were reclassified into Interest expense, Cost of products sold or Other (income) and expense, net as a result of the discontinuance of cash flow hedges due to the original forecasted transaction no longer being probable of occurring. At June 30, 2023, amounts to be reclassified from AOCI into Interest expense, Cost of products sold or Other (income) and expense, net during the next twelve months are not expected to be material. The maximum maturity of cash flow hedges in place at June 30, 2023 is June 2026.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Investment Hedges</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For derivative instruments that are designated and qualify as net investment hedges, the aggregate notional value was $1.7 billion at June 30, 2023. We exclude the interest accruals on cross-currency swap contracts and the forward points on foreign exchange forward contracts from the assessment and measurement of hedge effectiveness.  We recognize the interest accruals on cross-currency swap contracts in earnings within Interest expense.  We amortize the forward points on foreign exchange contracts into earnings within Interest expense over the life of the hedging relationship.  Changes in fair value of net investment hedges are recorded in AOCI and offset the change in the value of the net investment being hedged.  For the six months ended June 30, 2023, unrealized losses of $15 related to net investment hedge fair value changes were recorded in AOCI and no significant amounts were reclassified from AOCI to Interest expense.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No significant amounts were excluded from the assessment of net investment, fair value or cash flow hedge effectiveness as of June 30, 2023.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Undesignated Hedging Instruments</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses on undesignated foreign exchange hedging instruments are immediately recognized in Other (income) and expense, net. Losses of $14 and $1 were recorded in the three months ended June 30, 2023 and 2022, respectively. Losses of $6 and $35 were recorded in the six months ended June 30, 2023 and 2022. The effect on earnings from the use of these non-designated derivatives is substantially neutralized by the transactional gains and losses recorded on the underlying assets and liabilities. At June 30, 2023, the notional value of these undesignated derivative instruments was approximately $2.6 billion.</span></div> 89000000 99000000 328000000 318000000 525000000 471000000 2800000000 1700000000 -15000000 14000000 1000000 6000000 35000000 2600000000 Business Segment InformationWe are organized into operating segments based on product groupings. These operating segments have been aggregated into three reportable global business segments: Personal Care, Consumer Tissue and K-C Professional. The reportable segments were determined in accordance with how our chief operating decision maker and our executive managers develop and execute global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. <div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating profit excludes Other (income) and expense, net and income and expense not associated with ongoing operations of the business segments. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal sources of revenue in each global business segment are described below:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Personal Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands offer our consumers a trusted partner in caring for themselves and their families by delivering confidence, protection and discretion through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products.  Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex and other brand names.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Consumer Tissue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> offers a wide variety of innovative solutions and trusted brands that responsibly improve everyday living for families around the world.  Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Andrex, Viva, Scottex and other brand names.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">K-C Professional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> partners with businesses to create Exceptional Workplaces, helping to make them healthier, safer and more productive through a range of solutions and supporting products such as wipers, tissue, towels, apparel, soaps and sanitizers. Our brands, including Kleenex, Scott, WypAll, Kimtech and KleenGuard are well known for quality and trusted to help people around the world work better.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning consolidated operations by business segment is presented in the following tables: </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET SALES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,685</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer Tissue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,183</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K-C Professional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">887</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,734</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate &amp; Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.M.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL NET SALES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,134</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,063 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,329</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,158 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING PROFIT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">959</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer Tissue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">440</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K-C Professional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">187</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">346</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate &amp; Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(801)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.M.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) and expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.M.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL OPERATING PROFIT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)    Corporate &amp; Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N.M. - Not Meaningful</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sales of Principal Products:</span></div><div style="margin-bottom:3pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Billions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baby and child care products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer tissue products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Away-from-home professional products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning consolidated operations by business segment is presented in the following tables: </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET SALES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,685</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer Tissue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,183</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K-C Professional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">887</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,734</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate &amp; Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.M.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL NET SALES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,134</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,063 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,329</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,158 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING PROFIT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">959</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer Tissue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">440</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K-C Professional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">187</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">346</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate &amp; Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(801)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.M.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) and expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.M.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL OPERATING PROFIT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)    Corporate &amp; Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N.M. - Not Meaningful</span></div> 2685000000 2710000000 -0.01 5389000000 5439000000 -0.01 1549000000 1537000000 0.01 3183000000 3105000000 0.03 887000000 802000000 0.11 1734000000 1582000000 0.10 13000000 14000000 23000000 32000000 5134000000 5063000000 0.01 10329000000 10158000000 0.02 472000000 466000000 0.01 959000000 941000000 0.02 200000000 178000000 0.12 440000000 349000000 0.26 187000000 85000000 1.20 346000000 175000000 0.98 -801000000 -106000000 -885000000 -208000000 55000000 -2000000 40000000 57000000 -0.30 113000000 621000000 -0.82 900000000 1314000000 -0.32 <div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sales of Principal Products:</span></div><div style="margin-bottom:3pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Billions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baby and child care products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer tissue products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Away-from-home professional products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1800000000 1900000000 3500000000 3700000000 1500000000 1500000000 3200000000 3100000000 900000000 800000000 1700000000 1600000000 900000000 900000000 1900000000 1800000000 5100000000 5100000000 10300000000 10200000000 Supplemental Balance Sheet Data<div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following schedule presents a summary of inventories by major class:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIFO</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-LIFO</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIFO</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-LIFO</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">502</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">770</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,302</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">784</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,555</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,339</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess of FIFO or weighted-average cost over<br/>  LIFO cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">573</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,555</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or net realizable value, determined on the FIFO or weighted-average cost methods, and at the lower of cost or market, determined on the LIFO cost method.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following schedule presents a summary of property, plant and equipment, net: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:67.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,046</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,062 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">741</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,724</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,549 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,885 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Supplier Finance Program</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a supplier finance program managed through two global financial institutions under which we agree to pay the financial institutions the stated amount of confirmed invoices from our participating suppliers on the invoice due date. We, or the global financial institutions, may terminate our agreements at any time upon 30 days written notice. The global financial institutions may terminate our agreements at any time upon three days written notice in the event there are insufficient funds available for disbursement. We do not provide any forms of guarantees under these agreements. Supplier participation in the program is solely up to the supplier, and the participating suppliers negotiate their arrangements directly with the global financial institutions. We have no economic interest in a supplier’s decision to participate in the program, and their participation has no bearing on our payment terms or amounts due. The payment terms that we have with our suppliers under this program generally range from 75 to 180 days and are considered commercially reasonable. The outstanding amount related to the suppliers participating in this program was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.0 billion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of June 30, 2023 and December 31, 2022, and was recorded within Trade accounts payable.</span></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following schedule presents a summary of inventories by major class:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIFO</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-LIFO</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIFO</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-LIFO</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">502</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">770</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,302</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">784</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,555</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,339</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess of FIFO or weighted-average cost over<br/>  LIFO cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">573</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,555</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 139000000 363000000 502000000 147000000 425000000 572000000 113000000 107000000 220000000 139000000 107000000 246000000 532000000 770000000 1302000000 518000000 870000000 1388000000 0 315000000 315000000 0 302000000 302000000 784000000 1555000000 2339000000 804000000 1704000000 2508000000 211000000 0 211000000 239000000 0 239000000 573000000 1555000000 2128000000 565000000 1704000000 2269000000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following schedule presents a summary of property, plant and equipment, net: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:67.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,046</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,062 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">741</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,724</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,549 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,885 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 159000000 156000000 3046000000 3062000000 14778000000 14655000000 741000000 676000000 18724000000 18549000000 10909000000 10664000000 7815000000 7885000000 1000000000 Included in computation of net periodic benefit costs. Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.N.M. - Not Meaningful Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value. Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value. Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value. Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly. EXCEL 54 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 57 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 172 221 1 true 45 0 false 4 false false R1.htm 0000001 - Document - Document and Entity Information Sheet http://www.kimberly-clark.com/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 0000002 - Statement - Consolidated Income Statement Sheet http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement Consolidated Income Statement Statements 2 false false R3.htm 0000003 - Statement - Consolidated Statement Of Comprehensive Income Sheet http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome Consolidated Statement Of Comprehensive Income Statements 3 false false R4.htm 0000004 - Statement - Consolidated Balance Sheet Sheet http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheet Statements 4 false false R5.htm 0000005 - Statement - Consolidated Balance Sheet Parenthetical Sheet http://www.kimberly-clark.com/role/ConsolidatedBalanceSheetParenthetical Consolidated Balance Sheet Parenthetical Statements 5 false false R6.htm 0000006 - Statement - Statement of Stockholders' Equity Sheet http://www.kimberly-clark.com/role/StatementofStockholdersEquity Statement of Stockholders' Equity Statements 6 false false R7.htm 0000007 - Statement - Statement of Stockholders' Equity Stockholders' Equity Parentheticals Sheet http://www.kimberly-clark.com/role/StatementofStockholdersEquityStockholdersEquityParentheticals Statement of Stockholders' Equity Stockholders' Equity Parentheticals Statements 7 false false R8.htm 0000008 - Statement - Consolidated Cash Flow Statement Sheet http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement Consolidated Cash Flow Statement Statements 8 false false R9.htm 0000009 - Statement - Supplemental Balance Sheet Data Narrative Sheet http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataNarrative Supplemental Balance Sheet Data Narrative Statements 9 false false R10.htm 0000010 - Disclosure - Accounting Policies Sheet http://www.kimberly-clark.com/role/AccountingPolicies Accounting Policies Notes 10 false false R11.htm 0000011 - Disclosure - Acquisition Sheet http://www.kimberly-clark.com/role/Acquisition Acquisition Notes 11 false false R12.htm 0000012 - Disclosure - Impairment of Intangible Assets Sheet http://www.kimberly-clark.com/role/ImpairmentofIntangibleAssets Impairment of Intangible Assets Notes 12 false false R13.htm 0000013 - Disclosure - Fair Value Information Sheet http://www.kimberly-clark.com/role/FairValueInformation Fair Value Information Notes 13 false false R14.htm 0000014 - Disclosure - Earnings Per Share Sheet http://www.kimberly-clark.com/role/EarningsPerShare Earnings Per Share Notes 14 false false R15.htm 0000015 - Disclosure - Stockholders' Equity Sheet http://www.kimberly-clark.com/role/StockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 0000017 - Disclosure - Objectives And Strategies For Using Derivatives Sheet http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivatives Objectives And Strategies For Using Derivatives Notes 16 false false R17.htm 0000018 - Disclosure - Description Of Business Segments Sheet http://www.kimberly-clark.com/role/DescriptionOfBusinessSegments Description Of Business Segments Notes 17 false false R18.htm 0000019 - Disclosure - Supplemental Balance Sheet Data Sheet http://www.kimberly-clark.com/role/SupplementalBalanceSheetData Supplemental Balance Sheet Data Notes 18 false false R19.htm 9954702 - Disclosure - Acquisition (Tables) Sheet http://www.kimberly-clark.com/role/AcquisitionTables Acquisition (Tables) Tables http://www.kimberly-clark.com/role/Acquisition 19 false false R20.htm 9954704 - Disclosure - Fair Value Information (Tables) Sheet http://www.kimberly-clark.com/role/FairValueInformationTables Fair Value Information (Tables) Tables http://www.kimberly-clark.com/role/FairValueInformation 20 false false R21.htm 9954705 - Disclosure - Earnings Per Share (Tables) Sheet http://www.kimberly-clark.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.kimberly-clark.com/role/EarningsPerShare 21 false false R22.htm 9954706 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.kimberly-clark.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.kimberly-clark.com/role/StockholdersEquity 22 false false R23.htm 9954709 - Disclosure - Description Of Business Segments (Tables) Sheet http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsTables Description Of Business Segments (Tables) Tables http://www.kimberly-clark.com/role/DescriptionOfBusinessSegments 23 false false R24.htm 9954710 - Disclosure - Summary of Balance Sheet Data (Tables) Sheet http://www.kimberly-clark.com/role/SummaryofBalanceSheetDataTables Summary of Balance Sheet Data (Tables) Tables 24 false false R25.htm 9954711 - Disclosure - Accounting Policies Narrative (Details) Sheet http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails Accounting Policies Narrative (Details) Details 25 false false R26.htm 9954712 - Disclosure - Acquisition Narrative (Details) Sheet http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails Acquisition Narrative (Details) Details 26 false false R27.htm 9954713 - Disclosure - Acquisition (Schedule of Recognized Identified Assets Acquired and Liabilities Assumed) (Details) Sheet http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails Acquisition (Schedule of Recognized Identified Assets Acquired and Liabilities Assumed) (Details) Details http://www.kimberly-clark.com/role/AcquisitionTables 27 false false R28.htm 9954714 - Disclosure - Impairment of Intangible Assets Narrative (Details) Sheet http://www.kimberly-clark.com/role/ImpairmentofIntangibleAssetsNarrativeDetails Impairment of Intangible Assets Narrative (Details) Details 28 false false R29.htm 9954716 - Disclosure - Fair Value Information (Narrative) (Details) Sheet http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails Fair Value Information (Narrative) (Details) Details http://www.kimberly-clark.com/role/FairValueInformationTables 29 false false R30.htm 9954717 - Disclosure - Fair Value Information (Fair Value Of Financial Instruments) (Details) Sheet http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails Fair Value Information (Fair Value Of Financial Instruments) (Details) Details http://www.kimberly-clark.com/role/FairValueInformationTables 30 false false R31.htm 9954718 - Disclosure - Earnings Per Share (Narrative) (Details) Sheet http://www.kimberly-clark.com/role/EarningsPerShareNarrativeDetails Earnings Per Share (Narrative) (Details) Details http://www.kimberly-clark.com/role/EarningsPerShareTables 31 false false R32.htm 9954719 - Disclosure - Earnings Per Share (Average Common Shares Outstanding Basic And Diluted) (Details) Sheet http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails Earnings Per Share (Average Common Shares Outstanding Basic And Diluted) (Details) Details http://www.kimberly-clark.com/role/EarningsPerShareTables 32 false false R33.htm 9954720 - Disclosure - Stockholders' Equity (Components of Accumulated Other Comprehensive Income) (Details) Sheet http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails Stockholders' Equity (Components of Accumulated Other Comprehensive Income) (Details) Details http://www.kimberly-clark.com/role/StockholdersEquityTables 33 false false R34.htm 9954727 - Disclosure - Objectives And Strategies For Using Derivatives (Narratives) (Details) Sheet http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails Objectives And Strategies For Using Derivatives (Narratives) (Details) Details http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivatives 34 false false R35.htm 9954728 - Disclosure - Description Of Business Segments (Details) Sheet http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails Description Of Business Segments (Details) Details http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsTables 35 false false R36.htm 9954729 - Disclosure - Description Of Business Segments Sales of Principle Products (Details) Sheet http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails Description Of Business Segments Sales of Principle Products (Details) Details 36 false false R37.htm 9954730 - Disclosure - Supplemental Balance Sheet Data - Inventory (Details) Sheet http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails Supplemental Balance Sheet Data - Inventory (Details) Details 37 false false R38.htm 9954731 - Disclosure - Supplemental Balance Sheet Data - Property Plant and Equipment (Details) Sheet http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails Supplemental Balance Sheet Data - Property Plant and Equipment (Details) Details 38 false false All Reports Book All Reports kmb-20230630.htm kimberly-clarkcorporationa.htm kimberly-clarkcorporationo.htm kimberly-clarkcorporationp.htm kmb-20230630.xsd kmb-20230630_cal.xml kmb-20230630_def.xml kmb-20230630_lab.xml kmb-20230630_pre.xml kmb10qq22023exhibit31a.htm kmb10qq22023exhibit31b.htm kmb10qq22023exhibit32a.htm kmb10qq22023exhibit32b.htm kmb-20230630_g1.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 59 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kmb-20230630.htm": { "axisCustom": 2, "axisStandard": 18, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 643, "http://xbrl.sec.gov/dei/2023": 32 }, "contextCount": 172, "dts": { "calculationLink": { "local": [ "kmb-20230630_cal.xml" ] }, "definitionLink": { "local": [ "kmb-20230630_def.xml" ] }, "inline": { "local": [ "kmb-20230630.htm" ] }, "labelLink": { "local": [ "kmb-20230630_lab.xml" ] }, "presentationLink": { "local": [ "kmb-20230630_pre.xml" ] }, "schema": { "local": [ "kmb-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd" ] } }, "elementCount": 363, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 5, "total": 5 }, "keyCustom": 22, "keyStandard": 199, "memberCustom": 16, "memberStandard": 26, "nsprefix": "kmb", "nsuri": "http://www.kimberly-clark.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.kimberly-clark.com/role/DocumentandEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Accounting Policies", "menuCat": "Notes", "order": "10", "role": "http://www.kimberly-clark.com/role/AccountingPolicies", "shortName": "Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Acquisition", "menuCat": "Notes", "order": "11", "role": "http://www.kimberly-clark.com/role/Acquisition", "shortName": "Acquisition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Impairment of Intangible Assets", "menuCat": "Notes", "order": "12", "role": "http://www.kimberly-clark.com/role/ImpairmentofIntangibleAssets", "shortName": "Impairment of Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Fair Value Information", "menuCat": "Notes", "order": "13", "role": "http://www.kimberly-clark.com/role/FairValueInformation", "shortName": "Fair Value Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Earnings Per Share", "menuCat": "Notes", "order": "14", "role": "http://www.kimberly-clark.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Stockholders' Equity", "menuCat": "Notes", "order": "15", "role": "http://www.kimberly-clark.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Objectives And Strategies For Using Derivatives", "menuCat": "Notes", "order": "16", "role": "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivatives", "shortName": "Objectives And Strategies For Using Derivatives", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Description Of Business Segments", "menuCat": "Notes", "order": "17", "role": "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegments", "shortName": "Description Of Business Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Supplemental Balance Sheet Data", "menuCat": "Notes", "order": "18", "role": "http://www.kimberly-clark.com/role/SupplementalBalanceSheetData", "shortName": "Supplemental Balance Sheet Data", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-76", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954702 - Disclosure - Acquisition (Tables)", "menuCat": "Tables", "order": "19", "role": "http://www.kimberly-clark.com/role/AcquisitionTables", "shortName": "Acquisition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-76", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Consolidated Income Statement", "menuCat": "Statements", "order": "2", "role": "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement", "shortName": "Consolidated Income Statement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-6", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954704 - Disclosure - Fair Value Information (Tables)", "menuCat": "Tables", "order": "20", "role": "http://www.kimberly-clark.com/role/FairValueInformationTables", "shortName": "Fair Value Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "kmb:ScheduleOfAverageCommonSharesOutstandingBasicAndDilutedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954705 - Disclosure - Earnings Per Share (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.kimberly-clark.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "kmb:ScheduleOfAverageCommonSharesOutstandingBasicAndDilutedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954706 - Disclosure - Stockholders' Equity (Tables)", "menuCat": "Tables", "order": "22", "role": "http://www.kimberly-clark.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954709 - Disclosure - Description Of Business Segments (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsTables", "shortName": "Description Of Business Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954710 - Disclosure - Summary of Balance Sheet Data (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.kimberly-clark.com/role/SummaryofBalanceSheetDataTables", "shortName": "Summary of Balance Sheet Data (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskPercentage1", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-71", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954711 - Disclosure - Accounting Policies Narrative (Details)", "menuCat": "Details", "order": "25", "role": "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails", "shortName": "Accounting Policies Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskPercentage1", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-71", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954712 - Disclosure - Acquisition Narrative (Details)", "menuCat": "Details", "order": "26", "role": "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "shortName": "Acquisition Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-84", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ProceedsFromDivestitureOfBusinesses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954713 - Disclosure - Acquisition (Schedule of Recognized Identified Assets Acquired and Liabilities Assumed) (Details)", "menuCat": "Details", "order": "27", "role": "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails", "shortName": "Acquisition (Schedule of Recognized Identified Assets Acquired and Liabilities Assumed) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-77", "decimals": "-6", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-6", "first": true, "lang": "en-US", "name": "kmb:UsGaap_ImpairmentOfIntangibleAssetsExcludingGoodwillSoftexBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954714 - Disclosure - Impairment of Intangible Assets Narrative (Details)", "menuCat": "Details", "order": "28", "role": "http://www.kimberly-clark.com/role/ImpairmentofIntangibleAssetsNarrativeDetails", "shortName": "Impairment of Intangible Assets Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-6", "first": true, "lang": "en-US", "name": "kmb:UsGaap_ImpairmentOfIntangibleAssetsExcludingGoodwillSoftexBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-89", "decimals": "-6", "first": true, "lang": "en-US", "name": "kmb:RedeemablePreferredSecuritiesOfSubsidiariesFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954716 - Disclosure - Fair Value Information (Narrative) (Details)", "menuCat": "Details", "order": "29", "role": "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails", "shortName": "Fair Value Information (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-89", "decimals": "-6", "first": true, "lang": "en-US", "name": "kmb:RedeemablePreferredSecuritiesOfSubsidiariesFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Consolidated Statement Of Comprehensive Income", "menuCat": "Statements", "order": "3", "role": "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome", "shortName": "Consolidated Statement Of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeOtherNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-93", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954717 - Disclosure - Fair Value Information (Fair Value Of Financial Instruments) (Details)", "menuCat": "Details", "order": "30", "role": "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails", "shortName": "Fair Value Information (Fair Value Of Financial Instruments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-93", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954718 - Disclosure - Earnings Per Share (Narrative) (Details)", "menuCat": "Details", "order": "31", "role": "http://www.kimberly-clark.com/role/EarningsPerShareNarrativeDetails", "shortName": "Earnings Per Share (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954719 - Disclosure - Earnings Per Share (Average Common Shares Outstanding Basic And Diluted) (Details)", "menuCat": "Details", "order": "32", "role": "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails", "shortName": "Earnings Per Share (Average Common Shares Outstanding Basic And Diluted) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954720 - Disclosure - Stockholders' Equity (Components of Accumulated Other Comprehensive Income) (Details)", "menuCat": "Details", "order": "33", "role": "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails", "shortName": "Stockholders' Equity (Components of Accumulated Other Comprehensive Income) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-114", "decimals": "-6", "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954727 - Disclosure - Objectives And Strategies For Using Derivatives (Narratives) (Details)", "menuCat": "Details", "order": "34", "role": "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails", "shortName": "Objectives And Strategies For Using Derivatives (Narratives) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954728 - Disclosure - Description Of Business Segments (Details)", "menuCat": "Details", "order": "35", "role": "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails", "shortName": "Description Of Business Segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "2", "lang": "en-US", "name": "kmb:SalesRevenueNetPercentChange", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954729 - Disclosure - Description Of Business Segments Sales of Principle Products (Details)", "menuCat": "Details", "order": "36", "role": "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails", "shortName": "Description Of Business Segments Sales of Principle Products (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-157", "decimals": "-8", "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954730 - Disclosure - Supplemental Balance Sheet Data - Inventory (Details)", "menuCat": "Details", "order": "37", "role": "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails", "shortName": "Supplemental Balance Sheet Data - Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954731 - Disclosure - Supplemental Balance Sheet Data - Property Plant and Equipment (Details)", "menuCat": "Details", "order": "38", "role": "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails", "shortName": "Supplemental Balance Sheet Data - Property Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Consolidated Balance Sheet", "menuCat": "Statements", "order": "4", "role": "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "shortName": "Consolidated Balance Sheet", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Consolidated Balance Sheet Parenthetical", "menuCat": "Statements", "order": "5", "role": "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheetParenthetical", "shortName": "Consolidated Balance Sheet Parenthetical", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-58", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Statement of Stockholders' Equity", "menuCat": "Statements", "order": "6", "role": "http://www.kimberly-clark.com/role/StatementofStockholdersEquity", "shortName": "Statement of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-58", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-5", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - Statement of Stockholders' Equity Stockholders' Equity Parentheticals", "menuCat": "Statements", "order": "7", "role": "http://www.kimberly-clark.com/role/StatementofStockholdersEquityStockholdersEquityParentheticals", "shortName": "Statement of Stockholders' Equity Stockholders' Equity Parentheticals", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000008 - Statement - Consolidated Cash Flow Statement", "menuCat": "Statements", "order": "8", "role": "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement", "shortName": "Consolidated Cash Flow Statement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-1", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-8", "first": true, "lang": "en-US", "name": "us-gaap:SupplierFinanceProgramObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000009 - Statement - Supplemental Balance Sheet Data Narrative", "menuCat": "Statements", "order": "9", "role": "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataNarrative", "shortName": "Supplemental Balance Sheet Data Narrative", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "kmb-20230630.htm", "contextRef": "c-8", "decimals": "-8", "first": true, "lang": "en-US", "name": "us-gaap:SupplierFinanceProgramObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 45, "tag": { "country_TR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "T\u00dcRKIYE", "terseLabel": "Turkey" } } }, "localname": "TR", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r663" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r664" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityListingsExchangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Listings, Exchange [Axis]", "terseLabel": "Entity Listings, Exchange [Axis]" } } }, "localname": "EntityListingsExchangeAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_ExchangeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.", "label": "Exchange [Domain]", "terseLabel": "Exchange [Domain]" } } }, "localname": "ExchangeDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "domainItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r660" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "exch_XNYS": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEW YORK STOCK EXCHANGE, INC. [Member]", "terseLabel": "NEW YORK STOCK EXCHANGE, INC." } } }, "localname": "XNYS", "nsuri": "http://xbrl.sec.gov/exch/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "domainItemType" }, "kmb_A0.625NotesDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.625% Notes Due 2024 [Member]", "label": "0.625% Notes Due 2024 [Member]", "terseLabel": "0.625% Notes Due 2024 [Member]" } } }, "localname": "A0.625NotesDue2024Member", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "domainItemType" }, "kmb_AfterTaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "After Tax [Member]", "label": "After Tax [Member]", "terseLabel": "After Tax" } } }, "localname": "AfterTaxMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "kmb_AllOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All Other [Member]", "label": "All Other [Member]", "terseLabel": "All Other" } } }, "localname": "AllOtherMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails" ], "xbrltype": "domainItemType" }, "kmb_AverageCommonSharesOutstandingBasicandDilutedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Average Common Shares Outstanding Basic and Diluted [Table]", "label": "Average Common Shares Outstanding Basic and Diluted [Line Items]", "terseLabel": "Average Common Shares Outstanding Basic and Diluted" } } }, "localname": "AverageCommonSharesOutstandingBasicandDilutedLineItems", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails" ], "xbrltype": "stringItemType" }, "kmb_AverageCommonSharesOutstandingBasicandDilutedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average Common Shares Outstanding Basic and Diluted [Table]", "label": "Average Common Shares Outstanding Basic and Diluted [Table]", "terseLabel": "Average Common Shares Outstanding Basic and Diluted [Table]" } } }, "localname": "AverageCommonSharesOutstandingBasicandDilutedTable", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails" ], "xbrltype": "stringItemType" }, "kmb_BabyandchildcareproductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Baby and Child Care Products [Member]", "label": "Baby and child care products [Member]", "terseLabel": "Baby and Child Care Products" } } }, "localname": "BabyandchildcareproductsMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails" ], "xbrltype": "domainItemType" }, "kmb_BeforeTaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Before Tax [Member]", "label": "Before Tax [Member]", "terseLabel": "Before Tax" } } }, "localname": "BeforeTaxMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "kmb_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainTransactionAndRelatedCostsNetBenefit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain, Transaction and Related Costs, Net Benefit", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain, Transaction and Related Costs, Net Benefit", "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain, Transaction and Related Costs, Net Benefit" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainTransactionAndRelatedCostsNetBenefit", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kmb_ClosingDateAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Closing Date Adjustment", "label": "Closing Date Adjustment", "terseLabel": "Closing Date Adjustment" } } }, "localname": "ClosingDateAdjustment", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kmb_ConsumerTissueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer Tissue [Member]", "label": "Consumer Tissue [Member]", "terseLabel": "Consumer Tissue Products", "verboseLabel": "Consumer Tissue" } } }, "localname": "ConsumerTissueMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails" ], "xbrltype": "domainItemType" }, "kmb_CostsRelatedToDivestiture": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs Related to Divestiture", "label": "Costs Related to Divestiture", "terseLabel": "Costs Related to Divestiture" } } }, "localname": "CostsRelatedToDivestiture", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kmb_DivestitureNetBenefit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Divestiture Net Benefit", "label": "Divestiture Net Benefit", "terseLabel": "Divestiture Net Benefit" } } }, "localname": "DivestitureNetBenefit", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kmb_DivestureBasePurchasePrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Divesture Base Purchase Price", "label": "Divesture Base Purchase Price", "terseLabel": "Divesture Base Purchase Price" } } }, "localname": "DivestureBasePurchasePrice", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kmb_IncomeBeforeEquityInterest": { "auth_ref": [], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income Before Equity Interest", "label": "Income Before Equity Interest", "totalLabel": "Income Before Equity Interests" } } }, "localname": "IncomeBeforeEquityInterest", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "kmb_IntangibleAssetsFairValueDisclosureSoftexThinxInc": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intangible Assets, Fair Value Disclosure - Softex, Thinx, Inc.", "label": "Intangible Assets, Fair Value Disclosure - Softex, Thinx, Inc.", "terseLabel": "Intangible Assets Impaired, Fair Value Disclosure" } } }, "localname": "IntangibleAssetsFairValueDisclosureSoftexThinxInc", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/ImpairmentofIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kmb_InvestmentsInTimeDeposits": { "auth_ref": [], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investments in time deposits", "label": "Investments in time deposits", "negatedLabel": "Investments in time deposits" } } }, "localname": "InvestmentsInTimeDeposits", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "kmb_KCArgentinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "K-C Argentina [Member]", "label": "K-C Argentina [Member]", "terseLabel": "K-C Argentina" } } }, "localname": "KCArgentinaMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kmb_KCProfessionalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "K-C Professional [Member]", "label": "K-C Professional [Member]", "terseLabel": "Away-from-home Professional Products", "verboseLabel": "K-C Professional" } } }, "localname": "KCProfessionalMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails" ], "xbrltype": "domainItemType" }, "kmb_LifoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LIFO [Member]", "label": "LIFO [Member]", "terseLabel": "LIFO" } } }, "localname": "LifoMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "domainItemType" }, "kmb_MarketingResearchAndGeneralExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. The aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Marketing, research and general expenses", "terseLabel": "Marketing, research and general expenses" } } }, "localname": "MarketingResearchAndGeneralExpenses", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "kmb_MaturitiesOfTimeDeposits": { "auth_ref": [], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Maturities of time deposits", "label": "Maturities of time deposits", "terseLabel": "Maturities of time deposits" } } }, "localname": "MaturitiesOfTimeDeposits", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "kmb_NetAssetValueInvestmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Asset Value Investments [Axis]", "label": "Net Asset Value Investments [Axis]", "terseLabel": "Net Asset Value Investments [Axis]" } } }, "localname": "NetAssetValueInvestmentsAxis", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kmb_NetAssetValueInvestmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Net Asset Value Investments [Axis]", "label": "Net Asset Value Investments [Domain]", "terseLabel": "Net Asset Value Investments [Domain]" } } }, "localname": "NetAssetValueInvestmentsDomain", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kmb_NetAssetValueorItsEquivalentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Asset Value or Its Equivalent", "label": "Net Asset Value or Its Equivalent [Member]", "terseLabel": "Net Asset Value or Its Equivalent" } } }, "localname": "NetAssetValueorItsEquivalentMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kmb_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludesRedeemableInterestsShare": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share", "terseLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share" } } }, "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludesRedeemableInterestsShare", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "kmb_NonLifoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non LIFO [Member]", "label": "Non-LIFO [Member]", "terseLabel": "Non-LIFO" } } }, "localname": "NonLifoMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "domainItemType" }, "kmb_ObligationToNoncontrollingInterests": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligation to Noncontrolling Interests", "label": "Obligation to Noncontrolling Interests", "terseLabel": "Accruals, Common Securities Redeemed" } } }, "localname": "ObligationToNoncontrollingInterests", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kmb_OperatingIncomeLossPercentChange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Income (Loss), Percent Change", "label": "Operating Income (Loss), Percent Change", "terseLabel": "Operating Profit, Percent Change" } } }, "localname": "OperatingIncomeLossPercentChange", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "percentItemType" }, "kmb_OtherComprehensiveIncomeLossNetofTaxExcludesRedeemableInterestsShare": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share", "label": "Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share", "terseLabel": "Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share" } } }, "localname": "OtherComprehensiveIncomeLossNetofTaxExcludesRedeemableInterestsShare", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "kmb_OtherincomeandexpensenetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other income and expense, net [Member]", "label": "Other income and expense, net [Member]", "terseLabel": "Other (income) and expense, net" } } }, "localname": "OtherincomeandexpensenetMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "kmb_PersonalCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Personal Care [Member]", "label": "Personal Care [Member]", "terseLabel": "Personal Care [Member]", "verboseLabel": "Personal Care" } } }, "localname": "PersonalCareMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "kmb_RedeemableCommonAndPreferredSecuritiesOfSubsidiaries": { "auth_ref": [], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redeemable Common and Preferred Securities of Subsidiaries", "label": "Redeemable Common and Preferred Securities of Subsidiaries", "terseLabel": "Redeemable Common and Preferred Securities of Subsidiaries" } } }, "localname": "RedeemableCommonAndPreferredSecuritiesOfSubsidiaries", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "kmb_RedeemablePreferredSecuritiesOfSubsidiariesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of redeemable preferred securities of subsidiaries", "label": "Redeemable Preferred Securities Of Subsidiaries Fair Value Disclosure", "negatedTerseLabel": "Redeemable Preferred Securities Of Subsidiaries Fair Value Disclosure" } } }, "localname": "RedeemablePreferredSecuritiesOfSubsidiariesFairValueDisclosure", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kmb_SaleOfBrazilTissueAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of Brazil tissue assets", "label": "Sale of Brazil tissue assets [Member]", "terseLabel": "Sale of Brazil tissue assets" } } }, "localname": "SaleOfBrazilTissueAssetsMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "kmb_SalesRevenueNetPercentChange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales Revenue, Net, Percent Change", "label": "Sales Revenue, Net, Percent Change", "terseLabel": "Sales Revenue, Net, Percent Change" } } }, "localname": "SalesRevenueNetPercentChange", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "percentItemType" }, "kmb_ScheduleOfAverageCommonSharesOutstandingBasicAndDilutedTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of average common shares outstanding, basic and diluted [Text Block].", "label": "Schedule of Average Common Shares Outstanding Basic and Diluted [Text Block]", "terseLabel": "Average Common Shares Outstanding Basic and Diluted" } } }, "localname": "ScheduleOfAverageCommonSharesOutstandingBasicAndDilutedTextBlock", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "kmb_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]", "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedLineItems", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "kmb_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table]", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table]", "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTable", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "kmb_TaxEffectAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Effect [Axis]", "label": "Tax Effect [Axis]", "terseLabel": "Tax Effect [Axis]" } } }, "localname": "TaxEffectAxis", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "kmb_TaxEffectDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Tax Effect [Axis]", "label": "Tax Effect [Domain]", "terseLabel": "Tax Effect [Domain]" } } }, "localname": "TaxEffectDomain", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "kmb_ThinxIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Thinx Inc", "label": "Thinx Inc [Member]", "terseLabel": "Thinx Inc" } } }, "localname": "ThinxIncMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "kmb_TimeDepositsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Time Deposits Fair Value Disclosure", "label": "Time Deposits Fair Value Disclosure", "terseLabel": "Time deposits" } } }, "localname": "TimeDepositsFairValueDisclosure", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "kmb_UnrealizedTranslationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unrealized Translation [Member]", "label": "Unrealized Translation [Member]", "terseLabel": "Unrealized Translation" } } }, "localname": "UnrealizedTranslationMember", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "kmb_UsGaap_ImpairmentOfIntangibleAssetsExcludingGoodwillSoftexBeforeTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex - Before Tax", "label": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex - Before Tax", "terseLabel": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex - Before Tax" } } }, "localname": "UsGaap_ImpairmentOfIntangibleAssetsExcludingGoodwillSoftexBeforeTax", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/ImpairmentofIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kmb_UsGaap_ImpairmentOfIntangibleAssetsExcludingGoodwillSoftexThinxIncAfterTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - After Tax", "label": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - After Tax", "terseLabel": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - After Tax" } } }, "localname": "UsGaap_ImpairmentOfIntangibleAssetsExcludingGoodwillSoftexThinxIncAfterTax", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/ImpairmentofIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kmb_UsGaap_ImpairmentOfIntangibleAssetsExcludingGoodwillSoftexThinxIncBeforeTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - Before Tax", "label": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - Before Tax", "terseLabel": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill - Softex, Thinx, Inc. - Before Tax" } } }, "localname": "UsGaap_ImpairmentOfIntangibleAssetsExcludingGoodwillSoftexThinxIncBeforeTax", "nsuri": "http://www.kimberly-clark.com/20230630", "presentation": [ "http://www.kimberly-clark.com/role/ImpairmentofIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r244", "r455", "r496", "r497", "r498", "r499", "r500", "r501", "r621", "r632", "r648", "r670", "r702", "r703", "r706", "r722" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsTables" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r244", "r455", "r496", "r497", "r498", "r499", "r500", "r501", "r621", "r632", "r648", "r670", "r702", "r703", "r706", "r722" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsTables" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r246", "r247", "r531", "r534", "r536", "r590", "r591", "r592", "r601", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r622", "r633", "r651", "r706", "r722" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r246", "r247", "r531", "r534", "r536", "r590", "r591", "r592", "r601", "r609", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r622", "r633", "r651", "r706", "r722" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r28", "r647" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Trade accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r249", "r250" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r54", "r144", "r473" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r6", "r36", "r409" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "Cash Flow Hedges and Other" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": { "auth_ref": [ "r7", "r36", "r707" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax", "negatedPeriodEndLabel": "Defined benefit and other postretirement benefit plans - Ending balance", "negatedPeriodStartLabel": "Defined benefit and other postretirement benefit plans - Beginning balance" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "auth_ref": [ "r158", "r159", "r160", "r161", "r435" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "periodEndLabel": "Unrealized translation - Ending balance", "periodStartLabel": "Unrealized translation - Beginning balance" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r35", "r36", "r101", "r152", "r469", "r506", "r507" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "negatedLabel": "Accumulated Other Comprehensive Income (Loss)", "terseLabel": "Accumulated Other Comprehensive Income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity", "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r3", "r16", "r36", "r417", "r420", "r451", "r502", "r503", "r681", "r682", "r683", "r693", "r694", "r695" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "AOCI Attributable to Parent" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.", "label": "Additional Financial Information Disclosure [Text Block]", "terseLabel": "Additional Financial Information Disclosure" } } }, "localname": "AdditionalFinancialInformationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetData" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r93", "r647", "r725" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional Paid in Capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital [Abstract]", "terseLabel": "Additional Paid in Capital [Abstract]" } } }, "localname": "AdditionalPaidInCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r391", "r392", "r393", "r517", "r693", "r694", "r695", "r713", "r727" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r58", "r59", "r363" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Recognition of stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r13", "r53" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Asset impairments" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r125", "r147", "r182", "r219", "r234", "r240", "r252", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r405", "r411", "r437", "r464", "r558", "r647", "r659", "r704", "r705", "r720" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r140", "r155", "r182", "r252", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r405", "r411", "r437", "r647", "r704", "r705", "r720" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingsAndImprovementsGross": { "auth_ref": [ "r115" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Buildings and Improvements, Gross", "terseLabel": "Buildings" } } }, "localname": "BuildingsAndImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r402", "r638", "r641" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r61", "r63", "r402", "r638", "r641" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "auth_ref": [ "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "negatedTerseLabel": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Business Combination, Acquisition Related Costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r0", "r1", "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Business Combination, Consideration Transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r65" ], "calculation": { "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r65" ], "calculation": { "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r65" ], "calculation": { "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r65" ], "calculation": { "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r64", "r65" ], "calculation": { "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r64", "r65" ], "calculation": { "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r65" ], "calculation": { "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r64", "r65" ], "calculation": { "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": { "auth_ref": [ "r62" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain", "negatedTerseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r84", "r85" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying (Reported) Amount, Fair Value Disclosure" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r44", "r142", "r623" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r44", "r110", "r180" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and Cash Equivalents - End of Period", "periodStartLabel": "Cash and Cash Equivalents - Beginning of Period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r2", "r110" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Change in Cash and Cash Equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashSurrenderValueFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).", "label": "Cash Surrender Value, Fair Value Disclosure", "terseLabel": "Cash Surrender Value, Fair Value Disclosure" } } }, "localname": "CashSurrenderValueFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r135", "r149", "r150", "r151", "r182", "r199", "r203", "r205", "r207", "r213", "r214", "r252", "r274", "r276", "r277", "r278", "r281", "r282", "r285", "r286", "r288", "r291", "r297", "r437", "r510", "r511", "r512", "r513", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r546", "r567", "r585", "r602", "r603", "r604", "r605", "r606", "r666", "r690", "r696" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends declared" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity", "http://www.kimberly-clark.com/role/StatementofStockholdersEquityStockholdersEquityParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r649", "r650", "r651", "r653", "r654", "r655", "r656", "r693", "r694", "r713", "r723", "r727" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r92", "r546" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r17", "r92", "r546", "r564", "r727", "r728" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r92", "r468", "r647" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common Stock, Value, Issued" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r37", "r165", "r167", "r176", "r460", "r482" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive Income Attributable to Kimberly-Clark Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r11", "r69", "r72", "r165", "r167", "r175", "r459", "r481" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r72", "r121", "r165", "r167", "r174", "r458", "r480" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Comprehensive Income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r45", "r47", "r86", "r87", "r248", "r610" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r45", "r47", "r86", "r87", "r248", "r508", "r610" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r45", "r47", "r86", "r87", "r248", "r610", "r669" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r45", "r47", "r86", "r87", "r248" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Net sales of K-C Argentina, percent" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r45", "r47", "r86", "r87", "r248", "r610" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r115" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress, Gross", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateAndOtherMember": { "auth_ref": [ "r697" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.", "label": "Corporate and Other [Member]", "terseLabel": "Corporate and Other" } } }, "localname": "CorporateAndOtherMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r106", "r455" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of products sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r148" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of debt and lease obligation, classified as current.", "label": "Debt, Current", "terseLabel": "Debt payable within one year" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r13", "r118", "r133", "r400", "r401", "r692" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r394", "r395", "r465" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred Income Taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r13", "r224" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r156", "r157", "r436", "r529", "r530", "r531", "r532", "r533", "r535", "r536", "r537", "r538", "r539", "r552", "r553", "r593", "r596", "r597", "r598", "r599", "r600", "r625", "r651", "r724" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative Asset", "verboseLabel": "Derivatives Assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails", "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [ "r537", "r539", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r559", "r560", "r561", "r562", "r573", "r574", "r575", "r576", "r579", "r580", "r581", "r582", "r593", "r594", "r597", "r599", "r649", "r651" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "verboseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r76", "r77", "r78", "r80", "r537", "r539", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r559", "r560", "r561", "r562", "r573", "r574", "r575", "r576", "r579", "r580", "r581", "r582", "r593", "r594", "r597", "r599", "r625", "r649", "r651" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "verboseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r124", "r415", "r422" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Objectives And Strategies For Using Derivatives" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r18", "r76", "r78" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r18", "r76", "r78", "r80", "r81", "r82", "r414" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss)" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r156", "r157", "r436", "r529", "r530", "r531", "r532", "r535", "r536", "r537", "r538", "r539", "r559", "r561", "r562", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r625", "r724" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative Liability", "verboseLabel": "Derivatives Liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails", "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r711", "r712" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r117" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "negatedTerseLabel": "Dividends, Common Stock, Cash" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends Payable, Current", "terseLabel": "Dividends payable" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r177", "r188", "r189", "r190", "r191", "r192", "r197", "r199", "r205", "r206", "r207", "r211", "r425", "r426", "r461", "r483", "r626" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Per Share Basis" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r177", "r188", "r189", "r190", "r191", "r192", "r199", "r205", "r206", "r207", "r211", "r425", "r426", "r461", "r483", "r626" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r196", "r208", "r209", "r210" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r440" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of Exchange Rate Changes on Cash and Cash Equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Consolidated", "verboseLabel": "Revenue from External Customer" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r17", "r136", "r168", "r169", "r170", "r183", "r184", "r185", "r187", "r193", "r195", "r212", "r253", "r254", "r298", "r391", "r392", "r393", "r397", "r398", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r443", "r445", "r446", "r447", "r448", "r449", "r451", "r502", "r503", "r504", "r517", "r585" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity", "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r229", "r251", "r671", "r698" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Investments in Equity Companies" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsFairValueDisclosure": { "auth_ref": [ "r672", "r714", "r715", "r716" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investments accounted under the equity method.", "label": "Equity Method Investments, Fair Value Disclosure", "terseLabel": "Equity Method Investments, Fair Value Disclosure" } } }, "localname": "EquityMethodInvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r283", "r436", "r630", "r631" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Estimated Fair Value, Fair Value Disclosure" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails", "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r428", "r429", "r432" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r428", "r429", "r432" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r83", "r84", "r85" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r83", "r84" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Fair value of financial instruments" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r283", "r324", "r325", "r326", "r327", "r328", "r329", "r429", "r452", "r453", "r454", "r630", "r631", "r634", "r635", "r636" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails", "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails", "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r23", "r83", "r283", "r630", "r631" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails", "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r428", "r429", "r430", "r431", "r433" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails", "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [ "r283", "r630", "r631" ], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails", "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Information" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueHedgingMember": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.", "label": "Fair Value Hedging [Member]", "terseLabel": "Fair Value Hedging" } } }, "localname": "FairValueHedgingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r283", "r324", "r329", "r429", "r452", "r634", "r635", "r636" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r283", "r324", "r329", "r429", "r453", "r630", "r631", "r634", "r635", "r636" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails", "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails", "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r283", "r324", "r325", "r326", "r327", "r328", "r329", "r429", "r454", "r630", "r631", "r634", "r635", "r636" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Fair Value, Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails", "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r283", "r324", "r325", "r326", "r327", "r328", "r329", "r452", "r453", "r454", "r630", "r631", "r634", "r635", "r636" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]", "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails", "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails", "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r427", "r433" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Measurements, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails", "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r625", "r634", "r646" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "verboseLabel": "Foreign currency exchange contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r688" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedTerseLabel": "Net (gains) losses on asset and business dispositions" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": { "auth_ref": [ "r76", "r79" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.", "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments", "terseLabel": "Gain (loss) on undesignated foreign exchange hedging instruments" } } }, "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r410", "r688" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "terseLabel": "Gain (Loss) on Disposition of Business" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r46", "r610" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r145", "r255", "r456", "r628", "r647", "r700", "r701" ], "calculation": { "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/AcquisitionScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r104", "r182", "r219", "r233", "r239", "r242", "r252", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r437", "r627", "r704" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r18", "r414" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r13", "r20" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r13", "r102", "r128", "r226", "r251", "r475" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "terseLabel": "Share of net income of equity companies" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "auth_ref": [ "r13" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.", "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions", "negatedLabel": "Equity companies' earnings (in excess of) less than dividends paid" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r105", "r683" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "kmb_IncomeBeforeEquityInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.", "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax", "terseLabel": "Income Before Income Taxes and Equity Interests" } } }, "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r132", "r134", "r194", "r195", "r227", "r396", "r399", "r484" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "kmb_IncomeBeforeEquityInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "(Provision for) benefit from income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapital": { "auth_ref": [ "r12" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.", "label": "Increase (Decrease) in Operating Capital", "negatedLabel": "Operating working capital" } } }, "localname": "IncreaseDecreaseInOperatingCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r200", "r201", "r202", "r207", "r364" ], "calculation": { "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Dilutive effect of stock options and restricted share unit awards" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets Disclosure" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ImpairmentofIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r88", "r130", "r171", "r223", "r450", "r570", "r657", "r726" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r620", "r625", "r634" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest Rate Contract" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r674" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r680" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "totalLabel": "Inventory, Gross" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLIFOReserve": { "auth_ref": [ "r679" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.", "label": "Inventory, LIFO Reserve", "negatedLabel": "Inventory, LIFO Reserve" } } }, "localname": "InventoryLIFOReserve", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r153", "r624", "r647" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "totalLabel": "Total", "verboseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r676" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r675" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProgressAndRawMaterialsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Work in Process and Raw Materials [Abstract]", "terseLabel": "Inventory, Work in Process and Raw Materials [Abstract]" } } }, "localname": "InventoryWorkInProgressAndRawMaterialsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r107", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_Land": { "auth_ref": [ "r673" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails": { "order": 4.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r97", "r127", "r472", "r647", "r691", "r699", "r717" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r30", "r141", "r182", "r252", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r406", "r411", "r412", "r437", "r647", "r704", "r720", "r721" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r25", "r466" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-Term Debt and Lease Obligation", "terseLabel": "Long-Term Debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-Term Debt, Fair Value", "terseLabel": "Long-term debt", "verboseLabel": "Long-term Debt, Fair Value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails", "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r115" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment, Gross", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r89", "r119" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "Mergers, Acquisitions and Dispositions Disclosures" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/Acquisition" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r34", "r126", "r182", "r252", "r274", "r276", "r277", "r278", "r281", "r282", "r437", "r471", "r548" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.", "label": "Equity, Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling Interests", "verboseLabel": "Noncontrolling Interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r117" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "terseLabel": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r179" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Cash Used for Financing" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r179" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Cash Used for Investing" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r110", "r111", "r112" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Cash Provided by Operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r103", "r112", "r129", "r139", "r163", "r166", "r170", "r182", "r186", "r188", "r189", "r190", "r191", "r194", "r195", "r204", "r219", "r233", "r239", "r242", "r252", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r426", "r437", "r478", "r566", "r583", "r584", "r627", "r657", "r704" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss)", "totalLabel": "Net Income Attributable to Kimberly-Clark Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r71", "r122", "r163", "r166", "r194", "r195", "r477", "r683" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net (income) loss attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r26", "r122", "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest" } } }, "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedging" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r67", "r298", "r693", "r694", "r695", "r727" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r219", "r233", "r239", "r242", "r627" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating Profit" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r154", "r647" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r146" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r5", "r101", "r438", "r439", "r442" ], "calculation": { "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Other comprehensive income/(loss) before reclassifications" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r24", "r36", "r169", "r443", "r446", "r449", "r681" ], "calculation": { "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r4" ], "calculation": { "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Unrealized currency translation adjustments", "totalLabel": "Net current period other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome", "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": { "auth_ref": [ "r9", "r10", "r101", "r162", "r441" ], "calculation": { "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax", "terseLabel": "(Income)/loss reclassified from AOCI" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "negatedTerseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ObjectivesAndStrategiesForUsingDerivativesNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r17", "r24", "r164", "r167", "r173", "r443", "r444", "r449", "r457", "r479", "r681", "r682" ], "calculation": { "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "negatedTerseLabel": "Other Comprehensive Income, Net of Tax", "terseLabel": "Total Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Total Other Comprehensive Income (Loss), Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity", "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other Comprehensive Income (Loss), Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": { "auth_ref": [ "r7", "r101" ], "calculation": { "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax", "negatedTerseLabel": "Other comprehensive income/(loss) before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r7", "r101" ], "calculation": { "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedLabel": "Employee postretirement benefits", "negatedTotalLabel": "Net current period other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome", "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": { "auth_ref": [ "r9", "r101", "r162", "r341" ], "calculation": { "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax", "negatedTerseLabel": "(Income)/loss reclassified from AOCI" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeOtherNetOfTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in other comprehensive income, after tax, from changes classified as other.", "label": "Other Comprehensive Income, Other, Net of Tax", "terseLabel": "Cash flow hedges and other" } } }, "localname": "OtherComprehensiveIncomeOtherNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsNet": { "auth_ref": [], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.", "label": "Other Intangible Assets, Net", "terseLabel": "Other Intangible Assets, Net" } } }, "localname": "OtherIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInventorySupplies": { "auth_ref": [ "r677" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails": { "order": 4.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.", "label": "Other Inventory, Supplies, Gross", "terseLabel": "Supplies and other" } } }, "localname": "OtherInventorySupplies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r31" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other Liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r108" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Nonoperating expense" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "auth_ref": [], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).", "label": "Other Operating Activities, Cash Flow Statement", "terseLabel": "Other" } } }, "localname": "OtherOperatingActivitiesCashFlowStatement", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "negatedLabel": "Other (income) and expense, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r636", "r637", "r638", "r639", "r640" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "verboseLabel": "Other Postretirement Benefit Plans" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r667", "r684" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r42" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Acquisitions of common stock for the treasury" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r42" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Cash dividends paid" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r42" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Payments of Ordinary Dividends, Noncontrolling Interest", "negatedTerseLabel": "Payments of Ordinary Dividends, Noncontrolling Interest" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r39", "r403" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to Acquire Businesses, Gross" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r39" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "verboseLabel": "Payments to Acquire Businesses, Net of Cash Acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r131", "r708", "r709", "r710" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedLabel": "Capital spending" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r41" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "negatedTerseLabel": "Payments to Noncontrolling Interests", "terseLabel": "Payments to Noncontrolling Interests" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "auth_ref": [], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)", "terseLabel": "Postretirement benefits" } } }, "localname": "PensionAndOtherPostretirementBenefitExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r90", "r299", "r300", "r321", "r636" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Liability, Defined Benefit Plan, Noncurrent", "terseLabel": "Noncurrent Employee Benefits" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r362", "r636", "r637", "r641", "r642", "r643" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Defined Benefit Pension Plans" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails", "http://www.kimberly-clark.com/role/FairValueInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r91", "r285" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r91", "r546" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r91", "r285" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r91", "r467", "r647" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred Stock, Value, Issued" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r38" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Proceeds from Divestiture of Businesses", "terseLabel": "Proceeds from Divestiture of Businesses" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r40", "r510" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Debt proceeds" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r668", "r685" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r686", "r687", "r689" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.", "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less", "terseLabel": "Change in short-term debt" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "auth_ref": [ "r109" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Proceeds from Sale of Productive Assets", "terseLabel": "Acquisition of business, net of cash acquired" } } }, "localname": "ProceedsFromSaleOfProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r8", "r19" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]", "terseLabel": "Accounting Policies" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r139", "r163", "r166", "r178", "r182", "r186", "r194", "r195", "r219", "r233", "r239", "r242", "r252", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r404", "r407", "r408", "r426", "r437", "r462", "r476", "r516", "r566", "r583", "r584", "r627", "r644", "r645", "r658", "r683", "r704" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income", "verboseLabel": "Net Income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement", "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement", "http://www.kimberly-clark.com/role/ConsolidatedStatementOfComprehensiveIncome", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r115", "r143", "r474" ], "calculation": { "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "totalLabel": "Property, Plant and Equipment, Gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r14", "r463", "r474", "r647" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, Plant and Equipment, Net", "totalLabel": "Total" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SummaryofBalanceSheetDataTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PublicUtilitiesInventoryAxis": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "Information by type of inventory held.", "label": "Inventory [Axis]", "terseLabel": "Inventory [Axis]" } } }, "localname": "PublicUtilitiesInventoryAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PublicUtilitiesInventoryTypeDomain": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.", "label": "Inventory [Domain]", "terseLabel": "Inventory [Domain]" } } }, "localname": "PublicUtilitiesInventoryTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r24", "r36", "r169", "r443", "r448", "r449", "r681" ], "calculation": { "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTerseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r43", "r513" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Debt repayments" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r94", "r117", "r470", "r505", "r507", "r514", "r547", "r647" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit) [Abstract]", "terseLabel": "Retained Earnings (Accumulated Deficit) [Abstract]" } } }, "localname": "RetainedEarningsAccumulatedDeficitAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r136", "r183", "r184", "r185", "r187", "r193", "r195", "r253", "r254", "r391", "r392", "r393", "r397", "r398", "r416", "r418", "r419", "r421", "r424", "r502", "r504", "r517", "r727" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r172", "r182", "r220", "r221", "r232", "r237", "r238", "r244", "r246", "r248", "r252", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r437", "r462", "r704" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedIncomeStatement", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.", "label": "Sale of Stock, Percentage of Ownership after Transaction", "terseLabel": "Sale of Stock, Percentage of Ownership after Transaction" } } }, "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SalesMember": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.", "label": "Sales [Member]", "terseLabel": "Net sales" } } }, "localname": "SalesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r36", "r718", "r719" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss), Attributable to Kimberly-Clark Corporation" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Revenue from External Customers by Products and Services [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsSalesofPrincipleProductsDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Sales of Principal Products" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r27", "r98", "r99", "r100" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory, Current" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SummaryofBalanceSheetDataTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]", "terseLabel": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule of Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r48", "r49", "r50", "r52" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r48", "r49", "r50", "r52" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Information Concerning Consolidated Operations by Business Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r216", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r242", "r248", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r272", "r273", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r628", "r670", "r722" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Reporting Segment [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r215", "r216", "r217", "r218", "r219", "r231", "r236", "r240", "r241", "r242", "r243", "r244", "r245", "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Business Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r12" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedCashFlowStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.", "label": "Share-Based Payment Arrangement, Accelerated Cost", "terseLabel": "Share-based Payment Arrangement, Accelerated Cost" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShorttermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.", "label": "Short-Term Debt, Fair Value", "terseLabel": "Short-term debt" } } }, "localname": "ShorttermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/FairValueInformationFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r138", "r216", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r242", "r248", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r266", "r272", "r273", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r628", "r670", "r722" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Business Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails", "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r135", "r149", "r150", "r151", "r182", "r199", "r203", "r205", "r207", "r213", "r214", "r252", "r274", "r276", "r277", "r278", "r281", "r282", "r285", "r286", "r288", "r291", "r297", "r437", "r510", "r511", "r512", "r513", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r546", "r567", "r585", "r602", "r603", "r604", "r605", "r606", "r666", "r690", "r696" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DocumentandEntityInformation" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r17", "r33", "r136", "r168", "r169", "r170", "r183", "r184", "r185", "r187", "r193", "r195", "r212", "r253", "r254", "r298", "r391", "r392", "r393", "r397", "r398", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r443", "r445", "r446", "r447", "r448", "r449", "r451", "r502", "r503", "r504", "r517", "r585" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity", "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r183", "r184", "r185", "r212", "r455", "r509", "r528", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r559", "r560", "r561", "r562", "r563", "r565", "r568", "r569", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r585", "r652" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/DescriptionOfBusinessSegmentsDetails", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity", "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails", "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r183", "r184", "r185", "r212", "r455", "r509", "r528", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r559", "r560", "r561", "r562", "r563", "r565", "r568", "r569", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r585", "r652" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity", "http://www.kimberly-clark.com/role/StockholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeDetails", "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r17", "r91", "r92", "r117" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "negatedTerseLabel": "Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r57", "r91", "r92", "r117" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based awards exercised or vested" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r92", "r95", "r96", "r114", "r548", "r564", "r586", "r587", "r647", "r659", "r691", "r699", "r717", "r727" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "terseLabel": "Total Kimberly-Clark Corporation Stockholders' Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r67", "r68", "r70", "r136", "r137", "r169", "r183", "r184", "r185", "r187", "r193", "r253", "r254", "r298", "r391", "r392", "r393", "r397", "r398", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r443", "r445", "r449", "r451", "r503", "r504", "r515", "r548", "r564", "r586", "r587", "r607", "r658", "r691", "r699", "r717", "r727" ], "calculation": { "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total Stockholders' Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "terseLabel": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r116", "r181", "r284", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r298", "r423", "r588", "r589", "r608" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Equity [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.", "label": "Stockholders' Equity, Other", "negatedTerseLabel": "Other" } } }, "localname": "StockholdersEquityOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.", "label": "Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions", "terseLabel": "Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SupplierFinanceProgramObligation": { "auth_ref": [ "r267", "r268", "r269", "r270", "r271", "r629" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation for supplier finance program.", "label": "Supplier Finance Program, Obligation", "terseLabel": "Supplier Finance Program, Obligation" } } }, "localname": "SupplierFinanceProgramObligation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/SupplementalBalanceSheetDataNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Text Block [Abstract]" } } }, "localname": "TextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_TransactionDomain": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction [Domain]", "terseLabel": "Transaction [Domain]" } } }, "localname": "TransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransactionTypeAxis": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction Type [Axis]", "terseLabel": "Transaction Type [Axis]" } } }, "localname": "TransactionTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/AcquisitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]", "terseLabel": "Treasury Stock, Common" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Treasury Stock, Common, Shares" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheetParenthetical", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r17", "r92", "r117" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Treasury Stock, Shares, Acquired" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r32", "r55", "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedTerseLabel": "Treasury Stock, Value" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet", "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury Stock, Value [Abstract]", "terseLabel": "Treasury Stock, Value [Abstract]" } } }, "localname": "TreasuryStockValueAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r17", "r55", "r117" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedTerseLabel": "Treasury Stock, Value, Acquired, Cost Method" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/StatementofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r198", "r207" ], "calculation": { "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r197", "r207" ], "calculation": { "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.kimberly-clark.com/role/EarningsPerShareAverageCommonSharesOutstandingBasicAndDilutedDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.18)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org//805/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org//815/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(21))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org//280/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(3)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//350-30/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "405", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)(1)", "Topic": "405", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)(2)(i)", "Topic": "405", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)(2)(iv)", "Topic": "405", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Topic": "405", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "40", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481724/830-30-40-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(17))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column G))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column H))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column I))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column J))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column K))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "55", "SubTopic": "50", "Topic": "405", "URI": "https://asc.fasb.org//1943274/2147477128/405-50-55-5", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r661": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r662": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r663": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r664": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r665": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "2E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2E", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//205-20/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 60 0000055785-23-000054-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000055785-23-000054-xbrl.zip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�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

M:S[3O[CJX813KXA3##T)A@8"SQ'[\"IZK*&#@E0_&G5?#\M7HX?EY6;<>63A MW#ZUG2$()30S4R:+)#^U8K8JG'003>5(::5\NO/V&&*8ZIQZ"^'&A$NB9INU M$+EFF:"<,ZSH=\8)'8P5TE'88R=.6R@58:@-X&X;_1B_8VO43EB;25 MMW@:XB#@]934"#^?Y(Q-(.%%F0%*)33W-[SR]>@.?P5:. =5+$(+YOM[$(ES ME#0X5:]$)BH\T=&:6PG+/P1/]"I'+[3QA(KX3 &#@IH\HLCAU4HC;JEK/(QH M-AR5!!Z(^=^Q_?L] )CY/Y5& C6%=;!@@^3]:"\!.7Q!CP")'_!/)SP)?&1$ M+=A?AT/W#!QBRK 6WBMUO M1C?ECY0PP2/*T;[WBFY" ECZ3BG;9GT36D.H%,8I<^[<1 H;<1%+&.DTPSL& M4*.@-*M_EQT8VK"X'VT4V!X40&-D"H9$V/1VD0)/RH92-?50+6E"9(%X'ONR MUCC:X1[.TFYU.90A5UX41HS[>(HT[BZZVG_Y=ZVD9FSK=WR,QAFP,Q\\BF@- MG%WW,N>H4G"9?3Y/NXIC.#7=TCH'V+R#@I\#O=7#;P91A3X988Q421QJ,8MF MR74F92QK98QPH5GSP=33G G 63-0^8JW"YB=$*OS)B):>";&C^I#/G>?)=6+ M44GUMJM!U?!>Z4%A!E&CH;="R5QD_1_C74\1@L0/&,FU1@RD/M&Y4_]K2*R(LNN.T48NW9>]/MJ7AP_V1 #X>@/ MNV9"^LI1B@N0QV7,=Q^F%IVOW0/^"$RA28Y?T%%X^@3N7%377I\HF$ATP9U& MZ]%O3Z60!,^>>D-R]BVRV>I=@0G_5M7%+/F7R6;_[D#U@>9R]N_X.\8\_J R MP!H8F@'WA[[(ETHT)*.0KW%:N)D7*92O>320$NLJ0 M!QV'@!88%X;-#/H!1$U84E+2L[7H/K+ 7OARE#R-XO^SKEC+[/A-1<"W*"@U M1FR,W.X"2?9 6F'FOZ3R57([KFM\X=J;(\R>(.UA0S4Z'/2G7 ;E]@TI=LPD MPC^X1(G*32@UL 8[BWHK<'T//[RB^-1^OM!CON7M*60:":9UFJQQF(_^/-E#I%3(: MK2%"Y*2[#'_R5U96M<1G_,F+J;!V45?=Q8+RC?RI9*&SJ4(0T(UOA!JT)GI; M1G1S?LV_28#TH,0,/1[>/FXW\9W04:C ^?(^\DHG(F/V"RV39@5' [B6-^N M^>C3#Z5)F*GJBZS<,$<'/:YYR2\&EW'30"\*%]9C6#IGO_+BV5??^,46AZFE M/T<%P52KMCBMR&&^>8ZB4!&0[,%BI_+>KE41_]VL"@ZR\&1)/D\&[?8 >\U= MC0$=!WL *8M2A&T:E)MZXD+(^" J"K<_R+A85,I7R6-+??,XE\E,D; MFF&,9)#51LLK8VV][?T=)4'(D0 M7%*D:FH<8R>+@4BV%+HS3XN,+ 33P"GL5;27Y> MA6*=P%MOZ=Y;:W&<);[&2R5K*K':ZVRP6H\:/W[M_-C&0];(P<9U&%I3FX@R M4"X:&-O<%5::^WR&QV'++H6&8N]UIB7*?L2!DLU!U0\QWE;P&&*NT@-!-K/- M0!,/BBIMRY5JEMO5')W43BG L5A#3#J:^@+:V%]H4AS6CUK6RCH(&B MVT=8I _; UQ-9@G&"@A4M$A,S$LV)?=M)YH+U$>1.RF63&E7(#B;Q"CP(52M?B\G#1U=<3XS0P$%_P*]J0E-TZU M*$[K?06I!/MW4I4= :.0-^)(OR?F/-.SNKEJ0<4R()T3O0+^TKB87%!I%G^.Y90)1#J3*4LG K3@'/LRDU21&6G[ZX MIO$'V(0!]<$@,^?R/#2"%<^^:GX::H ]8VB4C4A3;*C?,;K_@H\E;$XHQ(+% ME4T;LPQ:I) M7L);@"QX!=..4O6]^0 S^_673YY]DXXG/>_M@1O'NL&2S O,1-*TZEYF7^)E M->U8$@4&)2H,_$>O^CN2:99.#N]#4HN\H<2N8O&;;@4>LTU+AD[>D'XE25ZU M/8AY)JW-%&81^IC:"2TK9\."68)MTP2D_43PJC9765[$B$W8GN)YFYCVVI@! M>M* S+0=84Z]')JD&,IZ;;KDDB@\8/QVCKG&&&J@L,*%0,\]D390T251@ MB([MC87,+WV=>[O'QR%J[[#^N6FJNK>1O3;$+D(UM+\D.S3L5]ICI]\AIQ'" MJC!Q6 IP%Y]A$35S!>3PL!DTH^\0T4KW=U''45DG6&#DI),?O:*N!EY+Y:QH M.1A(14E^'"2DTR'Z-A_G0D4BR)HV0+\P@Z0N% 7J7.%)Z;%K_;5CVA[+&E?H M6"SS PSD4\) ;NEX!AG9A@IWM.0/F\6X4S-@>Q@JZ9T+"O7'(MO=%6=Z -VE MSP.^;R\/@>"E@Z\"XMF:6#6;=%H8ZA>O%WXO[>5QP+\P_E*4$%RA:?U,.[O MPHR#ILX]<^/4FAM((TGGQ//'FOM,VW-C'JE/2>D03-57CU\DRKQQ3R_ M:HSO<>W-$$HV 3DC8H2BFFW.GA]^@+GT::X09_0K,?^+^61J^N/XDVOEY3$;;R]D2ILOR.E SWX_9"],KF-\+^7RN1EI $OX;2P MYD&Q$;.JF\@,[#*\IL/PEIEI467,>^QO0F3(-"5'M?)2Z)*V;S!+W+%U >^S MJIC<(57Q[/EF5?$:COVIDP.WJRY.FC KX\?F3(FH_2Q2%DK,)5RM>M,6":GR MG8N73 UX^D'I7)'1&<4]\'FGGFA,7GG!XYRQ(H(2*3H"C^1 M:JQ0JXZ0W:!\36W)+OY$*6TL\0(_YD=34J'+J?#8C)8CYHI&Q7I$%;B(6>>N MI/S/7#J(NP!**"!G?BL4)%NL+PV31>1E65T)G?'SK^'T31B #6!%=GE@6GLD,"'-P9JKH92 M(I970.K7_*U#)-+ATNZVD7 N_'ZSFOU "OMGR7VT,*MO<-!X4VB8QKAE/>/ MZB./3-Y.BZ3]N6G4$:Z[6+.GJ7^EMA.XZQ&K_#IFN Q\PE3> M(I_80%[PZV2UY[IRH6*D83@9DM@EU3U\\,AHORP9-'.G\'BKZC)&_#2PLGTA MY$VGBHV NLNC>/T$_6S 9!"[+X&Y;6 M79&J@A8;OE5$WPJ6L6",#/:1KJLRG_*]4!%I63!H =B9]-&*6@^C:+XDZ6J6 MN"4:6!"T.[ [?;>D,-XU%D-EC2+.%NN&+F2V3JHZQ6&+0RIU'9.&"XOY.&.& M+7?=W:V+<#A(I*G42SD]F5.ER!1LWFI)_X0%P+9TJ#WFV*V;?5T0*=Q8;PR1 MZ"M_/?<"W\*'^\[?* _OVK>DR"DDKQ$+;7)J\HP>9J[D[^BY9&V62C&%U9V- M@,/B/'8] /4J0Z>9#H54?/C?3JO5FL "3 9,3IQ_H),M>XA4->\!0D# ]4BS M>@3^^^BZ[#+#%I[-O\WKD;4DK$?C&0<5?DK89B0E,G4C6E]JT7WC\F"8+CQT M@\3$+FT6$,(8!443PUQ0:3MO%8;<.E$J,RW8"_MGYD)+37A@:>&Y#IRL=MF( MJZJ57>25UH]L%NM+ M;L-BY9=O..@C=S<5T$AHV"]J> +QKJ!N,4;)M! -EWNYUQ5M.6[!V6^D/":S MLX_??#^^@.Y=^C]Z2&/> W9R7_7MO$-S;>/BN:,B,9USF7C=+ZVOBK=#^W=A MLJ)EV;A8@U8HC34K@L@I2']0185G%X-'""9FM61M7-67H&BF1JU"Y?!ILKEI MU_:>?4N3(P+L/)*JF5YF%PRGG6FQ$9S<"MO0-^((3]PG5M[8,6]1\QCKOJ[0 M6RFRTE+BR+6@N:ABA)*QU'TG[$/]SUL*N/IJ8SSI80 MVC_7TE=1S>^=+,Z!+1WM'SKC]BZE!!KA: ,1_=LA40+*")P:FB0HR6)X,^O3U)D>0>Z&OB,.=^%T'\_*J*JY< M=AN>7G=YJ_?U'I_^P>=3[52-#\8NOQLVQT?G"TAS_8'M>KM[\I-NR;N^&9F# M!"O4?2@&D?I5TSQK-0W@&9<48/,K99T[6JNS[[(N&1A[[$QE;5,Q2$*N\\+D M?^Q$W(V7>#PH(5IVC88Q!FN1+S'C5 M>"J1XRCL &-.QEP*/(+"I]ZE-GHT&6>PV30(_L3+?^QF MOC4W\RKP$9_<20C#1&^E=HY@T_)J;I9CWW[6:0[LU8USB:OAVU:EN:C:7')X M-YOHSS//O8Y18F/SQWF;A)O)DT8L""D%S<66&X0(658JUKU[;+;["5\+0O.6 MI^AF,[1CDN@/SN+]C8*9.V29;HN"G8:0[MLU1OON4&9;FOJPI2W\MH+\I*2: M)$!& 2AI$DWD8HWFMDO'M')O-(P:'WD&N.$U&<2C#_$$@1P+%?:YYSR1N28&)L5!.7;U7$@U9RY5BC3 MN0G>'?+7(=T4,M3V0I>(Q&S0-G7(!I^L>)!72CA,Y4$ %=;IT'0HIS8 M[<-%AU"OH=1-);05?]T;1:'DD[9:#56_V\YW4_7G=V>+OWC\XJO8#B?=3^EH M3Z4&U5J]>M@P2VH.'3^CU2"<+G4E"B/*R3GMS9:XCV4X%2-VJ!_\UR <5-14 M"*OQAAR!T=RXHMB%@\%RJ$X)UCYZI'5:EDM*VOOAVFB7-:[P6&17Y!]:?'RS M$3#KY(:=?S$1:!*X5.YF(&J_%2A]6?+H8Q2A4M?Z"(B8H'S,6J[EB!-LH6$X"=Y$'4BBOUUP*Q0:QZQH! M+01\&LS]B1<@=E=:LX;2VZX$$K'IRX<>&]_8>U*ODM*')F TGW"M.HS'?1#) M(/)IY7C_MA^_XT.0[+8MUU^ H/1UETI=?P\&3^;9L%,;?#<@;MB(K=@S17)W M-,G7CX]?X$3 +ES(Z<-=)$PWX5;B#_W&;8[1%4F><#N(M2,\HN.BSK(N;[9X M_+Y+'":SK%^XZZ@5DU#4":=6QTD\!A?AB +D$F]-R^(WD_I?SGM<&.)G=)S" MJFF\E[(E'=A@@F%CBB%"P+O[H?]>W D9A4OO?6CD?BB1B, SKBMK#6U;^C=V M59/>Q&S V@!/AK[=JC)E1DD%GB8]K2I0O8YH$LR7WNS:'D;B_[(,+ Y3EH_< M"/GWKV2@F'- MHQR50PM!B=)@+MIBK4MF*P6EGX2?-[4\AN'Z,X=?+"Q&DGG',Z% ,:W)(GMK M6&:-%-2ATLK ,JY+LSY,!'JHRQ\RM34N>\ 9)C;D9U*?0,N)VVWM[0%+"DG[ M"#Q]/&[D=!,RT+'7H*2W##;$9=40 .[@W=GI(:NC'VS-P"O8)]3^XMPU)S_A MZ025=/##J]?G)T*7K_1+Q?S(ZV3N<^&[.@GZJ6XRM!%; 8WH99D^XR:1Q;WV M-J[ND(Z(^],:O"EG \734X#^XG<1-\H**.M0MZDJ'^BH+?ZC ?JJ]8[MT M+K#=S4D]/),ZB)2'0"-F,]/3.21^B9 M5HJ3FDBN\JJPJ7@TF9)?X,A7PD:R\_K1RX#\Z+*"-;6+8O0*K$CI@EQ'!G9/ M@BM;)*D*[>56QG\]CDD.TXC=Y%9*.^C:4 M@<0A-6X\6&=C"(".+=(*3G[%#-LY27>9?]*\C3!&!]/.F9WKWKPM>KM0SH6N MN%[H#97>)G:I[<&!QDYO"GOWD%3<>?23CAD\-NC.&:I!Y%B9R&GIC"U[F#.+5 M[LE0?S&:$][]G9EJ */E1YTGB4&?[]4?IQU ^4\UJ'0KXB@J6F M1*+!;3LT]MY24Q!LZT+5IZDK\$U[0H?^PKJFQ/*F!_62LFTTY-;;-U(F;_E% ML#>?'_A1=T+NI2]AQ VC346,T96EIHCV$8IE$6%(3FF;=,MD<&1,BW(]R,GX M0&@[8GC_0JDW7"$S3E1_S<^PHUXTTO,QV]R/ O=W[B Y.3'^#G%UICA2>L'! M\P33T$@2L[GA='K29# 3(]-[T^D M3LMG@+=P3!)Q3B-PIR_TJ-*8J1L#AG1LA;MX.4RYQR6!\,O?N](K9B(M5D,)P@/P3#MM>E/"Q.U[GB M4E4L4L4)MC,TX-6KYK;!0K:">L'##: M<[&MJL)1AN#*@;:U5%6VU%9Z> C[ :LW_[ZN&1;U9L4-;?>SOYV]W;QQ,Q.) M%$Q$N)'CF)D=MJ/?/;+3OMYN].- (']O2N?%)O^0''QUB!"8=M%\#@68',SE M6U9RA[8;U0H39]+@%IM3A4K$)R<.&"@R6O@KORH&ML@4@49B!9176$D,N\Y< M<9QB:[0L&AN[\\[8Q6&R7]X8-K6>2S W.7?]OF^9KW=[@LY]"E^TQ%A_TF4O)&X%L"D?-?&<\O"U=XUCG MED2$,O=N@XVP2 U*__#HE_YEK_5Q.0X6UAG#[E]G!1;).L.MY) MC=Z(AXO=LBY*Z>BEC>S?T)A)7%4[% M(EOQ_3:M<$@[,,%@*')^(2>DDB=H"ZPMYV'XYG:PO:19 Q9+,1LTDQ_:3'W^ M3<& ,^$VBINDQS;K[]RK/(-) 8$7I)$J.+.9%7L\(3P!_3S1@%BVM'*"1/&;R ML=?RD$'^]8@+FG<%S&:!"*G[6^:<[]EA/S>(>[QM!I5(6[S 0PF73("=H84="!;Q&>4PN8,-46_XXC*\,8B MZMUBWM^"N]_W3$;^4-5SDP>=U&]97,9HZD)3OB=M$)A&;A1)*3.-"*,)MF)%1CV\S]K8JF#;9,)_, /L&T?O0N*<9N;^'N3+/3O(YR9?3K L M4SF&?KAU[KCDU@[*=GG@P=JMY=:UVQ*'(++V ^D88Y0[NZ MUF8SU"%J),BVJ4-O2G=5#%*_N0M=$ R"P#'(&.3W1[N!#G;$ M@>EV"I/:(#T2=2B@T#C%*T99[81N@G_U>Y67"GQG0YB3@%GITS6-G[:_.%YB MWX7-@]2P[\I(JJD#G%=3PA:K42Q$0V@) MV@H2'2=5"VTINDK[S,IQN=7@Q,%?EAJM[Z=3NH<;!= H.1/% \W9X7:S'#0PS=\7.-& MP6Y["#*_MVIM>JL%?D8F"/(U?8U!ADE=971]@T6^LI*I!I7F';RG5+0%Q;(1 MYFUY&7??,[XC>N6#NL%'9!F4LW6&Q86/$48 M7=XL&-4R"/'86-!-=\#@G RV@[-?KNZ+.+W M,D)REQYV$HQZF7-TB&%C1;><8#,$_*8PY46[L("!L%>RBR3!?<*6 F-I+:O@ M,"B%_,V8=OPT+\'E;/#@-RB>RN%Q)8WG$HW4]G+FM=!'+2J-HS270RNT(P"D66P4=]!=\0S1F,4? F=Z#5 M?:^/NU;FS- FOF@,&91)+(4K;^W=7^2Q3?(( /\Y 8KA/8IA1MIZP5OG&\QN;,N-W4X\*(+P+#+3@TJ4K4$A@V%$K M4-MQ@&SQD(_/Q4BEG]-(G&9@%)(PYZJPB_Q*FN94*TQQ@"W7K@=[=,K';#@! M6FE6&\0Q&^XG3R7#@TV\RP:SW>:8U*(J-:W3&BXOJ[Q'"4"$"H,G:S]6Y>W' MYI&$EJC5G# \-*YK(.>[+KS:-:7E,1_P.0WVW+4\67BJ\U*QEI'ESAMO\".$ M4+*1?^]F%]:7);^(CX*E'!FFQ3R2B!B4Q]^,"^X\1R@!.;3VQC!N[#6][);) M\?-DFH$ZG64U*WJ*G#-[;+B9G*_!D_#1ZA$UWUU6CT^?/!Y3C^=>3O'42N0? M0B:/)GG3M=C1BV;PU\?O[C-H*=LW4\+U,+T#-L.&F/K3)ZXW6;"YD+, 1937 MSB0TFZ7U,!H*;A>6E*.2%G DXCLK5W*PLXTIYT M-_ /QF$Z84.VB)#EE ;3W83 =$'/AY1G84V"1WK0\QVX/V#C-?!(^QG0U$&M MJ,:/Q*PT90_8%0]PV%( REP?,4B"5H,>QON@;K@0&06-F&/XMA([)0,2=1I3 M!%*1MA_OC>A@K*;;]""_#:2?(/*V+WM0'!"SE0@.6KMYHSMR%]KRJ18]1<)@ M49,3C W,AA$["I)3U$;P_5MBL+#_X0#S, Y^/V3: !D-'S[;Y:WS$H"L.1RQNA9"M PS9*/M?K E-R83(G '( MEHQX]=(UG%T.^)+18\EJY!3;@$N?2[$R-[/8J4_<(-,^2HR! R9@/TT<'R"/!ZJP.C2 MJ$O\UU1Z3.>S$18G'.;CY-U&OGE!^S5<22[!8!]@FP<_IJ:K@GJT'7B7Z MM0_CL#0E>L!PAR'/)OBD'0.;**E05[!A^5Y,+,\RY:($?W)*'ZU:8M0!&7&) M?R_-$K=$ PN"+0RQ'JY;4G'4M4$?LE%YL%@W="&\R%)(XG'8$JIA,QP4./73 MXHA"MUPR4-/2V8C;>ABP3K5>Z9>E?,'XMO;X:DC8H^!#JV>.%>-L.^-Q&SNH;L/2$E4D[D1RCILQZ'ZTJ*Y'UV67&4X]?P-^ MF]F*:5)+):BHL##:?,ET(3Q),;8;MDD]TB(Q'3 3-4&_G&Z)"1JOK\9\/9)T*'"#"U.MNMJ1O:,'4B43L*USF[B M<5%_" ?Y7 Q MG<\!Q3%/ GT0U:(]:69!9++MQGTD;M;"<+0-^Q;BT%ZHG61 MAFK>ZXJ>M*$-$O:V(1M'=_B;K!G );?T5AOP#0Y_M/O+R2"]HV"/&0-Y,V83 MMG!"FMY64M%H-"U,5G!O]62Q!E%2&JN+@I@RB R07X5G3%UG#=@E! E@^CN0 M3IP:;:5S*A_CN>&6*G3/OGF"H_?XSE;9]))Y=O GO$E0_518SMO02\!"N$_L M5K5CWJ(;,'5P754S$J6MC;_PM2#NB-2-8G=B+/L]8^?YA)5U5ZQ(*H#'1;+P M(\E.]C#LG!Q,]RSNW..TN5]QYQ3[Q>:-#RL8 3U0&%)Q1%)'CX#F.< M@K'(8Y HRBQ'7Q'GB7NE")L]1D";,B& MSG%#6D;FK!!%0^G%Z0)S,P.K$N-U#2'F!N'MS?VB89*V; N<@ZQQ\3]M"$8= M[Z@+K"A,KU'=J+ON _""I7%$0 ,N 6> ZI0T;"IF;7S9_N ;IYN[7%5=[@2A M]F6'-V\J$RP8E$*\Y>P3TE[=9]#3;-\81_^J_1_VLOW#0Z;P4Q8OWY*,^)-Z M>)PI_=]# X];:> A']EE>&CH\4<:>O1G\Z_3X..A6\1#MXB';A$/W2+VJ5O$ MWKIO9M_&$;?.V?W0]>&AZ\-#UX?/U_5AHRC[^LGT* M>-_:Z#ZTM_AD[2V>/KF7[2TVO-:G;V^QWVB/@XL]._VHRM[Y27U8:?6^[HX< MN$\0@2V9VR&SACNAUQ@QASO-!%B..M9$R!OP!UWUHK1\S2-.GV76V=@266WR>=:+<$F!KG0K>-UH;B?EE M)-%ABA8"O7J7VG# R*4;+DE=J7QL+![0S]FC.(4=6.*YP0QG]F% MZ54)"D:2FG]H2X];Y(#KZJ#]B@9FV?_;&']SS1C.T8]G& M'YS%^QMRV+>.FC&GXTQ3;7>@?<6=]1T$V,JU,R%1A;5-=B( \<[5#02%I6T< M%3\6:"L'?AO2]6-,%Z2R'6VL@?:Z%+CPO&"C.X.<4H2+\^+^T;D15RJL8,3A M3OPLHV]Q\-).ZRYO];[>X],_^'S7@F19U:-A*0RW?ZS/.^.&C1^]6^_1EKSK MFY'3X]A7S>?)(XX))&UH%?GNJ4H"@6/T3V_FD.JU)LE<@4&VRJ;LYV1M4S%S MG45;6'3X'SL1=^,EAHC=)2AU22$.TZ!++(+/B*:JDMYVY#IIAH^]#1]^[U-%7'8T_WM$W^=P=?9\^ MV;FC+[[5+7;TW?FTW86C]="_]O/UKP6;\:%_;6C.[FW_6FQ^LG?]:[&1Q8[] M:_']/D7_6KY/T+_V3VI@^P#?^&B2@EM2/@\MAS]YR^$[W\GL>+23F1?#0NER M#NJ_6PF&_MYZ-N/-RBC%=?[NUR;6%\L&\7D[4AQW/;">X09%5G+N0OUG<8+' M;OP3^+-@:JV/3@LDOP@+DKUGNM5)WB(69)T[F$Y[YK MJRDQ=T^S9H&5[HZ[&NR@SL;K1B[,FP:3!Y4^UL](TX#]<(+< PNV"U+$M")P MG##X,J,R^RMLO6A9Y*?!X*ESBYF1=5 0UW\LHLHK@*QS'K.A&['<>79(D@\9 MHH6;WVTN3_!WEB8XR.C3+?ZY-(824F+"M7A\OD,+$ MF(_)#MTAC+>P!VJPL>(ALKSIA8E@H'TU,M0KO=AP-9\C%R/YQ?*>1-Q[3?=B MSEZ$_]/90B<7*:7HYQ[A-0X<9C8KJ/HT+ UZ_N3%B5W^?.IYT2S)V MN_69>@B;;"MT),"*"7)' #=^\Z<=0"AX[6E&'8KZ6P'I08ES4;I]N*+=FPUO M2JZ#:\OG/?(C[J:4#\ZQC-S9ACXU/B-DX W-$TJ>E*1K_Y6M+TDB;8.@=$ZF M=#/QJS^RM3+Z1(.]5BLR*?/D*R0I6*PGO2>Q*MG5_"2-64?0\$?UUCWUI@>[Q'Y_=IC MOG!>V8\\:>*I>8I^E\;@7O(HC:!SZ'&>OWJ!STJWF'$1&;63T=7OT,57#\W[ MS;:,G8E^23)%[:WQ'#8VUWX3,]-,ZWS"&]=&@XY1TML(#@FT3V-VW5L'^>FH M@_P;;$N01Q.P5-"(H[9+U/RQ'Q>U;2>LMXA%%@1]&MG;'ESIG?* '[](!?7P M]'BTA+QG@F(E*,EK,K92A56EF-$U,V%=\PM6^SOY4<,]"S)P1"@:PN2,RD#) M/#;""3+4QVE(,..U@N*?NN!BZG5KHZA[(,8;VP8.OY(32.CC47[IU'$$]B'1 MCY!OLB%LV;RC^(;(]51DO4;]O;8N0AAH1<)UL/:-K#WEU+WV;Z1]NH+8,)E[ M$!G!N $8*4)V^#)O(HZ4%YR2 ^%C^!(8"LBNI7;FE!9H03\Q3:01&&\0P8UP M(-B>8DAJ*ZNJ+>3$-HY5*6L8VT/LKHB%L?+;EK( MEU@G!DWPI,43?8JJ,S2!*:<8YWW(D(1NJ,-6ILM>#=P]1]ZFE?C M;QC=R3Y8A,LVA]RRSRXG^47'L@&?E9?V02100="V+M57Z=SAT#72?']WZ_/1 MW7I"5IC2;//"WC!K?(+E)V,#/-[-I4%3YC:3U;2-_OSW/L5^FJ1/;SE3_^>_ M^LFM+G=?D3'1#X%C74>%$JYKU\G!BR>'R8SIW[#Z;&) %I0V.(R__/.GCQVS MEV \W>H\ALK,TB=&U40\$&P-G0U7)@RV%SXI;Y68'S&^3/"STOF5 >U/R3Z/RK1/Z+&;TEI MJ_4B '@,&VP_/0*-VH"Z)S9B^-]XQ$^VLR<$Y33!,WJ!"]AS]\!@^CJNG&RP M2F.;0TV]PSO?F;W4]RZW1.8L%2T+'LNR;N=@4!;M9 ])VT&@CLAE]W;F,%:( MJ4>+QIF! BC 9LBHIW=4!S3D!X/3@2X-1Y;*S&(W-)8\?,-[7P]B41&M5<[%ZQ^DM3-UUY;WXE!G-045QCZ9 M9I*H*YY*'>Z6RX7)E>,IL>%,FXMP\1=YM)^!@*DI)8I/]V"%4Q/I5?+@T?>*@*#?*2]V9@V'%"2?F2Q=5AUT5[J+!=G'[(D9< M&LNX:NBP9Y[YGGU&G=ZX<+WL46 C&@T#HKI)H^QT?O\9RK(.X["*ZI6=XK>0 M<46Q8^_@#2D@\O&.ZSL MIXK@0&.EIB..&,*5P&?,AQ71D6=-TRU7-K5H=11?;D^D2YX;^$FUQ+8IA8/. M,E%W'LGN:#I]4.I!#X3_)I!$,@$YB9F&4^R&^>_.E,1VN2$CUA\?O.A%CE). MWF_S>UFG@@\"\4UD 8E$ '&077\@;(>;N!D'+WK8.Q92D@T["!*Q==)&F4IN-R]BZ"'Y?R!*E[*$_)!PRMGRZ-"4' MG-TUSVF=NYV"DU916 ;NURPME%!ESV,(9:]?$SG+& =$E4>B%:DVZ%L443X76= S3 MJ1%)Z4Q&\H=J8PT"S>/6AKO;,Q5%20K+@6O\MT9<;4.1JO0CIYN;?[%H+S&G M2!8V*$#.?P93W"_[ S4W[:0?&B4%5>YBG0PV+]2TL$]Z!;,/AQA^M:96R7#L M&O0--.@FQI0FJ+ ;6=D1C*T =7BDWU-R%#]$2J@C[$!#K=>J+<\?K-]%"2_MZ1?4U%/5VTYP':H)RGCQ+5[>-"OA^Q/X86QS!OJQ8( ML80K4H\HAL@VR$K1L6*:Z/:88A=N$)3K_9TQWLR1+#53D# .;%:MO"A+6/OD MVD]R#EY089JOL+D2+VZ3DP/@0;X*@MI<7 *I\'[#Y.(I& M\ X9;*+;_EL*CB8GAO< MJP518/;FSBRA63'.'67UQ\%&CLH!SID-G: ]:']0L)\H)H"9H[)77RW"4EA_ M0M!TD5TWA\/B$ &"1_"SWFO96,<0.6G-<#T--2[[]00&8SU%.(-JP5-10B32_U#CB/2XP99^JA M*>QN-1:82W73T4[G3![94U*(-*H9'M*)NZ83[\PN]"7;KE$3)M(R[%S;AG)H M:8'\8^V.H03XFJ0.!B=@NS95O=/NL]E[MX>E2WJO4R]G+/;QZ+^6\-IF3Z&, MNPK.:X$_$5F@@0N<-7@W3-,LLO("] (Q3Q8=:G]A+VNOC1FOJ&(R-N)6*CT, M^Z\EQ5L1)@US\+(JT*FB38!VL?!5X \#VY%1@T+!OU/US8YC$E9([6J=,*\D)2: M_50>C-PYV^W+2&))84CQ5^WQ7=G>%('-FA\RVKRD>!CC2L0>(2Z<&3J#EY&R M@!83@;Y-'IF^@2\_X'&Q<02WI]L^WDOJT4B,2>85OO$^Q2[:H )],YX$$F6; M5.[4ZLF9?*4I=%<+SH7ILO73'>28E5M9&Y33#1ZRMJ7G@JP?JT.G6DWL-6\C ML$LDRB4Q,!-VCQDI'Z^1(14)MC4J$H'5!25%,H_UV+QS&)1(X-%UP_S=QOQG M>&B&*T[

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

MNN>&FZ(RM@A#[L+P3-C?C,P;LD.:Y'+]^T68SFO*Y-)R'"!7RB7NP(AZG>T% M0F0:(6/03A(DUO'*8^ON:3YVU',F[@:J=XV%K4?AK.4AC]7PS3G^@G MLP&7.62R]J'>>Y#Q$,AX"+&01D&#S/A8HG"LL!="J)B44SR'(@F $:QI& M;\89?_\W_#I0$FWQ2@!Z9VOE8 3GD6")R*(/DDQ$T\+6OKGLDV=Q=V)N8&^G MT-VE9\\DYN0= .? M.T7"7I!FR0OM,@J?!BBM,2YPJ,LN[[%C\!HR3XD,/\F"[Q;'OK'JVP^ MCLY]$,DVE2I]MRQ3_7,:36:8__+]?'J!5S^J']]D(TN%7JWHC[=]&T5.[;ZO2OF-Z879->:'T<*2@\1UXBN7ZU M<*=FGY'_I\G_Q] M!)L-@E(*P1M#%J10LG#AG-CI=CV(Y[=!',^::\69VXSN1-:&U>F_GL?!"_8G M(_0ODSG.7E\@45^M,!65E"6K!DI(U2ED%J*O*>!D8TKN,3KO;[+Z3I>*7<]_ MLEQL1K1>"M%_'LYJ'M-LG<*VT$H"0Y+&U@9!D;12L@4")[O$D*^ I)J<+RT* M8C:M_32-LH;T;%V?OL*Q$N!]D.QAB>W!X1OK'M?F:LF-25-2MGZ%;R(R3(MH MT$+R*H*2Y'H&5!9\\,DR;5#ICI=11V#J%E/J.#P]A((->8F$8O ?O_S?#X-H M,6)A'#PO->*F$WC)2?DH[Y2PW-FPSVU$?>#*5J*_73'QLYY=!\"^ MU;0+,6O&=' V&<6]#])Y'I +EK3TP@YV/[I1B.DJWA99BCR$!$55XTS3$>Y- M8I!T1&.]L2+OZL30*;9TB:)SZ&R1OO1F-KO /,C.6-J+!H99UJZ8#$CT,W K M$]P9V(VD, Y$7."P*&T;LPS&_&K\+G MX3R,!CXK;WQTP*01=.*9 ,X(3P+HK#%M>;T%RI-G>0L2-_2QUK ^3C', M+J9?K\FBUC867YW)&S#GF!K M1.]Q3G3 _&.8CJLC\B*EB_.+46V$_9KHFX;S@8UDQQ:?:J\R)'?>:'C2@IP)," *K*@LD.;-G0C[G8N' ;QR0M- MGRQIV')L#?=OP_%DNBXZQ-E\0"K-%R4T%*P6#3)7NY]ER,@L:B8+E[N:F3Q$ M1&YC>/(RT(FH#;N-76WOMC=,@CBZJ-4J[VI=,9%V/I\.X\6\1J0_3GZ9C&NF M!E&0GOCIM=_ R!(%)W,9)<$AOXD\J.0$F!PHRQ]_K_\&9^\O-[G^S6P1Z!MD&[2* M)H%VG$YUEP1$KS7$:'7A])L[+8DV9B#T#O3)"N7C8V/+'G1K8NWE)L3,-+>$ M2IMB03&B8

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�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�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end

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